[{"doc_id": 1174877, "edit_id": 0, "question": "What type of group was studied in this research?", "category": "omission", "label": "concept"}, {"doc_id": 1174877, "edit_id": 1, "question": "How were patients assigned to different treatment groups?", "category": "omission", "label": "procedural"}, {"doc_id": 1174877, "edit_id": 2, "question": "How often were the medications, Telmisartan and Losartan, given to the patients?", "category": "omission", "label": "extent"}, {"doc_id": 1174877, "edit_id": 3, "question": "What was the daily dosage of Telmisartan given to the patients?", "category": "omission", "label": "extent"}, {"doc_id": 1174877, "edit_id": 4, "question": "What was the daily dosage of Losartan given to the patients?", "category": "omission", "label": "extent"}, {"doc_id": 1174877, "edit_id": 5, "question": "How many patients were given Telmisartan in this study?", "category": "omission", "label": "extent"}, {"doc_id": 1174877, "edit_id": 6, "question": "How many patients were given Losartan in this study?", "category": "omission", "label": "extent"}, {"doc_id": 1174877, "edit_id": 7, "question": "How did Telmisartan affect insulin levels in the blood?", "category": "omission", "label": "consequence"}, {"doc_id": 1174877, "edit_id": 8, "question": "How certain are the scientists about the significant effects of Telmisartan?", "category": "omission", "label": "extent"}, {"doc_id": 1174877, "edit_id": 9, "question": "How did Telmisartan affect the systolic blood pressure of the patients in this study?", "category": "omission", "label": "consequence"}, {"doc_id": 1174877, "edit_id": 10, "question": "How did Telmisartan affect the diastolic blood pressure of the patients in this study?", "category": "omission", "label": "consequence"}, {"doc_id": 1174877, "edit_id": 11, "question": "How certain are the scientists about the significant reduction in diastolic blood pressure by Telmisartan?", "category": "omission", "label": "extent"}, {"doc_id": 1291385, "edit_id": 0, "question": "What besides pain and swelling was compared between the two treatment groups?", "category": "omission", "label": "concept"}, {"doc_id": 1291385, "edit_id": 1, "question": "What type of study design was used for the research?", "category": "omission", "label": "concept"}, {"doc_id": 1291385, "edit_id": 2, "question": "What dose of dexamethasone was given to the group receiving the combination treatment as a preventative measure?", "category": "omission", "label": "extent"}, {"doc_id": 1291385, "edit_id": 3, "question": "What was the postoperative dose of dexamethasone given to the patients in the combination treatment group?", "category": "omission", "label": "extent"}, {"doc_id": 1291385, "edit_id": 4, "question": "How and when was diclofenac potassium given to the patients in this study?", "category": "omission", "label": "procedural"}, {"doc_id": 1291385, "edit_id": 5, "question": "How was facial swelling measured in the patients postoperatively?", "category": "omission", "label": "procedural"}, {"doc_id": 1291385, "edit_id": 6, "question": "How was the ability of the patients' mouths to open measured in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 1618957, "edit_id": 0, "question": "What are depot somatostatin analogues used for in relation to acromegaly?", "category": "omission", "label": "concept"}, {"doc_id": 1618957, "edit_id": 1, "question": "Could depot somatostatin analogues be the main treatment, or primary therapy, for acromegaly?", "category": "omission", "label": "verification"}, {"doc_id": 1618957, "edit_id": 2, "question": "How well accepted are depot somatostatin analogues for the treatment of acromegaly?", "category": "omission", "label": "extent"}, {"doc_id": 1618957, "edit_id": 3, "question": "For how long had the patients used their previous treatment before the study started?", "category": "omission", "label": "extent"}, {"doc_id": 1618957, "edit_id": 4, "question": "What kind of trial was this study?", "category": "omission", "label": "concept"}, {"doc_id": 1618957, "edit_id": 5, "question": "How was the depot somatostatin analogue lanreotide delivered in this study?", "category": "omission", "label": "procedural"}, {"doc_id": 1618957, "edit_id": 6, "question": "How often were patients receiving the lanreotide microparticles before the study?", "category": "omission", "label": "extent"}, {"doc_id": 1618957, "edit_id": 7, "question": "Did the same patients switch from using lanreotide microparticles to using lanreotide Autogel\u00ae 120 mg?", "category": "omission", "label": "verification"}, {"doc_id": 1618957, "edit_id": 8, "question": "When was the level of growth hormone (GH) measured after the final injections?", "category": "omission", "label": "extent"}, {"doc_id": 1618957, "edit_id": 9, "question": "When was the level of insulin-like growth factor-1 (IGF-1) measured after the final injections?", "category": "omission", "label": "extent"}, {"doc_id": 1618957, "edit_id": 10, "question": "What was the upper limit of the 95% confidence interval in comparing the effectiveness of the two drug formulations?", "category": "omission", "label": "extent"}, {"doc_id": 1618957, "edit_id": 11, "question": "What was the average level of growth hormone found in patients treated with lanreotide Autogel\u00ae?", "category": "omission", "label": "extent"}, {"doc_id": 1618957, "edit_id": 12, "question": "What was the standard error for the growth hormone level measurements in patients treated with lanreotide Autogel\u00ae?", "category": "omission", "label": "extent"}, {"doc_id": 1618957, "edit_id": 13, "question": "What was the average level of growth hormone found in patients treated with lanreotide microparticles?", "category": "omission", "label": "extent"}, {"doc_id": 1618957, "edit_id": 14, "question": "What was the standard error for the growth hormone level measurements in patients treated with lanreotide microparticles?", "category": "omission", "label": "extent"}, {"doc_id": 1618957, "edit_id": 15, "question": "Was there a significant difference in the growth hormone levels between lanreotide Autogel\u00ae and lanreotide microparticles treatments?", "category": "omission", "label": "comparison"}, {"doc_id": 1618957, "edit_id": 16, "question": "What percentage of patients had growth hormone levels less than 2.5 ng/ml?", "category": "omission", "label": "extent"}, {"doc_id": 1618957, "edit_id": 17, "question": "Is it a mistake that both 54% and 46% of patients had growth hormone levels less than 2.5 ng/ml?", "category": "omission", "label": "verification"}, {"doc_id": 1618957, "edit_id": 18, "question": "What percentage of patients on lanreotide Autogel\u00ae had both growth hormone (GH) levels less than 2.5 ng/ml and normalized insulin-like growth factor-1 (IGF-1) levels?", "category": "omission", "label": "extent"}, {"doc_id": 1618957, "edit_id": 19, "question": "What percentage of patients on lanreotide microparticles had both lower than 2.5 ng/ml growth hormone levels and normalized insulin-like growth factor-1 levels?", "category": "omission", "label": "extent"}, {"doc_id": 1618957, "edit_id": 20, "question": "How often are lanreotide microparticles usually administered to patients?", "category": "omission", "label": "extent"}, {"doc_id": 165418, "edit_id": 0, "question": "Do a lot of people with type 2 diabetes also struggle with depression?", "category": "omission", "label": "extent"}, {"doc_id": 165418, "edit_id": 1, "question": "What was the daily dose of paroxetine that the group was given in the study?", "category": "omission", "label": "extent"}, {"doc_id": 165418, "edit_id": 2, "question": "What were the main measures used to see if the treatment was effective?", "category": "omission", "label": "procedural"}, {"doc_id": 165418, "edit_id": 3, "question": "Aside from glycemic control, what else was used as a main measure to determine the efficacy of the treatment?", "category": "omission", "label": "procedural"}, {"doc_id": 165418, "edit_id": 4, "question": "What kind of test was used to measure the participant's glycemic control?", "category": "omission", "label": "procedural"}, {"doc_id": 165418, "edit_id": 5, "question": "How did the researchers measure the participants' quality of life in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 165418, "edit_id": 6, "question": "Were any scoring instruments used by clinicians in the study?", "category": "omission", "label": "verification"}, {"doc_id": 165418, "edit_id": 7, "question": "What was one of the scoring instruments that the clinicians used?", "category": "omission", "label": "example"}, {"doc_id": 165418, "edit_id": 8, "question": "What was the second scoring instrument that the clinicians used?", "category": "omission", "label": "example"}, {"doc_id": 165418, "edit_id": 9, "question": "Did the patients in the study also use any scoring instruments to rate their own symptoms?", "category": "omission", "label": "verification"}, {"doc_id": 165418, "edit_id": 10, "question": "What was the scoring instrument that the patients used?", "category": "omission", "label": "example"}, {"doc_id": 165418, "edit_id": 11, "question": "How significant were the results showing that the paroxetine group had slightly better blood sugar control?", "category": "omission", "label": "extent"}, {"doc_id": 165418, "edit_id": 12, "question": "Were there any changes observed in sex-hormone-binding-globuline (SHBG) levels in the study?", "category": "omission", "label": "verification"}, {"doc_id": 165418, "edit_id": 13, "question": "Did the group taking paroxetine or the placebo have a greater increase in SHBG levels?", "category": "omission", "label": "comparison"}, {"doc_id": 165418, "edit_id": 14, "question": "How statistically significant was the increased level of SHBG in the group taking paroxetine?", "category": "omission", "label": "extent"}, {"doc_id": 165418, "edit_id": 15, "question": "What does an increase in SHBG levels mean in relation to insulin sensitivity?", "category": "omission", "label": "concept"}, {"doc_id": 165418, "edit_id": 16, "question": "Was paroxetine or the placebo found to be more effective in the study?", "category": "omission", "label": "comparison"}, {"doc_id": 165418, "edit_id": 17, "question": "Did any of the trends observed in the study support the idea that paroxetine has a beneficial impact on depression and diabetes?", "category": "omission", "label": "verification"}, {"doc_id": 165418, "edit_id": 18, "question": "What other trend was observed in relation to the paroxetine group?", "category": "omission", "label": "concept"}, {"doc_id": 165418, "edit_id": 19, "question": "Which group had a greater decrease in their serum cortisol levels, the paroxetine or the placebo group?", "category": "omission", "label": "comparison"}, {"doc_id": 165418, "edit_id": 20, "question": "How significant were the results showing a decrease in cortisol levels in the paroxetine group?", "category": "omission", "label": "extent"}, {"doc_id": 165418, "edit_id": 21, "question": "What are the standard health guidelines that dictate when patients should start taking antidepressants?", "category": "omission", "label": "concept"}, {"doc_id": 1774569, "edit_id": 0, "question": "What type of drugs are the people in this study trying to stop using?", "category": "omission", "label": "concept"}, {"doc_id": 1774569, "edit_id": 1, "question": "Where do these drug users go to ask for help with stopping their drug use?", "category": "omission", "label": "example"}, {"doc_id": 1774569, "edit_id": 2, "question": "Is there a specific drug that doctors recommend most for helping people stop using illegal drugs? ", "category": "omission", "label": "disjunction"}, {"doc_id": 1774569, "edit_id": 3, "question": "In what type of healthcare setting is this study conducted? ", "category": "omission", "label": "concept"}, {"doc_id": 1774569, "edit_id": 4, "question": "Do the people in the study know what drug they are getting? ", "category": "omission", "label": "verification"}, {"doc_id": 1774569, "edit_id": 5, "question": "What is the health system in which the study is being conducted? ", "category": "omission", "label": "concept"}, {"doc_id": 1774569, "edit_id": 6, "question": "Where did this trial take place? ", "category": "omission", "label": "concept"}, {"doc_id": 1774569, "edit_id": 7, "question": "Did everybody taking part in the study agree to take part willingly? ", "category": "omission", "label": "verification"}, {"doc_id": 1774569, "edit_id": 8, "question": "Which two drugs were given to people in this study? ", "category": "omission", "label": "concept"}, {"doc_id": 1774569, "edit_id": 9, "question": "How often were the people in the study given the medicine? ", "category": "omission", "label": "extent"}, {"doc_id": 1774569, "edit_id": 10, "question": "How was the buprenorphine administered to the patients in this study?", "category": "omission", "label": "procedural"}, {"doc_id": 1774569, "edit_id": 11, "question": "How was the dihydrocodeine given to patients in this study?", "category": "omission", "label": "procedural"}, {"doc_id": 1774569, "edit_id": 12, "question": "When was a urine sample collected from the people in this study? ", "category": "omission", "label": "procedural"}, {"doc_id": 1774569, "edit_id": 13, "question": "By how much did the risk decrease for those given buprenorphine compared to those given dihydrocodeine? ", "category": "omission", "label": "comparison"}, {"doc_id": 1774569, "edit_id": 14, "question": "What was the relative risk, or how the risk compared between the two groups, in this study? ", "category": "omission", "label": "comparison"}, {"doc_id": 1774569, "edit_id": 15, "question": "What range of results would we expect to see if this study was repeated many times? ", "category": "omission", "label": "extent"}, {"doc_id": 1774569, "edit_id": 16, "question": "What was the statistical significance of the results?", "category": "omission", "label": "concept"}, {"doc_id": 1774569, "edit_id": 17, "question": "What percent of the people who were given buprenorphine stopped using illegal drugs, according to the urine tests? ", "category": "omission", "label": "extent"}, {"doc_id": 1774569, "edit_id": 18, "question": "What percent of the people who were given dihydrocodeine stopped using drugs, according to the urine tests?", "category": "omission", "label": "extent"}, {"doc_id": 1774569, "edit_id": 19, "question": "How did the chance of having a clean urine sample compare between those on buprenorphine and those on dihydrocodeine?", "category": "omission", "label": "comparison"}, {"doc_id": 1774569, "edit_id": 20, "question": "What is the range of relative risks we could expect if this study was repeated?", "category": "omission", "label": "extent"}, {"doc_id": 1774569, "edit_id": 21, "question": "What was the statistical significance of the comparison between those on buprenorphine and those on dihydrocodeine?", "category": "omission", "label": "comparison"}, {"doc_id": 1774569, "edit_id": 22, "question": "How many people stopped using drugs for three months after the study finished?", "category": "omission", "label": "extent"}, {"doc_id": 1774569, "edit_id": 23, "question": "How much more likely were those on buprenorphine to be abstinent at three months compared to those on dihydrocodeine? ", "category": "omission", "label": "comparison"}, {"doc_id": 1774569, "edit_id": 24, "question": "What range of relative risks for abstinence at three months could we expect if this study was repeated? ", "category": "omission", "label": "extent"}, {"doc_id": 1774569, "edit_id": 25, "question": "How many people continued to not use drugs for six months after the study? ", "category": "omission", "label": "extent"}, {"doc_id": 1774569, "edit_id": 26, "question": "How much more likely were those on buprenorphine to be abstinent at six months compared to those on dihydrocodeine? ", "category": "omission", "label": "comparison"}, {"doc_id": 1774569, "edit_id": 27, "question": "What types of treatment regimens does this study examine? ", "category": "omission", "label": "concept"}, {"doc_id": 1868720, "edit_id": 0, "question": "What kind of experiment was conducted after the workers were chosen for the program?", "category": "omission", "label": "procedural"}, {"doc_id": 1868720, "edit_id": 1, "question": "How many workers were in the 'at risk' group as per the study's classification?", "category": "omission", "label": "extent"}, {"doc_id": 1868720, "edit_id": 2, "question": "How many workers were in the 'not at risk' group according to the study's classification?", "category": "omission", "label": "extent"}, {"doc_id": 1868720, "edit_id": 3, "question": "What was the range of uncertainty regarding the sick leave rates between the 'at risk' and 'not at risk' groups i.e., the confidence interval of the odds ratio?", "category": "omission", "label": "extent"}, {"doc_id": 1868720, "edit_id": 4, "question": "Were the workers, who were finally included in the test, suitable to be part of the experiment?", "category": "omission", "label": "verification"}, {"doc_id": 1868720, "edit_id": 5, "question": "What aspect of the program was the study referring to when it mentioned that it was effective?", "category": "omission", "label": "concept"}, {"doc_id": 1915612, "edit_id": 0, "question": "What severity of whiplash injury were the patients in this study suffering from?", "category": "omission", "label": "concept"}, {"doc_id": 1915612, "edit_id": 1, "question": "How much did the neck pain intensity decrease on the VAS scale in this study?", "category": "omission", "label": "extent"}, {"doc_id": 1915612, "edit_id": 2, "question": "What was the percentage change in the average number of days patients experienced neck pain?", "category": "omission", "label": "extent"}, {"doc_id": 1915612, "edit_id": 3, "question": "By how much did the number of hours per day patients suffer from neck pain change?", "category": "omission", "label": "extent"}, {"doc_id": 2253708, "edit_id": 0, "question": "How many doctor's offices were selected for participation in the study?", "category": "omission", "label": "extent"}, {"doc_id": 2253708, "edit_id": 1, "question": "How many patients participated in the study?", "category": "omission", "label": "extent"}, {"doc_id": 2253708, "edit_id": 2, "question": "What was the age range of the participants in the study?", "category": "omission", "label": "concept"}, {"doc_id": 2253708, "edit_id": 3, "question": "What was the common characteristic of all the participants in terms of smoking?", "category": "omission", "label": "concept"}, {"doc_id": 2253708, "edit_id": 4, "question": "What was the name of the group that received personalized letters as part of their intervention for smoking cessation?", "category": "omission", "label": "concept"}, {"doc_id": 2253708, "edit_id": 5, "question": "What type of letters did the \"tailored letters intervention group\" receive?", "category": "omission", "label": "concept"}, {"doc_id": 2253708, "edit_id": 6, "question": "How was the content of the letters received by the \"tailored letters intervention group\" characterized?", "category": "omission", "label": "concept"}, {"doc_id": 2253708, "edit_id": 7, "question": "When was the advice for smoking cessation delivered to the patients who received it?", "category": "omission", "label": "procedural"}, {"doc_id": 2253708, "edit_id": 8, "question": "What kind of preparation did the practitioners undergo before providing the smoking cessation advice?", "category": "omission", "label": "procedural"}, {"doc_id": 2253708, "edit_id": 9, "question": "When did the practitioners deliver the advice relative to their training session?", "category": "omission", "label": "procedural"}, {"doc_id": 2253708, "edit_id": 10, "question": "What theoretical model was used as the basis for the interventions?", "category": "omission", "label": "concept"}, {"doc_id": 2253708, "edit_id": 11, "question": "What does the Transtheoretical Model pertain to?", "category": "omission", "label": "concept"}, {"doc_id": 2253708, "edit_id": 12, "question": "How did the study measure smoking abstinence?", "category": "omission", "label": "procedural"}, {"doc_id": 2427034, "edit_id": 0, "question": "What exactly is the A2143G mutation that the study investigated?", "category": "omission", "label": "concept"}, {"doc_id": 2427034, "edit_id": 1, "question": "How many people were given a placebo in this study in 1995?", "category": "omission", "label": "extent"}, {"doc_id": 2427034, "edit_id": 2, "question": "Were the participants on an empty or full stomach when the gastric juice was collected?", "category": "omission", "label": "verification"}, {"doc_id": 2427034, "edit_id": 3, "question": "When was the DNA extracted from the gastric juice?", "category": "omission", "label": "procedural"}, {"doc_id": 2427034, "edit_id": 4, "question": "What method(s) did the researchers use to determine if a participant was infected with H. pylori?", "category": "omission", "label": "procedural"}, {"doc_id": 2427034, "edit_id": 5, "question": "What additional method was used to determine whether a participant was infected with H. pylori?", "category": "omission", "label": "procedural"}, {"doc_id": 2427034, "edit_id": 6, "question": "What other methods were used to determine if a person was infected with H. pylori in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 2427034, "edit_id": 7, "question": "On which gene did the A2143G mutations occur?", "category": "omission", "label": "concept"}, {"doc_id": 2427034, "edit_id": 8, "question": "Which method was used to detect mutations in the genes?", "category": "omission", "label": "procedural"}, {"doc_id": 2427034, "edit_id": 9, "question": "What was the percentage of people who had the 23S rRNA gene in their system in the OA group?", "category": "omission", "label": "extent"}, {"doc_id": 2427034, "edit_id": 10, "question": "How many people were there in the OA group of the study?", "category": "omission", "label": "extent"}, {"doc_id": 2427034, "edit_id": 11, "question": "How many people from the OA group tested positive for the 23S rRNA gene?", "category": "omission", "label": "extent"}, {"doc_id": 2427034, "edit_id": 12, "question": "What was the statistical significance (p-value) in these findings?", "category": "omission", "label": "extent"}, {"doc_id": 2427034, "edit_id": 13, "question": "Which group had a higher mutation rate in the study?", "category": "omission", "label": "comparison"}, {"doc_id": 2427034, "edit_id": 14, "question": "What was measured related to the 23S rRNA gene in the study?", "category": "omission", "label": "concept"}, {"doc_id": 2427034, "edit_id": 15, "question": "What percentage of people still had the 23S rRNA gene three years after triple therapy?", "category": "omission", "label": "extent"}, {"doc_id": 2427034, "edit_id": 16, "question": "What percentage of people in the OAC group who tested positive for the 23S rRNA gene also had the A2143G mutation?", "category": "omission", "label": "extent"}, {"doc_id": 2427034, "edit_id": 17, "question": "How many individuals in the OAC group had the A2143G mutation?", "category": "omission", "label": "extent"}, {"doc_id": 2427034, "edit_id": 18, "question": "What percentage of 23S rRNA-positive subjects in the OA group had the A2143G mutation?", "category": "omission", "label": "extent"}, {"doc_id": 2427034, "edit_id": 19, "question": "How many individuals in the OA group had the A2143G mutation?", "category": "omission", "label": "extent"}, {"doc_id": 2427034, "edit_id": 20, "question": "What percentage of the 23S rRNA-positive subjects in the placebo group had the A2143G mutation?", "category": "omission", "label": "extent"}, {"doc_id": 2427034, "edit_id": 21, "question": "How many individuals in the placebo group tested positive for the 23S rRNA gene?", "category": "omission", "label": "extent"}, {"doc_id": 2427034, "edit_id": 22, "question": "How many individuals in the placebo group had the A2143G mutation?", "category": "omission", "label": "extent"}, {"doc_id": 2427034, "edit_id": 23, "question": "What is the basic prevalence of the A2143G mutation among the tested subjects?", "category": "omission", "label": "extent"}, {"doc_id": 2427034, "edit_id": 24, "question": "In which population was this prevalence rate of A2143G mutation studied?", "category": "omission", "label": "example"}, {"doc_id": 2430614, "edit_id": 0, "question": "Is Artesunate+amodiaquine (AS+AQ) a suggested initial treatment for uncomplicated malaria in Africa?", "category": "omission", "label": "verification"}, {"doc_id": 2430614, "edit_id": 1, "question": "Is Artemether-lumefantrine (AL) also recommended for the initial treatment of uncomplicated malaria in Africa?", "category": "omission", "label": "verification"}, {"doc_id": 2430614, "edit_id": 2, "question": "What are the most commonly suggested treatments for uncomplicated malaria in Africa?", "category": "omission", "label": "example"}, {"doc_id": 2430614, "edit_id": 3, "question": "Apart from AS+AQ and AL, is there another potential treatment for uncomplicated malaria?", "category": "omission", "label": "verification"}, {"doc_id": 2430614, "edit_id": 4, "question": "How are the drug treatment policies for uncomplicated malaria developed?", "category": "omission", "label": "procedural"}, {"doc_id": 2430614, "edit_id": 5, "question": "What is the health condition of the children involved in the study?", "category": "omission", "label": "concept"}, {"doc_id": 2430614, "edit_id": 6, "question": "How were the children divided into groups for the study?", "category": "omission", "label": "procedural"}, {"doc_id": 2430614, "edit_id": 7, "question": "Where were the children followed up after they received the medication?", "category": "omission", "label": "procedural"}, {"doc_id": 2430614, "edit_id": 8, "question": "On which days was follow-up done on the children after they received the medication?", "category": "omission", "label": "procedural"}, {"doc_id": 2430614, "edit_id": 9, "question": "What type of analysis was conducted for the study?", "category": "omission", "label": "concept"}, {"doc_id": 2430614, "edit_id": 10, "question": "What exactly was measured during the analysis in the study?", "category": "omission", "label": "concept"}, {"doc_id": 2430614, "edit_id": 11, "question": "What was the corrected PCF28 for re-infections in the group that received Artesunate+amodiaquine (AS+AQ)?", "category": "omission", "label": "extent"}, {"doc_id": 2430614, "edit_id": 12, "question": "How about the AL group, what was their corrected PCF28 for re-infections?", "category": "omission", "label": "extent"}, {"doc_id": 2430614, "edit_id": 13, "question": "What was the corrected PCF28 for re-infections for the group that received the alternative treatment of AS+CD?", "category": "omission", "label": "extent"}, {"doc_id": 2430614, "edit_id": 14, "question": "What was the statistical significance (p-value) of the comparison of corrected PCF28 between the three groups?", "category": "omission", "label": "extent"}, {"doc_id": 2430614, "edit_id": 15, "question": "What was the uncorrected PCF28, or treatment failure rate excluding re-infections, for the group that received AS+AQ?", "category": "omission", "label": "extent"}, {"doc_id": 2430614, "edit_id": 16, "question": "What was the uncorrected PCF28 for the group that received AL?", "category": "omission", "label": "extent"}, {"doc_id": 2430614, "edit_id": 17, "question": "How was the early treatment failure rate in all the groups?", "category": "omission", "label": "extent"}, {"doc_id": 2430614, "edit_id": 18, "question": "What was the specific rate of early treatment failure for the group treated with AS+AQ?", "category": "omission", "label": "extent"}, {"doc_id": 2430614, "edit_id": 19, "question": "How about the AL group, what was their rate for early treatment failure?", "category": "omission", "label": "extent"}, {"doc_id": 2430614, "edit_id": 20, "question": "What was the rate of early treatment failure for the group treated with AS+CD?", "category": "omission", "label": "extent"}, {"doc_id": 2430614, "edit_id": 21, "question": "What was the main reason for the high rate of early treatment failure among the participants?", "category": "omission", "label": "cause"}, {"doc_id": 2430614, "edit_id": 22, "question": "What was the p-value of the analysis for early treatment failure across the three groups?", "category": "omission", "label": "extent"}, {"doc_id": 2430614, "edit_id": 23, "question": "In which group was the PCF28 corrected for re-infection lower?", "category": "omission", "label": "disjunction"}, {"doc_id": 2430614, "edit_id": 24, "question": "What was the PCF28 rate corrected for re-infection in the AL group?", "category": "omission", "label": "extent"}, {"doc_id": 2430614, "edit_id": 25, "question": "How about the PCF28 corrected for re-infection in the AS+CD group?", "category": "omission", "label": "extent"}, {"doc_id": 2430614, "edit_id": 26, "question": "What was the p-value for the comparison of PCF28 corrected for re-infection between the groups?", "category": "omission", "label": "extent"}, {"doc_id": 2430614, "edit_id": 27, "question": "Which treatment is considered as the first line treatment for uncomplicated malaria?", "category": "omission", "label": "concept"}, {"doc_id": 2500257, "edit_id": 0, "question": "What kind of probes does the test, fluorescence in situ hybridization, use to differentiate between bacteria?", "category": "omission", "label": "concept"}, {"doc_id": 2500257, "edit_id": 1, "question": "What kind of bacteria is the PNA-FISH test trying to differentiate Staphylococcus aureus from?", "category": "omission", "label": "concept"}, {"doc_id": 2500257, "edit_id": 2, "question": "How is the Staphylococcus aureus bacteria different from the other bacteria tested by PNA-FISH?", "category": "omission", "label": "comparison"}, {"doc_id": 2500257, "edit_id": 3, "question": "How do we know the difference in survival rates between the two groups of patients was not just due to chance?", "category": "omission", "label": "verification"}, {"doc_id": 2500257, "edit_id": 4, "question": "By how much were the patients able to reduce their use of antibiotics?", "category": "omission", "label": "extent"}, {"doc_id": 2500257, "edit_id": 5, "question": "How can we be sure that the reduction in antibiotic use was not just a random event?", "category": "omission", "label": "verification"}, {"doc_id": 2556743, "edit_id": 0, "question": "Have other studies been done about blood flow during risky surgeries?", "category": "omission", "label": "verification"}, {"doc_id": 2556743, "edit_id": 1, "question": "What kind of surgeries were the patients undergoing in the study?", "category": "omission", "label": "concept"}, {"doc_id": 2556743, "edit_id": 2, "question": "Is the goal of maintaining a healthy blood flow during major surgeries achievable?", "category": "omission", "label": "verification"}, {"doc_id": 2556743, "edit_id": 3, "question": "In the study, what specific type of blood pressure variation was minimized?", "category": "omission", "label": "concept"}, {"doc_id": 2556743, "edit_id": 4, "question": "What was the nature of the study conducted - was it looking forward into the future or analyzing past data?", "category": "omission", "label": "concept"}, {"doc_id": 2556743, "edit_id": 5, "question": "Did the study randomly assign patients to the treatment and control groups?", "category": "omission", "label": "verification"}, {"doc_id": 2556743, "edit_id": 6, "question": "Was the study conducted at multiple locations?", "category": "omission", "label": "verification"}, {"doc_id": 2556743, "edit_id": 7, "question": "What was the main outcome that the researchers were examining in the study?", "category": "omission", "label": "concept"}, {"doc_id": 2556743, "edit_id": 8, "question": "What was the second group of patients subject to in the study?", "category": "omission", "label": "concept"}, {"doc_id": 2556743, "edit_id": 9, "question": "How were the blood pressure changes of the patients monitored during surgery in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 2556743, "edit_id": 10, "question": "To what extent was the arterial pulse pressure (\u0394PP) minimized in the intervention group during the study?", "category": "omission", "label": "extent"}, {"doc_id": 2556743, "edit_id": 11, "question": "How was the arterial pulse pressure (\u0394PP) minimized in the intervention group?", "category": "omission", "label": "procedural"}, {"doc_id": 2556743, "edit_id": 12, "question": "Were the two groups of patients similar in their overall health condition as determined by the American Society of Anesthesiology score?", "category": "omission", "label": "comparison"}, {"doc_id": 2556743, "edit_id": 13, "question": "How much fluid was given to the intervention group during surgery?", "category": "omission", "label": "extent"}, {"doc_id": 2556743, "edit_id": 14, "question": "How much fluid was given to the control group during surgery?", "category": "omission", "label": "extent"}, {"doc_id": 2556743, "edit_id": 15, "question": "To what kind of surgeries does the statement mainly refer?", "category": "omission", "label": "concept"}, {"doc_id": 2639329, "edit_id": 0, "question": "How were the patients divided into the two groups?", "category": "omission", "label": "procedural"}, {"doc_id": 2639329, "edit_id": 1, "question": "How soon did patients in the active group leave the hospital after having their pacemaker replaced?", "category": "omission", "label": "extent"}, {"doc_id": 2639329, "edit_id": 2, "question": "What is the technical term used in the study for major negative events related to treatment?", "category": "omission", "label": "concept"}, {"doc_id": 2639329, "edit_id": 3, "question": "What percentage of patients in the active group experienced one or more major negative events related to their treatment?", "category": "omission", "label": "extent"}, {"doc_id": 2639329, "edit_id": 4, "question": "How many patients were there in the control group?", "category": "omission", "label": "extent"}, {"doc_id": 2639329, "edit_id": 5, "question": "What proportion of patients in the control group experienced a major adverse event?", "category": "omission", "label": "extent"}, {"doc_id": 2639329, "edit_id": 6, "question": "What was the P-value for the comparison of adverse events between the control group and the active group?", "category": "omission", "label": "verification"}, {"doc_id": 2639329, "edit_id": 7, "question": "What was the P-value indicating the significance of the risk reduction?", "category": "omission", "label": "verification"}, {"doc_id": 2639329, "edit_id": 8, "question": "Was the difference in hospital stay length between patients who left early and those who stayed longer statistically significant?", "category": "omission", "label": "verification"}, {"doc_id": 2652457, "edit_id": 0, "question": "Who is the target audience of the autism awareness promotion?", "category": "omission", "label": "concept"}, {"doc_id": 2652457, "edit_id": 1, "question": "What resource was developed in the study to teach about autism?", "category": "omission", "label": "procedural"}, {"doc_id": 2652457, "edit_id": 2, "question": "What kind of educational tool was developed for teaching about autism in this study?", "category": "omission", "label": "concept"}, {"doc_id": 2652457, "edit_id": 3, "question": "What is Xerte?", "category": "omission", "label": "concept"}, {"doc_id": 2652457, "edit_id": 4, "question": "What is Flash Macromedia?", "category": "omission", "label": "concept"}, {"doc_id": 2652457, "edit_id": 5, "question": "Which software was used to create the Computer Assisted Learning (CAL) package on autism?", "category": "omission", "label": "procedural"}, {"doc_id": 2652457, "edit_id": 6, "question": "Besides Xerte, was there another software used to create the CAL package?", "category": "omission", "label": "verification"}, {"doc_id": 2652457, "edit_id": 7, "question": "Did the information leaflet have the same content as the Computer Assisted Learning (CAL) package?", "category": "omission", "label": "verification"}, {"doc_id": 2652457, "edit_id": 8, "question": "What statistical method was used to analyse the data obtained from the two groups?", "category": "omission", "label": "procedural"}, {"doc_id": 2652457, "edit_id": 9, "question": "What level of confidence was used in the statistical analysis of the data from the study?", "category": "omission", "label": "extent"}, {"doc_id": 2652457, "edit_id": 10, "question": "How did the students who learned about autism through the Computer Assisted Learning (CAL) package perform in terms of retaining the information compared to those who read the leaflet?", "category": "omission", "label": "comparison"}, {"doc_id": 2652457, "edit_id": 11, "question": "What was the p-value for the difference in retention of information between the Computer Assisted Learning (CAL) package and the information leaflet groups? ", "category": "omission", "label": "verification"}, {"doc_id": 2652457, "edit_id": 12, "question": "What was the p-value for the difference in the level of enjoyment between the CAL package and the information leaflet groups?", "category": "omission", "label": "verification"}, {"doc_id": 2652457, "edit_id": 13, "question": "What was the p-value for the difference in the level of confidence to identify a child with autism between the CAL package and the information leaflet groups?", "category": "omission", "label": "verification"}, {"doc_id": 2652457, "edit_id": 14, "question": "What topic does the Computer Assisted Learning (CAL) package focus on?", "category": "omission", "label": "concept"}, {"doc_id": 2699080, "edit_id": 0, "question": "What conditions can Ureteropelvic junction obstruction (UPJO) cause?", "category": "omission", "label": "example"}, {"doc_id": 2699080, "edit_id": 1, "question": "What are the potential long-term effects of Ureteropelvic junction obstruction (UPJO) if left untreated?", "category": "omission", "label": "consequence"}, {"doc_id": 2699080, "edit_id": 2, "question": "What kind of research design was used in the comparison study of laparoscopic versus open pyeloplasty for treating UPJO?", "category": "omission", "label": "procedural"}, {"doc_id": 2699080, "edit_id": 3, "question": "Over what time period was the study conducted?", "category": "omission", "label": "extent"}, {"doc_id": 2699080, "edit_id": 4, "question": "What type of procedure was used during the open pyeloplasty surgeries?", "category": "omission", "label": "procedural"}, {"doc_id": 2699080, "edit_id": 5, "question": "What diagnostic method was used to follow up with patients after the surgeries?", "category": "omission", "label": "procedural"}, {"doc_id": 2699080, "edit_id": 6, "question": "When was the DTPA scan performed after the patients' surgeries?", "category": "omission", "label": "extent"}, {"doc_id": 2699080, "edit_id": 7, "question": "Besides the DTPA scan, what other follow-up method was used for the patients?", "category": "omission", "label": "procedural"}, {"doc_id": 2699080, "edit_id": 8, "question": "When was the Intravenous Pyelogram (IVP) performed after the patients' surgeries?", "category": "omission", "label": "extent"}, {"doc_id": 2699080, "edit_id": 9, "question": "How long, on average, did the laparoscopic surgeries with stent placement take?", "category": "omission", "label": "extent"}, {"doc_id": 2699080, "edit_id": 10, "question": "What was the shortest time for a laparoscopic surgery with stent placement in this study?", "category": "omission", "label": "extent"}, {"doc_id": 2699080, "edit_id": 11, "question": "What was the longest time for a laparoscopic surgery with stent placement in this study?", "category": "omission", "label": "extent"}, {"doc_id": 2699080, "edit_id": 12, "question": "How long, on average, did the open surgeries with stent placement take?", "category": "omission", "label": "extent"}, {"doc_id": 2699080, "edit_id": 13, "question": "What was the longest time for an open surgery with stent placement in this study?", "category": "omission", "label": "extent"}, {"doc_id": 2699080, "edit_id": 14, "question": "Did the laparoscopic surgery group require more or less pain medication than the open surgery group following the procedure?", "category": "omission", "label": "comparison"}, {"doc_id": 2699080, "edit_id": 15, "question": "What was the average amount of diclofenac required by the patients who underwent laparoscopic surgery?", "category": "omission", "label": "extent"}, {"doc_id": 2699080, "edit_id": 16, "question": "What was the average amount of diclofenac required by the patients who underwent open surgery?", "category": "omission", "label": "extent"}, {"doc_id": 2699080, "edit_id": 17, "question": "On average, how long did patients stay in the hospital after undergoing laparoscopic surgery?", "category": "omission", "label": "extent"}, {"doc_id": 2699080, "edit_id": 18, "question": "What was the shortest hospital stay for patients who underwent laparoscopic surgery in this study?", "category": "omission", "label": "extent"}, {"doc_id": 2699080, "edit_id": 19, "question": "What was the longest hospital stay for patients who underwent laparoscopic surgery in this study?", "category": "omission", "label": "extent"}, {"doc_id": 2699080, "edit_id": 20, "question": "On average, how long did patients stay in the hospital after undergoing open surgery?", "category": "omission", "label": "extent"}, {"doc_id": 2699080, "edit_id": 21, "question": "What was the shortest hospital stay for patients who underwent open surgery in this study?", "category": "omission", "label": "extent"}, {"doc_id": 2699080, "edit_id": 22, "question": "What was the longest hospital stay for patients who underwent open surgery in this study?", "category": "omission", "label": "extent"}, {"doc_id": 2699080, "edit_id": 23, "question": "What were the associated risks or negative effects with laparoscopic surgery in this study?", "category": "omission", "label": "consequence"}, {"doc_id": 2699080, "edit_id": 24, "question": "Compared to laparoscopic surgery, how risky was the open surgery approach in this study?", "category": "omission", "label": "comparison"}, {"doc_id": 2699080, "edit_id": 25, "question": "What specific skills does laparoscopic pyeloplasty require?", "category": "omission", "label": "concept"}, {"doc_id": 2699080, "edit_id": 26, "question": "Based on the results of the study, what is the future outlook for laparoscopic pyeloplasty as a treatment for UPJO?", "category": "omission", "label": "consequence"}, {"doc_id": 2699714, "edit_id": 0, "question": "What type of treatment is being considered for the children newly diagnosed with type 1 diabetes in the study?", "category": "omission", "label": "concept"}, {"doc_id": 2699714, "edit_id": 1, "question": "What type of study was conducted to test the effects of etanercept therapy on children with Type 1 diabetes? ", "category": "omission", "label": "concept"}, {"doc_id": 2699714, "edit_id": 2, "question": "How many boys participated in the study? ", "category": "omission", "label": "extent"}, {"doc_id": 2699714, "edit_id": 3, "question": "How many girls participated in the study?", "category": "omission", "label": "extent"}, {"doc_id": 2699714, "edit_id": 4, "question": "What specific health markers did the study participants need to have? ", "category": "omission", "label": "concept"}, {"doc_id": 2699714, "edit_id": 5, "question": "How regularly were the study participants already receiving insulin injections?", "category": "omission", "label": "extent"}, {"doc_id": 2699714, "edit_id": 6, "question": "What criterion concerning white blood cell count was set for the participants? ", "category": "omission", "label": "concept"}, {"doc_id": 2699714, "edit_id": 7, "question": "What was the required platelet count to participate in the study?", "category": "omission", "label": "concept"}, {"doc_id": 2699714, "edit_id": 8, "question": "What were the conditions regarding liver health for the participants?", "category": "omission", "label": "concept"}, {"doc_id": 2699714, "edit_id": 9, "question": "What were the conditions regarding kidney health for the participants?", "category": "omission", "label": "concept"}, {"doc_id": 2699714, "edit_id": 10, "question": "What was the significance of the difference in A1C levels between the etanercept group and the placebo group at the end of the study?", "category": "omission", "label": "comparison"}, {"doc_id": 2699714, "edit_id": 11, "question": "What was the percentage decrease in baseline A1C levels for the placebo group?", "category": "omission", "label": "extent"}, {"doc_id": 2699714, "edit_id": 12, "question": "How significant were the results of the study?", "category": "omission", "label": "extent"}, {"doc_id": 2699714, "edit_id": 13, "question": "What change was observed in the placebo group in terms of C-peptide area under the curve from the beginning to the end of the study?", "category": "omission", "label": "consequence"}, {"doc_id": 2703617, "edit_id": 0, "question": "How widespread is the issue of overcrowding in emergency departments?", "category": "omission", "label": "extent"}, {"doc_id": 2703617, "edit_id": 1, "question": "What are the implications of overcrowding in emergency departments on public health?", "category": "omission", "label": "consequence"}, {"doc_id": 2703617, "edit_id": 2, "question": "Did the study also look into the effects of the Fast Track Area on mortality rates in non-urgent patients?", "category": "omission", "label": "verification"}, {"doc_id": 2703617, "edit_id": 3, "question": "Where is the hospital, where the study was conducted, located?", "category": "omission", "label": "concept"}, {"doc_id": 2703617, "edit_id": 4, "question": "What type of hospital is the study conducted in?", "category": "omission", "label": "concept"}, {"doc_id": 2703617, "edit_id": 5, "question": "How many individuals were in the control group before the introduction of the Fast Track Area?", "category": "omission", "label": "extent"}, {"doc_id": 2703617, "edit_id": 6, "question": "How many individuals were in the study group after the Fast Track Area was introduced?", "category": "omission", "label": "extent"}, {"doc_id": 2703617, "edit_id": 7, "question": "Did the introduction of a Fast Track Area improve the efficiency of the emergency department?", "category": "omission", "label": "verification"}, {"doc_id": 2703617, "edit_id": 8, "question": "Did the Fast Track Area have any effect on the length of stay for patients in the emergency department?", "category": "omission", "label": "verification"}, {"doc_id": 2703617, "edit_id": 9, "question": "Did the Fast Track Area have any notable impact on the quality of care given to patients?", "category": "omission", "label": "verification"}, {"doc_id": 2710065, "edit_id": 0, "question": "How was the study set up or carried out?", "category": "omission", "label": "procedural"}, {"doc_id": 2710065, "edit_id": 1, "question": "What type of procedure is a punch biopsy?", "category": "omission", "label": "concept"}, {"doc_id": 2710065, "edit_id": 2, "question": "What type of procedure is a transurethral resection of small bladder tumors?", "category": "omission", "label": "concept"}, {"doc_id": 2710065, "edit_id": 3, "question": "Was antibiotics (prophylaxis) used before carrying out a punch biopsy in this study?", "category": "omission", "label": "verification"}, {"doc_id": 2710065, "edit_id": 4, "question": "Were antibiotics used for prevention before the transurethral resection of small bladder tumors?", "category": "omission", "label": "verification"}, {"doc_id": 2710065, "edit_id": 5, "question": "What were the initial results of the patients' urine cultures?", "category": "omission", "label": "consequence"}, {"doc_id": 2710065, "edit_id": 6, "question": "What was the average age of the participants in the study?", "category": "omission", "label": "extent"}, {"doc_id": 2710065, "edit_id": 7, "question": "What was the age of the youngest participant in the study?", "category": "omission", "label": "extent"}, {"doc_id": 2710065, "edit_id": 8, "question": "What was the age of the oldest participant in the study?", "category": "omission", "label": "extent"}, {"doc_id": 2710065, "edit_id": 9, "question": "What kind of procedure did the participants undergo?", "category": "omission", "label": "concept"}, {"doc_id": 2710065, "edit_id": 10, "question": "What type of antibiotic treatment was given to the participants?", "category": "omission", "label": "concept"}, {"doc_id": 2710065, "edit_id": 11, "question": "Did all patients in the study have urine cultures?", "category": "omission", "label": "verification"}, {"doc_id": 2710065, "edit_id": 12, "question": "What additional interventions were included in the study?", "category": "omission", "label": "example"}, {"doc_id": 2710065, "edit_id": 13, "question": "What other procedures were performed aside from the bladder check-up?", "category": "omission", "label": "example"}, {"doc_id": 2710065, "edit_id": 14, "question": "Were the additional interventions planned as part of the study?", "category": "omission", "label": "verification"}, {"doc_id": 2710065, "edit_id": 15, "question": "Were the additional interventions conducted equally between the two groups?", "category": "omission", "label": "verification"}, {"doc_id": 2710065, "edit_id": 16, "question": "How many patients from the antibiotic group had positive urine cultures following the bladder check-up?", "category": "omission", "label": "extent"}, {"doc_id": 2710065, "edit_id": 17, "question": "How many patients from the group that didn't get antibiotics had bacteria in their urine after the bladder check-up?", "category": "omission", "label": "extent"}, {"doc_id": 2710065, "edit_id": 18, "question": "When were the urine cultures carried out in relation to the bladder check-up procedures?", "category": "omission", "label": "procedural"}, {"doc_id": 2710065, "edit_id": 19, "question": "Aside from bacteria in urine, what else did the researchers consider when comparing the two groups?", "category": "omission", "label": "comparison"}, {"doc_id": 2710065, "edit_id": 20, "question": "Has there been recent research conducted on the use of antibiotics before bladder check-up procedures?", "category": "omission", "label": "verification"}, {"doc_id": 2742700, "edit_id": 0, "question": "You mentioned diabetes patients. Do these patients have any other conditions?", "category": "omission", "label": "example"}, {"doc_id": 2742700, "edit_id": 1, "question": "What type of diabetes do these patients in the study have?", "category": "omission", "label": "concept"}, {"doc_id": 2742700, "edit_id": 2, "question": "What kind of blood pressure levels do the patients in the study have?", "category": "omission", "label": "concept"}, {"doc_id": 2742700, "edit_id": 3, "question": "How were the patients in this study identified?", "category": "omission", "label": "procedural"}, {"doc_id": 2742700, "edit_id": 4, "question": "What portion of the participants reached the target blood pressure level of less than 130/80?", "category": "omission", "label": "extent"}, {"doc_id": 2742700, "edit_id": 5, "question": "Was there any significant difference in the average diastolic blood pressure levels among the three groups?", "category": "omission", "label": "verification"}, {"doc_id": 2742700, "edit_id": 6, "question": "What was the difference in the average systolic and diastolic blood pressures among the three groups from a statistical standpoint?", "category": "omission", "label": "comparison"}, {"doc_id": 2742700, "edit_id": 7, "question": "How can successful management of chronic diseases such as diabetes and hypertension be ensured in future programs?", "category": "omission", "label": "procedural"}, {"doc_id": 2774638, "edit_id": 0, "question": "What was another primary goal of the study relating to the calcium-focused food frequency questionnaire (CFFFQ)?", "category": "omission", "label": "concept"}, {"doc_id": 2774638, "edit_id": 1, "question": "Apart from calcium-fortified foods, what other types of foods does the calcium-focused food frequency questionnaire (CFFFQ) consider?", "category": "omission", "label": "example"}, {"doc_id": 2774638, "edit_id": 2, "question": "Aside from black postmenopausal women, which other demographic did the study focus on?", "category": "omission", "label": "example"}, {"doc_id": 2774638, "edit_id": 3, "question": "What type of sampling method did the study use?", "category": "omission", "label": "concept"}, {"doc_id": 2774638, "edit_id": 4, "question": "How much did the age vary in the group of women participating in the study?", "category": "omission", "label": "extent"}, {"doc_id": 2774638, "edit_id": 5, "question": "What type of process did the participants go through as part of the study apart from questionnaires?", "category": "omission", "label": "procedural"}, {"doc_id": 2774638, "edit_id": 6, "question": "What kind of interview approach was used in the study?", "category": "omission", "label": "concept"}, {"doc_id": 2774638, "edit_id": 7, "question": "What was the correlation value between the calcium measures considered in the study?", "category": "omission", "label": "extent"}, {"doc_id": 2774638, "edit_id": 8, "question": "How strong was the relationship found between the different measurements for total daily calcium intake?", "category": "omission", "label": "extent"}, {"doc_id": 2774638, "edit_id": 9, "question": "How sure are we that the correlation found in the study didn't happen by chance?", "category": "omission", "label": "extent"}, {"doc_id": 2774638, "edit_id": 10, "question": "What was the variability in daily calcium intake estimated by the special questionnaire?", "category": "omission", "label": "extent"}, {"doc_id": 2774638, "edit_id": 11, "question": "On average, how much daily calcium did the participants report in the 24-hour recall?", "category": "omission", "label": "extent"}, {"doc_id": 2774638, "edit_id": 12, "question": "What was the variability in daily calcium intake estimated by the 24-hour recall?", "category": "omission", "label": "extent"}, {"doc_id": 2774638, "edit_id": 13, "question": "Was the difference in calcium intake estimated by the questionnaire and the 24-hour recall significant?", "category": "omission", "label": "verification"}, {"doc_id": 2774638, "edit_id": 14, "question": "How much correlation was found between underreporting of calcium by the 24-hour recall and increase in daily calcium intake?", "category": "omission", "label": "extent"}, {"doc_id": 2774638, "edit_id": 15, "question": "What type of statistical analysis was used on the special questionnaire data?", "category": "omission", "label": "concept"}, {"doc_id": 2774638, "edit_id": 16, "question": "Which different statistical method was used to analyze the special questionnaire's data?", "category": "omission", "label": "concept"}, {"doc_id": 2774638, "edit_id": 17, "question": "How did the researchers conclude that the special questionnaire was accurate in identifying individuals with low calcium intakes?", "category": "omission", "label": "procedural"}, {"doc_id": 2774638, "edit_id": 18, "question": "What was the correlation between dairy consumption and calcium intake?", "category": "omission", "label": "extent"}, {"doc_id": 2774638, "edit_id": 19, "question": "How much of a relationship is there between fruit consumption and calcium intake?", "category": "omission", "label": "extent"}, {"doc_id": 2774638, "edit_id": 20, "question": "What is the correlation between fruit consumption and the amount of calcium intake?", "category": "omission", "label": "extent"}, {"doc_id": 2774638, "edit_id": 21, "question": "By how much did the questionnaire overestimate daily calcium intake compared to the 24-hour recall?", "category": "omission", "label": "extent"}, {"doc_id": 2774638, "edit_id": 22, "question": "Is the difference in how much the questionnaire overestimates total calcium for black women statistically significant?", "category": "omission", "label": "verification"}, {"doc_id": 2774638, "edit_id": 23, "question": "By how much did the questionnaire overestimate the daily calcium intake for white women?", "category": "omission", "label": "extent"}, {"doc_id": 2774638, "edit_id": 24, "question": "Is the difference in how much the questionnaire overestimates total calcium for white women statistically significant?", "category": "omission", "label": "verification"}, {"doc_id": 2774638, "edit_id": 25, "question": "What proportion of black women's calcium intake came from dairy products?", "category": "omission", "label": "extent"}, {"doc_id": 2774638, "edit_id": 26, "question": "How much calcium did dairy provide in the diet of the white women in the study?", "category": "omission", "label": "extent"}, {"doc_id": 2784391, "edit_id": 0, "question": "What are some factors that contribute to muscle loss in critically ill patients?", "category": "omission", "label": "example"}, {"doc_id": 2784391, "edit_id": 1, "question": "Besides sepsis, what other complications of critical illness can lead to muscle loss?", "category": "omission", "label": "example"}, {"doc_id": 2784391, "edit_id": 2, "question": "What types of patients did the original studies focus on?", "category": "omission", "label": "concept"}, {"doc_id": 2784391, "edit_id": 3, "question": "Apart from COPD, what other disease conditions were focused on in the study?", "category": "omission", "label": "example"}, {"doc_id": 2784391, "edit_id": 4, "question": "What is the condition of the muscles in the patients studied?", "category": "omission", "label": "concept"}, {"doc_id": 2784391, "edit_id": 5, "question": "What diagnostic tool was used in the study to measure muscle mass?", "category": "omission", "label": "procedural"}, {"doc_id": 2784391, "edit_id": 6, "question": "How was muscle mass evaluated in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 2784391, "edit_id": 7, "question": "What specific muscles were observed in the study?", "category": "omission", "label": "concept"}, {"doc_id": 2784391, "edit_id": 8, "question": "What part of the body do the vastus intermedius and the rectus femoris belong to?", "category": "omission", "label": "concept"}, {"doc_id": 2784391, "edit_id": 9, "question": "Was there any change in the muscle measurements in both treatment groups?", "category": "omission", "label": "verification"}, {"doc_id": 2784391, "edit_id": 10, "question": "What was the change in muscle size in the group that received electrical muscle stimulation?", "category": "omission", "label": "extent"}, {"doc_id": 2784391, "edit_id": 11, "question": "Was the change in muscle size significant in the group that received electrical muscle stimulation?", "category": "omission", "label": "verification"}, {"doc_id": 2784391, "edit_id": 12, "question": "What was the change in muscle size in the control group that did not receive electrical muscle stimulation?", "category": "omission", "label": "extent"}, {"doc_id": 2784391, "edit_id": 13, "question": "Was the change in muscle size significant in the control group that didn't receive EMS?", "category": "omission", "label": "verification"}, {"doc_id": 2784391, "edit_id": 14, "question": "What more can you tell me about the change in muscle size in the group treated with electrical muscle stimulation?", "category": "omission", "label": "extent"}, {"doc_id": 2784391, "edit_id": 15, "question": "Was this additional decrease in muscle size significant in the group treated with electrical muscle stimulation?", "category": "omission", "label": "verification"}, {"doc_id": 2784391, "edit_id": 16, "question": "What more can you tell me about the change in muscle size in the control group?", "category": "omission", "label": "extent"}, {"doc_id": 2784391, "edit_id": 17, "question": "Was this additional decrease in muscle size significant in the control group that didn't receive EMS treatment?", "category": "omission", "label": "verification"}, {"doc_id": 2784391, "edit_id": 18, "question": "Did the size of all thigh muscles decrease in the group that received electrical muscle stimulation?", "category": "omission", "label": "verification"}, {"doc_id": 2784391, "edit_id": 19, "question": "How much did the size of the right rectus femoris decrease in the group that received electrical muscle stimulation?", "category": "omission", "label": "extent"}, {"doc_id": 2784391, "edit_id": 20, "question": "What was the percentage decrease in the muscle size of the right rectus femoris in the group that received electrical muscle stimulation?", "category": "omission", "label": "extent"}, {"doc_id": 2784391, "edit_id": 21, "question": "Did the size of the right rectus femoris also decrease in the control group?", "category": "omission", "label": "verification"}, {"doc_id": 2784391, "edit_id": 22, "question": "How much did the size of the right rectus femoris decrease in the control group?", "category": "omission", "label": "extent"}, {"doc_id": 2784391, "edit_id": 23, "question": "What was the percentage decrease in the muscle size of the right rectus femoris in the control group?", "category": "omission", "label": "extent"}, {"doc_id": 2784391, "edit_id": 24, "question": "Which group had a smaller decrease in the muscle size of the right rectus femoris - the group that received electrical muscle stimulation or the control group?", "category": "omission", "label": "comparison"}, {"doc_id": 2864284, "edit_id": 0, "question": "Does Afghanistan have any national guidelines for treating diseases?", "category": "omission", "label": "verification"}, {"doc_id": 2864284, "edit_id": 1, "question": "Which specific treatment does Afghanistan's national guidelines recommend the use of chloroquine for?", "category": "omission", "label": "concept"}, {"doc_id": 2864284, "edit_id": 2, "question": "What kind of infection is the drug chloroquine used to treat, according to Afghanistan's national guidelines?", "category": "omission", "label": "concept"}, {"doc_id": 2864284, "edit_id": 3, "question": "Which type of malaria infection is most common in Afghanistan?", "category": "omission", "label": "concept"}, {"doc_id": 2864284, "edit_id": 4, "question": "Where is the resistance to the malaria drug chloroquine emerging?", "category": "omission", "label": "concept"}, {"doc_id": 2864284, "edit_id": 5, "question": "Was the trial testing the malaria treatments open-label or blind?", "category": "omission", "label": "verification"}, {"doc_id": 2864284, "edit_id": 6, "question": "Was the assignment of patients to different treatment groups in the trial randomized?", "category": "omission", "label": "verification"}, {"doc_id": 2864284, "edit_id": 7, "question": "Was there a control group used in the study testing malaria treatments?", "category": "omission", "label": "verification"}, {"doc_id": 2864284, "edit_id": 8, "question": "What method was used to confirm malaria infection in the patients participating in the trial?", "category": "omission", "label": "procedural"}, {"doc_id": 2864284, "edit_id": 9, "question": "Why wasn't the drug primaquine administered to the patients in the trial?", "category": "omission", "label": "cause"}, {"doc_id": 2864284, "edit_id": 10, "question": "How often were patients in the trial checked during the first few days of illness?", "category": "omission", "label": "extent"}, {"doc_id": 2864284, "edit_id": 11, "question": "What time period is referred to as the acute phase of the illness in the study?", "category": "omission", "label": "concept"}, {"doc_id": 2864284, "edit_id": 12, "question": "How long was the total follow-up period for the patients in the trial?", "category": "omission", "label": "extent"}, {"doc_id": 2864284, "edit_id": 13, "question": "What was the primary metric measured at day 56 in the study?", "category": "omission", "label": "concept"}, {"doc_id": 2864284, "edit_id": 14, "question": "What was considered as the criterion for one treatment not being inferior to the other in terms of their failure rates?", "category": "omission", "label": "concept"}, {"doc_id": 2864284, "edit_id": 15, "question": "When could the use of dihydroartemisinin-piperaquine be considered for treating malaria?", "category": "omission", "label": "verification"}, {"doc_id": 2882922, "edit_id": 0, "question": "Did the patients show any signs of the cancer spreading when the study was conducted?", "category": "omission", "label": "verification"}, {"doc_id": 2882922, "edit_id": 1, "question": "Were there any reasons why the patients couldn't take Tamoxifen according to the study?", "category": "omission", "label": "cause"}, {"doc_id": 2882922, "edit_id": 2, "question": "Did the control group receive any additional treatment apart from regular follow-up?", "category": "omission", "label": "verification"}, {"doc_id": 2882922, "edit_id": 3, "question": "What types of events did the research study track in the patients?", "category": "omission", "label": "concept"}, {"doc_id": 2882922, "edit_id": 4, "question": "What are some other significant events that the study tracked in patients?", "category": "omission", "label": "example"}, {"doc_id": 2882922, "edit_id": 5, "question": "What is metachronous breast cancer and was it one of the categories that the study monitored?", "category": "omission", "label": "concept"}, {"doc_id": 2882922, "edit_id": 6, "question": "Did the categories in the study include tracking death from any causes?", "category": "omission", "label": "verification"}, {"doc_id": 2882922, "edit_id": 7, "question": "How did the researchers decide how to categorize patients in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 2882922, "edit_id": 8, "question": "At what rate were the significant events expected to occur in the patients, according to the study?", "category": "omission", "label": "extent"}, {"doc_id": 2882922, "edit_id": 9, "question": "What was the median age of the patients in the study?", "category": "omission", "label": "extent"}, {"doc_id": 2882922, "edit_id": 10, "question": "What was the median time since surgery for the patients in the study?", "category": "omission", "label": "extent"}, {"doc_id": 2882922, "edit_id": 11, "question": "What was the range of time since surgery for the patients in the study?", "category": "omission", "label": "extent"}, {"doc_id": 2882922, "edit_id": 12, "question": "How many cases of in situ carcinoma were there in each group?", "category": "omission", "label": "extent"}, {"doc_id": 2882922, "edit_id": 13, "question": "How many patients tested negative for the oestrogen receptor (ER) in each group?", "category": "omission", "label": "extent"}, {"doc_id": 2882922, "edit_id": 14, "question": "In how many patients was the status of oestrogen receptor (ER) unknown in each group?", "category": "omission", "label": "extent"}, {"doc_id": 2882922, "edit_id": 15, "question": "Did the previous treatments received by the patients include chemotherapy?", "category": "omission", "label": "verification"}, {"doc_id": 2882922, "edit_id": 16, "question": "Did the patients receive an LHRH analogue as a part of their previous adjuvant treatment?", "category": "omission", "label": "verification"}, {"doc_id": 2882922, "edit_id": 17, "question": "Was Tamoxifen discontinued prematurely by some patients in the study?", "category": "omission", "label": "verification"}, {"doc_id": 2882922, "edit_id": 18, "question": "How many cases of locoregional relapse were there in the Tamoxifen group?", "category": "omission", "label": "extent"}, {"doc_id": 2882922, "edit_id": 19, "question": "How many cases of other types of tumours were there in the Tamoxifen group?", "category": "omission", "label": "extent"}, {"doc_id": 2882922, "edit_id": 20, "question": "Was there a statistically significant difference in the occurrence of ER-positive secondary breast cancers between the group that took Tamoxifen and the follow-up group?", "category": "omission", "label": "verification"}, {"doc_id": 2882922, "edit_id": 21, "question": "So far, have any other statistically significant differences been identified between the two groups in the study?", "category": "omission", "label": "verification"}, {"doc_id": 2900076, "edit_id": 0, "question": "What type of drug is Tranexamic acid?", "category": "omission", "label": "concept"}, {"doc_id": 2900076, "edit_id": 1, "question": "How was the total knee arthroplasty (TKA) performed in this study?", "category": "omission", "label": "procedural"}, {"doc_id": 2900076, "edit_id": 2, "question": "What type of anesthesia was used for the TKA surgery?", "category": "omission", "label": "procedural"}, {"doc_id": 2900076, "edit_id": 3, "question": "How was the study design conducted?", "category": "omission", "label": "procedural"}, {"doc_id": 2900076, "edit_id": 4, "question": "How many patients were in the placebo group of the study?", "category": "omission", "label": "extent"}, {"doc_id": 2900076, "edit_id": 5, "question": "How many patients were in the Tranexamic acid group in this study?", "category": "omission", "label": "extent"}, {"doc_id": 2900076, "edit_id": 6, "question": "What was the dosage of Tranexamic acid given to the patients?", "category": "omission", "label": "procedural"}, {"doc_id": 2900076, "edit_id": 7, "question": "When was the Tranexamic acid given to the patients during the procedure?", "category": "omission", "label": "procedural"}, {"doc_id": 2900076, "edit_id": 8, "question": "How much additional Tranexamic acid was given to the patients after the initial dose during the operation?", "category": "omission", "label": "procedural"}, {"doc_id": 2900076, "edit_id": 9, "question": "How much drainage fluid was collected on average from the patients who had one knee replaced and were given a placebo?", "category": "omission", "label": "extent"}, {"doc_id": 2900076, "edit_id": 10, "question": "How much blood drainage was found in patients who had both their knees replacement surgery and were given a placebo?", "category": "omission", "label": "extent"}, {"doc_id": 2900076, "edit_id": 11, "question": "How many units of packed red blood cells (PRBC) were given to the patients in the control group?", "category": "omission", "label": "extent"}, {"doc_id": 2900076, "edit_id": 12, "question": "How many units of packed red blood cells (PRBC) were given to the patients in the tranexamic acid group?", "category": "omission", "label": "extent"}, {"doc_id": 2900076, "edit_id": 13, "question": "How much did Tranexamic acid decrease total blood loss in patients who had both knees replaced?", "category": "omission", "label": "extent"}, {"doc_id": 2900076, "edit_id": 14, "question": "How much did Tranexamic acid decrease total blood loss in patients who had one knee replaced?", "category": "omission", "label": "extent"}, {"doc_id": 2967098, "edit_id": 0, "question": "What type of medication is typically used in high doses for psychotic patients?", "category": "omission", "label": "concept"}, {"doc_id": 2967098, "edit_id": 1, "question": "What specific type of mental illness were all the patients diagnosed with in this study?", "category": "omission", "label": "concept"}, {"doc_id": 2967098, "edit_id": 2, "question": "Were the number of subjects in the high and low dosage groups equal?", "category": "omission", "label": "verification"}, {"doc_id": 2967098, "edit_id": 3, "question": "How did the researchers measure improvements in the patients' symptoms?", "category": "omission", "label": "procedural"}, {"doc_id": 2967098, "edit_id": 4, "question": "How were the side effects of Haloperidol tracked in this study?", "category": "omission", "label": "procedural"}, {"doc_id": 2967098, "edit_id": 5, "question": "When was the first assessment conducted after starting the treatment?", "category": "omission", "label": "procedural"}, {"doc_id": 2967098, "edit_id": 6, "question": "Was there an assessment process two weeks into the treatment?", "category": "omission", "label": "verification"}, {"doc_id": 2967098, "edit_id": 7, "question": "Were there any assessments conducted three weeks into the treatment?", "category": "omission", "label": "verification"}, {"doc_id": 2967098, "edit_id": 8, "question": "When was the fourth assessment conducted after starting the treatment?", "category": "omission", "label": "procedural"}, {"doc_id": 2967098, "edit_id": 9, "question": "Was there an assessment five weeks into the treatment?", "category": "omission", "label": "verification"}, {"doc_id": 2967098, "edit_id": 10, "question": "When was the final assessment conducted in the six-week treatment period?", "category": "omission", "label": "procedural"}, {"doc_id": 2967098, "edit_id": 11, "question": "Did both the high-dose and low-dose groups show improvement in the Brief Psychiatric Rating Scale scores?", "category": "omission", "label": "verification"}, {"doc_id": 2967098, "edit_id": 12, "question": "Was the improvement in symptoms, as measured by the Brief Psychiatric Rating Scale scores, significant in both groups?", "category": "omission", "label": "verification"}, {"doc_id": 2967098, "edit_id": 13, "question": "How was the improvement in symptoms calculated or measured in this study?", "category": "omission", "label": "procedural"}, {"doc_id": 3118076, "edit_id": 0, "question": "What was the dental condition of the patients in the study?", "category": "omission", "label": "concept"}, {"doc_id": 3118076, "edit_id": 1, "question": "Which part of the mouth were the patients missing their teeth from?", "category": "omission", "label": "concept"}, {"doc_id": 3118076, "edit_id": 2, "question": "What was done to the implants in the immediately loaded group after they were put in place?", "category": "omission", "label": "procedural"}, {"doc_id": 3118076, "edit_id": 3, "question": "How soon after the implants were placed were they restored with a metal ceramic crown in the immediately loaded group?", "category": "omission", "label": "procedural"}, {"doc_id": 3118076, "edit_id": 4, "question": "What type of implants were used for the immediately loaded group in the study?", "category": "omission", "label": "concept"}, {"doc_id": 3118076, "edit_id": 5, "question": "What kind of implants were used for the group that had their implants delayed in use?", "category": "omission", "label": "procedural"}, {"doc_id": 3118076, "edit_id": 6, "question": "What is one of the soft tissue parameters measured in the study?", "category": "omission", "label": "example"}, {"doc_id": 3118076, "edit_id": 7, "question": "What other soft tissue parameter was measured in the study?", "category": "omission", "label": "example"}, {"doc_id": 3118076, "edit_id": 8, "question": "Was there any other soft tissue parameter measured in the dental implant study?", "category": "omission", "label": "verification"}, {"doc_id": 3118076, "edit_id": 9, "question": "Were there any other parameters related to soft tissue that were measured in the dental implant study?", "category": "omission", "label": "verification"}, {"doc_id": 3118076, "edit_id": 10, "question": "Were there any other soft tissue measurements taken in the dental implant study?", "category": "omission", "label": "verification"}, {"doc_id": 3118076, "edit_id": 11, "question": "When was the first set of measurements taken for the parameters in the study?", "category": "omission", "label": "extent"}, {"doc_id": 3118076, "edit_id": 12, "question": "Were there other times when the parameters were measured in the study?", "category": "omission", "label": "verification"}, {"doc_id": 3118076, "edit_id": 13, "question": "At what other times were the parameters measured in the study?", "category": "omission", "label": "extent"}, {"doc_id": 3118076, "edit_id": 14, "question": "What was the last time the parameters were measured in the study?", "category": "omission", "label": "extent"}, {"doc_id": 3118076, "edit_id": 15, "question": "Which parameters were compared in the study between the two groups?", "category": "omission", "label": "comparison"}, {"doc_id": 3118076, "edit_id": 16, "question": "Was there a significant difference in the modified plaque index (mPI) between the groups over time?", "category": "omission", "label": "verification"}, {"doc_id": 3118076, "edit_id": 17, "question": "Did the groups significantly differ in their modified bleeding index (mBI) over time?", "category": "omission", "label": "verification"}, {"doc_id": 3118076, "edit_id": 18, "question": "Did the marginal level of soft tissue (ML) significantly change between the groups over time?", "category": "omission", "label": "verification"}, {"doc_id": 3118076, "edit_id": 19, "question": "Was there a significant change in the width of keratinized mucosa (WKM) between the groups over time?", "category": "omission", "label": "verification"}, {"doc_id": 3118076, "edit_id": 20, "question": "Did each group in the study have a mean papillary index (PPI) score?", "category": "omission", "label": "verification"}, {"doc_id": 3136370, "edit_id": 0, "question": "Do the people with fibromyalgia in the study use any type of medicine?", "category": "omission", "label": "verification"}, {"doc_id": 3136370, "edit_id": 1, "question": "What type of medicine do most people with fibromyalgia use?", "category": "omission", "label": "concept"}, {"doc_id": 3136370, "edit_id": 2, "question": "How should trials to study treatments for fibromyalgia be conducted?", "category": "omission", "label": "procedural"}, {"doc_id": 3136370, "edit_id": 3, "question": "Was the study designed in such a way that neither the participants nor the researchers knew which treatment each participant was getting?", "category": "omission", "label": "verification"}, {"doc_id": 3136370, "edit_id": 4, "question": "At what stage of testing was this trial conducted?", "category": "omission", "label": "extent"}, {"doc_id": 3136370, "edit_id": 5, "question": "Where were the patients treated for their fibromyalgia?", "category": "omission", "label": "concept"}, {"doc_id": 3136370, "edit_id": 6, "question": "How did the researchers measure the impact of the treatments on the participants' fibromyalgia symptoms?", "category": "omission", "label": "procedural"}, {"doc_id": 3136370, "edit_id": 7, "question": "How did the researchers measure the participants' depressive symptoms?", "category": "omission", "label": "procedural"}, {"doc_id": 3136370, "edit_id": 8, "question": "What type of statistical analysis did the researchers use in this trial?", "category": "omission", "label": "procedural"}, {"doc_id": 3136370, "edit_id": 9, "question": "What kind of statistics were used in the analysis?", "category": "omission", "label": "concept"}, {"doc_id": 3136370, "edit_id": 10, "question": "Can soy shakes be combined with other treatments for fibromyalgia?", "category": "omission", "label": "verification"}, {"doc_id": 3136370, "edit_id": 11, "question": "Can shakes that contain casein be used along with other treatments in a fibromyalgia treatment program?", "category": "omission", "label": "verification"}, {"doc_id": 3136370, "edit_id": 12, "question": "Can a combination of soy shakes and a comprehensive treatment program help reduce fibromyalgia symptoms?", "category": "omission", "label": "verification"}, {"doc_id": 3136370, "edit_id": 13, "question": "Are larger studies being planned for patients with fibromyalgia?", "category": "omission", "label": "verification"}, {"doc_id": 3137438, "edit_id": 0, "question": "What method was used in the study to conduct the experiment?", "category": "omission", "label": "procedural"}, {"doc_id": 3137438, "edit_id": 1, "question": "What aspect of the dental seal was being evaluated in this study?", "category": "omission", "label": "concept"}, {"doc_id": 3137438, "edit_id": 2, "question": "How were the results of the experiment statistically analyzed?", "category": "omission", "label": "procedural"}, {"doc_id": 3172326, "edit_id": 0, "question": "What type of study was used in this research?", "category": "omission", "label": "concept"}, {"doc_id": 3172326, "edit_id": 1, "question": "What was the type of operation conducted in this study?", "category": "omission", "label": "concept"}, {"doc_id": 3172326, "edit_id": 2, "question": "What dosage of ketamine was administered to the patients?", "category": "omission", "label": "extent"}, {"doc_id": 3172326, "edit_id": 3, "question": "When was the ketamine administered to the patients?", "category": "omission", "label": "procedural"}, {"doc_id": 3172326, "edit_id": 4, "question": "Where were the patients when they received the ketamine?", "category": "omission", "label": "procedural"}, {"doc_id": 3172326, "edit_id": 5, "question": "What was the substance injected into the control group?", "category": "omission", "label": "concept"}, {"doc_id": 3172326, "edit_id": 6, "question": "What dosage of normal saline was injected into the control group?", "category": "omission", "label": "extent"}, {"doc_id": 3172326, "edit_id": 7, "question": "What scale was used to measure the patients' pain levels?", "category": "omission", "label": "procedural"}, {"doc_id": 3172326, "edit_id": 8, "question": "How did the levels of pain, as measured on the VAS, compare between the ketamine group and the control group?", "category": "omission", "label": "comparison"}, {"doc_id": 3172326, "edit_id": 9, "question": "How long did it take for the ketamine group to first request additional pain relief?", "category": "omission", "label": "extent"}, {"doc_id": 3172326, "edit_id": 10, "question": "How long did it take for the control group to first request additional pain relief?", "category": "omission", "label": "extent"}, {"doc_id": 3172326, "edit_id": 11, "question": "How many strong pain relief injections were needed by the ketamine group in the 24 hours after surgery?", "category": "omission", "label": "extent"}, {"doc_id": 3172326, "edit_id": 12, "question": "How many strong pain relief injections were needed by the control group in the 24 hours after surgery?", "category": "omission", "label": "extent"}, {"doc_id": 3172326, "edit_id": 13, "question": "Can ketamine cause any side effects in patients?", "category": "omission", "label": "verification"}, {"doc_id": 3214395, "edit_id": 0, "question": "What exactly is induction of anesthesia?", "category": "omission", "label": "concept"}, {"doc_id": 3214395, "edit_id": 1, "question": "How important is the induction phase of anesthesia?", "category": "omission", "label": "extent"}, {"doc_id": 3214395, "edit_id": 2, "question": "Is the technique you mentioned used in anesthesia for adults or children?", "category": "omission", "label": "disjunction"}, {"doc_id": 3214395, "edit_id": 3, "question": "What is the most common method used to put children to sleep for surgery?", "category": "omission", "label": "concept"}, {"doc_id": 3214395, "edit_id": 4, "question": "What does the bispectral index (BIS) measure?", "category": "omission", "label": "concept"}, {"doc_id": 3214395, "edit_id": 5, "question": "What type of anesthesia was used for the children and in what mixture?", "category": "omission", "label": "procedural"}, {"doc_id": 3214395, "edit_id": 6, "question": "What was done after the children were put to sleep with the anesthesia?", "category": "omission", "label": "procedural"}, {"doc_id": 3214395, "edit_id": 7, "question": "What type of surgery were the children in the study having?", "category": "omission", "label": "concept"}, {"doc_id": 3214395, "edit_id": 8, "question": "What was recorded after the children were put to sleep and the tube was put in?", "category": "omission", "label": "procedural"}, {"doc_id": 3214395, "edit_id": 9, "question": "What types of complications were being watched for during the study?", "category": "omission", "label": "example"}, {"doc_id": 3214395, "edit_id": 10, "question": "Were there any other complications being monitored during the study?", "category": "omission", "label": "verification"}, {"doc_id": 3214395, "edit_id": 11, "question": "What other issues did you record during the study?", "category": "omission", "label": "procedural"}, {"doc_id": 3214395, "edit_id": 12, "question": "What other types of measurements were taken during the study?", "category": "omission", "label": "procedural"}, {"doc_id": 3214395, "edit_id": 13, "question": "How did you analyze the information you collected in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 3214395, "edit_id": 14, "question": "What level of significance did you use in your analysis?", "category": "omission", "label": "procedural"}, {"doc_id": 3214395, "edit_id": 15, "question": "Were there any differences in the occurrence of bronchospasm between the three groups of children in the study?", "category": "omission", "label": "verification"}, {"doc_id": 3214395, "edit_id": 16, "question": "Were there any differences in the success of laryngoscopy between the three groups?", "category": "omission", "label": "verification"}, {"doc_id": 3214395, "edit_id": 17, "question": "What was the health status of the children in the study?", "category": "omission", "label": "concept"}, {"doc_id": 3214395, "edit_id": 18, "question": "What were the target levels of sleep that were used in the study?", "category": "omission", "label": "concept"}, {"doc_id": 3214395, "edit_id": 19, "question": "What were the range of BIS values observed in the study?", "category": "omission", "label": "extent"}, {"doc_id": 3215316, "edit_id": 0, "question": "When was this study on the effects of Dhatri Avaleha on Thalassemia conducted?", "category": "omission", "label": "verification"}, {"doc_id": 3215316, "edit_id": 1, "question": "What conditions is Dhatri Avaleha traditionally known to treat?", "category": "omission", "label": "concept"}, {"doc_id": 3215316, "edit_id": 2, "question": "How were the children participating in the study divided into the two groups?", "category": "omission", "label": "procedural"}, {"doc_id": 3215316, "edit_id": 3, "question": "Were the results of the study statistically significant?", "category": "omission", "label": "verification"}, {"doc_id": 3215316, "edit_id": 4, "question": "What was the level of significance for the results of the study?", "category": "omission", "label": "extent"}, {"doc_id": 3232074, "edit_id": 0, "question": "What is the most common complication of diabetes?", "category": "omission", "label": "concept"}, {"doc_id": 3232074, "edit_id": 1, "question": "What is one key impact of diabetic neuropathy?", "category": "omission", "label": "consequence"}, {"doc_id": 3232074, "edit_id": 2, "question": "Does diabetic neuropathy increase the chance of mortality? ", "category": "omission", "label": "verification"}, {"doc_id": 3232074, "edit_id": 3, "question": "Does the new medicine also have potential uses for other diabetes-related conditions?", "category": "omission", "label": "verification"}, {"doc_id": 3232074, "edit_id": 4, "question": "What type of diabetes did all the patients in the study have?", "category": "omission", "label": "concept"}, {"doc_id": 3232074, "edit_id": 5, "question": "What was given to the patients in the other group for the study?", "category": "omission", "label": "concept"}, {"doc_id": 3232074, "edit_id": 6, "question": "How long after treatment were the patients assessed?", "category": "omission", "label": "extent"}, {"doc_id": 3232074, "edit_id": 7, "question": "What kind of tests were conducted on all patients?", "category": "omission", "label": "procedural"}, {"doc_id": 3232074, "edit_id": 8, "question": "What specific screening test was conducted on all patients?", "category": "omission", "label": "procedural"}, {"doc_id": 3232074, "edit_id": 9, "question": "What method was used to assess the level of neuropathy in the patients?", "category": "omission", "label": "procedural"}, {"doc_id": 3232074, "edit_id": 10, "question": "How did they assess the impact of diabetes on the nerves?", "category": "omission", "label": "procedural"}, {"doc_id": 3232074, "edit_id": 11, "question": "What else was measured for all patients in the study?", "category": "omission", "label": "concept"}, {"doc_id": 3232074, "edit_id": 12, "question": "What type of touch-sensitivity test was conducted on the patients?", "category": "omission", "label": "procedural"}, {"doc_id": 3232074, "edit_id": 13, "question": "What happened to the Michigan diabetic neuropathy score over the study? ", "category": "omission", "label": "consequence"}, {"doc_id": 3232074, "edit_id": 14, "question": "How significant was the decrease in the Michigan diabetic neuropathy score?", "category": "omission", "label": "extent"}, {"doc_id": 3232074, "edit_id": 15, "question": "In which group did the Michigan diabetic neuropathy score decrease notably?", "category": "omission", "label": "disjunction"}, {"doc_id": 3232074, "edit_id": 16, "question": "Where were the changes observed in the nerve conduction study?", "category": "omission", "label": "consequence"}, {"doc_id": 3232074, "edit_id": 17, "question": "What requirements are there for these future studies?", "category": "omission", "label": "concept"}, {"doc_id": 3233513, "edit_id": 0, "question": "What type of medication is Formoterol?", "category": "omission", "label": "concept"}, {"doc_id": 3233513, "edit_id": 1, "question": "Can you describe the nature of the study?", "category": "omission", "label": "concept"}, {"doc_id": 3233513, "edit_id": 2, "question": "How were the patients split into different treatment groups?", "category": "omission", "label": "procedural"}, {"doc_id": 3233513, "edit_id": 3, "question": "What were the doses in which Formoterol was given to the patients?", "category": "omission", "label": "extent"}, {"doc_id": 3233513, "edit_id": 4, "question": "How was the medication given to the patients?", "category": "omission", "label": "procedural"}, {"doc_id": 3233513, "edit_id": 5, "question": "Beside Formoterol, was there any other medication used in the study? ", "category": "omission", "label": "verification"}, {"doc_id": 3233513, "edit_id": 6, "question": "How was the Salbutamol medication administered to the patients?", "category": "omission", "label": "procedural"}, {"doc_id": 3233513, "edit_id": 7, "question": " Was the use of Salbutamol allowed during the conduct of the study?", "category": "omission", "label": "verification"}, {"doc_id": 3233513, "edit_id": 8, "question": "How was the change in the patients' breathing ability measured?", "category": "omission", "label": "procedural"}, {"doc_id": 3233513, "edit_id": 9, "question": "Was the change related to any specific lung function test?", "category": "omission", "label": "verification"}, {"doc_id": 3233513, "edit_id": 10, "question": "How long after the dosage was given was the FEV1 measured?", "category": "omission", "label": "extent"}, {"doc_id": 3233513, "edit_id": 11, "question": "How many patients in the study received the 4.5 \u03bcg dose of Formoterol?", "category": "omission", "label": "extent"}, {"doc_id": 3233513, "edit_id": 12, "question": "How many patients in the study received the 9 \u03bcg dose of Formoterol?", "category": "omission", "label": "extent"}, {"doc_id": 3233513, "edit_id": 13, "question": "How many patients received a placebo instead of the actual drug in the study?", "category": "omission", "label": "extent"}, {"doc_id": 3269796, "edit_id": 0, "question": "What type of study was this research?", "category": "omission", "label": "concept"}, {"doc_id": 3269796, "edit_id": 1, "question": "Was the research performed in a specific way, perhaps with assignments given out without any order?", "category": "omission", "label": "verification"}, {"doc_id": 3269796, "edit_id": 2, "question": "How many standard bone marrow tests were performed in the study?", "category": "omission", "label": "extent"}, {"doc_id": 3269796, "edit_id": 3, "question": "And how many tests used the new OnControl device?", "category": "omission", "label": "extent"}, {"doc_id": 3269796, "edit_id": 4, "question": "How many doctors-in-training performed the bone marrow tests?", "category": "omission", "label": "extent"}, {"doc_id": 3269796, "edit_id": 5, "question": "How many fully qualified doctors oversaw the study?", "category": "omission", "label": "extent"}, {"doc_id": 3269796, "edit_id": 6, "question": "Who figured out the average length of the bone marrow samples?", "category": "omission", "label": "procedural"}, {"doc_id": 3269796, "edit_id": 7, "question": "Did the pathologist know which method was used for each sample?", "category": "omission", "label": "verification"}, {"doc_id": 3269796, "edit_id": 8, "question": "What was the average length of the samples taken out by the OnControl device?", "category": "omission", "label": "extent"}, {"doc_id": 3269796, "edit_id": 9, "question": "What was the average length of the samples taken out by the regular needle?", "category": "omission", "label": "extent"}, {"doc_id": 3269796, "edit_id": 10, "question": "Can we confidently say that the OnControl device led to longer samples?", "category": "omission", "label": "verification"}, {"doc_id": 3269796, "edit_id": 11, "question": "How sure can we be that the difference in sample lengths is not due to random chance?", "category": "omission", "label": "extent"}, {"doc_id": 3269796, "edit_id": 12, "question": "Besides sample size, what other result did the researchers measure?", "category": "omission", "label": "concept"}, {"doc_id": 3269796, "edit_id": 13, "question": "How long did the procedures take on average when using the OnControl device?", "category": "omission", "label": "extent"}, {"doc_id": 3269796, "edit_id": 14, "question": "How long did the procedures take on average when using the regular needle?", "category": "omission", "label": "extent"}, {"doc_id": 3269796, "edit_id": 15, "question": "Is the time difference between the two methods statistically significant?", "category": "omission", "label": "verification"}, {"doc_id": 3269796, "edit_id": 16, "question": "Besides sample length and procedure time, were there other factors that the researchers considered?", "category": "omission", "label": "concept"}, {"doc_id": 3269796, "edit_id": 17, "question": "Which method does the study suggest as the new standard for bone marrow tests?", "category": "omission", "label": "concept"}, {"doc_id": 3357231, "edit_id": 0, "question": "What was the health condition of all the participants in the study?", "category": "omission", "label": "concept"}, {"doc_id": 3357231, "edit_id": 1, "question": "What types of sugar were used in the sweet foods given to the participants?", "category": "omission", "label": "concept"}, {"doc_id": 3357231, "edit_id": 2, "question": "How much isomaltulose or sucrose were the participants consuming per day through sweet foods?", "category": "omission", "label": "extent"}, {"doc_id": 3357231, "edit_id": 3, "question": "Were the participants in a controlled environment or living freely during the study?", "category": "omission", "label": "verification"}, {"doc_id": 3357231, "edit_id": 4, "question": "What was the blood sugar level measurement, or HbA1c level, for the participants who consumed sucrose?", "category": "omission", "label": "extent"}, {"doc_id": 3357231, "edit_id": 5, "question": "What was the measured blood sugar level, or HbA1c level, for the participants who consumed isomaltulose?", "category": "omission", "label": "extent"}, {"doc_id": 3357231, "edit_id": 6, "question": "What was the regression coefficient, a statistical measurement, recorded in the study?", "category": "omission", "label": "extent"}, {"doc_id": 3357231, "edit_id": 7, "question": "What was the range for the 95% confidence interval for the regression coefficient in this study?", "category": "omission", "label": "extent"}, {"doc_id": 3357231, "edit_id": 8, "question": "Was there any difference in the triglyceride levels of the isomaltulose group compared to the sucrose group after 12 weeks?", "category": "omission", "label": "comparison"}, {"doc_id": 3357231, "edit_id": 9, "question": "Did the research involve evaluating other parameters, apart from HbA1c and triglycerides?", "category": "omission", "label": "verification"}, {"doc_id": 3357231, "edit_id": 10, "question": "Under what conditions was the assessment conducted?", "category": "omission", "label": "procedural"}, {"doc_id": 3425422, "edit_id": 0, "question": "What specific type and dose of insulin was used in this study?", "category": "omission", "label": "procedural"}, {"doc_id": 3425422, "edit_id": 1, "question": "What was the specific condition of all the patients in the study?", "category": "omission", "label": "concept"}, {"doc_id": 3425422, "edit_id": 2, "question": "Was platelet activation assessed with or without stimulation in the study?", "category": "omission", "label": "disjunction"}, {"doc_id": 3425422, "edit_id": 3, "question": "Apart from without stimulation, was there any other way platelet activation was assessed in this study?", "category": "omission", "label": "verification"}, {"doc_id": 3425422, "edit_id": 4, "question": "What substance was used for stimulation in the platelet activation assessment?", "category": "omission", "label": "procedural"}, {"doc_id": 3425422, "edit_id": 5, "question": "Besides U46619, was there any other substance used for stimulation in the platelet activation assessment?", "category": "omission", "label": "verification"}, {"doc_id": 3425422, "edit_id": 6, "question": "To what specific range was the premeal blood glucose standardized?", "category": "omission", "label": "procedural"}, {"doc_id": 3425422, "edit_id": 7, "question": "When besides before and after the pre-meal blood glucose standardization were measurements taken in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 3425422, "edit_id": 8, "question": "By how much did premeal insulin reduce post-meal high blood sugar levels compared to the placebo?", "category": "omission", "label": "comparison"}, {"doc_id": 3425422, "edit_id": 9, "question": "How did the placebo affect post-meal insulin levels?", "category": "omission", "label": "consequence"}, {"doc_id": 3425422, "edit_id": 10, "question": "What was administered after the placebo in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 3425422, "edit_id": 11, "question": "What impact did the standardized meal have on U46619-induced platelet P-selectin expression?", "category": "omission", "label": "consequence"}, {"doc_id": 3425422, "edit_id": 12, "question": "By how much did the placebo enhance U46619-induced platelet P-selectin expression?", "category": "omission", "label": "extent"}, {"doc_id": 3425422, "edit_id": 13, "question": "How much did premeal insulin increase the response of platelet P-selectin expression compared to the placebo?", "category": "omission", "label": "comparison"}, {"doc_id": 3425422, "edit_id": 14, "question": "What was the effect of placebo on fibrinogen binding after meal intake?", "category": "omission", "label": "consequence"}, {"doc_id": 3425422, "edit_id": 15, "question": "What was the effect of premeal insulin on fibrinogen binding after meal intake?", "category": "omission", "label": "consequence"}, {"doc_id": 3425422, "edit_id": 16, "question": "By how much did premeal insulin increase U46619-induced fibrinogen binding after meal intake?", "category": "omission", "label": "extent"}, {"doc_id": 3441250, "edit_id": 0, "question": "Are there any international guidelines that recommend the use of fluids during surgery?", "category": "omission", "label": "verification"}, {"doc_id": 3441250, "edit_id": 1, "question": "What are the specific post-operation symptoms that the use of these fluids during surgery is aimed at alleviating?", "category": "omission", "label": "concept"}, {"doc_id": 3441250, "edit_id": 2, "question": "Does there exist an ideal plan or practice for the administration of fluids during surgery?", "category": "omission", "label": "verification"}, {"doc_id": 3441250, "edit_id": 3, "question": "Is the optimal plan for fluid administration during surgery already defined or established?", "category": "omission", "label": "verification"}, {"doc_id": 3441250, "edit_id": 4, "question": "Was this study planned to track participants forward in time from that point onwards?", "category": "omission", "label": "verification"}, {"doc_id": 3441250, "edit_id": 5, "question": "Did this research include any measures to prevent bias, such as blinding?", "category": "omission", "label": "verification"}, {"doc_id": 3441250, "edit_id": 6, "question": "What specific type of colloid fluid was used during this study?", "category": "omission", "label": "concept"}, {"doc_id": 3441250, "edit_id": 7, "question": "Was this study conducted on patients with health issues or on healthy individuals?", "category": "omission", "label": "disjunction"}, {"doc_id": 3441250, "edit_id": 8, "question": "What specific type of surgery were the volunteers in the study undergoing?", "category": "omission", "label": "concept"}, {"doc_id": 3441250, "edit_id": 9, "question": "How many patients in the study were given the colloid fluid?", "category": "omission", "label": "extent"}, {"doc_id": 3441250, "edit_id": 10, "question": "How many patients in the study were given the crystalloid fluid?", "category": "omission", "label": "extent"}, {"doc_id": 3482439, "edit_id": 0, "question": "What type of study was conducted to compare the two types of implants used to fix broken hips in older people?", "category": "omission", "label": "concept"}, {"doc_id": 3482439, "edit_id": 1, "question": "What were the specific types of implants being compared in the study?", "category": "omission", "label": "concept"}, {"doc_id": 3482439, "edit_id": 2, "question": "What kind of fractures were these implants used to treat?", "category": "omission", "label": "concept"}, {"doc_id": 3482439, "edit_id": 3, "question": "What type of hip fractures did the patients in the study have?", "category": "omission", "label": "concept"}, {"doc_id": 3482439, "edit_id": 4, "question": "How were the fractures classified in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 3482439, "edit_id": 5, "question": "Over what time period did the study take place?", "category": "omission", "label": "extent"}, {"doc_id": 3482439, "edit_id": 6, "question": "How were the patients included in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 3482439, "edit_id": 7, "question": "How many hip fractures were included in Group A of the study?", "category": "omission", "label": "extent"}, {"doc_id": 3482439, "edit_id": 8, "question": "How many fractures were included in Group B of the study?", "category": "omission", "label": "extent"}, {"doc_id": 3482439, "edit_id": 9, "question": "Besides factors like recovery and complications, what other specific measure was recorded in the study?", "category": "omission", "label": "concept"}, {"doc_id": 3482439, "edit_id": 10, "question": "How long was the average follow-up period for patients in the study?", "category": "omission", "label": "extent"}, {"doc_id": 3482439, "edit_id": 11, "question": "What was the shortest follow-up period for patients in the study?", "category": "omission", "label": "extent"}, {"doc_id": 3482439, "edit_id": 12, "question": "What was the longest follow-up period for patients in the study?", "category": "omission", "label": "extent"}, {"doc_id": 3482439, "edit_id": 13, "question": "Which group had a longer fluoroscopy time in the study?", "category": "omission", "label": "comparison"}, {"doc_id": 3482439, "edit_id": 14, "question": "What was the new complication noticed in the group treated with cephalomedullary nails?", "category": "omission", "label": "consequence"}, {"doc_id": 3482439, "edit_id": 15, "question": "What specific type of fractures were the two implants compared for treating in the study?", "category": "omission", "label": "concept"}, {"doc_id": 3483284, "edit_id": 0, "question": "Is the process of ATP release from cells generally regulated?", "category": "omission", "label": "verification"}, {"doc_id": 3483284, "edit_id": 1, "question": "Through what mechanism do ATP and adenosine facilitate their functions in the body?", "category": "omission", "label": "procedural"}, {"doc_id": 3483284, "edit_id": 2, "question": "What type of study design was employed for this research on the effects of ATP supplementation?", "category": "omission", "label": "concept"}, {"doc_id": 3483284, "edit_id": 3, "question": "Was there a significant effect of ATP supplementation on low peak torque in set 2?", "category": "omission", "label": "verification"}, {"doc_id": 3483284, "edit_id": 4, "question": "Did the ATP supplementation have any observed effects on fatigue levels during the exercise?", "category": "omission", "label": "verification"}, {"doc_id": 3511949, "edit_id": 0, "question": "What is the main aim in treating people with knee osteoarthritis?", "category": "omission", "label": "concept"}, {"doc_id": 3511949, "edit_id": 1, "question": "What two treatments are being compared in this study?", "category": "omission", "label": "concept"}, {"doc_id": 3511949, "edit_id": 2, "question": "What is the purpose of the treatments being compared in the study?", "category": "omission", "label": "concept"}, {"doc_id": 3511949, "edit_id": 3, "question": "How were the patients assigned to the different treatment groups?", "category": "omission", "label": "procedural"}, {"doc_id": 3511949, "edit_id": 4, "question": "What treatment did Group M receive?", "category": "omission", "label": "concept"}, {"doc_id": 3511949, "edit_id": 5, "question": "Apart from morphine, what other substance did Group M receive?", "category": "omission", "label": "concept"}, {"doc_id": 3511949, "edit_id": 6, "question": "What treatment did Group T receive?", "category": "omission", "label": "concept"}, {"doc_id": 3511949, "edit_id": 7, "question": "How was the supplementary pain reliever given to the patients?", "category": "omission", "label": "procedural"}, {"doc_id": 3511949, "edit_id": 8, "question": "How much paracetamol was given to the patients each day?", "category": "omission", "label": "extent"}, {"doc_id": 3511949, "edit_id": 9, "question": "Did the paracetamol always provide enough pain relief for the patients?", "category": "omission", "label": "verification"}, {"doc_id": 3511949, "edit_id": 10, "question": "What was recommended if the paracetamol didn't provide enough relief?", "category": "omission", "label": "procedural"}, {"doc_id": 3511949, "edit_id": 11, "question": "How did the effectiveness of intra-articular morphine compare to that of intra-articular triamcinolone?", "category": "omission", "label": "comparison"}, {"doc_id": 3511949, "edit_id": 12, "question": "Why might morphine be a better choice for treating knee osteoarthritis pain than triamcinolone?", "category": "omission", "label": "cause"}, {"doc_id": 3515338, "edit_id": 0, "question": "What other problems are associated with mental health issues?", "category": "omission", "label": "consequence"}, {"doc_id": 3515338, "edit_id": 1, "question": "What two treatments were being compared in the study?", "category": "omission", "label": "disjunction"}, {"doc_id": 3515338, "edit_id": 2, "question": "From which perspective was this study conducted?", "category": "omission", "label": "concept"}, {"doc_id": 3515338, "edit_id": 3, "question": "Was the evaluation of the treatments part of a larger study?", "category": "omission", "label": "verification"}, {"doc_id": 3515338, "edit_id": 4, "question": "What indicates a positive score on the General Health Questionnaire used in this study?", "category": "omission", "label": "concept"}, {"doc_id": 3515338, "edit_id": 5, "question": "Were patients with a positive score on the General Health Questionnaire considered eligible for anything?", "category": "omission", "label": "verification"}, {"doc_id": 3515338, "edit_id": 6, "question": "What were the eligibility requirements for patients to participate in this study?", "category": "omission", "label": "procedural"}, {"doc_id": 3515338, "edit_id": 7, "question": "How did the study measure improvement in the patients' mental health?", "category": "omission", "label": "procedural"}, {"doc_id": 3515338, "edit_id": 8, "question": "Were there other metrics used to measure the outcome of the treatment in this study?", "category": "omission", "label": "verification"}, {"doc_id": 3515338, "edit_id": 9, "question": "How were the QALYs calculated?", "category": "omission", "label": "procedural"}, {"doc_id": 3515338, "edit_id": 10, "question": "How reliable is the questionnaire used to measure resource use in this study?", "category": "omission", "label": "extent"}, {"doc_id": 3515338, "edit_id": 11, "question": "Was all the cost data available for this study?", "category": "omission", "label": "verification"}, {"doc_id": 3515338, "edit_id": 12, "question": "Was all the effect data available?", "category": "omission", "label": "verification"}, {"doc_id": 3515338, "edit_id": 13, "question": "How were the missing cost and effect data dealt with?", "category": "omission", "label": "procedural"}, {"doc_id": 3515338, "edit_id": 14, "question": "What technique was used to deal with the missing data?", "category": "omission", "label": "procedural"}, {"doc_id": 3515338, "edit_id": 15, "question": "How did the researchers analyze the costs and cost-effectiveness of the two treatment methods?", "category": "omission", "label": "procedural"}, {"doc_id": 3515338, "edit_id": 16, "question": "What were the results in terms of any differences in clinical outcomes between the two groups?", "category": "omission", "label": "consequence"}, {"doc_id": 3515338, "edit_id": 17, "question": "What were the average total costs for the group receiving Problem-Solving Treatment?", "category": "omission", "label": "extent"}, {"doc_id": 3515338, "edit_id": 18, "question": "What were the average total costs for the group receiving usual care?", "category": "omission", "label": "extent"}, {"doc_id": 3515338, "edit_id": 19, "question": "What was the 95% confidence interval for the difference in costs between the two treatments?", "category": "omission", "label": "extent"}, {"doc_id": 3515338, "edit_id": 20, "question": "What were the two methods compared in the analysis?", "category": "omission", "label": "disjunction"}, {"doc_id": 3515338, "edit_id": 21, "question": "Which treatment method was found to be more cost-effective?", "category": "omission", "label": "disjunction"}, {"doc_id": 3515338, "edit_id": 22, "question": "Were any additional types of analysis done on the data from this study?", "category": "omission", "label": "verification"}, {"doc_id": 3515338, "edit_id": 23, "question": "Did the sensitivity analyses align with the primary findings of the study?", "category": "omission", "label": "verification"}, {"doc_id": 3515338, "edit_id": 24, "question": "In terms of cost-effectiveness, how do PST and UC compare?", "category": "omission", "label": "comparison"}, {"doc_id": 3515338, "edit_id": 25, "question": "Why was there a difference in the total costs between the PST and UC groups?", "category": "omission", "label": "cause"}, {"doc_id": 3515338, "edit_id": 26, "question": "What led to the high costs associated with the three outliers?", "category": "omission", "label": "cause"}, {"doc_id": 3515338, "edit_id": 27, "question": "In which group were these three outliers that had extremely high costs?", "category": "omission", "label": "disjunction"}, {"doc_id": 3564932, "edit_id": 0, "question": "How common is labor induction in obstetrics?", "category": "omission", "label": "extent"}, {"doc_id": 3564932, "edit_id": 1, "question": "What is the impact of labor induction on health service delivery?", "category": "omission", "label": "consequence"}, {"doc_id": 3564932, "edit_id": 2, "question": "What is an appealing method of labor induction in terms of setting?", "category": "omission", "label": "concept"}, {"doc_id": 3564932, "edit_id": 3, "question": "What medication is typically used for inpatient labor induction?", "category": "omission", "label": "concept"}, {"doc_id": 3564932, "edit_id": 4, "question": "What are the safety concerns regarding labor induction?", "category": "omission", "label": "consequence"}, {"doc_id": 3564932, "edit_id": 5, "question": "At what stage of pregnancy is the Foley catheter method used for labor induction?", "category": "omission", "label": "extent"}, {"doc_id": 3564932, "edit_id": 6, "question": "What characteristics did the women in the study have?", "category": "omission", "label": "concept"}, {"doc_id": 3564932, "edit_id": 7, "question": "Did the women in the outpatient group receive any tests before they were discharged?", "category": "omission", "label": "verification"}, {"doc_id": 3564932, "edit_id": 8, "question": "How much vaginal PGE2 was given to the nulliparous women in the inpatient group?", "category": "omission", "label": "extent"}, {"doc_id": 3564932, "edit_id": 9, "question": "Which group experienced less pain during cervical preparation?", "category": "omission", "label": "comparison"}, {"doc_id": 3564932, "edit_id": 10, "question": "Which group was more likely to require additional labor induction?", "category": "omission", "label": "comparison"}, {"doc_id": 3564932, "edit_id": 11, "question": "Is this study registered in any clinical trials registry?", "category": "omission", "label": "verification"}, {"doc_id": 3570228, "edit_id": 0, "question": "Did the study make use of a combination of drugs?", "category": "omission", "label": "verification"}, {"doc_id": 3570228, "edit_id": 1, "question": "What method was used to administer the drugs in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 3570228, "edit_id": 2, "question": "What drug concentrations were used for Group I in the study?", "category": "omission", "label": "extent"}, {"doc_id": 3570228, "edit_id": 3, "question": "What drug concentrations were used for Group II in the study?", "category": "omission", "label": "extent"}, {"doc_id": 3570228, "edit_id": 4, "question": "What drug concentrations were used for Group III during anesthesia induction in the study?", "category": "omission", "label": "extent"}, {"doc_id": 3570228, "edit_id": 5, "question": "What drug concentrations were used for Group III during anesthesia maintenance in the study?", "category": "omission", "label": "extent"}, {"doc_id": 3570228, "edit_id": 6, "question": "What drug concentration of remifentanil was used for Group IV during anesthesia induction in the study?", "category": "omission", "label": "extent"}, {"doc_id": 3570228, "edit_id": 7, "question": "What drug concentration of remifentanil was used for Group IV during anesthesia maintenance in the study?", "category": "omission", "label": "extent"}, {"doc_id": 3570228, "edit_id": 8, "question": "For which groups were the target concentrations used after intubation in the study?", "category": "omission", "label": "concept"}, {"doc_id": 3570228, "edit_id": 9, "question": "Why did the study measure levels of a hormone called norepinephrine in the blood?", "category": "omission", "label": "cause"}, {"doc_id": 3570228, "edit_id": 10, "question": "Why did the study measure levels of a hormone called epinephrine in the blood?", "category": "omission", "label": "cause"}, {"doc_id": 3570228, "edit_id": 11, "question": "Why did the study measure levels of a hormone called Angiotensin II in the blood?", "category": "omission", "label": "cause"}, {"doc_id": 3570228, "edit_id": 12, "question": "At what point after surgery did Group IV exhibit higher levels of the hormone norepinephrine?", "category": "omission", "label": "extent"}, {"doc_id": 3570228, "edit_id": 13, "question": "At what point after surgery did Group IV exhibit higher levels of the hormone epinephrine?", "category": "omission", "label": "extent"}, {"doc_id": 3570228, "edit_id": 14, "question": "Which group showed higher levels of the hormone Angiotensin II after surgery?", "category": "omission", "label": "comparison"}, {"doc_id": 3570228, "edit_id": 15, "question": "How long after surgery did Group IV exhibit higher levels of the hormone Angiotensin II?", "category": "omission", "label": "extent"}, {"doc_id": 3570228, "edit_id": 16, "question": "Were there any significant differences between the groups in terms of circulation fluctuation and hormone levels after surgery?", "category": "omission", "label": "verification"}, {"doc_id": 3570228, "edit_id": 17, "question": "Was there a significant difference in the time taken to wake up and remove the breathing tube after surgery between Group IV and the other groups?", "category": "omission", "label": "verification"}, {"doc_id": 3570228, "edit_id": 18, "question": "Was there a significant difference in the level of restlessness and pain reported by Group IV compared to the other groups after surgery?", "category": "omission", "label": "verification"}, {"doc_id": 3575357, "edit_id": 0, "question": "What else, besides heart health, were the researchers interested in analyzing?", "category": "omission", "label": "concept"}, {"doc_id": 3575357, "edit_id": 1, "question": "What type of study design did the researchers use for the experiment?", "category": "omission", "label": "concept"}, {"doc_id": 3575357, "edit_id": 2, "question": "What type of sampling method did the researchers use when selecting participants for the study?", "category": "omission", "label": "procedural"}, {"doc_id": 3575357, "edit_id": 3, "question": "How long did each session of the PAPP program last?", "category": "omission", "label": "extent"}, {"doc_id": 3575357, "edit_id": 4, "question": "How did the researchers measure the effectiveness of the program?", "category": "omission", "label": "procedural"}, {"doc_id": 3575357, "edit_id": 5, "question": "How did the researchers determine the participants' quality of life before and after the program?", "category": "omission", "label": "procedural"}, {"doc_id": 3575357, "edit_id": 6, "question": "What tool did the researchers in the study use to measure lung function?", "category": "omission", "label": "procedural"}, {"doc_id": 3575357, "edit_id": 7, "question": "Besides the spirometry, what other tool did the researchers use to measure cardiopulmonary function?", "category": "omission", "label": "procedural"}, {"doc_id": 3575357, "edit_id": 8, "question": "What protocol was followed when conducting the walking test?", "category": "omission", "label": "procedural"}, {"doc_id": 3575357, "edit_id": 9, "question": "Is this a full-scale study or a preliminary one?", "category": "omission", "label": "verification"}, {"doc_id": 3575357, "edit_id": 10, "question": "What was the statistical significance level of the results?", "category": "omission", "label": "extent"}, {"doc_id": 3575357, "edit_id": 11, "question": "What instrument was used to measure the quality of life in the group?", "category": "omission", "label": "procedural"}, {"doc_id": 3575357, "edit_id": 12, "question": "Were the changes in quality of life for the group of men who carried out the PAPP significant?", "category": "omission", "label": "verification"}, {"doc_id": 3580299, "edit_id": 0, "question": "What specific type of kidney stones was the treatment for in the study?", "category": "omission", "label": "concept"}, {"doc_id": 3580299, "edit_id": 1, "question": "How many physicians were involved in conducting the clinical trial? ", "category": "omission", "label": "extent"}, {"doc_id": 3580299, "edit_id": 2, "question": "What condition were the patients suffering from in this study?", "category": "omission", "label": "concept"}, {"doc_id": 3580299, "edit_id": 3, "question": "What was the dose of alfuzosin given to the first group of patients in the study?", "category": "omission", "label": "extent"}, {"doc_id": 3580299, "edit_id": 4, "question": "How often was the alfuzosin drug administered to the patients in the first group?", "category": "omission", "label": "procedural"}, {"doc_id": 3580299, "edit_id": 5, "question": "How often was the Loxoprofen sodium given to the patients in the first group?", "category": "omission", "label": "procedural"}, {"doc_id": 3580299, "edit_id": 6, "question": "How often was the Loxoprofen sodium given to the patients in the second group?", "category": "omission", "label": "procedural"}, {"doc_id": 3580299, "edit_id": 7, "question": "What measure was used to assess the patients' severity of pain in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 3580299, "edit_id": 8, "question": "What was the average pain severity score for the first group in the study?", "category": "omission", "label": "extent"}, {"doc_id": 3580299, "edit_id": 9, "question": "Was the difference in the time it took for patients to expel their kidney stones between the two groups statistically significant? ", "category": "omission", "label": "verification"}, {"doc_id": 3608893, "edit_id": 0, "question": "What type of diet was examined in the study?", "category": "omission", "label": "concept"}, {"doc_id": 3608893, "edit_id": 1, "question": "On what group of people was the portion-controlled diet tested?", "category": "omission", "label": "concept"}, {"doc_id": 3608893, "edit_id": 2, "question": "What was one of the health indicators monitored during the study?", "category": "omission", "label": "concept"}, {"doc_id": 3608893, "edit_id": 3, "question": "Was there a measure of the amount of variation or dispersion of a set of values in this study?", "category": "omission", "label": "verification"}, {"doc_id": 3608893, "edit_id": 4, "question": "Can you describe one of the programs used in the study?", "category": "omission", "label": "concept"}, {"doc_id": 3608893, "edit_id": 5, "question": "What was the other program used in the study?", "category": "omission", "label": "concept"}, {"doc_id": 3608893, "edit_id": 6, "question": "Did the participants in both groups see an improvement?", "category": "omission", "label": "verification"}, {"doc_id": 3608893, "edit_id": 7, "question": "What was the range of weight loss for participants on the portion-controlled diet?", "category": "omission", "label": "extent"}, {"doc_id": 3608893, "edit_id": 8, "question": "What was the range of weight loss for participants in the diabetes management group?", "category": "omission", "label": "extent"}, {"doc_id": 3608893, "edit_id": 9, "question": "Was the difference in weight loss between the portion-controlled diet group and the diabetes management group statistically significant?", "category": "omission", "label": "verification"}, {"doc_id": 3608893, "edit_id": 10, "question": "Was there a significant difference in the percentage of participants who lost 5% of their starting weight in the portion-controlled diet group and the diabetes management group?", "category": "omission", "label": "verification"}, {"doc_id": 3608893, "edit_id": 11, "question": "What percentage of the portion-controlled diet group lost 10% of their starting weight?", "category": "omission", "label": "extent"}, {"doc_id": 3608893, "edit_id": 12, "question": "Was the difference in the percentage of participants who lost 10% of their starting weight between the portion-controlled diet group and the diabetes management group statistically significant?", "category": "omission", "label": "verification"}, {"doc_id": 3608893, "edit_id": 13, "question": "By how much did the blood sugar levels decrease in the portion-controlled diet group?", "category": "omission", "label": "extent"}, {"doc_id": 3608893, "edit_id": 14, "question": "What was the interval for the decrease in blood sugar levels for participants on the portion-controlled diet?", "category": "omission", "label": "procedural"}, {"doc_id": 3608893, "edit_id": 15, "question": "Was the decrease in blood sugar levels in the portion-controlled diet group significantly greater than in the diabetes management group?", "category": "omission", "label": "comparison"}, {"doc_id": 3608893, "edit_id": 16, "question": "How are weight loss and the decrease in blood sugar levels related? ", "category": "omission", "label": "cause"}, {"doc_id": 3608893, "edit_id": 17, "question": "Can the portion-controlled meal plan lead to weight loss according to the findings of the study?", "category": "omission", "label": "verification"}, {"doc_id": 3608893, "edit_id": 18, "question": "Who provides management for obesity in primary care?", "category": "omission", "label": "example"}, {"doc_id": 3620559, "edit_id": 0, "question": "How were the patients in the study selected?", "category": "omission", "label": "procedural"}, {"doc_id": 3620559, "edit_id": 1, "question": "What was the anticipated outcome for the patients in this study?", "category": "omission", "label": "consequence"}, {"doc_id": 3620559, "edit_id": 2, "question": "Can you specify the sizes of the needles used for the egg collection in this study?", "category": "omission", "label": "procedural"}, {"doc_id": 3620559, "edit_id": 3, "question": "What classification was given to the 20 G/ 35 mm needle used in the study?", "category": "omission", "label": "concept"}, {"doc_id": 3620559, "edit_id": 4, "question": "And what about the 17 G/ 35 mm needle? How can we describe it?", "category": "omission", "label": "concept"}, {"doc_id": 3620559, "edit_id": 5, "question": " Apart from the standard size needle, what other type of needle was used to collect the eggs in this study?", "category": "omission", "label": "example"}, {"doc_id": 3620559, "edit_id": 6, "question": "Was there a relationship between a woman's weight and the number of eggs collected, and how strong was it?", "category": "omission", "label": "comparison"}, {"doc_id": 3620559, "edit_id": 7, "question": "Did the use of a thinner needle have a noteworthy impact on the length of the procedure?", "category": "omission", "label": "verification"}, {"doc_id": 3620559, "edit_id": 8, "question": "Does the conclusion about needle size and number of eggs collected apply to overweight women as well?", "category": "omission", "label": "verification"}, {"doc_id": 3620559, "edit_id": 9, "question": "What about women with fewer eggs left, does the same conclusion hold for them?", "category": "omission", "label": "verification"}, {"doc_id": 3628658, "edit_id": 0, "question": "What kind of method was used in the study to assign the patients to different treatment groups?", "category": "omission", "label": "procedural"}, {"doc_id": 3628658, "edit_id": 1, "question": "Did the group of patients who had surgery while lying on their back experience any complications post-surgery?", "category": "omission", "label": "consequence"}, {"doc_id": 3628658, "edit_id": 2, "question": "Who typically receives Proximal Femoral Nail Antirotation (PFNA) treatment, and for what type of injury?", "category": "omission", "label": "example"}, {"doc_id": 3630066, "edit_id": 0, "question": "What effects did the insufflation of CO2 have in previous models?", "category": "omission", "label": "consequence"}, {"doc_id": 3630066, "edit_id": 1, "question": "What specific type of neurons is activated by the insufflation of CO2 that could potentially result in pain relief?", "category": "omission", "label": "concept"}, {"doc_id": 3630066, "edit_id": 2, "question": "What is believed to be activated as a result of inhaling CO2 that could provide pain relief benefits?", "category": "omission", "label": "concept"}, {"doc_id": 3630066, "edit_id": 3, "question": "Which type of neurons is involved in the experience of craniofacial pain?", "category": "omission", "label": "concept"}, {"doc_id": 3630066, "edit_id": 4, "question": "How can inhaling CO2 potentially impact the neurons involved in craniofacial pain?", "category": "omission", "label": "cause"}, {"doc_id": 3630066, "edit_id": 5, "question": "Through what process are the effects of CO2 insufflation likely to be channeled?", "category": "omission", "label": "procedural"}, {"doc_id": 3630066, "edit_id": 6, "question": "Where in the body are these TRPV1 receptor-positive neurons located?", "category": "omission", "label": "concept"}, {"doc_id": 3630066, "edit_id": 7, "question": "What happens as a result of activating TRPV1 receptor-positive neurons?", "category": "omission", "label": "consequence"}, {"doc_id": 3630066, "edit_id": 8, "question": "What is one of the central inhibitory effects caused by the activation of TRPV1 receptor-positive neurons?", "category": "omission", "label": "consequence"}, {"doc_id": 3630066, "edit_id": 9, "question": "Was the experiment unique or had similar ones been conducted before?", "category": "omission", "label": "verification"}, {"doc_id": 3630066, "edit_id": 10, "question": "Why was capsaicin administered into the nose in this study?", "category": "omission", "label": "cause"}, {"doc_id": 3630066, "edit_id": 11, "question": "How was the trigeminal pain created in this study?", "category": "omission", "label": "procedural"}, {"doc_id": 3630066, "edit_id": 12, "question": "What was the flow rate of the CO2 or air that was insufflated?", "category": "omission", "label": "extent"}, {"doc_id": 3630066, "edit_id": 13, "question": "Did they conduct another experiment after the first one?", "category": "omission", "label": "verification"}, {"doc_id": 3630066, "edit_id": 14, "question": "How long were the participants exposed to the treatment or placebo?", "category": "omission", "label": "extent"}, {"doc_id": 3630066, "edit_id": 15, "question": "Have there been previous studies on the effects of CO2 on trigeminal pain?", "category": "omission", "label": "verification"}, {"doc_id": 3630066, "edit_id": 16, "question": "What did the recent study find about the effects of CO2 on experimental trigeminal pain?", "category": "omission", "label": "consequence"}, {"doc_id": 3630066, "edit_id": 17, "question": "What was the focus of the first experiment in this study?", "category": "omission", "label": "concept"}, {"doc_id": 3630066, "edit_id": 18, "question": "What was the measured statistical significance for the effect of the main factor GROUP in the first experiment?", "category": "omission", "label": "extent"}, {"doc_id": 3630066, "edit_id": 19, "question": "Was the interaction between TIME and GROUP significant in the experiment?", "category": "omission", "label": "verification"}, {"doc_id": 3630066, "edit_id": 20, "question": "What statistical test was used in the experiment to analyze the data?", "category": "omission", "label": "procedural"}, {"doc_id": 3630066, "edit_id": 21, "question": "What type of model was used in the study to evaluate the effect of CO2 on facial pain?", "category": "omission", "label": "concept"}, {"doc_id": 3656551, "edit_id": 0, "question": "How was the selection of participants for the different vaccine doses determined in this study?", "category": "omission", "label": "procedural"}, {"doc_id": 3656551, "edit_id": 1, "question": "In how many locations was the study carried out?", "category": "omission", "label": "extent"}, {"doc_id": 3656551, "edit_id": 2, "question": "How many children were given the smaller dose (0.25 ml) of the study vaccine?", "category": "omission", "label": "extent"}, {"doc_id": 3656551, "edit_id": 3, "question": "How many children were given the larger dose (0.5 ml) of the study vaccine?", "category": "omission", "label": "extent"}, {"doc_id": 3656551, "edit_id": 4, "question": "How many children were given the smaller dose (0.25 ml) of the vaccine that was being compared to the study vaccine (comparator vaccine)?", "category": "omission", "label": "extent"}, {"doc_id": 3656551, "edit_id": 5, "question": "Did the performance of all doses of the vaccine meet the standards or criteria set by regulatory bodies?", "category": "omission", "label": "verification"}, {"doc_id": 3656551, "edit_id": 6, "question": "Did the study look at how participants reacted to the two different doses in terms of side effects (reactogenicity)?", "category": "omission", "label": "verification"}, {"doc_id": 3656551, "edit_id": 7, "question": "Have other studies been conducted comparing different doses of flu vaccines in young children?", "category": "omission", "label": "verification"}, {"doc_id": 3656551, "edit_id": 8, "question": "What age group is the main focus of these studies?", "category": "omission", "label": "concept"}, {"doc_id": 3656551, "edit_id": 9, "question": "Which type of influenza vaccines were used in these studies?", "category": "omission", "label": "concept"}, {"doc_id": 3658388, "edit_id": 0, "question": "What kind of design was used for the study on low-level laser hearing treatment?", "category": "omission", "label": "concept"}, {"doc_id": 3658388, "edit_id": 1, "question": "What specific auditory tests were utilized in this study to measure the hearing abilities of the participants?", "category": "omission", "label": "procedural"}, {"doc_id": 3659039, "edit_id": 0, "question": "What are the most important omega-3 fatty acids?", "category": "omission", "label": "concept"}, {"doc_id": 3659039, "edit_id": 1, "question": "What happens to the level of omega-6 PUFAs when the levels of EPA and DHA increase?", "category": "omission", "label": "consequence"}, {"doc_id": 3659039, "edit_id": 2, "question": "What is one example of an omega-6 PUFA?", "category": "omission", "label": "example"}, {"doc_id": 3659039, "edit_id": 3, "question": "Apart from arachidonic acid, which other fatty acid is an omega-6 PUFA?", "category": "omission", "label": "example"}, {"doc_id": 3659039, "edit_id": 4, "question": "What was the duration of the omega-3 PUFA supply in the treatment?", "category": "omission", "label": "extent"}, {"doc_id": 3659039, "edit_id": 5, "question": "What was the main aim of the study in terms of fatty acid levels?", "category": "omission", "label": "concept"}, {"doc_id": 3659039, "edit_id": 6, "question": "Which fatty acids were measured in the study?", "category": "omission", "label": "concept"}, {"doc_id": 3659039, "edit_id": 7, "question": "Where else, apart from the blood plasma, were the fatty acid levels measured?", "category": "omission", "label": "concept"}, {"doc_id": 3659039, "edit_id": 8, "question": "When were the measurements taken after the cessation of the infusion?", "category": "omission", "label": "extent"}, {"doc_id": 3659039, "edit_id": 9, "question": "What was the average time for measurements after the infusion was stopped?", "category": "omission", "label": "extent"}, {"doc_id": 3659039, "edit_id": 10, "question": "What change was observed in the plasma PC EPA levels in the treatment group?", "category": "omission", "label": "consequence"}, {"doc_id": 3659039, "edit_id": 11, "question": "How did the plasma PC DHA levels change in the treatment group?", "category": "omission", "label": "comparison"}, {"doc_id": 3659039, "edit_id": 12, "question": "What change was observed in the erythrocyte linoleic acid levels in the treatment group?", "category": "omission", "label": "consequence"}, {"doc_id": 3659039, "edit_id": 13, "question": "How did the erythrocyte EPA levels change in the treatment group?", "category": "omission", "label": "comparison"}, {"doc_id": 3659039, "edit_id": 14, "question": "What happened to the plasma PC levels after the 5-12 day washout period?", "category": "omission", "label": "consequence"}, {"doc_id": 3659039, "edit_id": 15, "question": "What happened to the erythrocyte EPA and linoleic acid levels after the 5-12 day washout period?", "category": "omission", "label": "consequence"}, {"doc_id": 3659039, "edit_id": 16, "question": "What happened to the Plasma PC DHA levels after the washout period?", "category": "omission", "label": "consequence"}, {"doc_id": 3671234, "edit_id": 0, "question": "Are there any criticisms of spinal anesthesia commonly known?", "category": "omission", "label": "concept"}, {"doc_id": 3671234, "edit_id": 1, "question": "Are there other medicines given alongside the local anesthetic in spinal anesthesia procedures?", "category": "omission", "label": "procedural"}, {"doc_id": 3671234, "edit_id": 2, "question": "Was the study looking forward at future results or examining past data?", "category": "omission", "label": "verification"}, {"doc_id": 3671234, "edit_id": 3, "question": "In this study, did both the patients and the researchers know who received which treatment?", "category": "omission", "label": "verification"}, {"doc_id": 3671234, "edit_id": 4, "question": "Was the study design open label? ", "category": "omission", "label": "verification"}, {"doc_id": 3671234, "edit_id": 5, "question": "What was the American Society of Anaesthesiologists (ASA) status of the patients in the study?", "category": "omission", "label": "concept"}, {"doc_id": 3671234, "edit_id": 6, "question": "What type of surgery were the patients in the study scheduled for?", "category": "omission", "label": "concept"}, {"doc_id": 3671234, "edit_id": 7, "question": "What was given to patients in the first group along with the normal anesthetic?", "category": "omission", "label": "procedural"}, {"doc_id": 3671234, "edit_id": 8, "question": "Where was the treatment for the first group administered?", "category": "omission", "label": "procedural"}, {"doc_id": 3671234, "edit_id": 9, "question": "What was the anesthetic used for the second group of patients?", "category": "omission", "label": "procedural"}, {"doc_id": 3671234, "edit_id": 10, "question": "In addition to the anesthetic, what else was given to the patients in the second group?", "category": "omission", "label": "procedural"}, {"doc_id": 3671234, "edit_id": 11, "question": "What was the exact dosage of midazolam given to patients in the second group?", "category": "omission", "label": "extent"}, {"doc_id": 3671234, "edit_id": 12, "question": "How long does the pain relief typically last when only the regular anesthetic is used? ", "category": "omission", "label": "extent"}, {"doc_id": 3671234, "edit_id": 13, "question": "How does the use of midazolam affect numbness in the patient?", "category": "omission", "label": "comparison"}, {"doc_id": 3671234, "edit_id": 14, "question": "How long does the numbness last when only the regular anesthesia is used?", "category": "omission", "label": "extent"}, {"doc_id": 3681405, "edit_id": 0, "question": "What stage of non-small cell lung cancer did all the patients in the study have?", "category": "omission", "label": "concept"}, {"doc_id": 3681405, "edit_id": 1, "question": "Did the patients receive any treatment after the surgery?", "category": "omission", "label": "verification"}, {"doc_id": 3681405, "edit_id": 2, "question": "What was the average survival duration for the patients who received chemotherapy before surgery?", "category": "omission", "label": "extent"}, {"doc_id": 3681405, "edit_id": 3, "question": "Was the difference in average survival times between the group that received chemotherapy before surgery and the surgery-first group statistically significant?", "category": "omission", "label": "verification"}, {"doc_id": 3681405, "edit_id": 4, "question": "Was the survival difference for patients with Stage II non-small cell lung cancer significant?", "category": "omission", "label": "verification"}, {"doc_id": 3681405, "edit_id": 5, "question": "What was the hazard ratio for patients with Stage I non-small cell lung cancer?", "category": "omission", "label": "extent"}, {"doc_id": 3681405, "edit_id": 6, "question": "Was the hazard ratio for Stage I patients statistically significant?", "category": "omission", "label": "verification"}, {"doc_id": 3681405, "edit_id": 7, "question": "Was the difference in survival rates between those who seemed to get better after preoperative chemotherapy and the others statistically significant?", "category": "omission", "label": "verification"}, {"doc_id": 3687098, "edit_id": 0, "question": "Who conducted the initial pooled analysis of the 19 studies mentioned in the introduction?", "category": "omission", "label": "concept"}, {"doc_id": 3687098, "edit_id": 1, "question": "To which program do the completed studies on sitagliptin belong?", "category": "omission", "label": "concept"}, {"doc_id": 3687098, "edit_id": 2, "question": "How many studies was the data in the analysis derived from and what type were they?", "category": "omission", "label": "extent"}, {"doc_id": 3687098, "edit_id": 3, "question": "What condition did all the patients included in the studies have?", "category": "omission", "label": "concept"}, {"doc_id": 3687098, "edit_id": 4, "question": "What type of trials were the studies mentioned in the analysis?", "category": "omission", "label": "concept"}, {"doc_id": 3687098, "edit_id": 5, "question": "In what kind of therapy involving sitagliptin was used in some of the studies?", "category": "omission", "label": "example"}, {"doc_id": 3687098, "edit_id": 6, "question": "What type of diabetes did all patients in these studies have?", "category": "omission", "label": "concept"}, {"doc_id": 3691658, "edit_id": 0, "question": "What type of study was conducted to test the effects of vitamin D on Multiple Sclerosis patients receiving IFN-\u03b2 treatment?", "category": "omission", "label": "concept"}, {"doc_id": 3691658, "edit_id": 1, "question": "Were any other substances in the patient's blood checked during the test?", "category": "omission", "label": "verification"}, {"doc_id": 3691658, "edit_id": 2, "question": "Did the researchers check the patients' blood for any hormones?", "category": "omission", "label": "verification"}, {"doc_id": 3691658, "edit_id": 3, "question": "What other proteins were checked in the patients' blood?", "category": "omission", "label": "concept"}, {"doc_id": 3691658, "edit_id": 4, "question": "Did the researchers measure any other chemicals in the patients' blood during the study?", "category": "omission", "label": "verification"}, {"doc_id": 3691658, "edit_id": 5, "question": "Did the researchers document any adverse events during the trial?", "category": "omission", "label": "verification"}, {"doc_id": 3691658, "edit_id": 6, "question": "What happened to the levels of the hormone PTH in patients' blood during the trial?", "category": "omission", "label": "consequence"}, {"doc_id": 3691658, "edit_id": 7, "question": "Were there any changes in the flu-like symptoms experienced by the patients during the treatment?", "category": "omission", "label": "consequence"}, {"doc_id": 3691658, "edit_id": 8, "question": "How did IL-17 levels change in patients who were given the larger dose of Vitamin D3?", "category": "omission", "label": "comparison"}, {"doc_id": 3691658, "edit_id": 9, "question": "What were the changes in IL-10 levels observed in the trial?", "category": "omission", "label": "consequence"}, {"doc_id": 3730064, "edit_id": 0, "question": "What specific condition does the study focus on?", "category": "omission", "label": "concept"}, {"doc_id": 3730064, "edit_id": 1, "question": "How many patients with corneal NV were involved in the study?", "category": "omission", "label": "extent"}, {"doc_id": 3730064, "edit_id": 2, "question": "What treatment did the first group of patients receive?", "category": "omission", "label": "concept"}, {"doc_id": 3730064, "edit_id": 3, "question": "How many patients were in the first group (group 1)?", "category": "omission", "label": "extent"}, {"doc_id": 3730064, "edit_id": 4, "question": "What treatment did the second group of patients receive?", "category": "omission", "label": "concept"}, {"doc_id": 3730064, "edit_id": 5, "question": "How many patients were in the second group (group 2)?", "category": "omission", "label": "extent"}, {"doc_id": 3730064, "edit_id": 6, "question": "How were the injections administered?", "category": "omission", "label": "procedural"}, {"doc_id": 3730064, "edit_id": 7, "question": "What type of follow-up was used in the study?", "category": "omission", "label": "concept"}, {"doc_id": 3730064, "edit_id": 8, "question": "How long was the follow-up period in the study?", "category": "omission", "label": "extent"}, {"doc_id": 3730064, "edit_id": 9, "question": "What measurements were taken in the study?", "category": "omission", "label": "concept"}, {"doc_id": 3730064, "edit_id": 10, "question": "How were the corneal NV areas observed?", "category": "omission", "label": "procedural"}, {"doc_id": 3730064, "edit_id": 11, "question": "In what format were the photographs from the corneal slit-lamp stored?", "category": "omission", "label": "procedural"}, {"doc_id": 3730064, "edit_id": 12, "question": "How were the corneal NV areas measured precisely?", "category": "omission", "label": "procedural"}, {"doc_id": 3730064, "edit_id": 13, "question": "When was the calculation of corneal NV areas done?", "category": "omission", "label": "procedural"}, {"doc_id": 3730064, "edit_id": 14, "question": "How many women took part in the study and were found to have corneal NV?", "category": "omission", "label": "extent"}, {"doc_id": 3730064, "edit_id": 15, "question": "How many men took part in the study and were found to have corneal NV?", "category": "omission", "label": "extent"}, {"doc_id": 3730064, "edit_id": 16, "question": "What was the average age of the patients in the study?", "category": "omission", "label": "extent"}, {"doc_id": 3730064, "edit_id": 17, "question": "What caused most of the cases of corneal NV in this study?", "category": "omission", "label": "cause"}, {"doc_id": 3730064, "edit_id": 18, "question": "For what reason did some patients develop corneal NV?", "category": "omission", "label": "cause"}, {"doc_id": 3730064, "edit_id": 19, "question": "What uncommon condition resulted in corneal NV in one of the cases?", "category": "omission", "label": "example"}, {"doc_id": 3730064, "edit_id": 20, "question": "What other condition led to corneal NV in this study?", "category": "omission", "label": "cause"}, {"doc_id": 3730064, "edit_id": 21, "question": "What was the average size of the abnormal blood vessels in the eyes of the patients in group 1 before their treatments?", "category": "omission", "label": "extent"}, {"doc_id": 3730064, "edit_id": 22, "question": "What change was observed one week after the treatment in group 1?", "category": "omission", "label": "consequence"}, {"doc_id": 3730064, "edit_id": 23, "question": "What was the average size of the abnormal blood vessels in the eyes of the patients in group 1 one month after their injections?", "category": "omission", "label": "extent"}, {"doc_id": 3730064, "edit_id": 24, "question": "Was the decrease in the size of the abnormal blood vessels one week after the injection considered statistically significant?", "category": "omission", "label": "verification"}, {"doc_id": 3730064, "edit_id": 25, "question": "Was the decrease in the size of the abnormal blood vessels one month after the injection considered statistically significant?", "category": "omission", "label": "verification"}, {"doc_id": 3730064, "edit_id": 26, "question": "What was the average size of the abnormal blood vessels in the eyes of the patients in group 2 before their treatments?", "category": "omission", "label": "extent"}, {"doc_id": 3730064, "edit_id": 27, "question": "What change was observed one week after the treatment in group 2?", "category": "omission", "label": "consequence"}, {"doc_id": 3730064, "edit_id": 28, "question": "Was the reduction in the size of abnormal blood vessels one week after the injection in group 2 statistically significant?", "category": "omission", "label": "verification"}, {"doc_id": 3730064, "edit_id": 29, "question": "When was the change in the size of the abnormal blood vessels in the eyes of the patients in group 2 measured?", "category": "omission", "label": "procedural"}, {"doc_id": 3730064, "edit_id": 30, "question": "By how much did the abnormal blood vessels decrease on average in the eyes of the patients in group 1 after their injections?", "category": "omission", "label": "extent"}, {"doc_id": 3730064, "edit_id": 31, "question": "What was the variability in the decrease of the abnormal blood vessels in the eyes of the patients in group 1?", "category": "omission", "label": "extent"}, {"doc_id": 3730064, "edit_id": 32, "question": "By how much did the abnormal blood vessels decrease on average in the eyes of the patients in group 2 after their injections?", "category": "omission", "label": "extent"}, {"doc_id": 3730064, "edit_id": 33, "question": "What was the variability in the decrease of the abnormal blood vessels in the eyes of the patients in group 2?", "category": "omission", "label": "extent"}, {"doc_id": 3730064, "edit_id": 34, "question": "Was the difference between the reductions in abnormal blood vessels in groups 1 and 2 statistically significant?", "category": "omission", "label": "verification"}, {"doc_id": 3730064, "edit_id": 35, "question": "What was the result of the bevacizumab injection on corneal NV?", "category": "omission", "label": "consequence"}, {"doc_id": 3730064, "edit_id": 36, "question": "What was the result of the ranibizumab injection on corneal NV?", "category": "omission", "label": "consequence"}, {"doc_id": 3730064, "edit_id": 37, "question": "Which injection resulted in a more stable decrease in abnormal blood vessels?", "category": "omission", "label": "comparison"}, {"doc_id": 3730064, "edit_id": 38, "question": "How many drugs are being considered for the treatment of corneal NV?", "category": "omission", "label": "extent"}, {"doc_id": 3751568, "edit_id": 0, "question": "Have there been any previous studies examining the effects of exercising within the normal movement range on results?", "category": "omission", "label": "verification"}, {"doc_id": 3751568, "edit_id": 1, "question": "What population is this study mainly focused on?", "category": "omission", "label": "concept"}, {"doc_id": 3751568, "edit_id": 2, "question": "Besides quality of life and function, was there any other measurement done at the start of the study?", "category": "omission", "label": "verification"}, {"doc_id": 3751568, "edit_id": 3, "question": "Who were the participants of the study?", "category": "omission", "label": "concept"}, {"doc_id": 3751568, "edit_id": 4, "question": "Where there any advantages of exercising into the hypermobile range compared to neutral range?", "category": "omission", "label": "comparison"}, {"doc_id": 3751568, "edit_id": 5, "question": "What type of exercise program was applied in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 3751568, "edit_id": 6, "question": "In which group of children was knee pain occurring?", "category": "omission", "label": "concept"}, {"doc_id": 3780629, "edit_id": 0, "question": "What are CBM protocols and how are they used in experimental medicine?", "category": "omission", "label": "concept"}, {"doc_id": 3780629, "edit_id": 1, "question": "What other form of therapy could be beneficially combined with CBM protocols according to the study?", "category": "omission", "label": "concept"}, {"doc_id": 3780629, "edit_id": 2, "question": "What type of study was used to examine the effects of the program?", "category": "omission", "label": "concept"}, {"doc_id": 3780629, "edit_id": 3, "question": "What was the specific focus of the randomized controlled trial?", "category": "omission", "label": "concept"}, {"doc_id": 3780629, "edit_id": 4, "question": "Apart from CBM protocol, what was another aspect that the trial was evaluating?", "category": "omission", "label": "example"}, {"doc_id": 3780629, "edit_id": 5, "question": "How long was the treatment program and how was it broken down?", "category": "omission", "label": "procedural"}, {"doc_id": 3780629, "edit_id": 6, "question": "How many patients were in the group that underwent the treatment program?", "category": "omission", "label": "extent"}, {"doc_id": 3780629, "edit_id": 7, "question": "How many patients were in the control group?", "category": "omission", "label": "extent"}, {"doc_id": 3780629, "edit_id": 8, "question": "What kind of statistical models were used in the study?", "category": "omission", "label": "concept"}, {"doc_id": 3780629, "edit_id": 9, "question": "How were the statistical analyses conducted in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 3780629, "edit_id": 10, "question": "How were the effect sizes of the treatment measured in this study?", "category": "omission", "label": "procedural"}, {"doc_id": 3780629, "edit_id": 11, "question": "What was the range of the Cohen's d values in the study?", "category": "omission", "label": "extent"}, {"doc_id": 3780629, "edit_id": 12, "question": "When were the reductions in depression symptoms observed?", "category": "omission", "label": "consequence"}, {"doc_id": 3780629, "edit_id": 13, "question": "Were reductions in depression symptoms observed after the combined CBM and online therapy intervention as well?", "category": "omission", "label": "verification"}, {"doc_id": 3780629, "edit_id": 14, "question": "What effect did changes in interpretation bias have on depression symptoms?", "category": "omission", "label": "consequence"}, {"doc_id": 3780629, "edit_id": 15, "question": "After what treatment did the reduction in depression symptoms occur?", "category": "omission", "label": "cause"}, {"doc_id": 3780629, "edit_id": 16, "question": "What aspect of the treatment led to a change in the interpretation bias of the patients?", "category": "omission", "label": "cause"}, {"doc_id": 3780629, "edit_id": 17, "question": "How did the treatment compare to the control group?", "category": "omission", "label": "comparison"}, {"doc_id": 3780629, "edit_id": 18, "question": "How did the researchers measure the superiority of the treatment over the wait-list control group?", "category": "omission", "label": "procedural"}, {"doc_id": 3780629, "edit_id": 19, "question": "What was the range of the Cohen's d values seen in the secondary measures associated with depression like disability, anxiety, and repetitive negative thinking?", "category": "omission", "label": "extent"}, {"doc_id": 3780629, "edit_id": 20, "question": "How many patients showed a clinically significant change after the Computerized cognitive-bias modification intervention?", "category": "omission", "label": "extent"}, {"doc_id": 3781573, "edit_id": 0, "question": "What kind of trial was conducted to gather this information on the treatments for diabetes?", "category": "omission", "label": "concept"}, {"doc_id": 3781573, "edit_id": 1, "question": "How often was diabetic peripheral neuropathy assessed during the study?", "category": "omission", "label": "procedural"}, {"doc_id": 3781573, "edit_id": 2, "question": "For how long did the people participating in the study have their diabetic peripheral neuropathy assessed?", "category": "omission", "label": "extent"}, {"doc_id": 3781573, "edit_id": 3, "question": "What statistical modeling method was used to compare the data?", "category": "omission", "label": "procedural"}, {"doc_id": 3781573, "edit_id": 4, "question": "Can you tell me the average age of the people that were part of the study?", "category": "omission", "label": "extent"}, {"doc_id": 3781573, "edit_id": 5, "question": "On average, for how long have the study participants had diabetes?", "category": "omission", "label": "extent"}, {"doc_id": 3781573, "edit_id": 6, "question": "How many participants did not have diabetic peripheral neuropathy when the study began?", "category": "omission", "label": "extent"}, {"doc_id": 3781573, "edit_id": 7, "question": "In which group of people did the insulin-sensitizing treatment show a greater benefit?", "category": "omission", "label": "comparison"}, {"doc_id": 3781573, "edit_id": 8, "question": "What kind of therapy was used on some patients?", "category": "omission", "label": "example"}, {"doc_id": 3781573, "edit_id": 9, "question": "What other treatment strategy was used on patients apart from the insulin-sensitizing approach?", "category": "omission", "label": "example"}, {"doc_id": 3798949, "edit_id": 0, "question": "What is the suggested frequency of conducting clinical trials, according to the original text?", "category": "omission", "label": "concept"}, {"doc_id": 3798949, "edit_id": 1, "question": "How does the original text view the importance of clinical trials?", "category": "omission", "label": "judgmental"}, {"doc_id": 3798949, "edit_id": 2, "question": "According to the original text, what relationship should clinical trials have with routine patient care?", "category": "omission", "label": "judgmental"}, {"doc_id": 3798949, "edit_id": 3, "question": "What type of clinical trials were performed according to the original text?", "category": "omission", "label": "concept"}, {"doc_id": 3798949, "edit_id": 4, "question": "For which part of the trial were the treatment costs calculated, according to the original text?", "category": "omission", "label": "concept"}, {"doc_id": 3798949, "edit_id": 5, "question": "What type of clinical trials were conducted, as per the original text?", "category": "omission", "label": "concept"}, {"doc_id": 3798949, "edit_id": 6, "question": "What factors were considered while estimating the average treatment cost in the original text?", "category": "omission", "label": "concept"}, {"doc_id": 3798949, "edit_id": 7, "question": "How many of the clinical trial protocols referred to in the original statement were in Phase III?", "category": "omission", "label": "extent"}, {"doc_id": 3798949, "edit_id": 8, "question": "How many of the clinical trial protocols referred to in the original statement spanned both Phase II and Phase III? ", "category": "omission", "label": "extent"}, {"doc_id": 3798949, "edit_id": 9, "question": "How many of the trial protocols in the original text were of Phase II design?", "category": "omission", "label": "extent"}, {"doc_id": 3798949, "edit_id": 10, "question": "According to the original text, how many of the trials were sponsored by commercial entities?", "category": "omission", "label": "extent"}, {"doc_id": 3814649, "edit_id": 0, "question": "What specific aspect of the treatment were the studies looking at closely?", "category": "omission", "label": "concept"}, {"doc_id": 3814649, "edit_id": 1, "question": "What specific phases of cell growth and development were the studies examining?", "category": "omission", "label": "concept"}, {"doc_id": 3814649, "edit_id": 2, "question": "What ingredient is included in the warming solution?", "category": "omission", "label": "concept"}, {"doc_id": 3814649, "edit_id": 3, "question": "What stage were the cow egg cells at during the experiments?", "category": "omission", "label": "concept"}, {"doc_id": 3814649, "edit_id": 4, "question": "How were the cow egg cells divided for the experiments?", "category": "omission", "label": "procedural"}, {"doc_id": 3814649, "edit_id": 5, "question": "What was the name given to the second group in the studies?", "category": "omission", "label": "concept"}, {"doc_id": 3814649, "edit_id": 6, "question": "What treatment did the cow egg cells in the second group receive?", "category": "omission", "label": "concept"}, {"doc_id": 3814649, "edit_id": 7, "question": "What substances are included in the vitrification solution 1 (VS1)?", "category": "omission", "label": "concept"}, {"doc_id": 3814649, "edit_id": 8, "question": "How long and at what temperature were the egg cells in the second group, VS1, exposed to the vitrification solution 1 (VS1)?", "category": "omission", "label": "procedural"}, {"doc_id": 3814649, "edit_id": 9, "question": "What is the name of the third group in the experiments?", "category": "omission", "label": "concept"}, {"doc_id": 3814649, "edit_id": 10, "question": "What happened to the COCs after they were treated and/or warmed?", "category": "omission", "label": "consequence"}, {"doc_id": 3814649, "edit_id": 11, "question": "What happened to the COCs after they matured?", "category": "omission", "label": "consequence"}, {"doc_id": 3814649, "edit_id": 12, "question": "What happened to the COCs after they were fertilized?", "category": "omission", "label": "consequence"}, {"doc_id": 3814649, "edit_id": 13, "question": "What aspects of the COC's growth and development did the experiment specifically measure?", "category": "omission", "label": "concept"}, {"doc_id": 3814649, "edit_id": 14, "question": "What part of the treatment process showed no effect on the COC's growth and development?", "category": "omission", "label": "consequence"}, {"doc_id": 3814649, "edit_id": 15, "question": "How were the growth and development rates of the COCs in the Vitrified group affected by the process?", "category": "omission", "label": "consequence"}, {"doc_id": 3814649, "edit_id": 16, "question": "Was the difference in growth and development rates of the COCs between the Vitrified group and the other groups a small random variation or was it a large and meaningful difference?", "category": "omission", "label": "comparison"}, {"doc_id": 3814649, "edit_id": 17, "question": "What were the cell splitting and embryo formation rates of the COCs in the Vitrified group in the first experiment?", "category": "omission", "label": "extent"}, {"doc_id": 3814649, "edit_id": 18, "question": "What were the cell splitting and embryo formation rates of the COCs in the Control group in the first experiment?", "category": "omission", "label": "extent"}, {"doc_id": 3814649, "edit_id": 19, "question": "What were the cell splitting and embryo formation rates of the COCs in the VS1 group in the first experiment?", "category": "omission", "label": "extent"}, {"doc_id": 3814649, "edit_id": 20, "question": "What were the cell splitting and embryo formation rates of the COCs in the VS1 + VS2 group in the first experiment?", "category": "omission", "label": "extent"}, {"doc_id": 3814649, "edit_id": 21, "question": "What were the cell splitting and embryo formation rates of the COCs in the Vitrified group in the second experiment?", "category": "omission", "label": "extent"}, {"doc_id": 3814649, "edit_id": 22, "question": "What were the cell splitting and embryo formation rates of the COCs in the Control group in the second experiment?", "category": "omission", "label": "extent"}, {"doc_id": 3814649, "edit_id": 23, "question": "What were the cell splitting and embryo formation rates of the COCs in the VS1 group in the second experiment?", "category": "omission", "label": "extent"}, {"doc_id": 3814649, "edit_id": 24, "question": "What types of solutions were the COCs exposed to?", "category": "omission", "label": "procedural"}, {"doc_id": 3814649, "edit_id": 25, "question": "What special type of protectants do the VS1 and VS2 solutions contain?", "category": "omission", "label": "concept"}, {"doc_id": 3814649, "edit_id": 26, "question": "What are the names of the permeating cryoprotectants found in the VS1 and VS2 solutions?", "category": "omission", "label": "concept"}, {"doc_id": 3814649, "edit_id": 27, "question": "Besides the cryoprotectants, did the COCs receive any other types of treatment?", "category": "omission", "label": "verification"}, {"doc_id": 3814649, "edit_id": 28, "question": "Did the amount of time the COCs spent in the warming solution have any negative effects on their growth and development?", "category": "omission", "label": "verification"}, {"doc_id": 3814649, "edit_id": 29, "question": "Did the cryoprotectants used, EG and DMSO, have any negative effects on the COCs?", "category": "omission", "label": "verification"}, {"doc_id": 3816909, "edit_id": 0, "question": "Were specific genetic variants examined in the study, and if so, which ones?", "category": "omission", "label": "verification"}, {"doc_id": 3816909, "edit_id": 1, "question": "How many adults were part of the genotyping process in this study?", "category": "omission", "label": "extent"}, {"doc_id": 3816909, "edit_id": 2, "question": "What was the average age of the adults in the study?", "category": "omission", "label": "extent"}, {"doc_id": 3816909, "edit_id": 3, "question": "What was the average Body Mass Index (or BMI, a measure of body fat based on height and weight) of the adults in this study?", "category": "omission", "label": "extent"}, {"doc_id": 3816909, "edit_id": 4, "question": "How many individuals were part of the high-fat diet group in this study?", "category": "omission", "label": "extent"}, {"doc_id": 3816909, "edit_id": 5, "question": "How many people were part of the low-fat diet group in this study?", "category": "omission", "label": "extent"}, {"doc_id": 3816909, "edit_id": 6, "question": "What specific genetic type was considered in this study?", "category": "omission", "label": "concept"}, {"doc_id": 3816909, "edit_id": 7, "question": "Which other genetic variant was tested in addition to rs1522813 in this study?", "category": "omission", "label": "concept"}, {"doc_id": 3816909, "edit_id": 8, "question": "Did people with a certain genetic type see a higher decrease in MetS conditions with the high-fat diet?", "category": "omission", "label": "verification"}, {"doc_id": 3816909, "edit_id": 9, "question": "How much more likely were the rs1522813 A-allele carriers to see a decrease of MetS on the high-fat diet?", "category": "omission", "label": "extent"}, {"doc_id": 3816909, "edit_id": 10, "question": "What was the range of this odds ratio for those who do not carry the A-allele of rs1522813?", "category": "omission", "label": "extent"}, {"doc_id": 3816909, "edit_id": 11, "question": "Where is the rs1522813 variant located?", "category": "omission", "label": "concept"}, {"doc_id": 3821103, "edit_id": 0, "question": "What type of pain relief is commonly used after minor knee surgery?", "category": "omission", "label": "concept"}, {"doc_id": 3821103, "edit_id": 1, "question": "How were the medications, morphine and tramadol, administered in this study?", "category": "omission", "label": "procedural"}, {"doc_id": 3821103, "edit_id": 2, "question": "What type of surgery were the study's participants undergoing?", "category": "omission", "label": "concept"}, {"doc_id": 3821103, "edit_id": 3, "question": "Was this study single-masked or double-masked?", "category": "omission", "label": "verification"}, {"doc_id": 3821103, "edit_id": 4, "question": "What kind of surgery did the patients in the study undergo?", "category": "omission", "label": "concept"}, {"doc_id": 3821103, "edit_id": 5, "question": "What was the dosage of morphine given to one group of patients?", "category": "omission", "label": "extent"}, {"doc_id": 3821103, "edit_id": 6, "question": "How much tramadol was given to the other group of patients in this study?", "category": "omission", "label": "extent"}, {"doc_id": 3821103, "edit_id": 7, "question": "How were the drugs administered to the patients in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 3821103, "edit_id": 8, "question": "How was the patients' pain level evaluated in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 3821103, "edit_id": 9, "question": "What method was used to compare the effectiveness of the two painkillers?", "category": "omission", "label": "procedural"}, {"doc_id": 3821103, "edit_id": 10, "question": "Was there a significant difference in the VRS scores between the two groups of patients before surgery?", "category": "omission", "label": "verification"}, {"doc_id": 3821103, "edit_id": 11, "question": "Did patients who received tramadol experience significantly less pain one hour after surgery compared to those who received morphine?", "category": "omission", "label": "verification"}, {"doc_id": 3821103, "edit_id": 12, "question": "Did the pain level decrease for the patients who were prescribed tramadol after their surgery?", "category": "omission", "label": "verification"}, {"doc_id": 3821103, "edit_id": 13, "question": "How was the decrease in VRS scores evaluated in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 3821103, "edit_id": 14, "question": "Was the decrease in pain levels, as measured by the VRS scores, significant after the patients used the pain relievers?", "category": "omission", "label": "verification"}, {"doc_id": 3821103, "edit_id": 15, "question": "What type of pain relievers are morphine and tramadol?", "category": "omission", "label": "concept"}, {"doc_id": 3821103, "edit_id": 16, "question": "What caused the pain relief after surgery in the study?", "category": "omission", "label": "cause"}, {"doc_id": 3821103, "edit_id": 17, "question": "When were the painkillers given to the patients in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 3877023, "edit_id": 0, "question": "What was the average duration of the scans performed using the open scanner method in the study?", "category": "omission", "label": "extent"}, {"doc_id": 3877023, "edit_id": 1, "question": "What was the average duration of the scans performed using methods other than the open scanner in the study?", "category": "omission", "label": "extent"}, {"doc_id": 3892495, "edit_id": 0, "question": "What were the effects being studied in this research?", "category": "omission", "label": "consequence"}, {"doc_id": 3892495, "edit_id": 1, "question": "What other effect was the study focusing on, besides the human growth hormone response?", "category": "omission", "label": "consequence"}, {"doc_id": 3892495, "edit_id": 2, "question": "How was the glucose administered to the test subjects in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 3892495, "edit_id": 3, "question": "What was administered to the control group in the study who were not given glucose?", "category": "omission", "label": "procedural"}, {"doc_id": 3892495, "edit_id": 4, "question": "What did some participants receive instead of the glucose drink in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 3892495, "edit_id": 5, "question": "In the group that received glucose, what process did the researchers measure?", "category": "omission", "label": "procedural"}, {"doc_id": 3892495, "edit_id": 6, "question": "What was being measured for the study participants who were only given water?", "category": "omission", "label": "procedural"}, {"doc_id": 3892495, "edit_id": 7, "question": "Besides human growth hormone levels, what other physiological measurement was taken in this study?", "category": "omission", "label": "procedural"}, {"doc_id": 3892495, "edit_id": 8, "question": "Between which two groups was the comparison made in this study?", "category": "omission", "label": "comparison"}, {"doc_id": 3892495, "edit_id": 9, "question": "How did the insulin levels in the blood of the glucose group compare to the water-only group?", "category": "omission", "label": "comparison"}, {"doc_id": 3892495, "edit_id": 10, "question": "What was the purpose of having the study participants ingest glucose or water before their exercise?", "category": "omission", "label": "cause"}, {"doc_id": 3893439, "edit_id": 0, "question": "What did the study aim to do with regards to energy metabolism in the brain?", "category": "omission", "label": "cause"}, {"doc_id": 3893439, "edit_id": 1, "question": "Which areas of the brain were specifically focused on in the study?", "category": "omission", "label": "concept"}, {"doc_id": 3893439, "edit_id": 2, "question": "What kind of animals were used in the study?", "category": "omission", "label": "example"}, {"doc_id": 3893439, "edit_id": 3, "question": "What kind of brain injury was the treatment for in the study?", "category": "omission", "label": "concept"}, {"doc_id": 3893439, "edit_id": 4, "question": "How was the mild traumatic brain injury (mTBI) implemented in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 3893439, "edit_id": 5, "question": "How were the rats organized for the study?", "category": "omission", "label": "procedural"}, {"doc_id": 3893439, "edit_id": 6, "question": "What happened to the groups of rats after they were formed?", "category": "omission", "label": "procedural"}, {"doc_id": 3893439, "edit_id": 7, "question": "At what point in the study did the housing randomization for the rats occur?", "category": "omission", "label": "procedural"}, {"doc_id": 3893439, "edit_id": 8, "question": "What method was used to test the rats' cognitive abilities?", "category": "omission", "label": "procedural"}, {"doc_id": 3893439, "edit_id": 9, "question": "What was one of the inflammatory proteins that was measured in the study?", "category": "omission", "label": "concept"}, {"doc_id": 3893439, "edit_id": 10, "question": "What other inflammatory protein was measured in the study?", "category": "omission", "label": "concept"}, {"doc_id": 3893439, "edit_id": 11, "question": "Which anti-inflammatory protein was measured in the study?", "category": "omission", "label": "concept"}, {"doc_id": 3893439, "edit_id": 12, "question": "What is the function of IL-10 in the body?", "category": "omission", "label": "concept"}, {"doc_id": 3893439, "edit_id": 13, "question": "What did the scientists assess to measure the brain's energy homeostasis?", "category": "omission", "label": "procedural"}, {"doc_id": 3893439, "edit_id": 14, "question": "What does the acronym AMPK stand for?", "category": "omission", "label": "concept"}, {"doc_id": 3893439, "edit_id": 15, "question": "Alongside AMPK, what other related protein did the scientists measure?", "category": "omission", "label": "example"}, {"doc_id": 3893439, "edit_id": 16, "question": "Besides AMPK, was there any other protein that the scientists measured?", "category": "omission", "label": "verification"}, {"doc_id": 3893439, "edit_id": 17, "question": "What were AMPK, phosphorylated AMPK, and uMtCK used for in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 3893439, "edit_id": 18, "question": "What effect did environmental enrichment (EE) have on the inflammatory proteins IL-1\u03b2 and TNF-\u03b1 following a minor brain injury?", "category": "omission", "label": "consequence"}, {"doc_id": 3893439, "edit_id": 19, "question": "What effect did environmental enrichment (EE) have on the anti-inflammatory protein IL-10 following a minor brain injury?", "category": "omission", "label": "consequence"}, {"doc_id": 3893439, "edit_id": 20, "question": "What effect did environmental enrichment (EE) have on the levels of uMtCK following a minor brain injury?", "category": "omission", "label": "consequence"}, {"doc_id": 3893439, "edit_id": 21, "question": "What persistent response is seen following a minor traumatic brain injury (mTBI)?", "category": "omission", "label": "consequence"}, {"doc_id": 3917487, "edit_id": 0, "question": "What was the average age of the swimmers participating in the study?", "category": "omission", "label": "extent"}, {"doc_id": 3917487, "edit_id": 1, "question": "What was the range around the average age of participants?", "category": "omission", "label": "extent"}, {"doc_id": 3917487, "edit_id": 2, "question": "What was the average weight of the swimmers who participated in the study?", "category": "omission", "label": "extent"}, {"doc_id": 3917487, "edit_id": 3, "question": "What was the variation in weight among the participants in the study?", "category": "omission", "label": "extent"}, {"doc_id": 3917487, "edit_id": 4, "question": "How tall were the swimmers on average?", "category": "omission", "label": "extent"}, {"doc_id": 3917487, "edit_id": 5, "question": "What method was used in the study to measure oxygen consumption during exercise?", "category": "omission", "label": "procedural"}, {"doc_id": 3917487, "edit_id": 6, "question": "What is the registration number for the study?", "category": "omission", "label": "concept"}, {"doc_id": 3917487, "edit_id": 7, "question": "What was the average change in swimming speed for the probiotic yogurt group?", "category": "omission", "label": "extent"}, {"doc_id": 3917487, "edit_id": 8, "question": "What was the average change in swimming speed for the regular yogurt group?", "category": "omission", "label": "extent"}, {"doc_id": 3917487, "edit_id": 9, "question": "How long did the probiotic yogurt group report having difficulty breathing?", "category": "omission", "label": "extent"}, {"doc_id": 3917487, "edit_id": 10, "question": "How long did the regular yogurt group report having difficulty breathing?", "category": "omission", "label": "extent"}, {"doc_id": 3917487, "edit_id": 11, "question": "How long did the participants in the probiotic yogurt group experience ear pain?", "category": "omission", "label": "extent"}, {"doc_id": 3917487, "edit_id": 12, "question": "How long did the participants in the regular yogurt group experience ear pain?", "category": "omission", "label": "extent"}, {"doc_id": 3917487, "edit_id": 13, "question": "How many days on average did members of the probiotic yogurt group experience respiratory infections?", "category": "omission", "label": "extent"}, {"doc_id": 3917487, "edit_id": 14, "question": "How many days on average did members of the regular yogurt group experience respiratory infections?", "category": "omission", "label": "extent"}, {"doc_id": 3917487, "edit_id": 15, "question": "What symptom had its duration reduced as a result of consuming probiotic yogurt?", "category": "omission", "label": "consequence"}, {"doc_id": 3917487, "edit_id": 16, "question": "What caused the reduction in the duration of symptoms such as difficulty breathing?", "category": "omission", "label": "cause"}, {"doc_id": 3921228, "edit_id": 0, "question": "What happens to the brain's response reflected in blood flow changes in the amygdala to positive events when depression gets better?", "category": "omission", "label": "consequence"}, {"doc_id": 3921228, "edit_id": 1, "question": "Is the real-time functional MRI neurofeedback (rtfMRI-nf) technique invasive or non-invasive?", "category": "omission", "label": "verification"}, {"doc_id": 3921228, "edit_id": 2, "question": "From which parts of the brain was the real-time functional MRI neurofeedback taken for this experiment?", "category": "omission", "label": "procedural"}, {"doc_id": 3921228, "edit_id": 3, "question": "How many participants with depression were assigned to the experimental group in this study?", "category": "omission", "label": "extent"}, {"doc_id": 3921228, "edit_id": 4, "question": "From which part of the brain were the control group participants receiving real-time functional MRI neurofeedback?", "category": "omission", "label": "procedural"}, {"doc_id": 3921228, "edit_id": 5, "question": "How many people were in the control group of this study?", "category": "omission", "label": "extent"}, {"doc_id": 3921228, "edit_id": 6, "question": "What was the purpose of encouraging participants to think about their positive personal memories in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 3921228, "edit_id": 7, "question": "How was the brain activity facilitated during the study?", "category": "omission", "label": "procedural"}, {"doc_id": 3921228, "edit_id": 8, "question": "What were the other activities the participants performed apart from thinking about positive personal memories?", "category": "omission", "label": "procedural"}, {"doc_id": 3921228, "edit_id": 9, "question": "Apart from recalling happy events and resting, what other activity did the participants do during the experiment?", "category": "omission", "label": "procedural"}, {"doc_id": 3921228, "edit_id": 10, "question": "Which type of run was conducted at the end of the experiment?", "category": "omission", "label": "procedural"}, {"doc_id": 3921228, "edit_id": 11, "question": "When did the increased responses in the amygdala happen?", "category": "omission", "label": "extent"}, {"doc_id": 3921228, "edit_id": 12, "question": "Who showed a greater increase in the happiness ratings, the experimental or the control group?", "category": "omission", "label": "comparison"}, {"doc_id": 3921228, "edit_id": 13, "question": "What kind of analysis was carried out as part of this study?", "category": "omission", "label": "procedural"}, {"doc_id": 3921228, "edit_id": 14, "question": "During which run was the whole brain analysis performed?", "category": "omission", "label": "procedural"}, {"doc_id": 3921228, "edit_id": 15, "question": "Where was the increased brain activity observed in the experimental group?", "category": "omission", "label": "concept"}, {"doc_id": 3921228, "edit_id": 16, "question": "Any other brain area showed increased activity in the experimental group?", "category": "omission", "label": "example"}, {"doc_id": 3921228, "edit_id": 17, "question": "Was there another area in the brain that demonstrated increased activity in the experimental group?", "category": "omission", "label": "example"}, {"doc_id": 3921228, "edit_id": 18, "question": "Which brain area was monitored using real-time functional MRI neurofeedback during the recall of positive autobiographical memories?", "category": "omission", "label": "procedural"}, {"doc_id": 3926947, "edit_id": 0, "question": "Why is it crucial to assess pediatric psychiatric outpatient treatment regularly?", "category": "omission", "label": "cause"}, {"doc_id": 3926947, "edit_id": 1, "question": "What is one notable drawback of conducting systematic evaluations for pediatric psychiatric outpatient treatments?", "category": "omission", "label": "consequence"}, {"doc_id": 3926947, "edit_id": 2, "question": "What is the focus of this tracked medical care in the research?", "category": "omission", "label": "concept"}, {"doc_id": 3926947, "edit_id": 3, "question": "What specific type of outpatient treatment is discussed in the study?", "category": "omission", "label": "concept"}, {"doc_id": 3926947, "edit_id": 4, "question": "Where did the patients come from?", "category": "omission", "label": "concept"}, {"doc_id": 3926947, "edit_id": 5, "question": "What age range was the psychiatric outpatient unit catering to?", "category": "omission", "label": "concept"}, {"doc_id": 3926947, "edit_id": 6, "question": "Where is the psychiatric outpatient unit located?", "category": "omission", "label": "concept"}, {"doc_id": 3926947, "edit_id": 7, "question": "Who completed the BCFPI follow-up form for the patients?", "category": "omission", "label": "procedural"}, {"doc_id": 3926947, "edit_id": 8, "question": "When was the BCFPI follow-up form filled out?", "category": "omission", "label": "procedural"}, {"doc_id": 3926947, "edit_id": 9, "question": "How many parents used the IVR method for the follow-up form?", "category": "omission", "label": "extent"}, {"doc_id": 3926947, "edit_id": 10, "question": "How many parents completed the follow-up form using the postal survey methodology?", "category": "omission", "label": "extent"}, {"doc_id": 3926947, "edit_id": 11, "question": "Was there a significant difference in response rates between the phone and mail methods?", "category": "omission", "label": "verification"}, {"doc_id": 3926947, "edit_id": 12, "question": "Was the need for reminders in the IVR group vs. the mail group statistically significant?", "category": "omission", "label": "verification"}, {"doc_id": 3926947, "edit_id": 13, "question": "How promising is the IVR method in gauging the effectiveness of child and adolescent psychiatric care?", "category": "omission", "label": "judgmental"}, {"doc_id": 3926947, "edit_id": 14, "question": "Aside from being promising, how else is the IVR method beneficial in evaluating child and adolescent psychiatric care?", "category": "omission", "label": "judgmental"}, {"doc_id": 3926947, "edit_id": 15, "question": "What is the main goal of using IVR in this situation?", "category": "omission", "label": "consequence"}, {"doc_id": 3932017, "edit_id": 0, "question": "What was the nature of the study? Was it conducted in a laboratory setting, in animals or directly on humans?", "category": "omission", "label": "concept"}, {"doc_id": 3932017, "edit_id": 1, "question": "What kind of ultrasound techniques does this study use?", "category": "omission", "label": "procedural"}, {"doc_id": 3932017, "edit_id": 2, "question": "What did the investigators measure in the carotid artery wall? ", "category": "omission", "label": "procedural"}, {"doc_id": 3932017, "edit_id": 3, "question": "What else did the investigators measure in the carotid artery? ", "category": "omission", "label": "procedural"}, {"doc_id": 3932017, "edit_id": 4, "question": "Besides QIMT and QAS, what other technique was used in the investigation?", "category": "omission", "label": "procedural"}, {"doc_id": 3932017, "edit_id": 5, "question": "What specific technology was used to conduct the ultrasound investigation?", "category": "omission", "label": "procedural"}, {"doc_id": 3932017, "edit_id": 6, "question": "What was the value of the first measurement of carotid IMT? ", "category": "omission", "label": "extent"}, {"doc_id": 3932017, "edit_id": 7, "question": "What is the second value of carotid IMT that was measured in the control group? ", "category": "omission", "label": "extent"}, {"doc_id": 3932017, "edit_id": 8, "question": "What was the uncertainty in the second measurement of carotid IMT?", "category": "omission", "label": "extent"}, {"doc_id": 3932017, "edit_id": 9, "question": "What was the P-value for the difference in carotid IMT between the two groups? ", "category": "omission", "label": "extent"}, {"doc_id": 3932017, "edit_id": 10, "question": "What was the pulse wave velocity in the control group?", "category": "omission", "label": "extent"}, {"doc_id": 3932017, "edit_id": 11, "question": "What was the relationship between pulse wave velocity (PWV) and compliance coefficient (CC)? ", "category": "omission", "label": "consequence"}, {"doc_id": 3943081, "edit_id": 0, "question": "What were the names of the two groups in the study that were treated differently?", "category": "omission", "label": "example"}, {"doc_id": 3953523, "edit_id": 0, "question": "What specific tool was used to measure or track changes in the patients' pain levels during the study?", "category": "omission", "label": "procedural"}, {"doc_id": 3953523, "edit_id": 1, "question": "Were there any special tests performed to assess the safety of the medication on the heart, as part of the study?", "category": "omission", "label": "procedural"}, {"doc_id": 3953523, "edit_id": 2, "question": "What kind of heart-related test was included during the patient's evaluation in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 3953523, "edit_id": 3, "question": "Was there a different or new version of the aceclofenac medication used in this study?", "category": "omission", "label": "verification"}, {"doc_id": 3984795, "edit_id": 0, "question": "What was the physical condition of all participants in the trial?", "category": "omission", "label": "concept"}, {"doc_id": 3984795, "edit_id": 1, "question": "How was overweight defined in this study?", "category": "omission", "label": "concept"}, {"doc_id": 3984795, "edit_id": 2, "question": "Was there any preliminary process conducted before the trial?", "category": "omission", "label": "verification"}, {"doc_id": 3984795, "edit_id": 3, "question": "Was there any change in LDL cholesterol levels for the group that consumed the probiotic VSL#3?", "category": "omission", "label": "verification"}, {"doc_id": 3984795, "edit_id": 4, "question": "Was there any significant change in VLDL cholesterol levels in the participants who consumed the probiotic VSL#3?", "category": "omission", "label": "verification"}, {"doc_id": 3984795, "edit_id": 5, "question": "Did the group taking probiotic VSL#3 experience any change in their levels of HDL cholesterol?", "category": "omission", "label": "verification"}, {"doc_id": 3984795, "edit_id": 6, "question": "Were the changes in cholesterol, triglyceride, LDL, VLDL, and HDL levels statistically significant in the probiotic VSL#3 group?", "category": "omission", "label": "verification"}, {"doc_id": 3984795, "edit_id": 7, "question": "Did the consumption of VSL#3 have any effect on hsCRP levels?", "category": "omission", "label": "verification"}, {"doc_id": 3984795, "edit_id": 8, "question": "Did taking omega-3 have any significant effect on hsCRP levels?", "category": "omission", "label": "verification"}, {"doc_id": 3984795, "edit_id": 9, "question": "Did the combination of omega-3 fatty acid and probiotic VSL#3 influence HDL cholesterol levels?", "category": "omission", "label": "verification"}, {"doc_id": 3984795, "edit_id": 10, "question": "Did using both omega-3 and probiotic VSL#3 change levels of hsCRP?", "category": "omission", "label": "verification"}, {"doc_id": 3984795, "edit_id": 11, "question": "How were the levels of hsCRP in the subjects at the start of the study?", "category": "omission", "label": "extent"}, {"doc_id": 3984795, "edit_id": 12, "question": "How were the counts of lactobacilli in subjects who had issues like low levels of good cholesterol, insulin resistance, and high inflammation?", "category": "omission", "label": "extent"}, {"doc_id": 3984795, "edit_id": 13, "question": "What about the count of bifidobacteria in subjects with these issues?", "category": "omission", "label": "extent"}, {"doc_id": 3984795, "edit_id": 14, "question": "And how did these issues affect the count of bacteroides in the subjects?", "category": "omission", "label": "cause"}, {"doc_id": 3990364, "edit_id": 0, "question": "What gaps are there in present knowledge about structuring exercises for improving back flexibility?", "category": "omission", "label": "concept"}, {"doc_id": 3990364, "edit_id": 1, "question": "What type of training program was used in the study?", "category": "omission", "label": "concept"}, {"doc_id": 3990364, "edit_id": 2, "question": "How were the participants divided into the two groups? ", "category": "omission", "label": "procedural"}, {"doc_id": 3990364, "edit_id": 3, "question": "What were the two groups participating in the study called?", "category": "omission", "label": "concept"}, {"doc_id": 3990364, "edit_id": 4, "question": "How many women were in the control group (CG)?", "category": "omission", "label": "extent"}, {"doc_id": 3990364, "edit_id": 5, "question": "Did the trained group (TG) receive any kind of training?", "category": "omission", "label": "verification"}, {"doc_id": 3990364, "edit_id": 6, "question": "How exactly were the spinal flexibility measurements taken in this study?", "category": "omission", "label": "procedural"}, {"doc_id": 3990364, "edit_id": 7, "question": "Was there another position from which spinal flexibility measurements were taken?", "category": "omission", "label": "verification"}, {"doc_id": 3990364, "edit_id": 8, "question": "What sort of device was used to take the measurements of back flexibility?", "category": "omission", "label": "concept"}, {"doc_id": 3990364, "edit_id": 9, "question": "Which company makes the SpinalMouse\u00ae?", "category": "omission", "label": "concept"}, {"doc_id": 3990364, "edit_id": 10, "question": "Where is the company Idiag, the makers of the SpinalMouse\u00ae, based?", "category": "omission", "label": "concept"}, {"doc_id": 3990364, "edit_id": 11, "question": "Did the women in the trained group show any changes in their spinal flexibility after the training period?", "category": "omission", "label": "verification"}, {"doc_id": 3990364, "edit_id": 12, "question": "Was the increase in spinal flexibility in the trained group statistically significant?", "category": "omission", "label": "verification"}, {"doc_id": 3990364, "edit_id": 13, "question": "What other improvements did the trained group show after the training period?", "category": "omission", "label": "consequence"}, {"doc_id": 3990364, "edit_id": 14, "question": "By how much did the range of motion in the sacral/hip area improve in the trained group?", "category": "omission", "label": "extent"}, {"doc_id": 3990364, "edit_id": 15, "question": "Was the improvement in the sacral/hip area range of motion in the trained group statistically significant?", "category": "omission", "label": "verification"}, {"doc_id": 3990364, "edit_id": 16, "question": "Were there any parts of the back that did not show significant improvement in the trained group after the training period?", "category": "omission", "label": "verification"}, {"doc_id": 3990364, "edit_id": 17, "question": "Was the measured change in the lumbar area range of motion statistically significant?", "category": "omission", "label": "verification"}, {"doc_id": 3990364, "edit_id": 18, "question": "Can the training program used in this study be easily implemented for elderly people with autonomy and self-care capabilities?", "category": "omission", "label": "verification"}, {"doc_id": 4006208, "edit_id": 0, "question": "Why is there a need for a study on the effects of Aloe vera mouthwash on oral health issues?", "category": "omission", "label": "cause"}, {"doc_id": 4006208, "edit_id": 1, "question": "Beyond comparing to the usual chlorhexidine mouthwash, was the Aloe vera mouthwash also compared to any other substance?", "category": "omission", "label": "verification"}, {"doc_id": 4006208, "edit_id": 2, "question": "What is the usual mouthwash referred to in the study that was used for comparison?", "category": "omission", "label": "concept"}, {"doc_id": 4006208, "edit_id": 3, "question": "What was done to the study participants' plaque levels before they started using the mouthwash for the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4006208, "edit_id": 4, "question": "What method was used to professionally clean the teeth?", "category": "omission", "label": "procedural"}, {"doc_id": 4006208, "edit_id": 5, "question": "What type of usual mouthwash was used for comparison in this study?", "category": "omission", "label": "concept"}, {"doc_id": 4006208, "edit_id": 6, "question": "What was the contents of the placebo mouthwash used in the study?", "category": "omission", "label": "concept"}, {"doc_id": 4006208, "edit_id": 7, "question": "Was there a specified amount of mouthwash that the participants had to use during the study?", "category": "omission", "label": "verification"}, {"doc_id": 4006208, "edit_id": 8, "question": "What was used as a comparison that's not expected to have any effects in this study?", "category": "omission", "label": "concept"}, {"doc_id": 4015738, "edit_id": 0, "question": "What can be a potential effect of administering normal saline in the body?", "category": "omission", "label": "consequence"}, {"doc_id": 4015738, "edit_id": 1, "question": "How can normal saline potentially affect electrolytes in the plasma?", "category": "omission", "label": "consequence"}, {"doc_id": 4015738, "edit_id": 2, "question": "Can administering normal saline result in any type of acidosis?", "category": "omission", "label": "verification"}, {"doc_id": 4015738, "edit_id": 3, "question": "Besides the Balanced Solution group, what was the other group in the study called?", "category": "omission", "label": "concept"}, {"doc_id": 4015738, "edit_id": 4, "question": "What types of solutions were administered during the trial, balanced or unbalanced?", "category": "omission", "label": "disjunction"}, {"doc_id": 4015738, "edit_id": 5, "question": "What is the term used to denote the measurement period at the end of the surgery?", "category": "omission", "label": "concept"}, {"doc_id": 4015738, "edit_id": 6, "question": "When were the measurements taken after the surgery?", "category": "omission", "label": "procedural"}, {"doc_id": 4015738, "edit_id": 7, "question": "What term is used for the timing of the measurement taken within 2 hours after surgery?", "category": "omission", "label": "concept"}, {"doc_id": 4015738, "edit_id": 8, "question": "Besides immediate post-surgery, was there another time when measurements were taken?", "category": "omission", "label": "verification"}, {"doc_id": 4015738, "edit_id": 9, "question": "What is the term for the time of measurement taken 24 hours after the start of the surgery?", "category": "omission", "label": "concept"}, {"doc_id": 4015738, "edit_id": 10, "question": "Was any data on enzymes collected in the study?", "category": "omission", "label": "verification"}, {"doc_id": 4015738, "edit_id": 11, "question": "How did the Balanced Solutions group's level of IL-10 compare to the other group?", "category": "omission", "label": "comparison"}, {"doc_id": 4015738, "edit_id": 12, "question": "What was observed about the level of TIMP-1 in the Balanced Solutions group?", "category": "omission", "label": "consequence"}, {"doc_id": 4015738, "edit_id": 13, "question": "How did the level of active MMP-9 in the Balanced Solutions group compare to the Unbalanced Solutions group?", "category": "omission", "label": "comparison"}, {"doc_id": 4015738, "edit_id": 14, "question": "Did the Unbalanced Solutions group experience any changes in electrolyte balance?", "category": "omission", "label": "verification"}, {"doc_id": 4015738, "edit_id": 15, "question": "How did the Unbalanced Solutions group's calcium levels change?", "category": "omission", "label": "extent"}, {"doc_id": 4015738, "edit_id": 16, "question": "Did the Unbalanced Solutions group have any changes in acid-base balance?", "category": "omission", "label": "verification"}, {"doc_id": 4015738, "edit_id": 17, "question": "What was observed about the level of NGAL in the Unbalanced Solutions group?", "category": "omission", "label": "consequence"}, {"doc_id": 4018698, "edit_id": 0, "question": "What type of anesthesia was used during the hip surgery?", "category": "omission", "label": "procedural"}, {"doc_id": 4018698, "edit_id": 1, "question": "How were the patients selected for the two different groups in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4018698, "edit_id": 2, "question": "What is the name given to the first group of patients?", "category": "omission", "label": "concept"}, {"doc_id": 4018698, "edit_id": 3, "question": "What type of spinal anesthesia was given to the patients?", "category": "omission", "label": "procedural"}, {"doc_id": 4018698, "edit_id": 4, "question": "What additional treatment did the paravertebral group receive?", "category": "omission", "label": "procedural"}, {"doc_id": 4018698, "edit_id": 5, "question": "What was the concentration of bupivacaine in the continuous infusion?", "category": "omission", "label": "extent"}, {"doc_id": 4018698, "edit_id": 6, "question": "At what rate was the continuous infusion of bupivacaine administered?", "category": "omission", "label": "extent"}, {"doc_id": 4018698, "edit_id": 7, "question": "What is the name given to the second group of patients?", "category": "omission", "label": "concept"}, {"doc_id": 4018698, "edit_id": 8, "question": "Was the spinal anesthesia used for the epidural group the same as the paravertebral group?", "category": "omission", "label": "verification"}, {"doc_id": 4018698, "edit_id": 9, "question": "What additional treatment did the epidural group receive?", "category": "omission", "label": "procedural"}, {"doc_id": 4018698, "edit_id": 10, "question": "Where was the continuous infusion of bupivacaine given to the epidural group?", "category": "omission", "label": "procedural"}, {"doc_id": 4018698, "edit_id": 11, "question": "For how long was the continuous infusion of bupivacaine administered?", "category": "omission", "label": "extent"}, {"doc_id": 4018698, "edit_id": 12, "question": "Did the researchers use any scales to compare the amount of pain between the two groups?", "category": "omission", "label": "verification"}, {"doc_id": 4018698, "edit_id": 13, "question": "What statistical methods were utilized to analyze the data?", "category": "omission", "label": "procedural"}, {"doc_id": 4018698, "edit_id": 14, "question": "Were there any other statistical methods used to analyze the data?", "category": "omission", "label": "verification"}, {"doc_id": 4018698, "edit_id": 15, "question": "What was considered a significant result in this study?", "category": "omission", "label": "concept"}, {"doc_id": 4018698, "edit_id": 16, "question": "Did any group have more catheter-related problems?", "category": "omission", "label": "verification"}, {"doc_id": 4018698, "edit_id": 17, "question": "Did the study conclude any method to be more advantageous over the other?", "category": "omission", "label": "verification"}, {"doc_id": 4065461, "edit_id": 0, "question": "What was the main focus of this study?", "category": "omission", "label": "concept"}, {"doc_id": 4065461, "edit_id": 1, "question": "What were the other treatments used with oral dexamethasone?", "category": "omission", "label": "procedural"}, {"doc_id": 4065461, "edit_id": 2, "question": "What is one of the standalone treatment options for bronchiolitis that was considered in this study? ", "category": "omission", "label": "example"}, {"doc_id": 4065461, "edit_id": 3, "question": "What type of trial was this?", "category": "omission", "label": "concept"}, {"doc_id": 4065461, "edit_id": 4, "question": "Where were the infants diagnosed with bronchiolitis?", "category": "omission", "label": "procedural"}, {"doc_id": 4065461, "edit_id": 5, "question": "What were some secondary outcomes that the researchers were interested in?", "category": "omission", "label": "example"}, {"doc_id": 4065461, "edit_id": 6, "question": "Were there any other secondary outcomes observed in the study?", "category": "omission", "label": "verification"}, {"doc_id": 4065461, "edit_id": 7, "question": "Were there any other measurements taken as part of the secondary outcomes?", "category": "omission", "label": "verification"}, {"doc_id": 4065461, "edit_id": 8, "question": "How many infants were involved in the study?", "category": "omission", "label": "extent"}, {"doc_id": 4065461, "edit_id": 9, "question": "What treatment was given to the infants in Group A of the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4065461, "edit_id": 10, "question": "What was the finding in relation to heart rate?", "category": "omission", "label": "consequence"}, {"doc_id": 4065461, "edit_id": 11, "question": "How does this study relate to existing research?", "category": "omission", "label": "comparison"}, {"doc_id": 4065461, "edit_id": 12, "question": "What is the risk level of these infants for atopy?", "category": "omission", "label": "concept"}, {"doc_id": 4069047, "edit_id": 0, "question": "What was the average age of the Alzheimer's patients in this study?", "category": "omission", "label": "extent"}, {"doc_id": 4069047, "edit_id": 1, "question": "What type of method was used in this study to prevent bias?", "category": "omission", "label": "procedural"}, {"doc_id": 4069047, "edit_id": 2, "question": "What kind of study design was used in this research?", "category": "omission", "label": "concept"}, {"doc_id": 4069047, "edit_id": 3, "question": "How was cognition measured in patients?", "category": "omission", "label": "procedural"}, {"doc_id": 4069047, "edit_id": 4, "question": "How did the researchers assess the patients' ability to perform daily tasks?", "category": "omission", "label": "procedural"}, {"doc_id": 4069047, "edit_id": 5, "question": "How was mental function measured in patients?", "category": "omission", "label": "procedural"}, {"doc_id": 4069047, "edit_id": 6, "question": "What tool was used to determine the quality of sleep in patients?", "category": "omission", "label": "procedural"}, {"doc_id": 4069047, "edit_id": 7, "question": "How else did the researchers keep track of the patients' sleep patterns?", "category": "omission", "label": "procedural"}, {"doc_id": 4069047, "edit_id": 8, "question": "What tools were used to evaluate the cognitive performance of the patients?", "category": "omission", "label": "procedural"}, {"doc_id": 4069047, "edit_id": 9, "question": "Did the addition of melatonin to the treatment result in any significant changes in cognitive performance compared to the placebo group?", "category": "omission", "label": "verification"}, {"doc_id": 4069047, "edit_id": 10, "question": "Was the improvement in the IADL test statistically significant?", "category": "omission", "label": "verification"}, {"doc_id": 4069047, "edit_id": 11, "question": "Was the change in MMSE score statistically significant?", "category": "omission", "label": "verification"}, {"doc_id": 4069047, "edit_id": 12, "question": "Did the researchers utilize the Alzheimer's Disease Assessment Scale\u2013Cognition (ADAS-Cog) for comparison purposes?", "category": "omission", "label": "verification"}, {"doc_id": 4069047, "edit_id": 13, "question": "Were there any differences in the average ADAS-Cog scores among the patient groups?", "category": "omission", "label": "verification"}, {"doc_id": 4069047, "edit_id": 14, "question": "How was sleep efficiency measured in this study?", "category": "omission", "label": "procedural"}, {"doc_id": 4069047, "edit_id": 15, "question": "Was there a significant improvement in sleep efficiency with the addition of melatonin?", "category": "omission", "label": "verification"}, {"doc_id": 4069047, "edit_id": 16, "question": "Were the effects of melatonin supplementation on IADL scores statistically significant?", "category": "omission", "label": "verification"}, {"doc_id": 4069047, "edit_id": 17, "question": "Were there significant effects of melatonin supplementation on MMSE scores?", "category": "omission", "label": "verification"}, {"doc_id": 4069047, "edit_id": 18, "question": "What were the observed changes in MMSE scores between the melatonin treatment group and the placebo group?", "category": "omission", "label": "consequence"}, {"doc_id": 4069047, "edit_id": 19, "question": "Were there any significant effects of melatonin supplementation on sleep efficiency?", "category": "omission", "label": "verification"}, {"doc_id": 4069047, "edit_id": 20, "question": "How did the median ADAS-Cog values compare between the treatment groups?", "category": "omission", "label": "comparison"}, {"doc_id": 4069047, "edit_id": 21, "question": "Was the comparison of the median ADAS-Cog values between the treatment groups statistically significant?", "category": "omission", "label": "verification"}, {"doc_id": 4069047, "edit_id": 22, "question": "Did the differences between the treatment groups change over time?", "category": "omission", "label": "verification"}, {"doc_id": 4069047, "edit_id": 23, "question": "How long could the treatment duration be?", "category": "omission", "label": "extent"}, {"doc_id": 4069047, "edit_id": 24, "question": "How would you describe the relationship between poor sleep and cognitive decline in this study?", "category": "omission", "label": "concept"}, {"doc_id": 4078065, "edit_id": 0, "question": "What is the significance of reverse cholesterol transport (RCT) in relation to heart disease?", "category": "omission", "label": "concept"}, {"doc_id": 4078065, "edit_id": 1, "question": "What is the role of good cholesterol or HDL in the prevention of heart disease?", "category": "omission", "label": "concept"}, {"doc_id": 4078065, "edit_id": 2, "question": "How was the experimental process of this study carried out?", "category": "omission", "label": "procedural"}, {"doc_id": 4078065, "edit_id": 3, "question": "What effect did citrulline have on ABCA1 mRNA and protein levels in the immune cells used in the study?", "category": "omission", "label": "consequence"}, {"doc_id": 4078065, "edit_id": 4, "question": "Did citrulline also impact the levels of another protein, ABCG1, in THP-1 immune cells?", "category": "omission", "label": "verification"}, {"doc_id": 4078065, "edit_id": 5, "question": "How much citrulline did the subjects in this study take each day?", "category": "omission", "label": "extent"}, {"doc_id": 4078065, "edit_id": 6, "question": "How did the researchers assess the effectiveness of citrulline on immune cells?", "category": "omission", "label": "procedural"}, {"doc_id": 4078065, "edit_id": 7, "question": "Did the laboratory tests support the observations made in the human study about the effects of citrulline?", "category": "omission", "label": "verification"}, {"doc_id": 4078065, "edit_id": 8, "question": "What could be a potential benefit of citrulline based on the study's findings?", "category": "omission", "label": "consequence"}, {"doc_id": 4092926, "edit_id": 0, "question": "Was the research executed recently in this scenario?", "category": "omission", "label": "verification"}, {"doc_id": 4092926, "edit_id": 1, "question": "How many young Boer goats were involved in the experiment?", "category": "omission", "label": "extent"}, {"doc_id": 4092926, "edit_id": 2, "question": "What breed are these Boer young goats?", "category": "omission", "label": "concept"}, {"doc_id": 4092926, "edit_id": 3, "question": "What is the gender of the goats involved in the study?", "category": "omission", "label": "concept"}, {"doc_id": 4092926, "edit_id": 4, "question": "Were the male goats in the study castrated?", "category": "omission", "label": "verification"}, {"doc_id": 4092926, "edit_id": 5, "question": "How old were the young goats at the start of the experiment?", "category": "omission", "label": "extent"}, {"doc_id": 4092926, "edit_id": 6, "question": "How much did the young goats weigh at the beginning of this study?", "category": "omission", "label": "extent"}, {"doc_id": 4092926, "edit_id": 7, "question": "How were the young goats assigned to their pens for this study?", "category": "omission", "label": "procedural"}, {"doc_id": 4092926, "edit_id": 8, "question": "What were the different levels of substitution of soybean by sunflower cake in the goats' diets?", "category": "omission", "label": "concept"}, {"doc_id": 4092926, "edit_id": 9, "question": "What happened to the goats at the end of the experimental period?", "category": "omission", "label": "consequence"}, {"doc_id": 4092926, "edit_id": 10, "question": "What was the average body weight of the goats at the time of slaughter?", "category": "omission", "label": "extent"}, {"doc_id": 4092926, "edit_id": 11, "question": "What was the hot carcass weight for the goats in the experiment?", "category": "omission", "label": "extent"}, {"doc_id": 4092926, "edit_id": 12, "question": "What was the cold carcass weight of the goats in the experiment?", "category": "omission", "label": "extent"}, {"doc_id": 4092926, "edit_id": 13, "question": "What was the hot carcass yield of the slaughtered goats on average?", "category": "omission", "label": "extent"}, {"doc_id": 4092926, "edit_id": 14, "question": "What is the recommendation about substituting soybean meal in goat's diet?", "category": "omission", "label": "consequence"}, {"doc_id": 4106715, "edit_id": 0, "question": "Did the study on NicVAX\u00ae also aim to understand the connection between the vaccine dosage, how often it's given, and the body's immune response?", "category": "omission", "label": "verification"}, {"doc_id": 4106715, "edit_id": 1, "question": "Was the NicVAX\u00ae study set up in a way that neither the doctors nor the patients knew who was getting the real vaccine or a placebo?", "category": "omission", "label": "verification"}, {"doc_id": 4106715, "edit_id": 2, "question": "Was the NicVAX\u00ae trial conducted in just one location?", "category": "omission", "label": "verification"}, {"doc_id": 4106715, "edit_id": 3, "question": "Who had the most notable immune response to the NicVAX\u00ae in the trial?", "category": "omission", "label": "consequence"}, {"doc_id": 4106715, "edit_id": 4, "question": "How successful were the trial participants who responded strongly to the NicVAX\u00ae in terms of quitting smoking?", "category": "omission", "label": "consequence"}, {"doc_id": 4106715, "edit_id": 5, "question": "How significant were the results of NicVAX\u00ae trial?", "category": "omission", "label": "extent"}, {"doc_id": 4106715, "edit_id": 6, "question": "How confident can we be in the results of the NicVAX\u00ae study?", "category": "omission", "label": "extent"}, {"doc_id": 4106715, "edit_id": 7, "question": "What's the upper limit of the range within which the true results of the NicVAX\u00ae trial would lie if repeated again and again?", "category": "omission", "label": "extent"}, {"doc_id": 4106715, "edit_id": 8, "question": "Which vaccine regimen resulted in the highest amount of antibodies produced in response to nicotine?", "category": "omission", "label": "disjunction"}, {"doc_id": 4106715, "edit_id": 9, "question": "What does 3'AmNic-rEPA, the scientific name for NicVAX\u00ae, do in the body?", "category": "omission", "label": "concept"}, {"doc_id": 4115605, "edit_id": 0, "question": "How were the results of the study measured?", "category": "omission", "label": "procedural"}, {"doc_id": 4115605, "edit_id": 1, "question": "How many people participated in the study?", "category": "omission", "label": "extent"}, {"doc_id": 4115605, "edit_id": 2, "question": "How much did the patients' symptoms improve according to the study's measures?", "category": "omission", "label": "extent"}, {"doc_id": 4115605, "edit_id": 3, "question": "How statistically significant was this improvement?", "category": "omission", "label": "extent"}, {"doc_id": 4115605, "edit_id": 4, "question": "How much improvement did the study find in how the symptoms affected patients' daily activities?", "category": "omission", "label": "extent"}, {"doc_id": 4115605, "edit_id": 5, "question": "What was the p-value for the improvement in how the symptoms affected patients' daily activities?", "category": "omission", "label": "extent"}, {"doc_id": 4115605, "edit_id": 6, "question": "How many of the patients experienced side effects from the drug?", "category": "omission", "label": "extent"}, {"doc_id": 4115605, "edit_id": 7, "question": "What percentage of the patients experienced headaches as a side effect?", "category": "omission", "label": "extent"}, {"doc_id": 4115605, "edit_id": 8, "question": "What percentage of the patients experienced dizziness as a side effect?", "category": "omission", "label": "extent"}, {"doc_id": 4115605, "edit_id": 9, "question": "What level of evidence does this study provide?", "category": "omission", "label": "concept"}, {"doc_id": 4115605, "edit_id": 10, "question": "How did the patients in this study react to the drug droxidopa?", "category": "omission", "label": "consequence"}, {"doc_id": 4121500, "edit_id": 0, "question": "What are some of the uses of Dexmedetomidine?", "category": "omission", "label": "example"}, {"doc_id": 4121500, "edit_id": 1, "question": "What else beside clinical effects were the researchers looking to study about the different doses of dexmedetomidine?", "category": "omission", "label": "concept"}, {"doc_id": 4121500, "edit_id": 2, "question": "Exactly how much of the drug Dexmedetomidine was given to the two groups in the study?", "category": "omission", "label": "extent"}, {"doc_id": 4121500, "edit_id": 3, "question": "What was the overall health status of the patients who participated in the study?", "category": "omission", "label": "concept"}, {"doc_id": 4121500, "edit_id": 4, "question": "What kind of operations were the patients undergoing in the study?", "category": "omission", "label": "concept"}, {"doc_id": 4121500, "edit_id": 5, "question": "How were the patients assigned to the two groups; with lower dose and higher does of Dexmedetomidine?", "category": "omission", "label": "procedural"}, {"doc_id": 4121500, "edit_id": 6, "question": "How was the lower dose of Dexmedetomidine administered to group L? ", "category": "omission", "label": "procedural"}, {"doc_id": 4121500, "edit_id": 7, "question": "How much Dexmedetomidine was given to the patients in the group receiving the higher dose?", "category": "omission", "label": "extent"}, {"doc_id": 4121500, "edit_id": 8, "question": "What body vitals were monitored during the study along with consciousness level?", "category": "omission", "label": "procedural"}, {"doc_id": 4121500, "edit_id": 9, "question": "Apart from systolic blood pressure and level of consciousness, were there any other vitals being monitored in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4121500, "edit_id": 10, "question": "At what times were these body vitals and consciousness levels recorded?", "category": "omission", "label": "procedural"}, {"doc_id": 4121500, "edit_id": 11, "question": "What quantity of Dexmedetomidine is considered a higher loading dose in the study?", "category": "omission", "label": "extent"}, {"doc_id": 4140238, "edit_id": 0, "question": "How many clinical trials were conducted for this study?", "category": "omission", "label": "extent"}, {"doc_id": 4140238, "edit_id": 1, "question": "What type of approach was used in the trials?", "category": "omission", "label": "concept"}, {"doc_id": 4140238, "edit_id": 2, "question": "At how many different locations were the trials conducted?", "category": "omission", "label": "extent"}, {"doc_id": 4140238, "edit_id": 3, "question": "What model was used in the trials to induce allergic responses?", "category": "omission", "label": "concept"}, {"doc_id": 4140238, "edit_id": 4, "question": "How soon after exposure to the allergen was itching reported?", "category": "omission", "label": "extent"}, {"doc_id": 4140238, "edit_id": 5, "question": "Which parameters were assessed as part of the primary outcomes of the study?", "category": "omission", "label": "concept"}, {"doc_id": 4140238, "edit_id": 6, "question": "What other eye symptoms were observed as secondary outcomes in the study?", "category": "omission", "label": "example"}, {"doc_id": 4140238, "edit_id": 7, "question": "How significant was the reduction in ocular itching?", "category": "omission", "label": "extent"}, {"doc_id": 4140238, "edit_id": 8, "question": "How effective was the eye drop over time?", "category": "omission", "label": "extent"}, {"doc_id": 4140238, "edit_id": 9, "question": "What was the main symptom the BBOS 1.5% eyedrop aimed to alleviate? ", "category": "omission", "label": "concept"}, {"doc_id": 4166055, "edit_id": 0, "question": "How many patients did the study include?", "category": "omission", "label": "extent"}, {"doc_id": 4166055, "edit_id": 1, "question": "How were these patients grouped for the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4166055, "edit_id": 2, "question": "What treatment did one of the groups in the study receive?", "category": "omission", "label": "concept"}, {"doc_id": 4166055, "edit_id": 3, "question": "What dosage of the hypertonic saline solution did the patients receive?", "category": "omission", "label": "extent"}, {"doc_id": 4166055, "edit_id": 4, "question": "What treatment did the second group receive?", "category": "omission", "label": "concept"}, {"doc_id": 4166055, "edit_id": 5, "question": "How much normal saline did the second group receive?", "category": "omission", "label": "extent"}, {"doc_id": 4166055, "edit_id": 6, "question": "How long did the infusion of saline solutions take?", "category": "omission", "label": "extent"}, {"doc_id": 4166055, "edit_id": 7, "question": "Was any demographic information gathered from the patients?", "category": "omission", "label": "verification"}, {"doc_id": 4166055, "edit_id": 8, "question": "Did the study consider the patient's Body Mass Index (BMI)?", "category": "omission", "label": "verification"}, {"doc_id": 4166055, "edit_id": 9, "question": "Were any vital signs checked for patients in the study?", "category": "omission", "label": "verification"}, {"doc_id": 4166055, "edit_id": 10, "question": "Other than Systolic Blood Pressure, did the researchers check any other blood pressure measures from the patients?", "category": "omission", "label": "verification"}, {"doc_id": 4166055, "edit_id": 11, "question": "Did the researchers check the heart rate of the patients?", "category": "omission", "label": "verification"}, {"doc_id": 4166055, "edit_id": 12, "question": "Did the study monitor the average pressure in the arteries of the patients?", "category": "omission", "label": "verification"}, {"doc_id": 4166055, "edit_id": 13, "question": "What was the range of different ages of the patients in this study?", "category": "omission", "label": "extent"}, {"doc_id": 4166055, "edit_id": 14, "question": "Were there any differences in blood pressure right after the saline solutions were given?", "category": "omission", "label": "verification"}, {"doc_id": 4166055, "edit_id": 15, "question": "What does a p-value greater than 0.05 mean?", "category": "omission", "label": "concept"}, {"doc_id": 4166055, "edit_id": 16, "question": "What does a p-value less than 0.05 mean?", "category": "omission", "label": "concept"}, {"doc_id": 4166055, "edit_id": 17, "question": "Were there significant trends over time in the data?", "category": "omission", "label": "verification"}, {"doc_id": 4166055, "edit_id": 18, "question": "At what time was the hypertonic saline given to the patients?", "category": "omission", "label": "extent"}, {"doc_id": 4166055, "edit_id": 19, "question": "What dose of the hypertonic saline solution was given to the patients?", "category": "omission", "label": "extent"}, {"doc_id": 4166055, "edit_id": 20, "question": "How did the administration of hypertonic saline affect the average pressure in the arteries?", "category": "omission", "label": "cause"}, {"doc_id": 4166055, "edit_id": 21, "question": "How was the heart rate affected by the hypertonic saline infusion?", "category": "omission", "label": "cause"}, {"doc_id": 4166055, "edit_id": 22, "question": "Were there any severe episodes of low blood pressure after the hypertonic saline was given?", "category": "omission", "label": "verification"}, {"doc_id": 4166058, "edit_id": 0, "question": "Can you tell me more about the method of giving the children oxygen in this study?", "category": "omission", "label": "procedural"}, {"doc_id": 4166058, "edit_id": 1, "question": "Were there specific conditions that the oxygen needed to meet before being given to the babies?", "category": "omission", "label": "verification"}, {"doc_id": 4166058, "edit_id": 2, "question": "Was there a specific temperature the oxygen needed to be before being delivered to the babies?", "category": "omission", "label": "verification"}, {"doc_id": 4166058, "edit_id": 3, "question": "How important were the conditions of 100% relative humidity and a temperature of 37\u00b0C for the oxygen therapy?", "category": "omission", "label": "extent"}, {"doc_id": 4166058, "edit_id": 4, "question": "Were the devices used in this study approved by a health authority?", "category": "omission", "label": "verification"}, {"doc_id": 4166058, "edit_id": 5, "question": "What specific oxygen therapy can the approved devices provide?", "category": "omission", "label": "example"}, {"doc_id": 4166058, "edit_id": 6, "question": "Do these devices have the ability to warm the oxygen before delivery?", "category": "omission", "label": "verification"}, {"doc_id": 4166058, "edit_id": 7, "question": "What type of research study was conducted?", "category": "omission", "label": "concept"}, {"doc_id": 4166058, "edit_id": 8, "question": "What was the health condition of the newborns in this study?", "category": "omission", "label": "concept"}, {"doc_id": 4166058, "edit_id": 9, "question": "How was the initial therapy delivered to the babies in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4166058, "edit_id": 10, "question": "What was the concentration of oxygen given to the newborns during the initial therapy?", "category": "omission", "label": "extent"}, {"doc_id": 4166058, "edit_id": 11, "question": "How were the babies divided for the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4166058, "edit_id": 12, "question": "How many babies were in each group of the study?", "category": "omission", "label": "extent"}, {"doc_id": 4166058, "edit_id": 13, "question": "What treatment did the babies receive after the initial nasal mask therapy?", "category": "omission", "label": "procedural"}, {"doc_id": 4166058, "edit_id": 14, "question": "What device was used to deliver oxygen therapy to the babies in one of the groups?", "category": "omission", "label": "procedural"}, {"doc_id": 4166058, "edit_id": 15, "question": "What device was used to deliver oxygen therapy to the babies in the other group?", "category": "omission", "label": "procedural"}, {"doc_id": 4166058, "edit_id": 16, "question": "Did the researchers compare how often the babies needed to go back to the initial therapy?", "category": "omission", "label": "verification"}, {"doc_id": 4166058, "edit_id": 17, "question": "Did the study also compare any breathing problems between the two groups of babies?", "category": "omission", "label": "verification"}, {"doc_id": 4166058, "edit_id": 18, "question": "Was the presence of chronic lung disease among the babies also compared in the study?", "category": "omission", "label": "verification"}, {"doc_id": 4166058, "edit_id": 19, "question": "Did the study consider any injuries to the nose from the oxygen therapy?", "category": "omission", "label": "verification"}, {"doc_id": 4166058, "edit_id": 20, "question": "Did the researchers measure moisture levels in the oxygen being delivered to the babies?", "category": "omission", "label": "verification"}, {"doc_id": 4166058, "edit_id": 21, "question": "Was there a difference in how long the babies were kept on the heated and humidified nasal cannula therapy between the two groups?", "category": "omission", "label": "verification"}, {"doc_id": 4166058, "edit_id": 22, "question": "Was there a difference in the need for the babies to go back to the nasal mask therapy between the two groups?", "category": "omission", "label": "verification"}, {"doc_id": 4166058, "edit_id": 23, "question": "Was there a difference in the requirement for more serious breathing support, such as invasive ventilation, between the two groups?", "category": "omission", "label": "verification"}, {"doc_id": 4166058, "edit_id": 24, "question": "Did there happen to be a difference in the occurrence of breath pauses, or apnea, between the two groups?", "category": "omission", "label": "verification"}, {"doc_id": 4166058, "edit_id": 25, "question": "Was there a difference in nose injuries from the oxygen therapy between the two groups?", "category": "omission", "label": "verification"}, {"doc_id": 4166058, "edit_id": 26, "question": "Was there a difference in the occurrence of chronic lung disease between the two groups of babies?", "category": "omission", "label": "verification"}, {"doc_id": 4166058, "edit_id": 27, "question": "Did the study find any major differences between the two groups of babies?", "category": "omission", "label": "verification"}, {"doc_id": 4166058, "edit_id": 28, "question": "Was there a difference in the temperature and moisture levels of the oxygen delivered by the two systems?", "category": "omission", "label": "verification"}, {"doc_id": 4171519, "edit_id": 0, "question": "How was the treatment administered to the rats?", "category": "omission", "label": "procedural"}, {"doc_id": 4171519, "edit_id": 1, "question": "Which parts of the rats' bodies were examined after they were sacrificed?", "category": "omission", "label": "procedural"}, {"doc_id": 4171519, "edit_id": 2, "question": "In addition to femora, were any other part of the rats' bodies examined after they were sacrificed?", "category": "omission", "label": "verification"}, {"doc_id": 4171519, "edit_id": 3, "question": "What testing was performed on the femora and lumbar vertebrae that were harvested from the rats?", "category": "omission", "label": "procedural"}, {"doc_id": 4171519, "edit_id": 4, "question": "What kind of testing was carried out on the harvested femora and lumbar vertebrae?", "category": "omission", "label": "procedural"}, {"doc_id": 4171519, "edit_id": 5, "question": "Was there a comparison group in this study? If so, what kind of treatment did they receive?", "category": "omission", "label": "verification"}, {"doc_id": 4171519, "edit_id": 6, "question": "Were there any differences observed in the occurrence of diabetes between the different groups of rats?", "category": "omission", "label": "verification"}, {"doc_id": 4171519, "edit_id": 7, "question": "What were the effects of Raloxifene in relation to the prevention of diabetes?", "category": "omission", "label": "consequence"}, {"doc_id": 4171519, "edit_id": 8, "question": "What type of rats was used in this study?", "category": "omission", "label": "concept"}, {"doc_id": 4183415, "edit_id": 0, "question": "Where are Artemisinin combination therapies for malaria available?", "category": "omission", "label": "example"}, {"doc_id": 4183415, "edit_id": 1, "question": "What might compromise the patient's adherence to the medication regimen for the malaria drug?", "category": "omission", "label": "cause"}, {"doc_id": 4183415, "edit_id": 2, "question": "What information did the text message reminders given to drug store staff contain?", "category": "omission", "label": "procedural"}, {"doc_id": 4183415, "edit_id": 3, "question": "What type of trial was conducted to see if text messages could improve medication adherence?", "category": "omission", "label": "concept"}, {"doc_id": 4183415, "edit_id": 4, "question": "Where did the follow-ups on the patients' medication habits take place?", "category": "omission", "label": "procedural"}, {"doc_id": 4183415, "edit_id": 5, "question": "What information was collected from the patients during the follow-up?", "category": "omission", "label": "procedural"}, {"doc_id": 4183415, "edit_id": 6, "question": "Who else were interviewed apart from the patients in this study?", "category": "omission", "label": "procedural"}, {"doc_id": 4183415, "edit_id": 7, "question": "What information was gathered from the interviews with the drug store staff (dispensers)?", "category": "omission", "label": "procedural"}, {"doc_id": 4183415, "edit_id": 8, "question": "How many shops were involved in the study?", "category": "omission", "label": "extent"}, {"doc_id": 4183415, "edit_id": 9, "question": "What percentage of patients in the group that received text message reminders completed all of their doses?", "category": "omission", "label": "extent"}, {"doc_id": 4183415, "edit_id": 10, "question": "What percentage of patients in the group that did not receive text message reminders completed all of their doses?", "category": "omission", "label": "extent"}, {"doc_id": 4183415, "edit_id": 11, "question": "Was there a significant difference between the two groups in terms of completing all doses?", "category": "omission", "label": "verification"}, {"doc_id": 4183415, "edit_id": 12, "question": "What percentage of patients in the group that received text message reminders took each dose of the medicine at the correct time?", "category": "omission", "label": "extent"}, {"doc_id": 4183415, "edit_id": 13, "question": "What percentage of patients in the group that did not receive text message reminders took each dose of the medicine at the correct time?", "category": "omission", "label": "extent"}, {"doc_id": 4183415, "edit_id": 14, "question": "Was there a significant difference between the two groups in terms of taking each dose of the medicine at the correct time?", "category": "omission", "label": "verification"}, {"doc_id": 4183415, "edit_id": 15, "question": "What is the main goal of conducting these studies involving text message reminders?", "category": "omission", "label": "cause"}, {"doc_id": 4202567, "edit_id": 0, "question": "Have any scientific studies been conducted to learn more about working memory?", "category": "omission", "label": "verification"}, {"doc_id": 4202567, "edit_id": 1, "question": "Have these studies identified specific areas in the brain related to working memory?", "category": "omission", "label": "verification"}, {"doc_id": 4202567, "edit_id": 2, "question": "Who took part in this study?", "category": "omission", "label": "procedural"}, {"doc_id": 4202567, "edit_id": 3, "question": "What type of study was conducted to understand the role of tDCS in working memory?", "category": "omission", "label": "concept"}, {"doc_id": 4202567, "edit_id": 4, "question": "What type of task did the participants have to perform in this study?", "category": "omission", "label": "procedural"}, {"doc_id": 4202567, "edit_id": 5, "question": "What statistical analysis was used in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4202567, "edit_id": 6, "question": "Did the statistical analysis show any significant results?", "category": "omission", "label": "verification"}, {"doc_id": 4202567, "edit_id": 7, "question": "What types of stimulation were compared in the study?", "category": "omission", "label": "comparison"}, {"doc_id": 4202567, "edit_id": 8, "question": "To which part of the brain was the positive electrical charge (anodal stimulation) from the tDCS applied in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4202567, "edit_id": 9, "question": "How complex was the working memory task that participants had to perform?", "category": "omission", "label": "extent"}, {"doc_id": 4202567, "edit_id": 10, "question": "Was the effect of the tDCS on memory statistically significant or just by chance?", "category": "omission", "label": "verification"}, {"doc_id": 4202567, "edit_id": 11, "question": "What was the F-value, a statistic indicating the ratio of between-group variance to within-group variance, for the effect of tDCS on memory?", "category": "omission", "label": "extent"}, {"doc_id": 4202567, "edit_id": 12, "question": "What was the P-value, a measure of the probability that the observed results occurred by chance, for the effect of tDCS on memory?", "category": "omission", "label": "extent"}, {"doc_id": 4202567, "edit_id": 13, "question": "Did the position of tDCS stimulation or inhibition electrodes have any effect on the results?", "category": "omission", "label": "verification"}, {"doc_id": 4202567, "edit_id": 14, "question": "Does the position of the electrodes applied during tDCS have an impact on working memory?", "category": "omission", "label": "cause"}, {"doc_id": 4231047, "edit_id": 0, "question": "What is known about the effectiveness of the form of radiation therapy used in this treatment approach?", "category": "omission", "label": "concept"}, {"doc_id": 4231047, "edit_id": 1, "question": "Why is there a limit to the amount of radiation the liver can handle in these treatments?", "category": "omission", "label": "cause"}, {"doc_id": 4231047, "edit_id": 2, "question": "What specific type of radiotherapy was used in this study?", "category": "omission", "label": "concept"}, {"doc_id": 4231047, "edit_id": 3, "question": "How was the occurrence of radiation-induced liver injury assessed after treatment?", "category": "omission", "label": "procedural"}, {"doc_id": 4231047, "edit_id": 4, "question": "What type of MRI was used to assess for radiation-induced liver injury?", "category": "omission", "label": "concept"}, {"doc_id": 4231047, "edit_id": 5, "question": "How did researchers determine the smallest radiation dose that caused injury?", "category": "omission", "label": "procedural"}, {"doc_id": 4231047, "edit_id": 6, "question": "Was there a planned analysis to be undertaken during the study?", "category": "omission", "label": "verification"}, {"doc_id": 4231047, "edit_id": 7, "question": "What was the smallest mean dose that caused liver injury in the group that did not receive the additional drug treatment?", "category": "omission", "label": "extent"}, {"doc_id": 4231047, "edit_id": 8, "question": "What proportion of patients who received the combination treatment showed signs of radiation-induced liver injury at 6 weeks?", "category": "omission", "label": "extent"}, {"doc_id": 4236282, "edit_id": 0, "question": "Can motivational interviewing (MI) be used in scalable interventions?", "category": "omission", "label": "verification"}, {"doc_id": 4236282, "edit_id": 1, "question": "Can internet resources be used to support these interventions?", "category": "omission", "label": "verification"}, {"doc_id": 4236282, "edit_id": 2, "question": "Can these interventions help overcome challenges to effectively spread obesity treatment?", "category": "omission", "label": "verification"}, {"doc_id": 4236282, "edit_id": 3, "question": "Apart from motivational interviewing (MIC), what other intervention was tested in the study?", "category": "omission", "label": "example"}, {"doc_id": 4236282, "edit_id": 4, "question": "Where was the treatment conducted?", "category": "omission", "label": "concept"}, {"doc_id": 4236282, "edit_id": 5, "question": "How were the patients' assessments done?", "category": "omission", "label": "procedural"}, {"doc_id": 4236282, "edit_id": 6, "question": "Were there any changes observed in triglyceride levels, particularly in NPC compared to UC?", "category": "omission", "label": "comparison"}, {"doc_id": 4236282, "edit_id": 7, "question": "Was there a difference in depression scores between participants in NPC and UC?", "category": "omission", "label": "comparison"}, {"doc_id": 4236282, "edit_id": 8, "question": "Was there a significant difference in triglyceride levels between the NPC and MIC groups?", "category": "omission", "label": "comparison"}, {"doc_id": 4236282, "edit_id": 9, "question": "Did the study find a significant difference in triglyceride levels between the UC and MIC groups?", "category": "omission", "label": "comparison"}, {"doc_id": 4236282, "edit_id": 10, "question": "What was the relationship between depression scores in the UC and MIC groups?", "category": "omission", "label": "concept"}, {"doc_id": 4236282, "edit_id": 11, "question": "Were the weight-loss results sustained even at a 3-month follow-up?", "category": "omission", "label": "verification"}, {"doc_id": 4236282, "edit_id": 12, "question": "What was the fidelity rating of the interventions?", "category": "omission", "label": "concept"}, {"doc_id": 4236282, "edit_id": 13, "question": "What makes this study unique in terms of the use of motivational interviewing?", "category": "omission", "label": "concept"}, {"doc_id": 4236282, "edit_id": 14, "question": "Does this study include an attention-control intervention alongside the other interventions?", "category": "omission", "label": "verification"}, {"doc_id": 4236282, "edit_id": 15, "question": "What is the attention-control intervention called in this study?", "category": "omission", "label": "concept"}, {"doc_id": 4236282, "edit_id": 16, "question": "Did one method show consistently better results than the others?", "category": "omission", "label": "comparison"}, {"doc_id": 4260384, "edit_id": 0, "question": "What is the condition that the treatments in the study aim to address?", "category": "omission", "label": "concept"}, {"doc_id": 4260384, "edit_id": 1, "question": "What kind of study design was used for this research?", "category": "omission", "label": "concept"}, {"doc_id": 4260384, "edit_id": 2, "question": "How were the treatments assigned to different sides of the each patient's mouth?", "category": "omission", "label": "procedural"}, {"doc_id": 4260384, "edit_id": 3, "question": "What was the additional treatment given to Group B apart from the surgical technique?", "category": "omission", "label": "concept"}, {"doc_id": 4260384, "edit_id": 4, "question": "What other measurements were taken at the start of the study, besides the depth and width of the gum recession?", "category": "omission", "label": "example"}, {"doc_id": 4260384, "edit_id": 5, "question": "What was the severity of the gum recessions treated in the study?", "category": "omission", "label": "extent"}, {"doc_id": 4260384, "edit_id": 6, "question": "Can you elaborate on the statistical significance of the recession depth reduction in both treatments?", "category": "omission", "label": "extent"}, {"doc_id": 4260384, "edit_id": 7, "question": "How statistically significant was the greater reduction of recession depth in Group B compared to Group A?", "category": "omission", "label": "comparison"}, {"doc_id": 4260384, "edit_id": 8, "question": "How statistically significant were the changes in probing depth in both treatments?", "category": "omission", "label": "extent"}, {"doc_id": 4260384, "edit_id": 9, "question": "What was the increase in clinical attachment level in Group B?", "category": "omission", "label": "extent"}, {"doc_id": 4260384, "edit_id": 10, "question": "How statistically significant was the increase in the clinical attachment level in Group B?", "category": "omission", "label": "extent"}, {"doc_id": 4260384, "edit_id": 11, "question": "Was there any notable increase in the clinical attachment level in Group A?", "category": "omission", "label": "verification"}, {"doc_id": 4260384, "edit_id": 12, "question": "How statistically significant was the increase in the clinical attachment level in Group A?", "category": "omission", "label": "extent"}, {"doc_id": 4260384, "edit_id": 13, "question": "How statistically significant was the difference in clinical attachment level gains between Group A and Group B?", "category": "omission", "label": "comparison"}, {"doc_id": 4260384, "edit_id": 14, "question": "Besides the recession depth, was there any other improvement observed in both groups?", "category": "omission", "label": "verification"}, {"doc_id": 4260384, "edit_id": 15, "question": "How statistically significant was the increase in the width of the keratinized tissue?", "category": "omission", "label": "extent"}, {"doc_id": 4260384, "edit_id": 16, "question": "What was the increase in the width of the keratinized tissue in Group B?", "category": "omission", "label": "extent"}, {"doc_id": 4260384, "edit_id": 17, "question": "What was the increase in the width of the keratinized tissue in Group A?", "category": "omission", "label": "extent"}, {"doc_id": 4260384, "edit_id": 18, "question": "Was the difference in the increase of the width of keratinized tissue between group A and B statistically significant?", "category": "omission", "label": "comparison"}, {"doc_id": 4260384, "edit_id": 19, "question": "Can you specify what treatments were used alone in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4260384, "edit_id": 20, "question": "What was the primary aim of the treatments in the study?", "category": "omission", "label": "concept"}, {"doc_id": 4260384, "edit_id": 21, "question": "What was the result of using both the surgical technique and the collagen membrane (NEOMEM) in terms of the width of the keratinized tissue?", "category": "omission", "label": "consequence"}, {"doc_id": 4262215, "edit_id": 0, "question": "What else does the study aim to understand apart from how mental health nursing plans affect thoughts of suicide in patients?", "category": "omission", "label": "concept"}, {"doc_id": 4262215, "edit_id": 1, "question": "How many patients with serious types of cancer were included in the study?", "category": "omission", "label": "extent"}, {"doc_id": 4262215, "edit_id": 2, "question": "How were the patients grouped into the study and control groups?", "category": "omission", "label": "procedural"}, {"doc_id": 4262215, "edit_id": 3, "question": "What does the normal nursing care given to the control group include?", "category": "omission", "label": "concept"}, {"doc_id": 4262215, "edit_id": 4, "question": "What are some other features of the normal nursing care given to the control group?", "category": "omission", "label": "example"}, {"doc_id": 4262215, "edit_id": 5, "question": "Was there a significant difference in the hiding of feelings between the patients who were given special mental health nursing and those who weren't?", "category": "omission", "label": "verification"}, {"doc_id": 4262215, "edit_id": 6, "question": "Was there any significant relationship found between the suicide thoughts and physical and mental abilities in patients?", "category": "omission", "label": "verification"}, {"doc_id": 4283690, "edit_id": 0, "question": "Does this study have a unique identifier for reference?", "category": "omission", "label": "verification"}, {"doc_id": 4283690, "edit_id": 1, "question": "Which phase of the clinical trial is the RAPID-PsA study in?", "category": "omission", "label": "concept"}, {"doc_id": 4283690, "edit_id": 2, "question": "What type of clinical trial is RAPID-PsA?", "category": "omission", "label": "concept"}, {"doc_id": 4283690, "edit_id": 3, "question": "How were the patients in the study divided into groups for treatment?", "category": "omission", "label": "procedural"}, {"doc_id": 4283690, "edit_id": 4, "question": "What was the dose and frequency of CZP for some of the patients?", "category": "omission", "label": "extent"}, {"doc_id": 4283690, "edit_id": 5, "question": "Was there a different dose and frequency of CZP given to other patients?", "category": "omission", "label": "verification"}, {"doc_id": 4283690, "edit_id": 6, "question": "What kind of survey tool was used in this study? ", "category": "omission", "label": "procedural"}, {"doc_id": 4283690, "edit_id": 7, "question": "Over what period of time was productivity measured in this survey?", "category": "omission", "label": "extent"}, {"doc_id": 4283690, "edit_id": 8, "question": "What statistical method did the researchers use to compare the results between different groups?", "category": "omission", "label": "procedural"}, {"doc_id": 4283690, "edit_id": 9, "question": "Was there a significant difference in the productivity at home between the patients who took CZP and those who took the placebo?", "category": "omission", "label": "comparison"}, {"doc_id": 4283690, "edit_id": 10, "question": "How much improvement did the patients who took the placebo report in their productivity at home?", "category": "omission", "label": "extent"}, {"doc_id": 4283690, "edit_id": 11, "question": "Can we refer to this study using a specific identifier?", "category": "omission", "label": "verification"}, {"doc_id": 4283690, "edit_id": 12, "question": "What type of studies usually uses identifiers that start with 'NCT'?", "category": "omission", "label": "concept"}, {"doc_id": 4302388, "edit_id": 0, "question": "Apart from investigating the connection between selenium levels and high blood pressure conditions during pregnancy, what was another aim of the study?", "category": "omission", "label": "example"}, {"doc_id": 4302388, "edit_id": 1, "question": "When was the research about selenium levels and high blood pressure conditions during pregnancy conducted?", "category": "omission", "label": "extent"}, {"doc_id": 4302388, "edit_id": 2, "question": "What was the source of the samples used in the selenium study?", "category": "omission", "label": "concept"}, {"doc_id": 4302388, "edit_id": 3, "question": "How were the selection of women for treatment or placebo determined in the SPRINT study?", "category": "omission", "label": "procedural"}, {"doc_id": 4302388, "edit_id": 4, "question": "How much selenium was given to the women in the treatment group of the SPRINT study?", "category": "omission", "label": "extent"}, {"doc_id": 4302388, "edit_id": 5, "question": "When was the first measurement of selenium concentration in the women's blood taken during the study?", "category": "omission", "label": "extent"}, {"doc_id": 4302388, "edit_id": 6, "question": "When was the selenium concentration in the women's blood measured for the second time in the study?", "category": "omission", "label": "extent"}, {"doc_id": 4302388, "edit_id": 7, "question": "When was the toenail selenium concentration measurement taken in the study?", "category": "omission", "label": "extent"}, {"doc_id": 4302388, "edit_id": 8, "question": "Apart from the measurement of selenium concentration in the blood, was there any other measurements taken at 35 weeks into the women's pregnancy in the study? ", "category": "omission", "label": "verification"}, {"doc_id": 4302388, "edit_id": 9, "question": "Were there standard intervals for measuring the activity of plasma glutathione peroxidase (GPx3) in the study? ", "category": "omission", "label": "verification"}, {"doc_id": 4302388, "edit_id": 10, "question": "Besides taking measurements during the pregnancy, when else did researchers collect data for the selenium study?", "category": "omission", "label": "extent"}, {"doc_id": 4302388, "edit_id": 11, "question": "What was the questionnaire completed by the pregnant women in the study?", "category": "omission", "label": "concept"}, {"doc_id": 4302388, "edit_id": 12, "question": "How did the activity level of the GPx3 enzyme in UK pregnant women compare to those in US and Australian pregnant women in the study?", "category": "omission", "label": "comparison"}, {"doc_id": 4302388, "edit_id": 13, "question": "What was the baseline concentration of SEPP1, the protein known to transport selenium, in UK pregnant women in the study?", "category": "omission", "label": "extent"}, {"doc_id": 4302388, "edit_id": 14, "question": "What was the median SEPP1 concentration in the blood of UK pregnant women in the study?", "category": "omission", "label": "extent"}, {"doc_id": 4302388, "edit_id": 15, "question": "What was the range of SEPP1 concentration in the blood of UK pregnant women in the study?", "category": "omission", "label": "extent"}, {"doc_id": 4302388, "edit_id": 16, "question": "Did the researchers make any changes to the measurement of selenium concentration in the blood of women in the study?", "category": "omission", "label": "verification"}, {"doc_id": 4302388, "edit_id": 17, "question": "Did the intake of Brazil nuts influence the concentration of selenium in the blood of the pregnant women in the study?", "category": "omission", "label": "verification"}, {"doc_id": 4302388, "edit_id": 18, "question": "Did the intake of seafood impact the concentration of selenium in the blood of the pregnant women in the study?", "category": "omission", "label": "verification"}, {"doc_id": 4302388, "edit_id": 19, "question": "What kind of statistical model was employed in the study to assess the selenium-related risk factors?", "category": "omission", "label": "concept"}, {"doc_id": 4302388, "edit_id": 20, "question": "Among the selenium-related risk factors, which one significantly influenced the odds ratio for developing high blood pressure conditions during pregnancy?", "category": "omission", "label": "disjunction"}, {"doc_id": 4302388, "edit_id": 21, "question": "What was the odds ratio for toenail selenium concentration in the study?", "category": "omission", "label": "extent"}, {"doc_id": 4302388, "edit_id": 22, "question": "What was the 95% confidence interval for the odds ratio of toenail selenium concentration in the study? ", "category": "omission", "label": "extent"}, {"doc_id": 4302388, "edit_id": 23, "question": "What was the p-value for the effect of toenail selenium concentration on the odds of developing high blood pressure conditions during pregnancy?", "category": "omission", "label": "extent"}, {"doc_id": 4302388, "edit_id": 24, "question": "What does a p-value less than 0.05 indicate in a study?", "category": "omission", "label": "concept"}, {"doc_id": 4302388, "edit_id": 25, "question": "What was the effect of selenium supplementation on the odds of developing high blood pressure conditions during pregnancy in the study?", "category": "omission", "label": "consequence"}, {"doc_id": 4302388, "edit_id": 26, "question": "What was the odds ratio of developing high blood pressure conditions during pregnancy with selenium supplementation in the study?", "category": "omission", "label": "extent"}, {"doc_id": 4302388, "edit_id": 27, "question": "What was the 95% confidence interval for the odds ratio of selenium supplementation in the study?", "category": "omission", "label": "extent"}, {"doc_id": 4302388, "edit_id": 28, "question": "What was the p-value for the effect of selenium supplementation on reducing the odds of developing high blood pressure conditions during pregnancy in the study?", "category": "omission", "label": "extent"}, {"doc_id": 4313493, "edit_id": 0, "question": "What kind of study was conducted?", "category": "omission", "label": "concept"}, {"doc_id": 4313493, "edit_id": 1, "question": "What was the maximum eye pressure (intraocular pressure) of the patients involved in the study?", "category": "omission", "label": "extent"}, {"doc_id": 4313493, "edit_id": 2, "question": "What was required from the patients before they could participate in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4313493, "edit_id": 3, "question": "What happened to the eye pressure of the patients during the study?", "category": "omission", "label": "consequence"}, {"doc_id": 4313493, "edit_id": 4, "question": "How was the daily cost of each eye drop calculated?", "category": "omission", "label": "procedural"}, {"doc_id": 4313493, "edit_id": 5, "question": "What statistical method was used to figure out the results in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4313493, "edit_id": 6, "question": "What was the daily cost of the more expensive drug per eye?", "category": "omission", "label": "extent"}, {"doc_id": 4313493, "edit_id": 7, "question": "By how much can the cost of the more affordable drug per eye vary?", "category": "omission", "label": "extent"}, {"doc_id": 4313493, "edit_id": 8, "question": "In what currency was the cost-effectiveness ratio measured?", "category": "omission", "label": "concept"}, {"doc_id": 4313493, "edit_id": 9, "question": "What additional concept also was discussed in the original report?", "category": "omission", "label": "concept"}, {"doc_id": 4313493, "edit_id": 10, "question": "How does the cost per mm Hg of eye pressure reduction by the more effective drug compare to the unit of currency?", "category": "omission", "label": "comparison"}, {"doc_id": 4313493, "edit_id": 11, "question": "What is the cost-effectiveness ratio for the less effective drug in Rupees?", "category": "omission", "label": "extent"}, {"doc_id": 4323432, "edit_id": 0, "question": "What are some of the uses of antispasmodic agents in gastrointestinal procedures like endoscopy? ", "category": "omission", "label": "example"}, {"doc_id": 4323432, "edit_id": 1, "question": "Can you name a specific antispasmodic agent used in gastrointestinal procedures? ", "category": "omission", "label": "example"}, {"doc_id": 4323432, "edit_id": 2, "question": "Can you name any other antispasmodic agents besides hyoscine butylbromide?", "category": "omission", "label": "example"}, {"doc_id": 4323432, "edit_id": 3, "question": "Are that any antispasmodic agents other than hyoscine butylbromide and atropine?", "category": "omission", "label": "verification"}, {"doc_id": 4323432, "edit_id": 4, "question": "What was the study specifically investigating about the use of oral phloroglucin?", "category": "omission", "label": "concept"}, {"doc_id": 4323432, "edit_id": 5, "question": "Was this study conducted on past data or was it planned for the future?", "category": "omission", "label": "verification"}, {"doc_id": 4323432, "edit_id": 6, "question": "How many patients were involved in the study and how were they divided?", "category": "omission", "label": "extent"}, {"doc_id": 4323432, "edit_id": 7, "question": "How many patients were in the first group that was given the oral phloroglucin?", "category": "omission", "label": "extent"}, {"doc_id": 4323432, "edit_id": 8, "question": "How many patients were in the second group that was administered cimetropium bromide?", "category": "omission", "label": "extent"}, {"doc_id": 4323432, "edit_id": 9, "question": "In this study, where were the muscle contractions assessed?", "category": "omission", "label": "concept"}, {"doc_id": 4323432, "edit_id": 10, "question": "How many stomach muscle contractions were observed in the group that was given oral phloroglucin?", "category": "omission", "label": "extent"}, {"doc_id": 4323432, "edit_id": 11, "question": "How many stomach muscle contractions were observed in the group that was given cimetropium bromide?", "category": "omission", "label": "extent"}, {"doc_id": 4323432, "edit_id": 12, "question": "What was the significance level (also known as the p-value) of the findings from the study?", "category": "omission", "label": "extent"}, {"doc_id": 4323432, "edit_id": 13, "question": "How often did patients who were given cimetropium bromide report having dry mouth?", "category": "omission", "label": "extent"}, {"doc_id": 4323432, "edit_id": 14, "question": "How often did patients who were given oral phloroglucin report having dry mouth?", "category": "omission", "label": "extent"}, {"doc_id": 4323432, "edit_id": 15, "question": "What is a valid use for oral phloroglucin according to the study?", "category": "omission", "label": "consequence"}, {"doc_id": 4323432, "edit_id": 16, "question": "Can you list another type of antispasmodic agent other than hyoscine butylbromide, atropine and glucagon?", "category": "omission", "label": "example"}, {"doc_id": 4329963, "edit_id": 0, "question": "What is the family-centered empowerment program?", "category": "omission", "label": "concept"}, {"doc_id": 4329963, "edit_id": 1, "question": "What models provided the basis for the educational intervention used in this study?", "category": "omission", "label": "concept"}, {"doc_id": 4329963, "edit_id": 2, "question": "Besides lifestyle changes, what other aspect did the study concentrate on?", "category": "omission", "label": "comparison"}, {"doc_id": 4329963, "edit_id": 3, "question": "Who were the targeted participants of the study?", "category": "omission", "label": "concept"}, {"doc_id": 4329963, "edit_id": 4, "question": "What type of study was conducted on the methamphetamine users?", "category": "omission", "label": "concept"}, {"doc_id": 4329963, "edit_id": 5, "question": "Where was the trial conducted?", "category": "omission", "label": "concept"}, {"doc_id": 4329963, "edit_id": 6, "question": "What stage were the methamphetamine users at during the trial?", "category": "omission", "label": "concept"}, {"doc_id": 4329963, "edit_id": 7, "question": "How many participants did the first group of the educational intervention include?", "category": "omission", "label": "extent"}, {"doc_id": 4329963, "edit_id": 8, "question": "What tool did the researchers use to collect participants' demographic data?", "category": "omission", "label": "procedural"}, {"doc_id": 4329963, "edit_id": 9, "question": "What are the main concepts or constructs used in Pender's health promotion model?", "category": "omission", "label": "concept"}, {"doc_id": 4329963, "edit_id": 10, "question": "Among whom can the family-centered empowerment model be applied?", "category": "omission", "label": "example"}, {"doc_id": 4329963, "edit_id": 11, "question": "Is it practical to apply the family-centered empowerment model in real-life scenarios?", "category": "omission", "label": "verification"}, {"doc_id": 4334515, "edit_id": 0, "question": "What type of study was conducted for 'Mastery over Dementia' online program?", "category": "omission", "label": "concept"}, {"doc_id": 4334515, "edit_id": 1, "question": "What was the form of intervention provided to the comparison group in the study?", "category": "omission", "label": "concept"}, {"doc_id": 4334515, "edit_id": 2, "question": "How did the researchers measure the levels of depression in the caregivers?", "category": "omission", "label": "procedural"}, {"doc_id": 4334515, "edit_id": 3, "question": "Apart from depression, what other symptoms were the researchers looking for in the caregivers?", "category": "omission", "label": "concept"}, {"doc_id": 4334515, "edit_id": 4, "question": "What tool did the researchers use to assess the level of anxiety in the caregivers?", "category": "omission", "label": "procedural"}, {"doc_id": 4334515, "edit_id": 5, "question": "What was the relationship of most of the caregivers to the person with dementia?", "category": "omission", "label": "concept"}, {"doc_id": 4334515, "edit_id": 6, "question": "Was there any other familial relationship among the caregivers?", "category": "omission", "label": "verification"}, {"doc_id": 4334515, "edit_id": 7, "question": "What was the age of the youngest caregiver participating in the study?", "category": "omission", "label": "extent"}, {"doc_id": 4334515, "edit_id": 8, "question": "What was the age of the oldest caregiver participating in the study?", "category": "omission", "label": "extent"}, {"doc_id": 4334515, "edit_id": 9, "question": "What was the lowest level of education among the caregivers participating in the study?", "category": "omission", "label": "extent"}, {"doc_id": 4334515, "edit_id": 10, "question": "What type of statistical analysis was used in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4334515, "edit_id": 11, "question": "What was the statistical significance, or p-value, associated with the reduction in depression symptoms among the caregivers?", "category": "omission", "label": "extent"}, {"doc_id": 4334515, "edit_id": 12, "question": "What was the statistical significance, or p-value, associated with the reduction in anxiety symptoms among the caregivers?", "category": "omission", "label": "extent"}, {"doc_id": 4334515, "edit_id": 13, "question": "Did the researchers take into account any differences among the caregivers when they started the program?", "category": "omission", "label": "verification"}, {"doc_id": 4334515, "edit_id": 14, "question": "Did the researchers control for the impact of the condition of the patients with dementia when analyzing the results?", "category": "omission", "label": "verification"}, {"doc_id": 4334515, "edit_id": 15, "question": "What was the strength of the effect of the program on reducing anxiety symptoms?", "category": "omission", "label": "extent"}, {"doc_id": 4334515, "edit_id": 16, "question": "What was the numerical value of the effect size for the decrease in symptoms of anxiety?", "category": "omission", "label": "extent"}, {"doc_id": 4334515, "edit_id": 17, "question": "What was the strength of the effect of the program on reducing depressive symptoms?", "category": "omission", "label": "extent"}, {"doc_id": 4334515, "edit_id": 18, "question": "What was the numerical value of the effect size for the decrease in symptoms of depression?", "category": "omission", "label": "extent"}, {"doc_id": 4334515, "edit_id": 19, "question": "Who was the target group for the 'Mastery over Dementia' online program?", "category": "omission", "label": "concept"}, {"doc_id": 4334515, "edit_id": 20, "question": "Can the 'Mastery over Dementia' online program be considered as an effective treatment for the caregivers of people with dementia?", "category": "omission", "label": "verification"}, {"doc_id": 4334515, "edit_id": 21, "question": "Apart from depression, does the 'Mastery over Dementia' online program help reduce any other psychological symptoms in caregivers?", "category": "omission", "label": "verification"}, {"doc_id": 4334515, "edit_id": 22, "question": "Is there a way to access information about the trial online?", "category": "omission", "label": "procedural"}, {"doc_id": 4334515, "edit_id": 23, "question": "What is the web address to access detailed information about this trial?", "category": "omission", "label": "concept"}, {"doc_id": 4354356, "edit_id": 0, "question": "What specific function do the reinforcement signals in the brain play when a person takes drugs?", "category": "omission", "label": "concept"}, {"doc_id": 4354356, "edit_id": 1, "question": "What methods were applied in this scientific study? ", "category": "omission", "label": "procedural"}, {"doc_id": 4354356, "edit_id": 2, "question": "What were the treatment conditions for the heroin-dependent patients in the study?", "category": "omission", "label": "concept"}, {"doc_id": 4354356, "edit_id": 3, "question": "What was the composition of the control group in this study?", "category": "omission", "label": "concept"}, {"doc_id": 4354356, "edit_id": 4, "question": "What kind of treatment did the healthy individuals in the control group receive?", "category": "omission", "label": "concept"}, {"doc_id": 4354356, "edit_id": 5, "question": "What type of analyses were done after the brain imaging data was collected?", "category": "omission", "label": "procedural"}, {"doc_id": 4354356, "edit_id": 6, "question": "What relationship did the researchers aim to establish with the correlation analyses?", "category": "omission", "label": "concept"}, {"doc_id": 4354356, "edit_id": 7, "question": "Did the researchers seek to find a relationship between the strength of the brain connections and the level of heroin in the patients' blood?", "category": "omission", "label": "verification"}, {"doc_id": 4354356, "edit_id": 8, "question": "Did the researchers also look for a relationship between the strength of the brain connections and the level of morphine in the patients' blood?", "category": "omission", "label": "verification"}, {"doc_id": 4354356, "edit_id": 9, "question": "How did heroin impact the connectivity in one specific part of the patients' brain?", "category": "omission", "label": "cause"}, {"doc_id": 4354356, "edit_id": 10, "question": "How did the use of placebo in the healthy control group impact their brain connectivity?", "category": "omission", "label": "cause"}, {"doc_id": 4354356, "edit_id": 11, "question": "In which specific brain network did the increased connectivity occur in the healthy participants?", "category": "omission", "label": "concept"}, {"doc_id": 4354356, "edit_id": 12, "question": "How did the increased brain connectivity in the healthy controls compare to the patients on placebo?", "category": "omission", "label": "comparison"}, {"doc_id": 4354356, "edit_id": 13, "question": "What does the study suggest about the continued reward effect in heroin-dependent patients?", "category": "omission", "label": "consequence"}, {"doc_id": 4355443, "edit_id": 0, "question": "What specific treatments are being compared in this study for liver cancer?", "category": "omission", "label": "comparison"}, {"doc_id": 4355443, "edit_id": 1, "question": "What was the specific condition of all the patients included in the study?", "category": "omission", "label": "concept"}, {"doc_id": 4355443, "edit_id": 2, "question": "In what pattern were the patients assigned to the treatment groups?", "category": "omission", "label": "procedural"}, {"doc_id": 4355443, "edit_id": 3, "question": "How is it determined when to stop the DEB-TACE treatment?", "category": "omission", "label": "procedural"}, {"doc_id": 4355443, "edit_id": 4, "question": "How often were the patients checked after the treatment?", "category": "omission", "label": "extent"}, {"doc_id": 4355443, "edit_id": 5, "question": "What type of treatment did the first group receive?", "category": "omission", "label": "concept"}, {"doc_id": 4355443, "edit_id": 6, "question": "What type of treatment did the second group of patients receive?", "category": "omission", "label": "concept"}, {"doc_id": 4355443, "edit_id": 7, "question": "How many males and females were included in the SIRT treatment group?", "category": "omission", "label": "extent"}, {"doc_id": 4355443, "edit_id": 8, "question": "How many males and females were included in the TACE treatment group?", "category": "omission", "label": "extent"}, {"doc_id": 4355443, "edit_id": 9, "question": "Was there any difference in the initial tumor load between the two treatment groups?", "category": "omission", "label": "verification"}, {"doc_id": 4355443, "edit_id": 10, "question": "What was the p-value when comparing how long it took for the cancer to spread in the SIRT group versus the TACE group?", "category": "omission", "label": "concept"}, {"doc_id": 4355443, "edit_id": 11, "question": "What was the median time it took for the cancer to spread for patients in the SIRT group?", "category": "omission", "label": "extent"}, {"doc_id": 4355443, "edit_id": 12, "question": "What was the median time it took for the cancer to spread for patients in the TACE group or DEB-TACE group?", "category": "omission", "label": "extent"}, {"doc_id": 4355443, "edit_id": 13, "question": "What was the p-value when comparing the median time it took for the cancer to spread in the SIRT group versus the TACE group?", "category": "omission", "label": "concept"}, {"doc_id": 4355443, "edit_id": 14, "question": "What was the p-value when comparing the average lifespan of patients in the SIRT group versus the TACE group?", "category": "omission", "label": "concept"}, {"doc_id": 4355443, "edit_id": 15, "question": "What caused the deaths of some patients in the SIRT group?", "category": "omission", "label": "cause"}, {"doc_id": 4355443, "edit_id": 16, "question": "Were there any significant differences in how long patients lived between the two treatment groups?", "category": "omission", "label": "comparison"}, {"doc_id": 4355443, "edit_id": 17, "question": "Were there any significant differences in the median time it took for the cancer to spread between the two treatment groups?", "category": "omission", "label": "comparison"}, {"doc_id": 4355443, "edit_id": 18, "question": "Which group had a lower rate of tumor progression or cancer spread?", "category": "omission", "label": "comparison"}, {"doc_id": 4355443, "edit_id": 19, "question": "Why didn't the lower rate of tumor spread in the SIRT group lead to a better outcome?", "category": "omission", "label": "cause"}, {"doc_id": 4355443, "edit_id": 20, "question": "What is special about this study comparing SIRT and TACE treatments for liver cancer?", "category": "omission", "label": "concept"}, {"doc_id": 4355443, "edit_id": 21, "question": "What type of study design was used to compare the SIRT and TACE treatments for liver cancer?", "category": "omission", "label": "concept"}, {"doc_id": 4355443, "edit_id": 22, "question": "What types of liver cancer were the treatments SIRT and TACE being compared for in this study?", "category": "omission", "label": "concept"}, {"doc_id": 4355443, "edit_id": 23, "question": "What can the results of this study be used for in future research?", "category": "omission", "label": "consequence"}, {"doc_id": 4358417, "edit_id": 0, "question": "How was the rosehip extract discovered as a potential treatment for obesity?", "category": "omission", "label": "procedural"}, {"doc_id": 4358417, "edit_id": 1, "question": "What were the results of previous investigations with rosehip extract on mice?", "category": "omission", "label": "consequence"}, {"doc_id": 4358417, "edit_id": 2, "question": "What was the health status of the participants in the study?", "category": "omission", "label": "concept"}, {"doc_id": 4358417, "edit_id": 3, "question": " Where was the rosehip extract study conducted? ", "category": "omission", "label": "concept"}, {"doc_id": 4358417, "edit_id": 4, "question": "What type of study was conducted to assess the effects of rosehip extract on obesity?", "category": "omission", "label": "concept"}, {"doc_id": 4358417, "edit_id": 5, "question": "What was the minimum body mass index of the study participants?", "category": "omission", "label": "extent"}, {"doc_id": 4358417, "edit_id": 6, "question": "What was the maximum body mass index of the study participants?", "category": "omission", "label": "extent"}, {"doc_id": 4358417, "edit_id": 7, "question": "How were the participants grouped for the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4358417, "edit_id": 8, "question": "What were the primary outcomes that the study focused on?", "category": "omission", "label": "concept"}, {"doc_id": 4358417, "edit_id": 9, "question": "How was the change in body fat percentage considered in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4358417, "edit_id": 10, "question": "How did the body fat percentages of participants compare before and after the use of the rosehip extract?", "category": "omission", "label": "comparison"}, {"doc_id": 4360612, "edit_id": 0, "question": "Is sacroiliac joint pain a common condition?", "category": "omission", "label": "verification"}, {"doc_id": 4360612, "edit_id": 1, "question": "Is sacroiliac joint pain usually diagnosed correctly or is it often missed?", "category": "omission", "label": "verification"}, {"doc_id": 4360612, "edit_id": 2, "question": "Have there been any other studies that have compared both surgical and non-surgical treatments for sacroiliac joint problems at the same time?", "category": "omission", "label": "verification"}, {"doc_id": 4360612, "edit_id": 3, "question": "Did all of the patients in the study have problems with their sacroiliac joint?", "category": "omission", "label": "verification"}, {"doc_id": 4360612, "edit_id": 4, "question": "What specifically was causing the sacroiliac joint problems in the patients?", "category": "omission", "label": "concept"}, {"doc_id": 4360612, "edit_id": 5, "question": "Can you explain in more detail the specific treatments the patients were assigned?", "category": "omission", "label": "procedural"}, {"doc_id": 4360612, "edit_id": 6, "question": "How many patients were assigned to the minimally invasive sacroiliac joint fusion surgery?", "category": "omission", "label": "extent"}, {"doc_id": 4360612, "edit_id": 7, "question": "Did the study collect information on the patient's initial levels of sacroiliac joint pain before their treatments began?", "category": "omission", "label": "verification"}, {"doc_id": 4360612, "edit_id": 8, "question": "What information, other than pain scores, was collected before the patients began their treatment?", "category": "omission", "label": "concept"}, {"doc_id": 4360612, "edit_id": 9, "question": "At the start of the study, were the patients in good or poor health?", "category": "omission", "label": "verification"}, {"doc_id": 4360612, "edit_id": 10, "question": "What was the average initial level of pain, according to the Visual Analogue Scale (VAS), experienced by the patients in the study?", "category": "omission", "label": "extent"}, {"doc_id": 4360612, "edit_id": 11, "question": "What was the average initial Oswestry Disability Index (ODI) score of the patients in the study?", "category": "omission", "label": "extent"}, {"doc_id": 4360612, "edit_id": 12, "question": "How many of the patients were able to be followed-up with after their treatments?", "category": "omission", "label": "extent"}, {"doc_id": 4360612, "edit_id": 13, "question": "What are the minimum and maximum success rates we can expect with a 95% certainty?", "category": "omission", "label": "extent"}, {"doc_id": 4360612, "edit_id": 14, "question": "How much improvement was considered as significant in the study?", "category": "omission", "label": "extent"}, {"doc_id": 4360612, "edit_id": 15, "question": "On average, how many complications or adverse events did patients in the surgery group experience?", "category": "omission", "label": "extent"}, {"doc_id": 4360612, "edit_id": 16, "question": "Can you explain again what was causing the sacroiliac joint problems in the patients of the study?", "category": "omission", "label": "cause"}, {"doc_id": 4360612, "edit_id": 17, "question": "Can sacroiliac joint dysfunction become chronic because of degenerative sacroiliitis?", "category": "omission", "label": "consequence"}, {"doc_id": 4360612, "edit_id": 18, "question": "Can sacroiliac joint dysfunction also become chronic because of sacroiliac joint disruptions?", "category": "omission", "label": "consequence"}, {"doc_id": 4360612, "edit_id": 19, "question": "What type of patients were considered for the less-invasive surgery in the study?", "category": "omission", "label": "concept"}, {"doc_id": 4382580, "edit_id": 0, "question": "Aside from reducing pain, was another goal of the study to see if the exercises could increase patients' overall physical abilities?", "category": "omission", "label": "verification"}, {"doc_id": 4382580, "edit_id": 1, "question": "Did all volunteers give their permission in writing before participating in the study?", "category": "omission", "label": "verification"}, {"doc_id": 4382580, "edit_id": 2, "question": "Did the researchers use a variety of tools to assess how well the patients were doing?", "category": "omission", "label": "verification"}, {"doc_id": 4382580, "edit_id": 3, "question": "Was a test called the \"Lequesne's Algofunctional Questionnaire\" used in the study?", "category": "omission", "label": "verification"}, {"doc_id": 4382580, "edit_id": 4, "question": "Was the \"Oswestry Disability Index\" test used in the evaluations?", "category": "omission", "label": "verification"}, {"doc_id": 4382580, "edit_id": 5, "question": "Did they use a technique known as goniometry as one of their testing methods?", "category": "omission", "label": "verification"}, {"doc_id": 4382580, "edit_id": 6, "question": "Did the researchers use a device called a load cell to measure muscle strength?", "category": "omission", "label": "verification"}, {"doc_id": 4382580, "edit_id": 7, "question": "What type of therapy did the non-water exercise group receive?", "category": "omission", "label": "concept"}, {"doc_id": 4382580, "edit_id": 8, "question": "What was the average age of the group that did water exercises?", "category": "omission", "label": "extent"}, {"doc_id": 4382580, "edit_id": 9, "question": "How old were the youngest and oldest volunteers in the water exercise group?", "category": "omission", "label": "extent"}, {"doc_id": 4382580, "edit_id": 10, "question": "What was the average age of the group that did non-water exercises?", "category": "omission", "label": "extent"}, {"doc_id": 4382580, "edit_id": 11, "question": "How old were the youngest and oldest volunteers in the non-water exercise group?", "category": "omission", "label": "extent"}, {"doc_id": 4382580, "edit_id": 12, "question": "Were there significant differences between the two groups in terms of their flexibility or movement in certain areas after the 12 weeks?", "category": "omission", "label": "comparison"}, {"doc_id": 4382580, "edit_id": 13, "question": "Is physical therapy an effective treatment for muscle and joint problems in patients with sickle cell disease?", "category": "omission", "label": "verification"}, {"doc_id": 4382580, "edit_id": 14, "question": "Do we need to include more people in future studies to get clearer results?", "category": "omission", "label": "judgmental"}, {"doc_id": 4382580, "edit_id": 15, "question": "Do we need to extend the treatment period in future studies to get clearer results?", "category": "omission", "label": "judgmental"}, {"doc_id": 4391192, "edit_id": 0, "question": "What specific type of sleep did the earplugs and eye masks help improve?", "category": "omission", "label": "concept"}, {"doc_id": 4391192, "edit_id": 1, "question": "In which type of environment was this study conducted?", "category": "omission", "label": "concept"}, {"doc_id": 4391192, "edit_id": 2, "question": "For how long were the patients expected to stay in the ICU following their surgery?", "category": "omission", "label": "extent"}, {"doc_id": 4391192, "edit_id": 3, "question": "In which specific type of ICU did the surgeries of the patients take place?", "category": "omission", "label": "concept"}, {"doc_id": 4391192, "edit_id": 4, "question": "Did the study involve the use of earplugs for sleep?", "category": "omission", "label": "verification"}, {"doc_id": 4391192, "edit_id": 5, "question": "Were eye masks used in this study for sleep?", "category": "omission", "label": "verification"}, {"doc_id": 4391192, "edit_id": 6, "question": "When did this study take place within the patients' treatment timeline?", "category": "omission", "label": "procedural"}, {"doc_id": 4391192, "edit_id": 7, "question": "What hormone levels, related to sleep, were analyzed in this study?", "category": "omission", "label": "concept"}, {"doc_id": 4391192, "edit_id": 8, "question": "Was any other hormone, besides melatonin, analyzed in this research?", "category": "omission", "label": "verification"}, {"doc_id": 4391192, "edit_id": 9, "question": "At what time of the day were the cortisol levels analyzed?", "category": "omission", "label": "procedural"}, {"doc_id": 4391192, "edit_id": 10, "question": "What specific tool was used to evaluate sleep quality in these patients?", "category": "omission", "label": "procedural"}, {"doc_id": 4391192, "edit_id": 11, "question": "What type of scale is the Richards-Campbell Sleep Questionnaire?", "category": "omission", "label": "concept"}, {"doc_id": 4391192, "edit_id": 12, "question": "What is the range of the Richards-Campbell Sleep Questionnaire scale?", "category": "omission", "label": "extent"}, {"doc_id": 4391192, "edit_id": 13, "question": "How many groups of patients were there in this study and what were they called?", "category": "omission", "label": "extent"}, {"doc_id": 4391192, "edit_id": 14, "question": "How many patients were there in the group that used the earplugs, eye masks, and relaxing music?", "category": "omission", "label": "extent"}, {"doc_id": 4391192, "edit_id": 15, "question": "How many patients were in the control group, that did not use any of the sleep-aid methods?", "category": "omission", "label": "extent"}, {"doc_id": 4391192, "edit_id": 16, "question": "Whose data was analyzed in this study?", "category": "omission", "label": "verification"}, {"doc_id": 4391192, "edit_id": 17, "question": "Did the study evaluate the ease of falling back asleep after being awakened?", "category": "omission", "label": "verification"}, {"doc_id": 4391192, "edit_id": 18, "question": "Was there any difference between the groups in how often they woke up during sleep?", "category": "omission", "label": "verification"}, {"doc_id": 4391192, "edit_id": 19, "question": "Which group had a better quality of sleep according to the patients' perceptions?", "category": "omission", "label": "comparison"}, {"doc_id": 4391192, "edit_id": 20, "question": "When after the surgery were the hormone levels and sleep quality measured?", "category": "omission", "label": "procedural"}, {"doc_id": 4391192, "edit_id": 21, "question": "On which other night following surgery were the measurements taken?", "category": "omission", "label": "procedural"}, {"doc_id": 4391192, "edit_id": 22, "question": "Were the differences in hormone levels between the two groups statistically significant?", "category": "omission", "label": "verification"}, {"doc_id": 4391192, "edit_id": 23, "question": "When were the urinary melatonin levels measured?", "category": "omission", "label": "procedural"}, {"doc_id": 4391192, "edit_id": 24, "question": "Was there any change in the urinary melatonin levels after surgery compared to before?", "category": "omission", "label": "verification"}, {"doc_id": 4391192, "edit_id": 25, "question": "How did the urinary melatonin levels on the second night after surgery compare to the levels before surgery?", "category": "omission", "label": "comparison"}, {"doc_id": 4391192, "edit_id": 26, "question": "Was the change in urinary melatonin levels from before surgery to after surgery statistically significant?", "category": "omission", "label": "verification"}, {"doc_id": 4391192, "edit_id": 27, "question": "What is the 'p-value' associated with the difference in urinary melatonin levels?", "category": "omission", "label": "extent"}, {"doc_id": 4391192, "edit_id": 28, "question": "What is the 'p-value' associated with the change in urinary cortisol levels?", "category": "omission", "label": "extent"}, {"doc_id": 4391192, "edit_id": 29, "question": "Are factors such as surgery timings, medication, and individual differences related to specific type of markers in this study?", "category": "omission", "label": "verification"}, {"doc_id": 4391192, "edit_id": 30, "question": "Could the factors of surgery timing, medication, and individual differences have an impact on how effective the earplugs, eye masks, and relaxing music are on improving sleep?", "category": "omission", "label": "cause"}, {"doc_id": 4391192, "edit_id": 31, "question": "In which registry was this trial registered and what identifier was given to it?", "category": "omission", "label": "procedural"}, {"doc_id": 4398332, "edit_id": 0, "question": "What is the primary psychoactive constituent of cannabis?", "category": "omission", "label": "concept"}, {"doc_id": 4398332, "edit_id": 1, "question": "What effect does acute administration of THC have on the recognition of human emotions based on facial expressions?", "category": "omission", "label": "consequence"}, {"doc_id": 4398332, "edit_id": 2, "question": "Does Cannabidiol (CBD) have any effects on the brain?", "category": "omission", "label": "verification"}, {"doc_id": 4398332, "edit_id": 3, "question": "What is the specific focus of the study with respect to the effects of THC and CBD?", "category": "omission", "label": "concept"}, {"doc_id": 4398332, "edit_id": 4, "question": "How many volunteers participated in the study?", "category": "omission", "label": "extent"}, {"doc_id": 4398332, "edit_id": 5, "question": "On what basis were the volunteers selected for the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4398332, "edit_id": 6, "question": "What substance was administered to the volunteers in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4398332, "edit_id": 7, "question": "How much THC was administered to the volunteers in the study?", "category": "omission", "label": "extent"}, {"doc_id": 4398332, "edit_id": 8, "question": "At what emotional intensity did CBD improve emotional facial affect recognition?", "category": "omission", "label": "extent"}, {"doc_id": 4398332, "edit_id": 9, "question": "At what intensity was the detrimental effect of THC on emotional facial recognition observed?", "category": "omission", "label": "extent"}, {"doc_id": 4398332, "edit_id": 10, "question": "What system do these pharmacological agents THC and CBD act upon in the brain?", "category": "omission", "label": "concept"}, {"doc_id": 4435702, "edit_id": 0, "question": "What is the specific substance being tested in the study?", "category": "omission", "label": "concept"}, {"doc_id": 4435702, "edit_id": 1, "question": "Can you describe the type of trial used in this study?", "category": "omission", "label": "concept"}, {"doc_id": 4435702, "edit_id": 2, "question": "What was the method of administration of VM202 in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4435702, "edit_id": 3, "question": "What was the specific dosage of VM202 given to patients in this study?", "category": "omission", "label": "extent"}, {"doc_id": 4435702, "edit_id": 4, "question": "What was the medical condition of the patients participating in the study?", "category": "omission", "label": "concept"}, {"doc_id": 4435702, "edit_id": 5, "question": "What specific aspect of pain measurement showed significant improvement for the patients?", "category": "omission", "label": "concept"}, {"doc_id": 4435702, "edit_id": 6, "question": "What is the broader implication of the study on VM202 and its approach?", "category": "omission", "label": "consequence"}, {"doc_id": 4435702, "edit_id": 7, "question": "Is there any other medication that certain patients in the study were not taking?", "category": "omission", "label": "verification"}, {"doc_id": 4435702, "edit_id": 8, "question": "Apart from gabapentin, were there any other specific medicines that patients were not taking during the study?", "category": "omission", "label": "verification"}, {"doc_id": 4439020, "edit_id": 0, "question": "What condition can occur after a certain type of brain surgery called posterior fossa surgery?", "category": "omission", "label": "concept"}, {"doc_id": 4439020, "edit_id": 1, "question": "What position is the patient in during posterior fossa surgery?", "category": "omission", "label": "procedural"}, {"doc_id": 4439020, "edit_id": 2, "question": "What effect can the brain condition supratentorial pneumocephalus have on a patient?", "category": "omission", "label": "consequence"}, {"doc_id": 4439020, "edit_id": 3, "question": "Does supratentorial pneumocephalus only lead to decreased alertness, or can it cause other symptoms as well?", "category": "omission", "label": "disjunction"}, {"doc_id": 4439020, "edit_id": 4, "question": "What was the aim of the medical trial?", "category": "omission", "label": "concept"}, {"doc_id": 4439020, "edit_id": 5, "question": "How was the medical trial carried out to test the effectiveness of normobaric hyperoxia therapy?", "category": "omission", "label": "procedural"}, {"doc_id": 4439020, "edit_id": 6, "question": "How many patients participated in the medical trial?", "category": "omission", "label": "extent"}, {"doc_id": 4439020, "edit_id": 7, "question": "What condition did the patients in the medical trial suffer from?", "category": "omission", "label": "concept"}, {"doc_id": 4439020, "edit_id": 8, "question": "What was the volume of air build-up in the patients' brain?", "category": "omission", "label": "extent"}, {"doc_id": 4439020, "edit_id": 9, "question": "What type of surgery had the patients in the study undergone?", "category": "omission", "label": "concept"}, {"doc_id": 4439020, "edit_id": 10, "question": "In what position was the posterior fossa surgery performed on the patients?", "category": "omission", "label": "procedural"}, {"doc_id": 4439020, "edit_id": 11, "question": "How were patients chosen to receive the oxygen treatment or not in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4439020, "edit_id": 12, "question": "What treatment did some of the patients receive in the study?", "category": "omission", "label": "concept"}, {"doc_id": 4439020, "edit_id": 13, "question": "At what percentage of oxygen concentration was the normobaric hyperoxia therapy administered?", "category": "omission", "label": "extent"}, {"doc_id": 4439020, "edit_id": 14, "question": "How was the normobaric hyperoxia treatment, or pure oxygen, given to the patients?", "category": "omission", "label": "procedural"}, {"doc_id": 4439020, "edit_id": 15, "question": "How long did the normobaric hyperoxia treatment last for the patients in the study?", "category": "omission", "label": "extent"}, {"doc_id": 4439020, "edit_id": 16, "question": "How is the group of patients who received pure oxygen therapy referred to in the study?", "category": "omission", "label": "concept"}, {"doc_id": 4439020, "edit_id": 17, "question": "How is the group of patients who did not receive the pure oxygen therapy referred to in the study?", "category": "omission", "label": "concept"}, {"doc_id": 4439020, "edit_id": 18, "question": "What procedures were done right after the patients' surgery?", "category": "omission", "label": "procedural"}, {"doc_id": 4439020, "edit_id": 19, "question": "When were these cranial CT scans performed again?", "category": "omission", "label": "procedural"}, {"doc_id": 4439020, "edit_id": 20, "question": "How were the CT scans of the patients' brains evaluated during the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4439020, "edit_id": 21, "question": "Were there different instances of the CT scans conducted on the patients' brains, and how were they referred to?", "category": "omission", "label": "procedural"}, {"doc_id": 4439020, "edit_id": 22, "question": "What does CT1 refer to in the study?", "category": "omission", "label": "concept"}, {"doc_id": 4439020, "edit_id": 23, "question": "What does CT2 refer to in the study?", "category": "omission", "label": "concept"}, {"doc_id": 4439020, "edit_id": 24, "question": "What main criteria were examined in the study to measure the outcome?", "category": "omission", "label": "concept"}, {"doc_id": 4439020, "edit_id": 25, "question": "What was the first primary endpoint assessed in the study?", "category": "omission", "label": "consequence"}, {"doc_id": 4439020, "edit_id": 26, "question": "What was the second primary endpoint assessed in the study?", "category": "omission", "label": "consequence"}, {"doc_id": 4439020, "edit_id": 27, "question": "Aside from the primary endpoints, were there any other criteria evaluated in the study?", "category": "omission", "label": "verification"}, {"doc_id": 4439020, "edit_id": 28, "question": "What was one of the secondary endpoints evaluated in the study?", "category": "omission", "label": "consequence"}, {"doc_id": 4439020, "edit_id": 29, "question": "How was the alertness level of the patients measured in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4439020, "edit_id": 30, "question": "When was the patients' alertness level evaluated in the study?", "category": "omission", "label": "extent"}, {"doc_id": 4439020, "edit_id": 31, "question": "Was anything else apart from alertness level measured as a secondary endpoint in the study?", "category": "omission", "label": "verification"}, {"doc_id": 4439020, "edit_id": 32, "question": "How was the attention level of the patients measured in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4439020, "edit_id": 33, "question": "When was the patients' attention level evaluated in the study?", "category": "omission", "label": "extent"}, {"doc_id": 4439020, "edit_id": 34, "question": "When was the patients' attention level evaluated again?", "category": "omission", "label": "extent"}, {"doc_id": 4439020, "edit_id": 35, "question": "What condition were the patients suffering from in the study?", "category": "omission", "label": "concept"}, {"doc_id": 4439020, "edit_id": 36, "question": "How were the patients in the study divided for treatment?", "category": "omission", "label": "procedural"}, {"doc_id": 4439020, "edit_id": 37, "question": "What was being measured in the patients during the study?", "category": "omission", "label": "concept"}, {"doc_id": 4439020, "edit_id": 38, "question": "How did the mean change in pneumocephalus volume differ between the patients who received the oxygen treatment and those who didn't?", "category": "omission", "label": "comparison"}, {"doc_id": 4439020, "edit_id": 39, "question": "How did the treatment impact the pneumocephalus volume in the control arm patients compared to those in the treatment arm?", "category": "omission", "label": "comparison"}, {"doc_id": 4439020, "edit_id": 40, "question": "How significant was the difference in the mean change in pneumocephalus volume between the two groups?", "category": "omission", "label": "extent"}, {"doc_id": 4439020, "edit_id": 41, "question": "How did the rate at which the air in the brain was absorbed differ between the two groups of patients?", "category": "omission", "label": "comparison"}, {"doc_id": 4439020, "edit_id": 42, "question": "How did the rate of absorbing air in the brain compare between the group that received oxygen therapy and the group that did not?", "category": "omission", "label": "comparison"}, {"doc_id": 4439020, "edit_id": 43, "question": "How statistically significant was the difference in air resorption rate between the group that received oxygen therapy and the group that did not?", "category": "omission", "label": "extent"}, {"doc_id": 4439020, "edit_id": 44, "question": "Was there a particular group of patients who experienced more pronounced results from the oxygen therapy?", "category": "omission", "label": "disjunction"}, {"doc_id": 4439020, "edit_id": 45, "question": "What test was given to both groups of patients to measure their attention levels?", "category": "omission", "label": "procedural"}, {"doc_id": 4439020, "edit_id": 46, "question": "Did the Stroop test results show any difference in attention levels between the group of patients who received oxygen treatment and the group who did not?", "category": "omission", "label": "comparison"}, {"doc_id": 4439020, "edit_id": 47, "question": "On what scale were the scores of the patients' alertness level distributed?", "category": "omission", "label": "concept"}, {"doc_id": 4439020, "edit_id": 48, "question": "Was there any difference observed in the average scores of the patients' alertness level?", "category": "omission", "label": "comparison"}, {"doc_id": 4439020, "edit_id": 49, "question": "How significant was the difference observed in the average scores of the patients' alertness level?", "category": "omission", "label": "extent"}, {"doc_id": 4439020, "edit_id": 50, "question": "At what oxygen concentration is normobaric hyperoxia therapy given?", "category": "omission", "label": "extent"}, {"doc_id": 4439020, "edit_id": 51, "question": "How is the normobaric hyperoxia or pure oxygen administered to the patients?", "category": "omission", "label": "procedural"}, {"doc_id": 4439020, "edit_id": 52, "question": "How long does the administration of the normobaric hyperoxia or pure oxygen last?", "category": "omission", "label": "extent"}, {"doc_id": 4439020, "edit_id": 53, "question": "What condition is this treatment of normobaric hyperoxia or pure oxygen used for?", "category": "omission", "label": "concept"}, {"doc_id": 4439020, "edit_id": 54, "question": "When is the treatment of normobaric hyperoxia or pure oxygen applied to the patients?", "category": "omission", "label": "procedural"}, {"doc_id": 4439020, "edit_id": 55, "question": "In what position is the posterior fossa surgery performed on the patients?", "category": "omission", "label": "procedural"}, {"doc_id": 4439020, "edit_id": 56, "question": "How effective is the administration of normobaric hyperoxia or pure oxygen in treating pneumocephalus?", "category": "omission", "label": "extent"}, {"doc_id": 4439020, "edit_id": 57, "question": "Is the medical trial registered and if yes, what is the identifier?", "category": "omission", "label": "verification"}, {"doc_id": 4450858, "edit_id": 0, "question": "What happens if a woman needs a prostaglandin for cervical ripening?", "category": "omission", "label": "consequence"}, {"doc_id": 4450858, "edit_id": 1, "question": "Are there any social implications for using a prostaglandin for cervical ripening?", "category": "omission", "label": "consequence"}, {"doc_id": 4450858, "edit_id": 2, "question": "What type of research was carried out to investigate the use of balloon catheter for cervical ripening?", "category": "omission", "label": "concept"}, {"doc_id": 4450858, "edit_id": 3, "question": "What was one of the objectives of the pilot randomised trial?", "category": "omission", "label": "concept"}, {"doc_id": 4450858, "edit_id": 4, "question": "What was the ratio in which women were split into the at-home and in-hospital treatment groups?", "category": "omission", "label": "procedural"}, {"doc_id": 4450858, "edit_id": 5, "question": "How many women participated in the at-home ripening process usinig a balloon catheter?", "category": "omission", "label": "extent"}, {"doc_id": 4450858, "edit_id": 6, "question": "How many women underwent the hospital-based procedure using a double-balloon catheter?", "category": "omission", "label": "extent"}, {"doc_id": 4450858, "edit_id": 7, "question": "Was the study suited to find statistically significant differences between the groups?", "category": "omission", "label": "verification"}, {"doc_id": 4450858, "edit_id": 8, "question": "What were some of the key outcomes in the study?", "category": "omission", "label": "consequence"}, {"doc_id": 4450858, "edit_id": 9, "question": "When was feedback collected from the women who participated in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4450858, "edit_id": 10, "question": "From whom was feedback sought at the end of the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4450858, "edit_id": 11, "question": "How did most of the women feel about the insertion of the catheter?", "category": "omission", "label": "extent"}, {"doc_id": 4450858, "edit_id": 12, "question": "Was there a difference in the need for oxytocin between the at-home and in-hospital groups?", "category": "omission", "label": "comparison"}, {"doc_id": 4450858, "edit_id": 13, "question": "How did women in the at-home group feel emotionally compared to women in the hospital group?", "category": "omission", "label": "comparison"}, {"doc_id": 4450858, "edit_id": 14, "question": "How do most midwives and doctors feel about sending a woman home with a balloon catheter compared to with prostaglandins?", "category": "omission", "label": "judgmental"}, {"doc_id": 4450858, "edit_id": 15, "question": "What is the registration number of the trial?", "category": "omission", "label": "verification"}, {"doc_id": 4472927, "edit_id": 0, "question": "How extensive is the past research on the relation between chronic consumption of alcohol and H. pylori infection?", "category": "omission", "label": "extent"}, {"doc_id": 4472927, "edit_id": 1, "question": "What other factors were measured in the study besides BMI and inflammation markers? ", "category": "omission", "label": "concept"}, {"doc_id": 4472927, "edit_id": 2, "question": "Were the levels of interleukin (IL)-10 also measured during the study?", "category": "omission", "label": "verification"}, {"doc_id": 4472927, "edit_id": 3, "question": "What are some other inflammation markers that were measured during the study?", "category": "omission", "label": "example"}, {"doc_id": 4472927, "edit_id": 4, "question": "Were there other cytokines measured in the study besides IL-10?", "category": "omission", "label": "verification"}, {"doc_id": 4472927, "edit_id": 5, "question": "Were markers of cell damage also measured during the study?", "category": "omission", "label": "verification"}, {"doc_id": 4472927, "edit_id": 6, "question": "Was the activity of any compounds measured during the study?", "category": "omission", "label": "verification"}, {"doc_id": 4472927, "edit_id": 7, "question": "How were all these different proteins and substances measured in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4472927, "edit_id": 8, "question": "Was the age factor taken into account while dividing the subjects into groups?", "category": "omission", "label": "procedural"}, {"doc_id": 4472927, "edit_id": 9, "question": "Were there any other factors that were made comparable among the groups?", "category": "omission", "label": "procedural"}, {"doc_id": 4472927, "edit_id": 10, "question": "Was the age at which the subjects began drinking alcohol considered while dividing them into groups?", "category": "omission", "label": "procedural"}, {"doc_id": 4472927, "edit_id": 11, "question": "How was the alcohol consumption factor considered while forming the groups?", "category": "omission", "label": "procedural"}, {"doc_id": 4472927, "edit_id": 12, "question": "What statistical measures were used in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4472927, "edit_id": 13, "question": "Were the serum CagA levels different among the three groups?", "category": "omission", "label": "verification"}, {"doc_id": 4472927, "edit_id": 14, "question": "Does H. pylori infection have any effects on body responses?", "category": "omission", "label": "verification"}, {"doc_id": 4472927, "edit_id": 15, "question": "Is there a connection between H. pylori infection and oxidative balance?", "category": "omission", "label": "verification"}, {"doc_id": 4472927, "edit_id": 16, "question": "Is there a link between the chronic drinking of alcohol and oxidative balance?", "category": "omission", "label": "verification"}, {"doc_id": 4488551, "edit_id": 0, "question": "What else was investigated in the study apart from the effect of Astaxanthin (Asx) on the saliva immune response (sIgA)?", "category": "omission", "label": "example"}, {"doc_id": 4488551, "edit_id": 1, "question": "What was the quantity of Astaxanthin (Asx) provided to the group that was taking the supplement?", "category": "omission", "label": "extent"}, {"doc_id": 4488551, "edit_id": 2, "question": "How substantial was the decrease in the levels of enzymes related to muscle damage in the blood (plasma)?", "category": "omission", "label": "extent"}, {"doc_id": 4488551, "edit_id": 3, "question": "Was there any other factor, apart from the supplement Astaxanthin (Asx), that contributed to the lowering of levels of enzymes related to muscle damage in the blood (plasma)?", "category": "omission", "label": "verification"}, {"doc_id": 4488551, "edit_id": 4, "question": "What triggers the inflammation that was observed in the study?", "category": "omission", "label": "cause"}, {"doc_id": 4488551, "edit_id": 5, "question": "In what kind of individuals might similar physiological changes, as observed in this study with Astaxanthin supplement, occur?", "category": "omission", "label": "example"}, {"doc_id": 4493951, "edit_id": 0, "question": "Have there been precise studies on how much drug is needed to prevent nausea and vomiting after surgery?", "category": "omission", "label": "extent"}, {"doc_id": 4493951, "edit_id": 1, "question": "Are there patients who are at a high risk of feeling sick or vomiting after surgery?", "category": "omission", "label": "verification"}, {"doc_id": 4493951, "edit_id": 2, "question": "What kind of treatment do high-risk patients need to prevent nausea and vomiting after surgery?", "category": "omission", "label": "concept"}, {"doc_id": 4493951, "edit_id": 3, "question": "Do these high-risk patients need more detailed studies about how much drug is needed to prevent nausea and vomiting?", "category": "omission", "label": "verification"}, {"doc_id": 4493951, "edit_id": 4, "question": "What type of surgery are the study patients undergoing?", "category": "omission", "label": "concept"}, {"doc_id": 4493951, "edit_id": 5, "question": "How many risk factors for postoperative nausea and vomiting do the women in the study have?", "category": "omission", "label": "extent"}, {"doc_id": 4493951, "edit_id": 6, "question": "How were the risk factors for postoperative nausea and vomiting established?", "category": "omission", "label": "procedural"}, {"doc_id": 4493951, "edit_id": 7, "question": "How were the drugs given to the patients in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4493951, "edit_id": 8, "question": "Was there a common drug that all study patients were given?", "category": "omission", "label": "verification"}, {"doc_id": 4493951, "edit_id": 9, "question": "What was measured in relation to how sleepy the patients were after the surgery?", "category": "omission", "label": "concept"}, {"doc_id": 4493951, "edit_id": 10, "question": "Where was the sedation score recorded?", "category": "omission", "label": "concept"}, {"doc_id": 4493951, "edit_id": 11, "question": "Did the group that received 1mg of haloperidol (H1) have fewer people who felt nauseous or vomited than the group that received saline (H0)?", "category": "omission", "label": "verification"}, {"doc_id": 4493951, "edit_id": 12, "question": "Was there a difference in the number of nausea and vomiting incidences between the group that received 2mg of haloperidol (H2) and the group that received saline (H0)?", "category": "omission", "label": "verification"}, {"doc_id": 4493951, "edit_id": 13, "question": "What were the total occurrences of nauseous or vomiting in each of the groups?", "category": "omission", "label": "extent"}, {"doc_id": 4493951, "edit_id": 14, "question": "Was the difference in the number of people feeling nauseous or vomiting between the saline group (H0) and the 1mg haloperidol group (H1) statistically relevant?", "category": "omission", "label": "verification"}, {"doc_id": 4493951, "edit_id": 15, "question": "Was there a statistically significant difference in the occurrence of nausea and vomiting between the saline group (H0) and the 2mg haloperidol group (H2)?", "category": "omission", "label": "verification"}, {"doc_id": 4493951, "edit_id": 16, "question": "Was there a statistically significant difference in the occurrence of nausea and vomiting between the 1mg haloperidol group (H1) and the 2mg haloperidol group (H2)?", "category": "omission", "label": "verification"}, {"doc_id": 4493951, "edit_id": 17, "question": "Where was the sleepiness of the group that received 2mg of haloperidol (H2) measured?", "category": "omission", "label": "concept"}, {"doc_id": 4493951, "edit_id": 18, "question": "Where was the sleepiness or sedation of the saline and 1mg haloperidol groups measured?", "category": "omission", "label": "concept"}, {"doc_id": 4493951, "edit_id": 19, "question": "Between the 1mg and 2mg haloperidol groups, which had a higher level of sleepiness or sedation after their surgery?", "category": "omission", "label": "comparison"}, {"doc_id": 4493951, "edit_id": 20, "question": "Did the 2mg haloperidol group have a higher level of sleepiness or sedation after their surgery compared to the saline group?", "category": "omission", "label": "comparison"}, {"doc_id": 4493951, "edit_id": 21, "question": "Was the difference in sleepiness across the saline, 1mg haloperidol, and 2mg haloperidol groups statistically significant?", "category": "omission", "label": "verification"}, {"doc_id": 4493951, "edit_id": 22, "question": "Are the study patients at a higher risk of feeling nauseous or vomiting after their surgery?", "category": "omission", "label": "verification"}, {"doc_id": 4493951, "edit_id": 23, "question": "What sort of procedure are the women in the study going through?", "category": "omission", "label": "procedural"}, {"doc_id": 4517637, "edit_id": 0, "question": "What could cause a negative protein balance in babies?", "category": "omission", "label": "cause"}, {"doc_id": 4517637, "edit_id": 1, "question": "Besides an increase in protein breakdown, what else can lead to a negative protein balance in infants?", "category": "omission", "label": "example"}, {"doc_id": 4517637, "edit_id": 2, "question": "What area was the study focused on in understanding protein levels in the babies?", "category": "omission", "label": "concept"}, {"doc_id": 4517637, "edit_id": 3, "question": "For how long was the high-protein diet given to the babies in the study?", "category": "omission", "label": "extent"}, {"doc_id": 4517637, "edit_id": 4, "question": "When was the high-protein diet introduced to the infants in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4517637, "edit_id": 5, "question": "Was the trial performed in hindsight or was it planned ahead?", "category": "omission", "label": "verification"}, {"doc_id": 4517637, "edit_id": 6, "question": "How was the trial conducted to limit bias?", "category": "omission", "label": "procedural"}, {"doc_id": 4517637, "edit_id": 7, "question": "What diets were being compared in the trial?", "category": "omission", "label": "concept"}, {"doc_id": 4517637, "edit_id": 8, "question": "What was the quantity of protein in the high-protein diet given to the babies in the trial?", "category": "omission", "label": "extent"}, {"doc_id": 4517637, "edit_id": 9, "question": "What was the quantity of protein in the normal diet given to the babies in the trial?", "category": "omission", "label": "extent"}, {"doc_id": 4517637, "edit_id": 10, "question": "How were the diets given to the infants: orally or through the gastrointestinal tract?", "category": "omission", "label": "procedural"}, {"doc_id": 4517637, "edit_id": 11, "question": "What kind of protein synthesis was measured in the trial?", "category": "omission", "label": "concept"}, {"doc_id": 4517637, "edit_id": 12, "question": "How were the protein levels in the babies measured?", "category": "omission", "label": "procedural"}, {"doc_id": 4517637, "edit_id": 13, "question": "What specific method was used to measure the protein levels?", "category": "omission", "label": "procedural"}, {"doc_id": 4517637, "edit_id": 14, "question": "What statistical test was used to analyse the data from the trial?", "category": "omission", "label": "procedural"}, {"doc_id": 4517637, "edit_id": 15, "question": "Apart from the Mann-Whitney U test, what other statistical method was used in data analysis?", "category": "omission", "label": "example"}, {"doc_id": 4517637, "edit_id": 16, "question": "What was the typical age of the babies in the study?", "category": "omission", "label": "extent"}, {"doc_id": 4517637, "edit_id": 17, "question": "What was the typical weight of the babies involved in the study?", "category": "omission", "label": "extent"}, {"doc_id": 4517637, "edit_id": 18, "question": "Was the study able to detect a statistically significant effect with the number of participants it had?", "category": "omission", "label": "verification"}, {"doc_id": 4517637, "edit_id": 19, "question": "How much valine were the bodies of babies on a high-protein diet producing per minute per kilogram of body weight?", "category": "omission", "label": "extent"}, {"doc_id": 4517637, "edit_id": 20, "question": "What was the net balance of valine in the bodies of babies on a high-protein diet?", "category": "omission", "label": "extent"}, {"doc_id": 4517637, "edit_id": 21, "question": "Did the high-protein diet affect oxidation levels in the infants?", "category": "omission", "label": "verification"}, {"doc_id": 4517637, "edit_id": 22, "question": "Did the high-protein diet affect BUN levels in the infants?", "category": "omission", "label": "verification"}, {"doc_id": 4517637, "edit_id": 23, "question": "How is the surplus protein from the high-protein diet potentially being used in the body?", "category": "omission", "label": "consequence"}, {"doc_id": 4517637, "edit_id": 24, "question": "Which two diets were being compared when the researchers observed the potential fate of surplus protein?", "category": "omission", "label": "comparison"}, {"doc_id": 4517637, "edit_id": 25, "question": "Which diet group had a surplus of protein in their body?", "category": "omission", "label": "verification"}, {"doc_id": 4517637, "edit_id": 26, "question": "What might the surplus protein in the high-protein diet cause in the babies?", "category": "omission", "label": "consequence"}, {"doc_id": 4517637, "edit_id": 27, "question": "Why couldn't the researchers draw conclusions about the effect of a high-protein diet on protein levels?", "category": "omission", "label": "cause"}, {"doc_id": 4517637, "edit_id": 28, "question": "Why were researchers unable to reach any conclusions from the study?", "category": "omission", "label": "cause"}, {"doc_id": 4555141, "edit_id": 0, "question": "What nutrients are important for brain growth?", "category": "omission", "label": "concept"}, {"doc_id": 4555141, "edit_id": 1, "question": "Are micronutrients essential for the development of the brain?", "category": "omission", "label": "verification"}, {"doc_id": 4555141, "edit_id": 2, "question": "How does a deficiency in micronutrients during early development affect cellular activity?", "category": "omission", "label": "consequence"}, {"doc_id": 4555141, "edit_id": 3, "question": "What type of initial trial was carried out in this study?", "category": "omission", "label": "procedural"}, {"doc_id": 4555141, "edit_id": 4, "question": "How old were the infants in the original study when they received the supplements?", "category": "omission", "label": "extent"}, {"doc_id": 4555141, "edit_id": 5, "question": "How old were the children when they were selected for follow-up tests two years later?", "category": "omission", "label": "extent"}, {"doc_id": 4555141, "edit_id": 6, "question": "What cognitive abilities were the children tested for during the follow-up?", "category": "omission", "label": "concept"}, {"doc_id": 4555141, "edit_id": 7, "question": "Were the children assessed for any self-control abilities during the follow-up examination?", "category": "omission", "label": "verification"}, {"doc_id": 4555141, "edit_id": 8, "question": "Which cognitive skills related to task management were tested in the follow-up assessment?", "category": "omission", "label": "concept"}, {"doc_id": 4555141, "edit_id": 9, "question": "Were there any gender differences in the verbal intelligence scores of the kids during the follow-up tests?", "category": "omission", "label": "verification"}, {"doc_id": 4555141, "edit_id": 10, "question": "Did boys and girls score differently on any cognitive test during the follow-up?", "category": "omission", "label": "verification"}, {"doc_id": 4555141, "edit_id": 11, "question": "Who scored higher on the social competency part of the Brief Infant-Toddler Social Emotional Assessment (BITSEA), boys or girls?", "category": "omission", "label": "disjunction"}, {"doc_id": 4555141, "edit_id": 12, "question": "Were the effects of multiple micronutrient (MMN) supplementation investigated in this study?", "category": "omission", "label": "verification"}, {"doc_id": 4562579, "edit_id": 0, "question": "What is the role of citrulline in the human body?", "category": "omission", "label": "concept"}, {"doc_id": 4562579, "edit_id": 1, "question": "What does the term \"anabolic resistance\" refer to in the context of Step-Reduction (SR)?", "category": "omission", "label": "concept"}, {"doc_id": 4562579, "edit_id": 2, "question": "Apart from reduced steps and resistance exercises, did the study include any other conditions for comparison?", "category": "omission", "label": "verification"}, {"doc_id": 4562579, "edit_id": 3, "question": "What kind of supplements were provided to the participants?", "category": "omission", "label": "concept"}, {"doc_id": 4562579, "edit_id": 4, "question": "How often did the participants perform the resistance exercises during the study period?", "category": "omission", "label": "extent"}, {"doc_id": 4562579, "edit_id": 5, "question": "Can you specify the components of the postprandial state experiment in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4562579, "edit_id": 6, "question": "Were there any differences in muscle protein synthesis after consuming different types of protein?", "category": "omission", "label": "verification"}, {"doc_id": 4562579, "edit_id": 7, "question": "How did researchers handle the data related to the different dietary groups in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4562579, "edit_id": 8, "question": "What was the impact of the Step-Reduction condition on myofibrillar FSR?", "category": "omission", "label": "consequence"}, {"doc_id": 4562579, "edit_id": 9, "question": "Was the change in myofibrillar FSR between the Step-Reduction only and the combined Step-Reduction and Resistance Training conditions significant?", "category": "omission", "label": "verification"}, {"doc_id": 4574984, "edit_id": 0, "question": "What type of medical centers were the surgeries performed at?", "category": "omission", "label": "concept"}, {"doc_id": 4574984, "edit_id": 1, "question": "What type of surgery were the patients undergoing?", "category": "omission", "label": "concept"}, {"doc_id": 4574984, "edit_id": 2, "question": "What type of cancer were some of the surgeries for?", "category": "omission", "label": "concept"}, {"doc_id": 4574984, "edit_id": 3, "question": "What other type of cancer were the surgeries for?", "category": "omission", "label": "example"}, {"doc_id": 4574984, "edit_id": 4, "question": "What is another type of cancer for which the surgeries were performed?", "category": "omission", "label": "example"}, {"doc_id": 4574984, "edit_id": 5, "question": "Besides the length of hospital stay, what else were the researchers measuring as a primary outcome?", "category": "omission", "label": "concept"}, {"doc_id": 4574984, "edit_id": 6, "question": "How did researchers measure the health-related quality of life in this study?", "category": "omission", "label": "procedural"}, {"doc_id": 4574984, "edit_id": 7, "question": "According to the study, was there a significant difference in the health-related quality of life after one year for women in the two groups?", "category": "omission", "label": "verification"}, {"doc_id": 4574984, "edit_id": 8, "question": "Was there a significant difference in reported pain after surgery between the two groups?", "category": "omission", "label": "comparison"}, {"doc_id": 4574984, "edit_id": 9, "question": "What is one factor that can predict how long a patient might stay in the hospital after surgery?", "category": "omission", "label": "example"}, {"doc_id": 4574984, "edit_id": 10, "question": "What is another factor that could predict the length of hospital stay after surgery?", "category": "omission", "label": "example"}, {"doc_id": 4574984, "edit_id": 11, "question": "How did researchers measure the physical ability of patients before surgery?", "category": "omission", "label": "procedural"}, {"doc_id": 4574984, "edit_id": 12, "question": "How were these predictors for the length of hospital stay identified?", "category": "omission", "label": "procedural"}, {"doc_id": 4574984, "edit_id": 13, "question": "What type of patients were included in this study?", "category": "omission", "label": "concept"}, {"doc_id": 4577567, "edit_id": 0, "question": "How is stride length analysis regarded in terms of ease in carrying it out?", "category": "omission", "label": "extent"}, {"doc_id": 4577567, "edit_id": 1, "question": "How long was the training period in which the investigation took place?", "category": "omission", "label": "extent"}, {"doc_id": 4577567, "edit_id": 2, "question": "What was the gradient of the uphill training in this research?", "category": "omission", "label": "concept"}, {"doc_id": 4577567, "edit_id": 3, "question": "What label or abbreviation was used for the group with structured step frequency?", "category": "omission", "label": "concept"}, {"doc_id": 4577567, "edit_id": 4, "question": "What label or abbreviation was used for the group without any specific stride frequency set during their training?", "category": "omission", "label": "concept"}, {"doc_id": 4577567, "edit_id": 5, "question": "How many race walkers were part of the RWM group, the one with structured step frequency?", "category": "omission", "label": "extent"}, {"doc_id": 4577567, "edit_id": 6, "question": "How many race walkers were in the RWF group, the one without any specific step frequency set during their training?", "category": "omission", "label": "extent"}, {"doc_id": 4577567, "edit_id": 7, "question": "At what points were the kinematic parameters measured in the RWM group during the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4577567, "edit_id": 8, "question": "By what percentage did the stride length increase in the RWM group after the three weeks of training?", "category": "omission", "label": "extent"}, {"doc_id": 4577567, "edit_id": 9, "question": "How significant was the increase in stride length in the RWM group after the training?", "category": "omission", "label": "extent"}, {"doc_id": 4577567, "edit_id": 10, "question": "How much did the foot contact time increase after the three weeks of training in the RWM group?", "category": "omission", "label": "extent"}, {"doc_id": 4577567, "edit_id": 11, "question": "How statistically significant was the increase in foot contact time in the RWM group?", "category": "omission", "label": "extent"}, {"doc_id": 4577567, "edit_id": 12, "question": "By what percentage did the stride frequency decrease in the RWM group after the three weeks of training?", "category": "omission", "label": "extent"}, {"doc_id": 4577567, "edit_id": 13, "question": "How significant was the decrease in stride frequency in the RWM group after the training?", "category": "omission", "label": "extent"}, {"doc_id": 4577567, "edit_id": 14, "question": "By what percentage did the energy used or internal work decrease in the RWM group after three weeks of training?", "category": "omission", "label": "extent"}, {"doc_id": 4577567, "edit_id": 15, "question": "How significant was the decrease in energy used or internal work in the RWM group after the training?", "category": "omission", "label": "extent"}, {"doc_id": 4577567, "edit_id": 16, "question": "How much did the stride length decrease in the RWF group?", "category": "omission", "label": "extent"}, {"doc_id": 4577567, "edit_id": 17, "question": "How significant was the decrease in stride length in the RWF group?", "category": "omission", "label": "extent"}, {"doc_id": 4577567, "edit_id": 18, "question": "What effect did the training have on the foot contact time in the RWF group?", "category": "omission", "label": "consequence"}, {"doc_id": 4577567, "edit_id": 19, "question": "By what percentage did the foot contact time decrease in the RWF group?", "category": "omission", "label": "extent"}, {"doc_id": 4577567, "edit_id": 20, "question": "How significant was the decrease in foot contact time in the RWF group?", "category": "omission", "label": "extent"}, {"doc_id": 4577567, "edit_id": 21, "question": "What effect did the training have on the stride frequency in the RWF group?", "category": "omission", "label": "consequence"}, {"doc_id": 4577567, "edit_id": 22, "question": "What effect did the training have on the energy used or internal work in the RWF group?", "category": "omission", "label": "consequence"}, {"doc_id": 4577567, "edit_id": 23, "question": "What was the percentage increase in stride frequency and internal work in the RWF group?", "category": "omission", "label": "extent"}, {"doc_id": 4577567, "edit_id": 24, "question": "According to the results of the study, what effect does training on a 2% slope as RWM have on an athlete's performance?", "category": "omission", "label": "consequence"}, {"doc_id": 4577567, "edit_id": 25, "question": "How could coaches use the results of this study in their training methods?", "category": "omission", "label": "procedural"}, {"doc_id": 4599047, "edit_id": 0, "question": "What type of trial results does the report discuss?", "category": "omission", "label": "concept"}, {"doc_id": 4599047, "edit_id": 1, "question": "What kind of approval was given for the trial of the Superion\u00ae device?", "category": "omission", "label": "concept"}, {"doc_id": 4599047, "edit_id": 2, "question": "What condition is the Superion\u00ae device used to treat?", "category": "omission", "label": "concept"}, {"doc_id": 4599047, "edit_id": 3, "question": "What symptoms were the patients in the study experiencing?", "category": "omission", "label": "concept"}, {"doc_id": 4599047, "edit_id": 4, "question": "What was the confirmed diagnosis related to the patients' symptoms?", "category": "omission", "label": "concept"}, {"doc_id": 4599047, "edit_id": 5, "question": "At how many levels was the spinal stenosis diagnosed in the patients?", "category": "omission", "label": "extent"}, {"doc_id": 4599047, "edit_id": 6, "question": "Which specific parts of the spine were affected by stenosis in the patients?", "category": "omission", "label": "concept"}, {"doc_id": 4599047, "edit_id": 7, "question": "When was the treatment carried out on the patients?", "category": "omission", "label": "procedural"}, {"doc_id": 4599047, "edit_id": 8, "question": "What is one of the criteria used to judge the success of the treatment?", "category": "omission", "label": "concept"}, {"doc_id": 4599047, "edit_id": 9, "question": "How many people in the X-STOP\u00ae group were considered successful by the primary composite endpoint?", "category": "omission", "label": "extent"}, {"doc_id": 4599047, "edit_id": 10, "question": "Was the difference in success between the Superion\u00ae and X-STOP\u00ae groups statistically significant?", "category": "omission", "label": "verification"}, {"doc_id": 4599047, "edit_id": 11, "question": "What condition did the patients have?", "category": "omission", "label": "concept"}, {"doc_id": 4599047, "edit_id": 12, "question": "How consistent were the improvements obtained from the Superion\u00ae treatment?", "category": "omission", "label": "extent"}, {"doc_id": 4599047, "edit_id": 13, "question": "Which treatment was the improvement specifically related to?", "category": "omission", "label": "concept"}, {"doc_id": 4609664, "edit_id": 0, "question": "What type of dental procedure was used to make the comparisons in the study?", "category": "omission", "label": "concept"}, {"doc_id": 4609664, "edit_id": 1, "question": "Which three tools or procedures were being compared in this study?", "category": "omission", "label": "comparison"}, {"doc_id": 4609664, "edit_id": 2, "question": "How many teeth were used in the study? ", "category": "omission", "label": "extent"}, {"doc_id": 4609664, "edit_id": 3, "question": "Were the teeth used in this study still in the jaw or were they removed? ", "category": "omission", "label": "verification"}, {"doc_id": 4609664, "edit_id": 4, "question": "What type of teeth were used in this study, regarding their internal structure? ", "category": "omission", "label": "concept"}, {"doc_id": 4609664, "edit_id": 5, "question": "Did the teeth undergo any preparatory procedure before being used in the study?", "category": "omission", "label": "verification"}, {"doc_id": 4609664, "edit_id": 6, "question": "How were the teeth divided into groups? ", "category": "omission", "label": "procedural"}, {"doc_id": 4609664, "edit_id": 7, "question": "Which tool was used to treat the teeth in the first group? ", "category": "omission", "label": "procedural"}, {"doc_id": 4609664, "edit_id": 8, "question": "Which tool was used to treat teeth in the second group? ", "category": "omission", "label": "procedural"}, {"doc_id": 4609664, "edit_id": 9, "question": "Were all teeth treated equally in the study? ", "category": "omission", "label": "verification"}, {"doc_id": 4609664, "edit_id": 10, "question": "How were the teeth cut for examination after treatment?", "category": "omission", "label": "procedural"}, {"doc_id": 4609664, "edit_id": 11, "question": "From how far away from the tip of the root were the teeth cut for examination?", "category": "omission", "label": "extent"}, {"doc_id": 4609664, "edit_id": 12, "question": "What level of magnification was used to examine the teeth? ", "category": "omission", "label": "extent"}, {"doc_id": 4609664, "edit_id": 13, "question": "What type of microscope was used to examine the teeth? ", "category": "omission", "label": "procedural"}, {"doc_id": 4609664, "edit_id": 14, "question": "Which statistical tests were used to analyze the data?", "category": "omission", "label": "procedural"}, {"doc_id": 4609664, "edit_id": 15, "question": "What level of significance was used in the analysis of the results? ", "category": "omission", "label": "extent"}, {"doc_id": 4609664, "edit_id": 16, "question": "Can these dental treatment equipment cause any harm or damage to the teeth?", "category": "omission", "label": "verification"}, {"doc_id": 4609664, "edit_id": 17, "question": "Do all types of dental equipment cause dentinal cracks?", "category": "omission", "label": "verification"}, {"doc_id": 4609664, "edit_id": 18, "question": "Is there a meaningful difference in the amount of damage caused by the three different dental tools used in the study? ", "category": "omission", "label": "comparison"}, {"doc_id": 4624894, "edit_id": 0, "question": "What type of trial was performed in this study?", "category": "omission", "label": "concept"}, {"doc_id": 4624894, "edit_id": 1, "question": "What specific type of hepatitis C were the patients in this trial diagnosed with?", "category": "omission", "label": "concept"}, {"doc_id": 4624894, "edit_id": 2, "question": "What outcome did the patients in the trial achieve before being divided into two groups for extended treatment?", "category": "omission", "label": "consequence"}, {"doc_id": 4624894, "edit_id": 3, "question": "What was the condition of the patients' liver in this trial?", "category": "omission", "label": "concept"}, {"doc_id": 4624894, "edit_id": 4, "question": "What was the health condition of the patients in this study?", "category": "omission", "label": "concept"}, {"doc_id": 4624894, "edit_id": 5, "question": "What specific type of medication was used to treat the patients in this study?", "category": "omission", "label": "concept"}, {"doc_id": 4624894, "edit_id": 6, "question": "How much pegylated interferon \u03b1-2a was given to the patients each week?", "category": "omission", "label": "extent"}, {"doc_id": 4624894, "edit_id": 7, "question": "Was any other medication used in conjunction with pegylated interferon \u03b1-2a?", "category": "omission", "label": "verification"}, {"doc_id": 4624894, "edit_id": 8, "question": "How much ribavirin did the patients receive?", "category": "omission", "label": "extent"}, {"doc_id": 4624894, "edit_id": 9, "question": "How was the appropriate dosage of ribavirin for each patient determined?", "category": "omission", "label": "procedural"}, {"doc_id": 4624894, "edit_id": 10, "question": "How was it determined that a patient had achieved a rapid virological response (RVR)?", "category": "omission", "label": "procedural"}, {"doc_id": 4624894, "edit_id": 11, "question": "What measure indicated that a patient achieved HCV RNA negativity?", "category": "omission", "label": "concept"}, {"doc_id": 4624894, "edit_id": 12, "question": "What was the main result this study was looking for?", "category": "omission", "label": "consequence"}, {"doc_id": 4624894, "edit_id": 13, "question": "Over what period was this study conducted?", "category": "omission", "label": "extent"}, {"doc_id": 4624894, "edit_id": 14, "question": "How many patients in the study had both HCV genotype 6a and a rapid virological response (RVR)?", "category": "omission", "label": "extent"}, {"doc_id": 4687242, "edit_id": 0, "question": "What is one traditional use of Dunal in regards to physical health?", "category": "omission", "label": "example"}, {"doc_id": 4687242, "edit_id": 1, "question": "Is Dunal traditionally used for life extension?", "category": "omission", "label": "verification"}, {"doc_id": 4687242, "edit_id": 2, "question": "Has Dunal been used for improving male reproductive health?", "category": "omission", "label": "verification"}, {"doc_id": 4687242, "edit_id": 3, "question": "Does Dunal have any traditional uses related to female reproductive health?", "category": "omission", "label": "verification"}, {"doc_id": 4687242, "edit_id": 4, "question": "What kind of study was conducted to understand the effects of Ashwagandha?", "category": "omission", "label": "concept"}, {"doc_id": 4687242, "edit_id": 5, "question": "Was the study conducted in a way that both the participants and researchers didn't know who received Ashwagandha or the placebo?", "category": "omission", "label": "verification"}, {"doc_id": 4687242, "edit_id": 6, "question": "Apart from improving cardiovascular fitness, was Ashwagandha root extract also studied for its effects on quality of life?", "category": "omission", "label": "verification"}, {"doc_id": 4687242, "edit_id": 7, "question": "How did the researchers measure the level of physical exertion in the study participants?", "category": "omission", "label": "procedural"}, {"doc_id": 4687242, "edit_id": 8, "question": "How were the peak physical exertion levels assessed during the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4687242, "edit_id": 9, "question": "What instrument was used in the study to assess the quality of life of the participants?", "category": "omission", "label": "procedural"}, {"doc_id": 4687242, "edit_id": 10, "question": "What statistical method was used in the study to compare the differences in the outcomes?", "category": "omission", "label": "procedural"}, {"doc_id": 4687242, "edit_id": 11, "question": "How were the changes in VO2 max levels from before and after the intervention compared in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4687242, "edit_id": 12, "question": "What statistical test was used to assess the changes in quality of life scores in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4687242, "edit_id": 13, "question": "How many participants were there in the group that took Ashwagandha?", "category": "omission", "label": "extent"}, {"doc_id": 4687242, "edit_id": 14, "question": "How many participants received a placebo in the study?", "category": "omission", "label": "extent"}, {"doc_id": 4687242, "edit_id": 15, "question": "Was there any improvement observed in the VO2 max levels in the Ashwagandha group after 8 weeks?", "category": "omission", "label": "verification"}, {"doc_id": 4687242, "edit_id": 16, "question": "By how much did the VO2 max levels increase in the Ashwagandha group after 8 weeks?", "category": "omission", "label": "extent"}, {"doc_id": 4687242, "edit_id": 17, "question": "By how much did the VO2 max levels increase in the placebo group after 8 weeks?", "category": "omission", "label": "extent"}, {"doc_id": 4687242, "edit_id": 18, "question": "Was the difference in improvement between the Ashwagandha group and the placebo group statistically significant?", "category": "omission", "label": "verification"}, {"doc_id": 4704894, "edit_id": 0, "question": "What was the participation rate of women in this study? ", "category": "omission", "label": "extent"}, {"doc_id": 4704894, "edit_id": 1, "question": "On what principles or theories were the Facebook postings based?", "category": "omission", "label": "concept"}, {"doc_id": 4704894, "edit_id": 2, "question": "What statistical method did the researchers use for analyzing the participant comments?", "category": "omission", "label": "procedural"}, {"doc_id": 4704894, "edit_id": 3, "question": "What specific processes of the Transtheoretical Model were highlighted in the study results?", "category": "omission", "label": "concept"}, {"doc_id": 4704894, "edit_id": 4, "question": "Were there any specific techniques used in the posts for the group of people preparing to quit smoking?", "category": "omission", "label": "procedural"}, {"doc_id": 4704894, "edit_id": 5, "question": "How effective were the posts aimed at raising consciousness about smoking and cessation?", "category": "omission", "label": "extent"}, {"doc_id": 4711101, "edit_id": 0, "question": "Where was this trial conducted?", "category": "omission", "label": "concept"}, {"doc_id": 4711101, "edit_id": 1, "question": "What surgical approaches were used in the CAS-TKA?", "category": "omission", "label": "procedural"}, {"doc_id": 4711101, "edit_id": 2, "question": "What surgical approach was used in the less invasive group (MIS)?", "category": "omission", "label": "procedural"}, {"doc_id": 4711101, "edit_id": 3, "question": "What surgical approach was used in the standard surgery group?", "category": "omission", "label": "procedural"}, {"doc_id": 4711101, "edit_id": 4, "question": "From which centers or hospitals were the patients recruited for this study?", "category": "omission", "label": "concept"}, {"doc_id": 4711101, "edit_id": 5, "question": "What was the medical condition of the patients involved in this study?", "category": "omission", "label": "concept"}, {"doc_id": 4711101, "edit_id": 6, "question": "What was the distinguishing feature for the patients in the less invasive group (MIS)?", "category": "omission", "label": "concept"}, {"doc_id": 4711101, "edit_id": 7, "question": "Apart from pain, what other primary outcome was compared between the different surgical groups?", "category": "omission", "label": "concept"}, {"doc_id": 4711101, "edit_id": 8, "question": "Aside from pain and knee flexibility, was there any other test performed during the trial?", "category": "omission", "label": "verification"}, {"doc_id": 4711101, "edit_id": 9, "question": "Was there a measure taken about the strength of a specific muscle during the trial?", "category": "omission", "label": "verification"}, {"doc_id": 4711101, "edit_id": 10, "question": "Was knee pain also measured as a secondary outcome in the trial?", "category": "omission", "label": "verification"}, {"doc_id": 4711101, "edit_id": 11, "question": "Was there any specific scoring tool used in this trial to assess the knee condition?", "category": "omission", "label": "procedural"}, {"doc_id": 4711101, "edit_id": 12, "question": "Was there another scoring system used apart from the Knee Society Score?", "category": "omission", "label": "verification"}, {"doc_id": 4711101, "edit_id": 13, "question": "What was the average pain score for the less invasive group (MIS) two weeks after surgery?", "category": "omission", "label": "extent"}, {"doc_id": 4711101, "edit_id": 14, "question": "And how about the standard surgery group? What was their average pain score two weeks after surgery?", "category": "omission", "label": "extent"}, {"doc_id": 4711101, "edit_id": 15, "question": "How significant was the difference in pain scores between the two groups two weeks post-surgery?", "category": "omission", "label": "extent"}, {"doc_id": 4711101, "edit_id": 16, "question": "Was there a significant difference in the duration of surgery for both groups?", "category": "omission", "label": "verification"}, {"doc_id": 4711101, "edit_id": 17, "question": "Was there any significant difference in the amount of blood lost between the two groups during surgery?", "category": "omission", "label": "verification"}, {"doc_id": 4711101, "edit_id": 18, "question": "What was the difference in the mean mechanical leg alignment between the two groups?", "category": "omission", "label": "extent"}, {"doc_id": 4711101, "edit_id": 19, "question": "What was the confidence interval for the difference in the mechanical leg alignment?", "category": "omission", "label": "extent"}, {"doc_id": 4711101, "edit_id": 20, "question": "Was the difference in mean mechanical leg alignment between the two groups statistically significant?", "category": "omission", "label": "verification"}, {"doc_id": 4711101, "edit_id": 21, "question": "In what parameters was the component alignment of the knee measured?", "category": "omission", "label": "concept"}, {"doc_id": 4711101, "edit_id": 22, "question": "Was there another parameter used to measure the component alignment of the knee?", "category": "omission", "label": "verification"}, {"doc_id": 4711101, "edit_id": 23, "question": "Was there a specific measurement for the alignment of the femur component?", "category": "omission", "label": "procedural"}, {"doc_id": 4711101, "edit_id": 24, "question": "Was there a specific measurement for the alignment of the tibial component?", "category": "omission", "label": "procedural"}, {"doc_id": 4711101, "edit_id": 25, "question": "Was there another specific measurement for the tibial component in the knee?", "category": "omission", "label": "procedural"}, {"doc_id": 4711101, "edit_id": 26, "question": "Was there a significant difference in knee's flexion and extension alignment between the two surgical groups?", "category": "omission", "label": "comparison"}, {"doc_id": 4711101, "edit_id": 27, "question": "What was the p-value for the difference in flexion/extension alignment between the two surgical groups?", "category": "omission", "label": "extent"}, {"doc_id": 4711101, "edit_id": 28, "question": "Was there a significant difference in varus/valgus alignment between the two surgical groups?", "category": "omission", "label": "comparison"}, {"doc_id": 4711101, "edit_id": 29, "question": "Given the results of the study, what can be said about the safety of combining the MIS surgical technique (MIS-TKA) and computer navigation?", "category": "omission", "label": "consequence"}, {"doc_id": 4717319, "edit_id": 0, "question": "What was the dosage of lurasidone given to the patients in this study?", "category": "omission", "label": "extent"}, {"doc_id": 4717319, "edit_id": 1, "question": "How was the dosage of lurasidone administered in this study?", "category": "omission", "label": "procedural"}, {"doc_id": 4717319, "edit_id": 2, "question": "Was the initial treatment with lurasidone blind or open-label?", "category": "omission", "label": "verification"}, {"doc_id": 4717319, "edit_id": 3, "question": "What happened to patients who showed improvement after the initial 12 weeks of lurasidone treatment?", "category": "omission", "label": "consequence"}, {"doc_id": 4717319, "edit_id": 4, "question": "How was the randomization of patients into two groups executed in the next phase?", "category": "omission", "label": "procedural"}, {"doc_id": 4717319, "edit_id": 5, "question": "What was the average score for the patients' symptoms at the start of the study?", "category": "omission", "label": "extent"}, {"doc_id": 4717319, "edit_id": 6, "question": "How did the average symptoms score change during the initial phase of the study?", "category": "omission", "label": "extent"}, {"doc_id": 4717319, "edit_id": 7, "question": "How was the significance of the delay in symptoms returning determined in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4717319, "edit_id": 8, "question": "How was the reduction in risk of symptoms returning measured in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4717319, "edit_id": 9, "question": "Did the study observe any changes in patients' lipid levels?", "category": "omission", "label": "verification"}, {"doc_id": 4717613, "edit_id": 0, "question": "What kind of diet is particularly necessary after surgical operations?", "category": "omission", "label": "example"}, {"doc_id": 4717613, "edit_id": 1, "question": "What kind of research methodology was planned for this study?", "category": "omission", "label": "procedural"}, {"doc_id": 4717613, "edit_id": 2, "question": "Where did the approval for this study come from?", "category": "omission", "label": "concept"}, {"doc_id": 4717613, "edit_id": 3, "question": "What kind of nutrition plan did the patients follow?", "category": "omission", "label": "procedural"}, {"doc_id": 4717613, "edit_id": 4, "question": "What were some of the specific nutrients in the immune modulating formula?", "category": "omission", "label": "example"}, {"doc_id": 4717613, "edit_id": 5, "question": "Were there any other special nutrients included in the immune modulating formula?", "category": "omission", "label": "verification"}, {"doc_id": 4717613, "edit_id": 6, "question": "What other ingredients were included in the immune modulating formula?", "category": "omission", "label": "example"}, {"doc_id": 4717613, "edit_id": 7, "question": "Were there any types of patients who were not included in the study?", "category": "omission", "label": "concept"}, {"doc_id": 4717613, "edit_id": 8, "question": "What health measures were taken before the nutrition program began?", "category": "omission", "label": "procedural"}, {"doc_id": 4717613, "edit_id": 9, "question": "Was the blood protein or albumin level the only data collected?", "category": "omission", "label": "verification"}, {"doc_id": 4717613, "edit_id": 10, "question": "How was the surgical procedure performed?", "category": "omission", "label": "procedural"}, {"doc_id": 4717613, "edit_id": 11, "question": "How many patients underwent the surgery through thoracotomy in this study?", "category": "omission", "label": "extent"}, {"doc_id": 4717613, "edit_id": 12, "question": "Did any patients in the nutrition group experience complications after surgery?", "category": "omission", "label": "verification"}, {"doc_id": 4717613, "edit_id": 13, "question": "What kind of cancer patients were the focus of the study?", "category": "omission", "label": "concept"}, {"doc_id": 4768925, "edit_id": 0, "question": "What condition is the butylphthalide sodium chloride injection used to treat?", "category": "omission", "label": "concept"}, {"doc_id": 4768925, "edit_id": 1, "question": "Has any research been done on how this medicine might work on the inflammatory cytokines in the body\u2019s immune system through the hypothalamus-pituitary-adrenal axis?", "category": "omission", "label": "verification"}, {"doc_id": 4768925, "edit_id": 2, "question": "Where did the stroke occur in the patients this medicine was given to?", "category": "omission", "label": "concept"}, {"doc_id": 4768925, "edit_id": 3, "question": "What part of the body is the effect of the butylphthalide sodium chloride injection being measured on?", "category": "omission", "label": "concept"}, {"doc_id": 4768925, "edit_id": 4, "question": "How were the patients divided into the group that got the medicine and the group that didn't?", "category": "omission", "label": "procedural"}, {"doc_id": 4768925, "edit_id": 5, "question": "Did they measure any hormone levels apart from adrenocorticotropic hormone (ACTH) in patients?", "category": "omission", "label": "verification"}, {"doc_id": 4768925, "edit_id": 6, "question": "How did they measure the hormone levels and stroke symptoms in the patients? ", "category": "omission", "label": "procedural"}, {"doc_id": 4768925, "edit_id": 7, "question": "Where was the stroke, or cerebral infarction, detected in the patients\u2019 brains?", "category": "omission", "label": "concept"}, {"doc_id": 4768925, "edit_id": 8, "question": "Was there a way to measure the symptoms of stroke in the group that got the medicine?", "category": "omission", "label": "verification"}, {"doc_id": 4768925, "edit_id": 9, "question": "Were ACTH levels measured in the group that didn't get the medicine?", "category": "omission", "label": "verification"}, {"doc_id": 4768925, "edit_id": 10, "question": "Was there a significant difference in ACTH levels between the group that got the medicine and the group that didn't? ", "category": "omission", "label": "verification"}, {"doc_id": 4768925, "edit_id": 11, "question": "Was there a way to measure the symptoms of stroke in the group that didn't get the medicine?", "category": "omission", "label": "verification"}, {"doc_id": 4768925, "edit_id": 12, "question": "Were cortisol levels measured in the group that got the medicine?", "category": "omission", "label": "verification"}, {"doc_id": 4768925, "edit_id": 13, "question": "Was the collected data from the hormone measurements and the stroke test scores processed or computed in any way? ", "category": "omission", "label": "verification"}, {"doc_id": 4768925, "edit_id": 14, "question": "Which software was used to compute the data collected from the hormone measurements and the stroke test scores?", "category": "omission", "label": "procedural"}, {"doc_id": 4768925, "edit_id": 15, "question": "Which software was used to analyze the computed data?", "category": "omission", "label": "procedural"}, {"doc_id": 4768925, "edit_id": 16, "question": "What kind of stroke do patients usually get the butylphthalide treatment for?", "category": "omission", "label": "concept"}, {"doc_id": 4768925, "edit_id": 17, "question": "What effect does butylphthalide treatment have on the hypothalamus-pituitary-adrenal (HPA) axis in patients?", "category": "omission", "label": "consequence"}, {"doc_id": 4769147, "edit_id": 0, "question": "Why is breastfeeding beneficial for babies in terms of their health?", "category": "omission", "label": "cause"}, {"doc_id": 4769147, "edit_id": 1, "question": "What can you tell me about the current rates of breastfeeding?", "category": "omission", "label": "extent"}, {"doc_id": 4769147, "edit_id": 2, "question": "Have there been any efforts to encourage more mothers to breastfeed?", "category": "omission", "label": "verification"}, {"doc_id": 4769147, "edit_id": 3, "question": "Despite these public health efforts, have breastfeeding rates increased significantly?", "category": "omission", "label": "verification"}, {"doc_id": 4769147, "edit_id": 4, "question": "When will the rate of breastfeeding be measured during the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4769147, "edit_id": 5, "question": "How were the babies divided into the two groups?", "category": "omission", "label": "procedural"}, {"doc_id": 4769147, "edit_id": 6, "question": "What exactly did the CLF intervention entail?", "category": "omission", "label": "concept"}, {"doc_id": 4769147, "edit_id": 7, "question": "How long did the CLF intervention last?", "category": "omission", "label": "extent"}, {"doc_id": 4769147, "edit_id": 8, "question": "Were precautions taken when analyzing statistical data in the study?", "category": "omission", "label": "verification"}, {"doc_id": 4769147, "edit_id": 9, "question": "How many newborns were analyzed in the CLF group?", "category": "omission", "label": "extent"}, {"doc_id": 4769147, "edit_id": 10, "question": "Did the study only look at exclusive breastfeeding rates?", "category": "omission", "label": "verification"}, {"doc_id": 4769147, "edit_id": 11, "question": "What was the p-value for exclusive breastfeeding rates when the mothers and babies left the hospital?", "category": "omission", "label": "extent"}, {"doc_id": 4769147, "edit_id": 12, "question": "What was the p-value for the rates of any breastfeeding at the time of discharge from the hospital?", "category": "omission", "label": "extent"}, {"doc_id": 4769147, "edit_id": 13, "question": "How did the researchers measure the newborns' weight loss during the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4769147, "edit_id": 14, "question": "How much weight, on average, did the infants in the CLF group lose while they were in the hospital?", "category": "omission", "label": "extent"}, {"doc_id": 4769147, "edit_id": 15, "question": "How much weight, on average, did the infants in the SA group lose while they were in the hospital?", "category": "omission", "label": "extent"}, {"doc_id": 4769147, "edit_id": 16, "question": "Was there a significant difference in weight loss between the two groups of newborns?", "category": "omission", "label": "comparison"}, {"doc_id": 4769147, "edit_id": 17, "question": "How significant was the difference in weight loss between the two groups?", "category": "omission", "label": "extent"}, {"doc_id": 4784207, "edit_id": 0, "question": "What was the age group of the patients involved in the study?", "category": "omission", "label": "concept"}, {"doc_id": 4784207, "edit_id": 1, "question": "What type of hospital was the study conducted in? ", "category": "omission", "label": "concept"}, {"doc_id": 4784207, "edit_id": 2, "question": "How were the patients divided into groups?", "category": "omission", "label": "procedural"}, {"doc_id": 4784207, "edit_id": 3, "question": "Was this study conducted retrospectively or prospectively?", "category": "omission", "label": "verification"}, {"doc_id": 4784207, "edit_id": 4, "question": "What method was used to collect information from the patients after the surgery?", "category": "omission", "label": "procedural"}, {"doc_id": 4784207, "edit_id": 5, "question": "How were the responses to the questionnaire measured?", "category": "omission", "label": "procedural"}, {"doc_id": 4784207, "edit_id": 6, "question": "What was the average score of the consent index for Group B?", "category": "omission", "label": "extent"}, {"doc_id": 4784207, "edit_id": 7, "question": "What was the standard deviation of the consent index score for group B?", "category": "omission", "label": "extent"}, {"doc_id": 4784207, "edit_id": 8, "question": "What was the p-value in the study?", "category": "omission", "label": "extent"}, {"doc_id": 4784207, "edit_id": 9, "question": "Why is the result of the study considered statistically significant?", "category": "omission", "label": "cause"}, {"doc_id": 4784207, "edit_id": 10, "question": "What was the p-value related to the impact of the separate consent form on patients' understanding of the nature and purpose of anesthesia procedures?", "category": "omission", "label": "consequence"}, {"doc_id": 4784207, "edit_id": 11, "question": "What was the impact of the separate written consent on patients' satisfaction regarding information about common side effects?", "category": "omission", "label": "consequence"}, {"doc_id": 4784207, "edit_id": 12, "question": "What was the p-value related to the impact of the extra form on patients' satisfaction with the information about common side effects of anesthesia?", "category": "omission", "label": "consequence"}, {"doc_id": 4784207, "edit_id": 13, "question": "How did the separate written consent affect patients' understanding of rare but serious complications?", "category": "omission", "label": "consequence"}, {"doc_id": 4784207, "edit_id": 14, "question": "What was the p-value related to the impact of the extra form on patients' understanding of rare but serious complications?", "category": "omission", "label": "consequence"}, {"doc_id": 4784207, "edit_id": 15, "question": "What type of information did the improved informed consent process provide better details about?", "category": "omission", "label": "consequence"}, {"doc_id": 4796524, "edit_id": 0, "question": "Is there any discussion surrounding the use of stents in kidney transplant surgery?", "category": "omission", "label": "verification"}, {"doc_id": 4796524, "edit_id": 1, "question": "Are there any complications associated with the use of stents in the urinary tract? ", "category": "omission", "label": "example"}, {"doc_id": 4796524, "edit_id": 2, "question": "Besides encrustation, are there any other complications that could occur with a stent in the urinary tract?", "category": "omission", "label": "disjunction"}, {"doc_id": 4796524, "edit_id": 3, "question": "Can stent crustation cause any severe complications?", "category": "omission", "label": "verification"}, {"doc_id": 4796524, "edit_id": 4, "question": "What are the potential complications with the procedure to remove the stents, also known as cystoscopy?", "category": "omission", "label": "example"}, {"doc_id": 4796524, "edit_id": 5, "question": "What implications does cystoscopy for stent extraction have, financial or otherwise?", "category": "omission", "label": "consequence"}, {"doc_id": 4796524, "edit_id": 6, "question": "How was the selection process of patients for the two different stent methods done? ", "category": "omission", "label": "procedural"}, {"doc_id": 4796524, "edit_id": 7, "question": "Can you explain more about the patient group where the stent was attached to a catheter?", "category": "omission", "label": "concept"}, {"doc_id": 4796524, "edit_id": 8, "question": "What was the rate of urinary tract infections in the study group by the fourth week post-surgery? ", "category": "omission", "label": "extent"}, {"doc_id": 4796524, "edit_id": 9, "question": "What was the overall reported rate of urinary leakage across both patient groups? ", "category": "omission", "label": "extent"}, {"doc_id": 4796524, "edit_id": 10, "question": "Was stent crustation observed in patients where the stent was used in the conventional way, separate from the catheter?", "category": "omission", "label": "verification"}, {"doc_id": 4796524, "edit_id": 11, "question": "What do the results suggest about the effectiveness of the new technique of attaching the stent to the catheter?", "category": "omission", "label": "consequence"}, {"doc_id": 4796524, "edit_id": 12, "question": "Overall, how would you rate the performance of the new stenting technique used in this study?", "category": "omission", "label": "judgmental"}, {"doc_id": 4808872, "edit_id": 0, "question": "What kind of biological processes is creatine involved in?", "category": "omission", "label": "concept"}, {"doc_id": 4808872, "edit_id": 1, "question": "What part of the body is most affected by the energy metabolism process that creatine is involved in?", "category": "omission", "label": "concept"}, {"doc_id": 4808872, "edit_id": 2, "question": "What affects the process of post-activation potentiation (PAP)?", "category": "omission", "label": "cause"}, {"doc_id": 4808872, "edit_id": 3, "question": "Besides muscle strength, what else was examined in the study?", "category": "omission", "label": "example"}, {"doc_id": 4808872, "edit_id": 4, "question": "When was the optimal individual post-activation potentiation (PAP) time examined during the study?", "category": "omission", "label": "extent"}, {"doc_id": 4808872, "edit_id": 5, "question": "What specific exercise was used in the study to test the athletes' maximum strength?", "category": "omission", "label": "procedural"}, {"doc_id": 4808872, "edit_id": 6, "question": "What was the purpose of the tests during the study?", "category": "omission", "label": "cause"}, {"doc_id": 4808872, "edit_id": 7, "question": "What other aspects of athletic performance did the tests aim to measure?", "category": "omission", "label": "example"}, {"doc_id": 4808872, "edit_id": 8, "question": "What substance was used as a placebo in this study?", "category": "omission", "label": "procedural"}, {"doc_id": 4808872, "edit_id": 9, "question": "What effect did the creatine have on the strength of the athletes?", "category": "omission", "label": "consequence"}, {"doc_id": 4808872, "edit_id": 10, "question": "How substantial was the increase in the athletes' strength after taking creatine?", "category": "omission", "label": "extent"}, {"doc_id": 4808872, "edit_id": 11, "question": "How did the researchers determine that the increase in strength in the creatine group was significant?", "category": "omission", "label": "procedural"}, {"doc_id": 4808872, "edit_id": 12, "question": "What was the p-value of the increase in strength in the creatine group?", "category": "omission", "label": "extent"}, {"doc_id": 4808872, "edit_id": 13, "question": "Did the creatine group show any changes in post-activation potentiation (PAP) time?", "category": "omission", "label": "verification"}, {"doc_id": 4808872, "edit_id": 14, "question": "Were the differences in the optimal individual post-activation potentiation (PAP) time between the creatine and placebo group significant?", "category": "omission", "label": "verification"}, {"doc_id": 4808872, "edit_id": 15, "question": "What does the study show about the effects of creatine supplementation on muscle strength?", "category": "omission", "label": "consequence"}, {"doc_id": 4808872, "edit_id": 16, "question": "What else does the study show about the effects of creatine supplementation, apart from muscle strength?", "category": "omission", "label": "consequence"}, {"doc_id": 4877819, "edit_id": 0, "question": "Besides treating inflammation and scarring, what other positive effects did Andrographis paniculata have in animal experiments?", "category": "omission", "label": "example"}, {"doc_id": 4877819, "edit_id": 1, "question": "What was another aspect of the Multiple Sclerosis (MS) patients' condition that the researchers examined in their study on A. paniculata?", "category": "omission", "label": "concept"}, {"doc_id": 4877819, "edit_id": 2, "question": "How did the researchers measure the fatigue levels of the MS patients?", "category": "omission", "label": "procedural"}, {"doc_id": 4877819, "edit_id": 3, "question": "How did they measure the disability of the MS patients in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4877819, "edit_id": 4, "question": "Did the researchers use any other methods to examine the state of the MS patients, other than testing for fatigue and disability?", "category": "omission", "label": "verification"}, {"doc_id": 4877819, "edit_id": 5, "question": "How was the fatigue of the MS patients who took A. paniculata affected?", "category": "omission", "label": "consequence"}, {"doc_id": 4877819, "edit_id": 6, "question": "How does the effectiveness of A. paniculata compare to a placebo in reducing fatigue in MS patients?", "category": "omission", "label": "comparison"}, {"doc_id": 4877819, "edit_id": 7, "question": "Is A. paniculata alone more effective at reducing fatigue in MS patients than the standard interferon beta treatment?", "category": "omission", "label": "comparison"}, {"doc_id": 4893758, "edit_id": 0, "question": "Do emergency departments often carry out painful procedures for diagnosis and treatment?", "category": "omission", "label": "verification"}, {"doc_id": 4893758, "edit_id": 1, "question": "Is it important for emergency doctors to know how to carry out procedural sedation and analgesia (PSA)?", "category": "omission", "label": "verification"}, {"doc_id": 4893758, "edit_id": 2, "question": "Who usually carries out procedural sedation and analgesia (PSA) in the emergency department?", "category": "omission", "label": "concept"}, {"doc_id": 4893758, "edit_id": 3, "question": "What specific condition was the study focusing on treating?", "category": "omission", "label": "concept"}, {"doc_id": 4893758, "edit_id": 4, "question": "What was the main goal of the treatment mentioned in the study?", "category": "omission", "label": "cause"}, {"doc_id": 4893758, "edit_id": 5, "question": "What kind of study was carried out?", "category": "omission", "label": "concept"}, {"doc_id": 4893758, "edit_id": 6, "question": "What was the condition of the patients included in the trial?", "category": "omission", "label": "concept"}, {"doc_id": 4893758, "edit_id": 7, "question": "When and why were the patients brought to the Emergency Department?", "category": "omission", "label": "cause"}, {"doc_id": 4893758, "edit_id": 8, "question": "What was the gender distribution in the study?", "category": "omission", "label": "extent"}, {"doc_id": 4893758, "edit_id": 9, "question": "How long did the procedure take on average for the group that received remifentanil?", "category": "omission", "label": "extent"}, {"doc_id": 4893758, "edit_id": 10, "question": "What was the average procedure time for the group that received the combination of fentanyl/midazolam?", "category": "omission", "label": "extent"}, {"doc_id": 4893758, "edit_id": 11, "question": "How did the success rates of the two treatments compare?", "category": "omission", "label": "comparison"}, {"doc_id": 4893758, "edit_id": 12, "question": "How many patients reported issues or side effects with the fentanyl/midazolam treatment?", "category": "omission", "label": "extent"}, {"doc_id": 4893758, "edit_id": 13, "question": "What was the percentage of patients in the fentanyl/midazolam group that experienced adverse events?", "category": "omission", "label": "extent"}, {"doc_id": 4893758, "edit_id": 14, "question": "How many patients in the remifentanil group experienced adverse events?", "category": "omission", "label": "extent"}, {"doc_id": 4893758, "edit_id": 15, "question": "What was the rate of adverse events in the remifentanil group?", "category": "omission", "label": "extent"}, {"doc_id": 4893758, "edit_id": 16, "question": "Which pain relief medication was used in treating anterior shoulder dislocations in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4893758, "edit_id": 17, "question": "What impact did the use of remifentanil have on the failure rate of the procedure?", "category": "omission", "label": "consequence"}, {"doc_id": 4893758, "edit_id": 18, "question": "How did the use of a midazolam/fentanyl combination affect the success of the procedure?", "category": "omission", "label": "consequence"}, {"doc_id": 4914313, "edit_id": 0, "question": "Is there currently an existing treatment approach for pancreatic cancer that is based on biomarkers?", "category": "omission", "label": "verification"}, {"doc_id": 4914313, "edit_id": 1, "question": "What type of pancreatic cancer did the patients involved in the study have?", "category": "omission", "label": "concept"}, {"doc_id": 4914313, "edit_id": 2, "question": "What phase of trial was the investigation in this study?", "category": "omission", "label": "concept"}, {"doc_id": 4914313, "edit_id": 3, "question": "Could the pancreatic cancer that the patients had in the trial be removed by surgery?", "category": "omission", "label": "verification"}, {"doc_id": 4914313, "edit_id": 4, "question": "What specific drugs were the patients offered as part of their treatment?", "category": "omission", "label": "procedural"}, {"doc_id": 4914313, "edit_id": 5, "question": "For how long did the patients receive the gemcitabine and capecitabine treatment?", "category": "omission", "label": "extent"}, {"doc_id": 4914313, "edit_id": 6, "question": "What is the term used to refer to the treatment combination of gemcitabine and capecitabine?", "category": "omission", "label": "concept"}, {"doc_id": 4914313, "edit_id": 7, "question": "What happened to the patients who responded positively after the GEM-CAP treatment phase?", "category": "omission", "label": "consequence"}, {"doc_id": 4937273, "edit_id": 0, "question": "How does Alirocumab, a medication used to lower cholesterol levels, get cleared from the body?", "category": "omission", "label": "procedural"}, {"doc_id": 4937273, "edit_id": 1, "question": "What is the specific substance that Alirocumab targets in the clearance process?", "category": "omission", "label": "concept"}, {"doc_id": 4937273, "edit_id": 2, "question": "What does Alirocumab do to PCSK9 during its clearance process?", "category": "omission", "label": "concept"}, {"doc_id": 4937273, "edit_id": 3, "question": "What is currently known about the effects of non-statin cholesterol-lowering therapies on Alirocumab?", "category": "omission", "label": "concept"}, {"doc_id": 4937273, "edit_id": 4, "question": "Is the dosing schedule of a 4-weeks interval applicable to all patients taking Alirocumab?", "category": "omission", "label": "verification"}, {"doc_id": 4937273, "edit_id": 5, "question": "Are the patients who may find the 4-week dosing schedule suitable taking any statin drugs?", "category": "omission", "label": "verification"}, {"doc_id": 4937273, "edit_id": 6, "question": "Is the dosing schedule of Alirocumab every 4 weeks officially approved?", "category": "omission", "label": "verification"}, {"doc_id": 4937273, "edit_id": 7, "question": "What was the cholesterol level of the subjects in this study?", "category": "omission", "label": "extent"}, {"doc_id": 4937273, "edit_id": 8, "question": "How many participants were there in each group of the study?", "category": "omission", "label": "extent"}, {"doc_id": 4937273, "edit_id": 9, "question": "What were the subjects taking during the run-in period before the Alirocumab was added?", "category": "omission", "label": "procedural"}, {"doc_id": 4937273, "edit_id": 10, "question": "How was the Alirocumab administered during the study, what was the dose and the frequency?", "category": "omission", "label": "procedural"}, {"doc_id": 4937273, "edit_id": 11, "question": "On which specific days was Alirocumab administered during the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4937273, "edit_id": 12, "question": "When was the maximum average reduction in LDL cholesterol levels noted after starting the Alirocumab treatment in the study?", "category": "omission", "label": "extent"}, {"doc_id": 4937273, "edit_id": 13, "question": "What was the reduction in LDL cholesterol levels in the group that received Alirocumab combined with a placebo?", "category": "omission", "label": "extent"}, {"doc_id": 4937273, "edit_id": 14, "question": "What was the reduction in LDL cholesterol in the group that was treated with Alirocumab plus ezetimibe?", "category": "omission", "label": "extent"}, {"doc_id": 4937273, "edit_id": 15, "question": "What was the reduction in LDL cholesterol in the group that was treated with Alirocumab plus fenofibrate?", "category": "omission", "label": "extent"}, {"doc_id": 4937273, "edit_id": 16, "question": "How long were the reductions in LDL cholesterol sustained in the group that took Alirocumab and a placebo?", "category": "omission", "label": "extent"}, {"doc_id": 4937273, "edit_id": 17, "question": "What was the rate of LDL cholesterol reduction in the group that took Alirocumab and a placebo?", "category": "omission", "label": "extent"}, {"doc_id": 4937273, "edit_id": 18, "question": "Did the effectiveness of the Alirocumab and ezetimibe combination stay the same throughout the study period?", "category": "omission", "label": "verification"}, {"doc_id": 4937273, "edit_id": 19, "question": "What was the rate of LDL cholesterol reduction with the combination of Alirocumab and ezetimibe?", "category": "omission", "label": "extent"}, {"doc_id": 4937273, "edit_id": 20, "question": "How did the effectiveness of the Alirocumab and fenofibrate combination change over time during the course of the study?", "category": "omission", "label": "comparison"}, {"doc_id": 4937273, "edit_id": 21, "question": "What was the rate of LDL cholesterol reduction with the combination of Alirocumab and fenofibrate?", "category": "omission", "label": "extent"}, {"doc_id": 4937273, "edit_id": 22, "question": "When were free PCSK9 concentrations at their lowest in the body of the subjects according to the study?", "category": "omission", "label": "extent"}, {"doc_id": 4937273, "edit_id": 23, "question": "How did the concentration levels of free PCSK9 change after Day 71 in the study?", "category": "omission", "label": "comparison"}, {"doc_id": 4937273, "edit_id": 24, "question": "What was the status of the free PCSK9 concentrations in the subjects' bodies by Day 85 of the study?", "category": "omission", "label": "extent"}, {"doc_id": 4937273, "edit_id": 25, "question": "How did the levels of Alirocumab change in the body by day 85?", "category": "omission", "label": "comparison"}, {"doc_id": 4937273, "edit_id": 26, "question": "How did the combination of Alirocumab and ezetimibe affect the concentrations of free PCSK9 by day 85?", "category": "omission", "label": "comparison"}, {"doc_id": 4937273, "edit_id": 27, "question": "How did the combination of Alirocumab and fenofibrate affect the levels of Alirocumab by day 85?", "category": "omission", "label": "comparison"}, {"doc_id": 4937273, "edit_id": 28, "question": "How did the combination of Alirocumab and ezetimibe affect the levels of Alirocumab by day 85?", "category": "omission", "label": "comparison"}, {"doc_id": 4937273, "edit_id": 29, "question": "Against what was the changes in free PCSK9 concentrations and Alirocumab levels compared?", "category": "omission", "label": "comparison"}, {"doc_id": 4937273, "edit_id": 30, "question": "What is the dosage frequency for Alirocumab?", "category": "omission", "label": "procedural"}, {"doc_id": 4937273, "edit_id": 31, "question": "What maximum LDL cholesterol reduction was achieved with 150 mg of Alirocumab combined with a placebo?", "category": "omission", "label": "extent"}, {"doc_id": 4937273, "edit_id": 32, "question": "What was the maximum LDL cholesterol reduction when Alirocumab was combined with ezetimibe?", "category": "omission", "label": "extent"}, {"doc_id": 4937273, "edit_id": 33, "question": "What was the maximum LDL cholesterol reduction when Alirocumab was combined with fenofibrate?", "category": "omission", "label": "extent"}, {"doc_id": 4937273, "edit_id": 34, "question": "How do increased PCSK9 levels affect the clearance of Alirocumab in the body?", "category": "omission", "label": "cause"}, {"doc_id": 4941128, "edit_id": 0, "question": "Has there been any previous trial related to aDBS before considering it for this study?", "category": "omission", "label": "verification"}, {"doc_id": 4941128, "edit_id": 1, "question": "What were the outcomes of the previous trial of aDBS?", "category": "omission", "label": "consequence"}, {"doc_id": 4941128, "edit_id": 2, "question": "What is conventional continuous DBS and for which disease is it used?", "category": "omission", "label": "concept"}, {"doc_id": 4941128, "edit_id": 3, "question": "Which part of the brain was targeted by the deep brain stimulation in this study?", "category": "omission", "label": "concept"}, {"doc_id": 4941128, "edit_id": 4, "question": "What was measured during the adaptive deep brain stimulation procedure in this study?", "category": "omission", "label": "procedural"}, {"doc_id": 4941128, "edit_id": 5, "question": "What was the average electrical power used during the adaptive deep brain stimulation in this study?", "category": "omission", "label": "extent"}, {"doc_id": 4941128, "edit_id": 6, "question": "Was there any uncertainty in the measurement of the average stimulation voltage during the aDBS procedure?", "category": "omission", "label": "verification"}, {"doc_id": 4941128, "edit_id": 7, "question": "How were the motor assessments conducted in this study in relation to knowledge of treatment?", "category": "omission", "label": "procedural"}, {"doc_id": 4941128, "edit_id": 8, "question": "How were the motor assessments documented in this study?", "category": "omission", "label": "procedural"}, {"doc_id": 4941128, "edit_id": 9, "question": "Which scores were used in the motor assessments during this study?", "category": "omission", "label": "procedural"}, {"doc_id": 4941128, "edit_id": 10, "question": "Which physical aspects were evaluated using the UPDRS scores during this study?", "category": "omission", "label": "procedural"}, {"doc_id": 4941128, "edit_id": 11, "question": "Was the improvement in UPDRS scores with aDBS statistically significant?", "category": "omission", "label": "verification"}, {"doc_id": 4941128, "edit_id": 12, "question": "How was the effect size of aDBS on UPDRS scores measured?", "category": "omission", "label": "procedural"}, {"doc_id": 4941128, "edit_id": 13, "question": "Did the use of the Parkinson's disease medication, Levodopa, have any effect on the Time on Stimulation (ToS)?", "category": "omission", "label": "verification"}, {"doc_id": 4941128, "edit_id": 14, "question": "How did the reductions in Time on Stimulation (ToS) compare to previous levels when patients were administered Levodopa?", "category": "omission", "label": "comparison"}, {"doc_id": 4941128, "edit_id": 15, "question": "Can bilateral aDBS improve symptoms related to balance and posture, known as axial symptoms, in Parkinson's patients?", "category": "omission", "label": "verification"}, {"doc_id": 4941128, "edit_id": 16, "question": "Can bilateral aDBS have any beneficial effects on the limb symptoms in Parkinson's patients?", "category": "omission", "label": "verification"}, {"doc_id": 4967511, "edit_id": 0, "question": "Why do we need more data on the effectiveness of the Health Promoting Schools program?", "category": "omission", "label": "cause"}, {"doc_id": 4967511, "edit_id": 1, "question": "What kind of a trial was implemented to test the Health Promoting Schools program? ", "category": "omission", "label": "concept"}, {"doc_id": 4967511, "edit_id": 2, "question": "When were the Year 3 primary school classes recruited for the study?", "category": "omission", "label": "extent"}, {"doc_id": 4967511, "edit_id": 3, "question": "Were the classes involved in the study exposed to any similar health program recently?", "category": "omission", "label": "verification"}, {"doc_id": 4967511, "edit_id": 4, "question": "How were the classes distributed in terms of participation in the program?", "category": "omission", "label": "procedural"}, {"doc_id": 4967511, "edit_id": 5, "question": "How long was the training that the teachers received?", "category": "omission", "label": "extent"}, {"doc_id": 4967511, "edit_id": 6, "question": "Apart from on-the-job training, what other training did the teachers receive?", "category": "omission", "label": "example"}, {"doc_id": 4967511, "edit_id": 7, "question": "How long did the additional workshops for the teachers last?", "category": "omission", "label": "extent"}, {"doc_id": 4967511, "edit_id": 8, "question": "Did the Health Promoting Schools program have any other goals aside from promoting health behavior in students?", "category": "omission", "label": "verification"}, {"doc_id": 4967511, "edit_id": 9, "question": "What were other categories they checked, apart from feelings and social activities in school, physical activity, well-being, and physical skills?", "category": "omission", "label": "example"}, {"doc_id": 4967511, "edit_id": 10, "question": "What were other categories measured apart from feelings and social activities at school, physical activity, well-being, and concentration?", "category": "omission", "label": "example"}, {"doc_id": 4967511, "edit_id": 11, "question": "How did the study measure \"emotional and social experience at school\"?", "category": "omission", "label": "procedural"}, {"doc_id": 4967511, "edit_id": 12, "question": "How did the study measure \"physical activity\"?", "category": "omission", "label": "procedural"}, {"doc_id": 4967511, "edit_id": 13, "question": "Did the study involve a final measurement or assessment?", "category": "omission", "label": "verification"}, {"doc_id": 4967511, "edit_id": 14, "question": "Did the people evaluating the data know which class participated in the study and which did not?", "category": "omission", "label": "verification"}, {"doc_id": 4967511, "edit_id": 15, "question": "What technique was used to ensure that assessors aren't biased in their evaluations?", "category": "omission", "label": "procedural"}, {"doc_id": 4967511, "edit_id": 16, "question": "What kind of analysis was used in the study to investigate the program's effectiveness?", "category": "omission", "label": "concept"}, {"doc_id": 4967511, "edit_id": 17, "question": "Were attention and concentration also evaluated as a part of the study?", "category": "omission", "label": "verification"}, {"doc_id": 4967511, "edit_id": 18, "question": "How were the differences in categories between two groups estimated statistically?", "category": "omission", "label": "procedural"}, {"doc_id": 4967511, "edit_id": 19, "question": "Was there any category where the intervention group exhibited significant differences?", "category": "omission", "label": "verification"}, {"doc_id": 4967511, "edit_id": 20, "question": "What specific abilities were considered under the \"Motor Skills\" category?", "category": "omission", "label": "concept"}, {"doc_id": 4967511, "edit_id": 21, "question": "Between the group using the program and the group waiting to begin, which showed better motor skills?", "category": "omission", "label": "comparison"}, {"doc_id": 4967511, "edit_id": 22, "question": "How significant were the differences in Motor Skills scores between the intervention group and control group?", "category": "omission", "label": "extent"}, {"doc_id": 4967511, "edit_id": 23, "question": "What were the findings of the study in terms of Motor Skills?", "category": "omission", "label": "consequence"}, {"doc_id": 4967511, "edit_id": 24, "question": "Were there any clinically relevant improvements in Motor Skills detected in the study?", "category": "omission", "label": "verification"}, {"doc_id": 4967511, "edit_id": 25, "question": "What was the identifier given to this study in the German register of clinical trials?", "category": "omission", "label": "concept"}, {"doc_id": 4967511, "edit_id": 26, "question": "When was the study approved by the Ethics Committee of Lower Austria? ", "category": "omission", "label": "extent"}, {"doc_id": 4972969, "edit_id": 0, "question": "Who designed and implemented the two health worker in-service training approaches that were used in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4972969, "edit_id": 1, "question": "What is the nature of the first approach to training that was used in the study?", "category": "omission", "label": "concept"}, {"doc_id": 4972969, "edit_id": 2, "question": "Does the Integrated Management of Infectious Diseases (IMID) course include any distance learning aspects?", "category": "omission", "label": "verification"}, {"doc_id": 4972969, "edit_id": 3, "question": "What is the On-Site Support (OSS) that was mentioned?", "category": "omission", "label": "concept"}, {"doc_id": 4972969, "edit_id": 4, "question": "What aspects of healthcare delivery did the study assess for the effect of On-Site Support (OSS)? ", "category": "omission", "label": "concept"}, {"doc_id": 4972969, "edit_id": 5, "question": "Besides workload and facility performance, what other area was included in the test of the On-Site Support (OSS)?", "category": "omission", "label": "concept"}, {"doc_id": 4972969, "edit_id": 6, "question": "Who were the participants in one of the subgroups in the study?", "category": "omission", "label": "concept"}, {"doc_id": 4972969, "edit_id": 7, "question": "How many mid-level practitioners (MLP) in each group went through the special classroom training?", "category": "omission", "label": "extent"}, {"doc_id": 4972969, "edit_id": 8, "question": "Did health care providers at all study sites receive On-Site Support (OSS) visits?", "category": "omission", "label": "verification"}, {"doc_id": 4972969, "edit_id": 9, "question": "How frequently did the On-Site Support (OSS) visits to Arm A facilities occur?", "category": "omission", "label": "extent"}, {"doc_id": 4972969, "edit_id": 10, "question": "When did the on-site support visits happen for the care providers at Arm A facilities?", "category": "omission", "label": "extent"}, {"doc_id": 4972969, "edit_id": 11, "question": "How many On-Site Support (OSS) visits were made in total to Arm A facilities?", "category": "omission", "label": "extent"}, {"doc_id": 4972969, "edit_id": 12, "question": "Did the care providers at Arm B facilities receive on-site support visits during the same time period as Arm A?", "category": "omission", "label": "verification"}, {"doc_id": 4972969, "edit_id": 13, "question": "Over what time period did the outpatient visits evaluated in the study occur?", "category": "omission", "label": "extent"}, {"doc_id": 4972969, "edit_id": 14, "question": "How many outpatient visits were there in total from November 2009 to December 2010?", "category": "omission", "label": "extent"}, {"doc_id": 4972969, "edit_id": 15, "question": "How many outpatient visits were analyzed in the study?", "category": "omission", "label": "extent"}, {"doc_id": 4972969, "edit_id": 16, "question": "What percentage of the total visits does the analyzed outpatient visits represent?", "category": "omission", "label": "extent"}, {"doc_id": 4972969, "edit_id": 17, "question": "Who were some of the health workers providing treatment during the study?", "category": "omission", "label": "example"}, {"doc_id": 4972969, "edit_id": 18, "question": "How many mid-level practitioners who undertook the course provided treatment during the study?", "category": "omission", "label": "extent"}, {"doc_id": 4972969, "edit_id": 19, "question": "Besides the mid-level practitioners who undertook the Integrated Management of Infectious Diseases (IMID) training, who else provided treatment?", "category": "omission", "label": "example"}, {"doc_id": 4972969, "edit_id": 20, "question": "How many health workers who did not receive the Integrated Management of Infectious Diseases (IMID) training, provided treatment in the study?", "category": "omission", "label": "extent"}, {"doc_id": 4972969, "edit_id": 21, "question": "Did the process of measurement take into account any other contributing factors?", "category": "omission", "label": "verification"}, {"doc_id": 4972969, "edit_id": 22, "question": "Was there a significant effect of On-Site Support (OSS) on the workload (patients-per-provider-per-day) of both the MLPs trained in IMID and those who weren't?", "category": "omission", "label": "verification"}, {"doc_id": 4972969, "edit_id": 23, "question": "For the mid-level practitioners who went through the special training, were there any areas where the OSS was found to be effective?", "category": "omission", "label": "verification"}, {"doc_id": 4972969, "edit_id": 24, "question": "For the health workers who hadn't been through the special classroom training, were there any areas where the OSS was found to be effective?", "category": "omission", "label": "verification"}, {"doc_id": 4972969, "edit_id": 25, "question": "Was there any significant effect of OSS on the workload of the health workers according to the study?", "category": "omission", "label": "verification"}, {"doc_id": 4972969, "edit_id": 26, "question": "Were there any significant effects of On-Site Support (OSS) on the performance of the facilities?", "category": "omission", "label": "verification"}, {"doc_id": 4972969, "edit_id": 27, "question": "Are the effects of On-Site Support (OSS) on facilities' performance the same across different participant subgroups?", "category": "omission", "label": "verification"}, {"doc_id": 4972969, "edit_id": 28, "question": "What is the identifier for the article that talks about this study?", "category": "omission", "label": "concept"}, {"doc_id": 4984916, "edit_id": 0, "question": "What type of trial is planned to be larger?", "category": "omission", "label": "concept"}, {"doc_id": 4984916, "edit_id": 1, "question": "How confident are researchers in the results they will get from the larger trial?", "category": "omission", "label": "extent"}, {"doc_id": 4984916, "edit_id": 2, "question": "Has the design for the larger trial been finalized yet?", "category": "omission", "label": "verification"}, {"doc_id": 4984916, "edit_id": 3, "question": "What phase was this trial in on the drug or device development process?", "category": "omission", "label": "concept"}, {"doc_id": 4984916, "edit_id": 4, "question": "How were patients distributed between the two treatments during the trial?", "category": "omission", "label": "procedural"}, {"doc_id": 4984916, "edit_id": 5, "question": "What was the P-value of the comparison made between the Hickman and TIVAS groups?", "category": "omission", "label": "extent"}, {"doc_id": 4984916, "edit_id": 6, "question": "Did complications in the Hickman group lead to any devices being removed before they were supposed to be?", "category": "omission", "label": "verification"}, {"doc_id": 4984916, "edit_id": 7, "question": "What percentage of Hickman devices had to be removed early?", "category": "omission", "label": "extent"}, {"doc_id": 4984916, "edit_id": 8, "question": "Did any complications in the TIVAS group lead to devices being removed earlier than planned?", "category": "omission", "label": "verification"}, {"doc_id": 4984916, "edit_id": 9, "question": "What percentage of TIVAS devices needed to be removed early?", "category": "omission", "label": "extent"}, {"doc_id": 4984916, "edit_id": 10, "question": "How did the researchers measure the patients' quality of life?", "category": "omission", "label": "procedural"}, {"doc_id": 4984916, "edit_id": 11, "question": "How many questions are on the device-specific questionnaire?", "category": "omission", "label": "extent"}, {"doc_id": 4984916, "edit_id": 12, "question": "How did the two groups compare in the device-specific quality of life questionnaire?", "category": "omission", "label": "comparison"}, {"doc_id": 4984916, "edit_id": 13, "question": "What was the average cost per patient for the Hickman treatment?", "category": "omission", "label": "extent"}, {"doc_id": 4984916, "edit_id": 14, "question": "What was the range for the average cost per patient for the Hickman treatment?", "category": "omission", "label": "extent"}, {"doc_id": 4984916, "edit_id": 15, "question": "What was the quality-adjusted life years (QALY) value for the Hickman group?", "category": "omission", "label": "extent"}, {"doc_id": 4984916, "edit_id": 16, "question": "What was the confidence range for the quality-adjusted life years value for the Hickman group?", "category": "omission", "label": "extent"}, {"doc_id": 4984916, "edit_id": 17, "question": "How confident are the researchers in their results?", "category": "omission", "label": "extent"}, {"doc_id": 4984916, "edit_id": 18, "question": "Is the larger trial planned to be conducted in one centre or more?", "category": "omission", "label": "concept"}, {"doc_id": 4994121, "edit_id": 0, "question": "Which specific aspects of heart function were being studied?", "category": "omission", "label": "concept"}, {"doc_id": 4994121, "edit_id": 1, "question": "Did the patients in this study need any other treatments for their hearts?", "category": "omission", "label": "verification"}, {"doc_id": 4994121, "edit_id": 2, "question": "What was the exact heart condition the patients had?", "category": "omission", "label": "concept"}, {"doc_id": 4994121, "edit_id": 3, "question": "How many patients received the drugs?", "category": "omission", "label": "extent"}, {"doc_id": 4994121, "edit_id": 4, "question": "What was given to the other patients who didn't receive the drugs?", "category": "omission", "label": "procedural"}, {"doc_id": 4994121, "edit_id": 5, "question": "Were there patients apart from the 35 who received the drug combination?", "category": "omission", "label": "verification"}, {"doc_id": 4994121, "edit_id": 6, "question": "At what dosage was the Levosimendan administered?", "category": "omission", "label": "extent"}, {"doc_id": 4994121, "edit_id": 7, "question": "Was Levosimendan given continuously throughout surgery?", "category": "omission", "label": "verification"}, {"doc_id": 4994121, "edit_id": 8, "question": "What was the dosage of sodium nitroprusside (SNP)?", "category": "omission", "label": "extent"}, {"doc_id": 4994121, "edit_id": 9, "question": "Were there any changes in blood pressure during the study?", "category": "omission", "label": "verification"}, {"doc_id": 4994121, "edit_id": 10, "question": "How many deaths occurred in the group that received the two drugs?", "category": "omission", "label": "extent"}, {"doc_id": 4994121, "edit_id": 11, "question": "In the group that received the drug combination, what was the average of the measurements taken?", "category": "omission", "label": "extent"}, {"doc_id": 4994121, "edit_id": 12, "question": "What caused the increase in the heart's ejection fraction (the percentage of blood leaving the heart each time it contracts)?", "category": "omission", "label": "cause"}, {"doc_id": 4994121, "edit_id": 13, "question": "Did the combination of levosimendan and sodium nitroprusside have any effect on the need for intra-aortic balloon pump support?", "category": "omission", "label": "consequence"}, {"doc_id": 5002324, "edit_id": 0, "question": "What was the main focus of the study?", "category": "omission", "label": "concept"}, {"doc_id": 5002324, "edit_id": 1, "question": "Was the study conducted in such a way that the participants didn't know what group they were in?", "category": "omission", "label": "verification"}, {"doc_id": 5002324, "edit_id": 2, "question": "Was the study conducted under controlled conditions? ", "category": "omission", "label": "verification"}, {"doc_id": 5002324, "edit_id": 3, "question": "What tests were used to assess the participants' stability?", "category": "omission", "label": "procedural"}, {"doc_id": 5002324, "edit_id": 4, "question": "What other tests besides the LOS test were used to assess stability?", "category": "omission", "label": "procedural"}, {"doc_id": 5002324, "edit_id": 5, "question": "What tests were used to assess balance in the participants?", "category": "omission", "label": "procedural"}, {"doc_id": 5002324, "edit_id": 6, "question": "Besides BBS, were there any other tests used to assess balance?", "category": "omission", "label": "verification"}, {"doc_id": 5002324, "edit_id": 7, "question": "Was there any improvement seen in specific conditions of the balance and stability tests?", "category": "omission", "label": "consequence"}, {"doc_id": 5002324, "edit_id": 8, "question": "In what areas were improvements seen after the training?", "category": "omission", "label": "consequence"}, {"doc_id": 5002324, "edit_id": 9, "question": "Apart from BBS, where else were improvements seen in participant performance?", "category": "omission", "label": "consequence"}, {"doc_id": 5002324, "edit_id": 10, "question": "What was the performance level in the LOS test for directional control in the group that used the Kinect exergame for balance training?", "category": "omission", "label": "extent"}, {"doc_id": 5002324, "edit_id": 11, "question": "How did the conventional balance training group perform in directional control in the LOS test?", "category": "omission", "label": "extent"}, {"doc_id": 5002324, "edit_id": 12, "question": "Was there a significant difference in the performance of the two groups in terms of directional control?", "category": "omission", "label": "comparison"}, {"doc_id": 5002324, "edit_id": 13, "question": "Is there a specific identification for the online version of the article?", "category": "omission", "label": "concept"}, {"doc_id": 5018291, "edit_id": 0, "question": "What is another purpose of ketamine apart from being injected into the bloodstream for pain relief?", "category": "omission", "label": "concept"}, {"doc_id": 5018291, "edit_id": 1, "question": "What procedure was conducted on the patients in Group C during the kidney stone removal surgery study?", "category": "omission", "label": "procedural"}, {"doc_id": 5018291, "edit_id": 2, "question": "How was the treatment for patients in Group B administered?", "category": "omission", "label": "procedural"}, {"doc_id": 5018291, "edit_id": 3, "question": "What treatment was performed on the patients in Group BK1?", "category": "omission", "label": "procedural"}, {"doc_id": 5018291, "edit_id": 4, "question": "How was the treatment for Group BK2 different from that of Group BK1?", "category": "omission", "label": "comparison"}, {"doc_id": 5018291, "edit_id": 5, "question": "How did the patients in Group K receive their treatment in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5018291, "edit_id": 6, "question": "Apart from pain levels, were there any other health indicators measured during the study?", "category": "omission", "label": "verification"}, {"doc_id": 5018291, "edit_id": 7, "question": "Were the health indicators like oxygen levels in the blood primary or secondary objectives in the study?", "category": "omission", "label": "concept"}, {"doc_id": 5018291, "edit_id": 8, "question": "Was there any change in the reported pain levels (using the VAS scores) in the immediate post-operative period among different groups?", "category": "omission", "label": "consequence"}, {"doc_id": 5018291, "edit_id": 9, "question": "How did the consumption of additional painkillers in the first 24 hours after surgery vary among the different patient groups?", "category": "omission", "label": "comparison"}, {"doc_id": 5018291, "edit_id": 10, "question": "Was the decreased pain and analgesic consumption in the groups BK1 and BK2 statistically significant?", "category": "omission", "label": "verification"}, {"doc_id": 5019463, "edit_id": 0, "question": "How were the patients chosen for the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5019463, "edit_id": 1, "question": "In which city and country did this study take place?", "category": "omission", "label": "concept"}, {"doc_id": 5019463, "edit_id": 2, "question": "How many locations were involved in patient selection for the study?", "category": "omission", "label": "extent"}, {"doc_id": 5019463, "edit_id": 3, "question": "Where are these 43 community sites located?", "category": "omission", "label": "concept"}, {"doc_id": 5019463, "edit_id": 4, "question": "What was unique about the treatment of Group 3 in the study?", "category": "omission", "label": "concept"}, {"doc_id": 5019463, "edit_id": 5, "question": "What statistical test was used to compare the results of the three groups in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5019463, "edit_id": 6, "question": "What level of significance was used for the statistical tests in this study?", "category": "omission", "label": "procedural"}, {"doc_id": 5019463, "edit_id": 7, "question": "What kind of health condition did all enrolled patients have?", "category": "omission", "label": "concept"}, {"doc_id": 5019463, "edit_id": 8, "question": "What was the average age of the patients in the study?", "category": "omission", "label": "extent"}, {"doc_id": 5019463, "edit_id": 9, "question": "What percentage of the patients were female?", "category": "omission", "label": "extent"}, {"doc_id": 5019463, "edit_id": 10, "question": "How many of the patients were female?", "category": "omission", "label": "extent"}, {"doc_id": 5019463, "edit_id": 11, "question": "What percentage of the patients identified as African-American?", "category": "omission", "label": "extent"}, {"doc_id": 5019463, "edit_id": 12, "question": "How many of the patients were African-American?", "category": "omission", "label": "extent"}, {"doc_id": 5019463, "edit_id": 13, "question": "What was the average number of follow-up visits for the group that received their check-ups in a community setting with a navigator (G1)?", "category": "omission", "label": "extent"}, {"doc_id": 5019463, "edit_id": 14, "question": "What was the standard deviation for the number of follow-up visits for the group that received their check-ups in a community setting with a navigator (G1)?", "category": "omission", "label": "extent"}, {"doc_id": 5019463, "edit_id": 15, "question": "What was the average number of follow-up visits for the group that received their check-ups in an office setting with a navigator (G2)?", "category": "omission", "label": "extent"}, {"doc_id": 5019463, "edit_id": 16, "question": "What was the standard deviation in the number of follow-up visits in the group who got office-based care with a patient navigator (G2)?", "category": "omission", "label": "extent"}, {"doc_id": 5019463, "edit_id": 17, "question": "What was the average number of follow-up visits for the group that received their check-ups in an office setting without a navigator (G3)?", "category": "omission", "label": "extent"}, {"doc_id": 5019463, "edit_id": 18, "question": "What was the range of follow-up visits in the group who got office-based care without a patient navigator (G3)?", "category": "omission", "label": "extent"}, {"doc_id": 5019463, "edit_id": 19, "question": "What was the P-value when comparing the number of follow-up visits among the three different groups?", "category": "omission", "label": "comparison"}, {"doc_id": 5019463, "edit_id": 20, "question": "What percentage of patients in the group who got community-based care with a patient navigator (G1) attended their follow-up appointments?", "category": "omission", "label": "extent"}, {"doc_id": 5019463, "edit_id": 21, "question": "How many patients in the group who got community-based care with a patient navigator (G1) went to their follow-up appointments?", "category": "omission", "label": "extent"}, {"doc_id": 5019463, "edit_id": 22, "question": "How many patients were in the group that got community-based care with a patient navigator (G1)?", "category": "omission", "label": "extent"}, {"doc_id": 5019463, "edit_id": 23, "question": "What was the adherence rate to follow-up appointments for the group that received office-based care with a patient navigator (G2)?", "category": "omission", "label": "extent"}, {"doc_id": 5019463, "edit_id": 24, "question": "How many patients in the group who got office-based care with a patient navigator (G2) actually attended their follow-up appointments?", "category": "omission", "label": "extent"}, {"doc_id": 5019463, "edit_id": 25, "question": "How many participants were there in the group that received office-based care with a patient navigator (G2)?", "category": "omission", "label": "extent"}, {"doc_id": 5019463, "edit_id": 26, "question": "What percentage of patients in the group who received office-based care without a patient navigator (G3) attended their follow-up appointments?", "category": "omission", "label": "extent"}, {"doc_id": 5019463, "edit_id": 27, "question": "How many patients in the group that got their check-ups in an office setting without a navigator (G3) followed through with their appointments?", "category": "omission", "label": "extent"}, {"doc_id": 5019463, "edit_id": 28, "question": "What was the rate of attendance for two or more follow-up visits among the group that received community-based care with a patient navigator (G1)?", "category": "omission", "label": "extent"}, {"doc_id": 5019463, "edit_id": 29, "question": "How many patients in G1 who had at least two appointments kept their appointments?", "category": "omission", "label": "extent"}, {"doc_id": 5019463, "edit_id": 30, "question": "What was the rate of appointment adherence for those patients in G2 who had at least two follow-up visits?", "category": "omission", "label": "extent"}, {"doc_id": 5019463, "edit_id": 31, "question": "How many patients in G2 who had at least two appointments kept their appointments?", "category": "omission", "label": "extent"}, {"doc_id": 5019463, "edit_id": 32, "question": "What was the percentage of patients in the group who received office-based care without a patient navigator (G3) that attended at least two follow-up visits?", "category": "omission", "label": "extent"}, {"doc_id": 5019463, "edit_id": 33, "question": "How many patients in the group that received office-based care without a patient navigator (G3) had at least two appointments and attended them?", "category": "omission", "label": "extent"}, {"doc_id": 5019463, "edit_id": 34, "question": "What was the P-value when comparing the adherence rates among the different groups?", "category": "omission", "label": "comparison"}, {"doc_id": 5019971, "edit_id": 0, "question": "Can you tell me more about how Maraviroc works?", "category": "omission", "label": "concept"}, {"doc_id": 5019971, "edit_id": 1, "question": "Does Maraviroc have any effect on the cells involved in immune response?", "category": "omission", "label": "verification"}, {"doc_id": 5019971, "edit_id": 2, "question": "Overall, where was the decrease in immune activation and monocyte presence observed in this study? ", "category": "omission", "label": "consequence"}, {"doc_id": 5019971, "edit_id": 3, "question": "What was the specific medical condition the researchers were looking at when trying to understand Maraviroc's effects?", "category": "omission", "label": "concept"}, {"doc_id": 5019971, "edit_id": 4, "question": "What was the major measurement the researchers focused on in this study?", "category": "omission", "label": "concept"}, {"doc_id": 5019971, "edit_id": 5, "question": "Was the study blind or open-label?", "category": "omission", "label": "verification"}, {"doc_id": 5019971, "edit_id": 6, "question": "What did the control period of the study entail in terms of the patients' treatment?", "category": "omission", "label": "procedural"}, {"doc_id": 5019971, "edit_id": 7, "question": "Did the researchers monitor anything related to how HIV enters cells?", "category": "omission", "label": "verification"}, {"doc_id": 5019971, "edit_id": 8, "question": "Did the researchers measure anything related to blood clotting over the course of the study?", "category": "omission", "label": "verification"}, {"doc_id": 5019971, "edit_id": 9, "question": "Did the researchers check for any indicators of immune system activity?", "category": "omission", "label": "verification"}, {"doc_id": 5019971, "edit_id": 10, "question": "What type of statistical methods did the researchers use for the analysis?", "category": "omission", "label": "procedural"}, {"doc_id": 5019971, "edit_id": 11, "question": "What specific relation were the researchers studying?", "category": "omission", "label": "concept"}, {"doc_id": 5019971, "edit_id": 12, "question": "What statistical method did the researchers use to study the relationship between different variables?", "category": "omission", "label": "procedural"}, {"doc_id": 5019971, "edit_id": 13, "question": "What is the HIV condition of the patient in the study?", "category": "omission", "label": "concept"}, {"doc_id": 5019971, "edit_id": 14, "question": "By how much did the blood vessel function (FMD) improve after the extra Maraviroc was added?", "category": "omission", "label": "extent"}, {"doc_id": 5019971, "edit_id": 15, "question": "What was the variation in FMD improvement after Maraviroc intensification?", "category": "omission", "label": "extent"}, {"doc_id": 5019971, "edit_id": 16, "question": "How did the blood vessel function change in the control period, when patients were not given extra Maraviroc?", "category": "omission", "label": "extent"}, {"doc_id": 5019971, "edit_id": 17, "question": "What was the variation in FMD decrease during the control stage of the study?", "category": "omission", "label": "extent"}, {"doc_id": 5019971, "edit_id": 18, "question": "Was the difference in blood vessel function between the Maraviroc intensification and control periods significant?", "category": "omission", "label": "verification"}, {"doc_id": 5019971, "edit_id": 19, "question": "Was there any relationship found between changes in blood vessel health and inflammation?", "category": "omission", "label": "verification"}, {"doc_id": 5019971, "edit_id": 20, "question": "What was the exact value of the relationship between changes in blood vessel function and inflammation?", "category": "omission", "label": "extent"}, {"doc_id": 5019971, "edit_id": 21, "question": "What was the range in which we can be 95% certain that the true value of the relationship between changes in blood vessel function and inflammation lies?", "category": "omission", "label": "extent"}, {"doc_id": 5019971, "edit_id": 22, "question": "How confident can we be that the relationship between changes in blood vessel health and inflammation is not due to chance?", "category": "omission", "label": "extent"}, {"doc_id": 5019971, "edit_id": 23, "question": "Did the study find any relationship between changes in blood vessel function and changes in some immune response cells?", "category": "omission", "label": "verification"}, {"doc_id": 5019971, "edit_id": 24, "question": "What was the numerical relationship between changes in blood vessel health and changes in these immune cells?", "category": "omission", "label": "extent"}, {"doc_id": 5019971, "edit_id": 25, "question": "What range did the researchers decide was likely to contain the true value of the relationship between changes in blood vessel function and immune cells?", "category": "omission", "label": "extent"}, {"doc_id": 5019971, "edit_id": 26, "question": "How confident were the researchers that the relationship between blood vessel health and immune cells is not due to chance?", "category": "omission", "label": "extent"}, {"doc_id": 5019971, "edit_id": 27, "question": "Did the researchers control for any other factors when studying these relationships?", "category": "omission", "label": "verification"}, {"doc_id": 5019971, "edit_id": 28, "question": "How is Maraviroc used in treating HIV patients?", "category": "omission", "label": "procedural"}, {"doc_id": 5019971, "edit_id": 29, "question": "Does the additional Maraviroc affect anything related to the lining of the blood vessels?", "category": "omission", "label": "verification"}, {"doc_id": 5019971, "edit_id": 30, "question": "Is there a unique identifier for the online version of this article?", "category": "omission", "label": "verification"}, {"doc_id": 5043523, "edit_id": 0, "question": "What other changes, beyond diet, does the hypothesis suggest individuals might make if they are aware of their genetic risks?", "category": "omission", "label": "consequence"}, {"doc_id": 5043523, "edit_id": 1, "question": "What type of dietary and lifestyle changes are implied by the hypothesis and results of the study?", "category": "omission", "label": "consequence"}, {"doc_id": 5043523, "edit_id": 2, "question": "Where did the data for this study come from?", "category": "omission", "label": "procedural"}, {"doc_id": 5043523, "edit_id": 3, "question": "What type of trial was conducted for this study?", "category": "omission", "label": "concept"}, {"doc_id": 5043523, "edit_id": 4, "question": "What specific genetic information were the participants in the trial given?", "category": "omission", "label": "concept"}, {"doc_id": 5043523, "edit_id": 5, "question": "What are the risk alleles of the MTHFR gene?", "category": "omission", "label": "concept"}, {"doc_id": 5043523, "edit_id": 6, "question": "What is the non-risk allele of the MTHFR gene?", "category": "omission", "label": "concept"}, {"doc_id": 5043523, "edit_id": 7, "question": "How many participants had the risk variants of the MTHFR gene?", "category": "omission", "label": "extent"}, {"doc_id": 5043523, "edit_id": 8, "question": "How many participants in the study had the non-risk allele of the MTHFR gene?", "category": "omission", "label": "extent"}, {"doc_id": 5043523, "edit_id": 9, "question": "What type of analysis was used in the study?", "category": "omission", "label": "concept"}, {"doc_id": 5043523, "edit_id": 10, "question": "What was the baseline folate intake for the non-risk group?", "category": "omission", "label": "extent"}, {"doc_id": 5043523, "edit_id": 11, "question": "What types of food are high in folate?", "category": "omission", "label": "example"}, {"doc_id": 5043523, "edit_id": 12, "question": "What specific genotype does the study involve?", "category": "omission", "label": "concept"}, {"doc_id": 5043523, "edit_id": 13, "question": "Is the MTHFR 677C \u2192 T genotype associated with both a risk variant and a non-risk variant?", "category": "omission", "label": "verification"}, {"doc_id": 5054596, "edit_id": 0, "question": "What is the current state of knowledge regarding how users of body-powered prostheses learn to perceive and perform actions?", "category": "omission", "label": "concept"}, {"doc_id": 5054596, "edit_id": 1, "question": "What tool was used to measure the performance of the prosthesis users in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5054596, "edit_id": 2, "question": "What kind of tests did the control group need to perform?", "category": "omission", "label": "procedural"}, {"doc_id": 5054596, "edit_id": 3, "question": "Did the performance of all the training groups improve according to the Southampton Hand Assessment Procedure (SHAP)?", "category": "omission", "label": "verification"}, {"doc_id": 5054596, "edit_id": 4, "question": "Was there any improvement in the control group based on the Southampton Hand Assessment Procedure (SHAP)?", "category": "omission", "label": "verification"}, {"doc_id": 5054596, "edit_id": 5, "question": "Did the group that practiced indirect grasping show any pattern in their performance over time?", "category": "omission", "label": "verification"}, {"doc_id": 5054596, "edit_id": 6, "question": "Did the rest of the training groups show any plateaus in their performance over time?", "category": "omission", "label": "verification"}, {"doc_id": 5054596, "edit_id": 7, "question": "How did the plateau times of the indirect grasping group compare to those of the other training groups?", "category": "omission", "label": "comparison"}, {"doc_id": 5054596, "edit_id": 8, "question": "What is the DOI of the online version of the article?", "category": "omission", "label": "concept"}, {"doc_id": 5117579, "edit_id": 0, "question": "What kind of drug is dexmedetomidine?", "category": "omission", "label": "concept"}, {"doc_id": 5117579, "edit_id": 1, "question": "Does dexmedetomidine have any effect on sleepiness?", "category": "omission", "label": "verification"}, {"doc_id": 5117579, "edit_id": 2, "question": "How does dexmedetomidine affect the cardiovascular system?", "category": "omission", "label": "cause"}, {"doc_id": 5117579, "edit_id": 3, "question": "Can dexmedetomidine influence blood pressure?", "category": "omission", "label": "verification"}, {"doc_id": 5117579, "edit_id": 4, "question": "What are some common complications related to anesthesia?", "category": "omission", "label": "example"}, {"doc_id": 5117579, "edit_id": 5, "question": "Why is it important to manage patient anxiety during surgical procedures?", "category": "omission", "label": "cause"}, {"doc_id": 5117579, "edit_id": 6, "question": "Does the patient's level of anxiety influence the quality of a medical procedure?", "category": "omission", "label": "verification"}, {"doc_id": 5117579, "edit_id": 7, "question": "Why is it important to aim for a high quality in medical procedures?", "category": "omission", "label": "cause"}, {"doc_id": 5117579, "edit_id": 8, "question": "How was dexmedetomidine given to the patients in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5117579, "edit_id": 9, "question": "What was the health status of the patients in the study?", "category": "omission", "label": "concept"}, {"doc_id": 5117579, "edit_id": 10, "question": "How were the patients divided for the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5117579, "edit_id": 11, "question": "What type of anesthesia was used in this study?", "category": "omission", "label": "concept"}, {"doc_id": 5117579, "edit_id": 12, "question": "What type of bupivacaine was used for the spinal anesthesia in the study?", "category": "omission", "label": "concept"}, {"doc_id": 5117579, "edit_id": 13, "question": "What was the concentration of the bupivacaine used in the study?", "category": "omission", "label": "extent"}, {"doc_id": 5117579, "edit_id": 14, "question": "How much bupivacaine was administered to the patients in the study?", "category": "omission", "label": "extent"}, {"doc_id": 5117579, "edit_id": 15, "question": "How much dexmedetomidine was given to Group A in the study and how was it administered?", "category": "omission", "label": "procedural"}, {"doc_id": 5117579, "edit_id": 16, "question": "How long was the dexmedetomidine administered for in the study?", "category": "omission", "label": "extent"}, {"doc_id": 5117579, "edit_id": 17, "question": "What happened after the initial dose of dexmedetomidine was given to the patients?", "category": "omission", "label": "consequence"}, {"doc_id": 5117579, "edit_id": 18, "question": "When was the maintenance infusion of dexmedetomidine given in relation to the bupivacaine injection?", "category": "omission", "label": "procedural"}, {"doc_id": 5117579, "edit_id": 19, "question": "Where was the bupivacaine injected?", "category": "omission", "label": "procedural"}, {"doc_id": 5117579, "edit_id": 20, "question": "How was dexmedetomidine given to the patients?", "category": "omission", "label": "procedural"}, {"doc_id": 5117579, "edit_id": 21, "question": "When was dexmedetomidine given in relation to the bupivacaine injection in certain patients?", "category": "omission", "label": "procedural"}, {"doc_id": 5117579, "edit_id": 22, "question": "Did the patients receive different doses of dexmedetomidine?", "category": "omission", "label": "verification"}, {"doc_id": 5117579, "edit_id": 23, "question": "How was bupivacaine administered to the patients?", "category": "omission", "label": "procedural"}, {"doc_id": 5117579, "edit_id": 24, "question": "How was patient anxiety measured in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5117579, "edit_id": 25, "question": "How were patient comfort levels measured in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5117579, "edit_id": 26, "question": "What percentage of patients in Group A experienced low blood pressure during the study?", "category": "omission", "label": "extent"}, {"doc_id": 5117579, "edit_id": 27, "question": "What percentage of patients in Group B experienced low blood pressure during the study?", "category": "omission", "label": "extent"}, {"doc_id": 5117579, "edit_id": 28, "question": "What was the p-value of the comparison of the incidence of hypotension between the two groups in the study?", "category": "omission", "label": "extent"}, {"doc_id": 5117579, "edit_id": 29, "question": "Was treatment for low blood pressure needed in both groups in the study?", "category": "omission", "label": "verification"}, {"doc_id": 5117579, "edit_id": 30, "question": "Is there a significant difference in the need for treatment of low blood pressure between the two groups in the study?", "category": "omission", "label": "comparison"}, {"doc_id": 5117579, "edit_id": 31, "question": "What was the p-value of the comparison between the need for treatment of hypotension between Group A and Group B?", "category": "omission", "label": "extent"}, {"doc_id": 5117579, "edit_id": 32, "question": "What other vital sign besides blood pressure was measured in both groups during the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5117579, "edit_id": 33, "question": "What other health indicator was measured in both groups during the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5117579, "edit_id": 34, "question": "Was there a significant difference in the incidence of desaturation between the two groups in the study?", "category": "omission", "label": "verification"}, {"doc_id": 5117579, "edit_id": 35, "question": "Were the patients' levels of anxiety and comfort analyzed statistically in the study?", "category": "omission", "label": "verification"}, {"doc_id": 5117579, "edit_id": 36, "question": "Which group experienced a higher frequency of low blood pressure in the study?", "category": "omission", "label": "comparison"}, {"doc_id": 5117579, "edit_id": 37, "question": "In one of the groups, when was dexmedetomidine administered in relation to the spinal anesthesia?", "category": "omission", "label": "procedural"}, {"doc_id": 5117579, "edit_id": 38, "question": "In the other group, when was dexmedetomidine administered in relation to the spinal anesthesia?", "category": "omission", "label": "procedural"}, {"doc_id": 5117579, "edit_id": 39, "question": "When was the study registered?", "category": "omission", "label": "extent"}, {"doc_id": 5122106, "edit_id": 0, "question": "What is a health problem linked to obesity that is discussed in this study?", "category": "omission", "label": "example"}, {"doc_id": 5122106, "edit_id": 1, "question": "What type of study was conducted to test the effectiveness of AE cream?", "category": "omission", "label": "concept"}, {"doc_id": 5122106, "edit_id": 2, "question": "Where was the study on AE cream and fat reduction conducted?", "category": "omission", "label": "procedural"}, {"doc_id": 5122106, "edit_id": 3, "question": "Where is Khorshid Hospital, where the study took place, located?", "category": "omission", "label": "procedural"}, {"doc_id": 5122106, "edit_id": 4, "question": "Before the study began, did the participants give their approval to be part of it?", "category": "omission", "label": "verification"}, {"doc_id": 5122106, "edit_id": 5, "question": "How were the participants divided into the two groups?", "category": "omission", "label": "procedural"}, {"doc_id": 5122106, "edit_id": 6, "question": "When were the first measurements of body mass index, waist and buttock size, and stomach fat taken?", "category": "omission", "label": "procedural"}, {"doc_id": 5122106, "edit_id": 7, "question": "What statistical method was used to compare the results between the two groups?", "category": "omission", "label": "procedural"}, {"doc_id": 5122106, "edit_id": 8, "question": "How did the researchers analyze changes from the start to the end of the trial?", "category": "omission", "label": "procedural"}, {"doc_id": 5122106, "edit_id": 9, "question": "How significant was the weight loss amongst the participants in the study?", "category": "omission", "label": "extent"}, {"doc_id": 5122238, "edit_id": 0, "question": "Why was a drug being tested on patients undergoing spinal anesthesia in this study?", "category": "omission", "label": "cause"}, {"doc_id": 5122238, "edit_id": 1, "question": "What characteristics should the new drug for preventing shivering after surgery have?", "category": "omission", "label": "concept"}, {"doc_id": 5122238, "edit_id": 2, "question": "How did the researchers determine whether the differences in shivering incidents between the different patient groups were due to chance or not?", "category": "omission", "label": "procedural"}, {"doc_id": 5125190, "edit_id": 0, "question": "Does Propofol have any other names?", "category": "omission", "label": "concept"}, {"doc_id": 5125190, "edit_id": 1, "question": "What type of study was used to test the effectiveness of the drugs?", "category": "omission", "label": "concept"}, {"doc_id": 5125190, "edit_id": 2, "question": "What were the drugs being compared for?", "category": "omission", "label": "concept"}, {"doc_id": 5125190, "edit_id": 3, "question": "How was the methylprednisolone administered to the third group?", "category": "omission", "label": "procedural"}, {"doc_id": 5125190, "edit_id": 4, "question": "How long did the doctors maintain the tourniquet before releasing the occlusion?", "category": "omission", "label": "procedural"}, {"doc_id": 5125190, "edit_id": 5, "question": "What was the total dose of Propofol administered to the patients?", "category": "omission", "label": "extent"}, {"doc_id": 5125190, "edit_id": 6, "question": "How quickly was the Propofol dosage given?", "category": "omission", "label": "procedural"}, {"doc_id": 5125190, "edit_id": 7, "question": "How was the pain experienced by the patients evaluated?", "category": "omission", "label": "procedural"}, {"doc_id": 5125190, "edit_id": 8, "question": "What statistical methods were used in this study?", "category": "omission", "label": "procedural"}, {"doc_id": 5125190, "edit_id": 9, "question": "What percentage of the patients in the group given methylprednisolone experienced pain?", "category": "omission", "label": "extent"}, {"doc_id": 5125190, "edit_id": 10, "question": "Was the difference in pain intensity between the group given lignocaine or methylprednisolone and the group given just saline statistically significant?", "category": "omission", "label": "verification"}, {"doc_id": 5125190, "edit_id": 11, "question": "What was the dosage of lignocaine given to the patients in group L?", "category": "omission", "label": "extent"}, {"doc_id": 5125190, "edit_id": 12, "question": "How many patients were in the group that was given lignocaine (Group L)?", "category": "omission", "label": "extent"}, {"doc_id": 5125190, "edit_id": 13, "question": "Which drugs were being considered as potentially reducing the pain of the Propofol injection?", "category": "omission", "label": "concept"}, {"doc_id": 5125721, "edit_id": 0, "question": "Can type 2 diabetes lead to any other complications?", "category": "omission", "label": "consequence"}, {"doc_id": 5125721, "edit_id": 1, "question": "What is diabetic kidney disease and how can it develop?", "category": "omission", "label": "concept"}, {"doc_id": 5125721, "edit_id": 2, "question": "What are the risk factors for diabetic kidney disease?", "category": "omission", "label": "concept"}, {"doc_id": 5125721, "edit_id": 3, "question": "What does UN stand for in the context of kidney function?", "category": "omission", "label": "concept"}, {"doc_id": 5125721, "edit_id": 4, "question": "Can you tell me more about the type of trial that was conducted?", "category": "omission", "label": "concept"}, {"doc_id": 5125721, "edit_id": 5, "question": "How were the patients assigned to the different groups in the trial?", "category": "omission", "label": "procedural"}, {"doc_id": 5125721, "edit_id": 6, "question": "What kind of support did the diet control group receive during the trial?", "category": "omission", "label": "procedural"}, {"doc_id": 5125721, "edit_id": 7, "question": "What type of education or guidance was provided to the diet control group?", "category": "omission", "label": "procedural"}, {"doc_id": 5125721, "edit_id": 8, "question": "What were the primary outcomes measured in this study?", "category": "omission", "label": "concept"}, {"doc_id": 5125721, "edit_id": 9, "question": "How did Tartary buckwheat affect the urinary albumin to creatinine ratio in the patients?", "category": "omission", "label": "comparison"}, {"doc_id": 5125721, "edit_id": 10, "question": "What was the effect of Tartary buckwheat on the patients' urinary albumin to creatinine ratio?", "category": "omission", "label": "consequence"}, {"doc_id": 5125721, "edit_id": 11, "question": "Did Tartary buckwheat have any effect on the urea nitrogen levels of the patients?", "category": "omission", "label": "verification"}, {"doc_id": 5125721, "edit_id": 12, "question": "What was the effect on the urea nitrogen levels after the consumption of Tartary buckwheat?", "category": "omission", "label": "consequence"}, {"doc_id": 5125721, "edit_id": 13, "question": "How significant were the changes brought by Tartary buckwheat on the key markers of kidney health?", "category": "omission", "label": "extent"}, {"doc_id": 5125721, "edit_id": 14, "question": "Did the subgroup analysis show any effects of Tartary buckwheat on T2DM patients with normal albumin levels?", "category": "omission", "label": "verification"}, {"doc_id": 5125721, "edit_id": 15, "question": "How did Tartary buckwheat affect T2DM patients with slightly elevated levels of albumin?", "category": "omission", "label": "comparison"}, {"doc_id": 5125721, "edit_id": 16, "question": "Did Tartary buckwheat affect the urea nitrogen levels in T2DM patients with normal albumin levels?", "category": "omission", "label": "verification"}, {"doc_id": 5125721, "edit_id": 17, "question": "How did Tartary buckwheat affect the urea nitrogen levels in T2DM patients with slightly elevated levels of albumin?", "category": "omission", "label": "comparison"}, {"doc_id": 5125721, "edit_id": 18, "question": "Were the reductions in the urinary albumin to creatinine ratio and urea nitrogen levels statistically significant in T2DM patients with normal and slightly elevated albumin levels?", "category": "omission", "label": "verification"}, {"doc_id": 5129820, "edit_id": 0, "question": "What is the benefit of olaparib treatment in patients with platinum-sensitive relapsed serous ovarian cancer?", "category": "omission", "label": "consequence"}, {"doc_id": 5129820, "edit_id": 1, "question": "What kind of drug is olaparib?", "category": "omission", "label": "concept"}, {"doc_id": 5129820, "edit_id": 2, "question": "What type of cancer do the patients in the study have?", "category": "omission", "label": "concept"}, {"doc_id": 5129820, "edit_id": 3, "question": "What genetic mutation do some of the patients in the study have?", "category": "omission", "label": "concept"}, {"doc_id": 5129820, "edit_id": 4, "question": "What factor is considered important when assessing the success of the maintenance therapy?", "category": "omission", "label": "concept"}, {"doc_id": 5129820, "edit_id": 5, "question": "What stage of clinical testing does this study represent?", "category": "omission", "label": "concept"}, {"doc_id": 5129820, "edit_id": 6, "question": "What is the identifier of the trial?", "category": "omission", "label": "concept"}, {"doc_id": 5129820, "edit_id": 7, "question": "What is the dosage of olaparib that the patients received?", "category": "omission", "label": "extent"}, {"doc_id": 5129820, "edit_id": 8, "question": "Until when does the use of olaparib capsules or placebo treatment continue in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5129820, "edit_id": 9, "question": "What tool was used to measure the patient's health-related quality of life?", "category": "omission", "label": "procedural"}, {"doc_id": 5223669, "edit_id": 0, "question": "What kind of a technique is 'constrained' longitudinal data analysis (cLDA)?", "category": "omission", "label": "concept"}, {"doc_id": 5223669, "edit_id": 1, "question": "How is the 'constraint' in constrained longitudinal data analysis applied in a research study with comparative treatments?", "category": "omission", "label": "procedural"}, {"doc_id": 5223669, "edit_id": 2, "question": "What type of study was conducted by the Group Medical Clinics (GMC)?", "category": "omission", "label": "concept"}, {"doc_id": 5223669, "edit_id": 3, "question": "Was the analysis carried out on real data or a hypothetical example?", "category": "omission", "label": "verification"}, {"doc_id": 5223669, "edit_id": 4, "question": "What type of statistical method was used for fitting all the models in the analysis?", "category": "omission", "label": "concept"}, {"doc_id": 5223669, "edit_id": 5, "question": "Can the 'constrained' longitudinal data analysis provide reliable statistics?", "category": "omission", "label": "verification"}, {"doc_id": 5223669, "edit_id": 6, "question": "Is the cLDA method considered more advantageous over any other traditional methods?", "category": "omission", "label": "verification"}, {"doc_id": 5223669, "edit_id": 7, "question": "Does cLDA also have benefits over longitudinal data analysis?", "category": "omission", "label": "comparison"}, {"doc_id": 5244020, "edit_id": 0, "question": "What kind of recovery is typically associated with the symptoms that follow colorectal cancer surgery?", "category": "omission", "label": "concept"}, {"doc_id": 5244020, "edit_id": 1, "question": "What specific substance was used in the study for inhalation therapy?", "category": "omission", "label": "concept"}, {"doc_id": 5244020, "edit_id": 2, "question": "Which natural substance was used in the study to treat urinary problems after colorectal cancer surgery?", "category": "omission", "label": "concept"}, {"doc_id": 5244020, "edit_id": 3, "question": "Besides lavender oil, which other substance was used in the study to treat urinary problems related to colorectal cancer surgery?", "category": "omission", "label": "example"}, {"doc_id": 5244020, "edit_id": 4, "question": "What type of research method was used in this study?", "category": "omission", "label": "procedural"}, {"doc_id": 5244020, "edit_id": 5, "question": "Was there any other procedure done on the patients after the colorectal cancer surgery?", "category": "omission", "label": "procedural"}, {"doc_id": 5244020, "edit_id": 6, "question": "What was the concentration of lavender used in the inhalation treatment in the study?", "category": "omission", "label": "extent"}, {"doc_id": 5244020, "edit_id": 7, "question": "What concentration of linalyl acetate did the patients inhale in the study?", "category": "omission", "label": "extent"}, {"doc_id": 5244020, "edit_id": 8, "question": "Were there any differences in the urinary symptoms between the groups?", "category": "omission", "label": "verification"}, {"doc_id": 5244020, "edit_id": 9, "question": "How did the effectiveness of inhaling linalyl acetate compare with that of inhaling a control substance?", "category": "omission", "label": "comparison"}, {"doc_id": 5244020, "edit_id": 10, "question": "Is the process of relieving pain and urinary discomfort after catheter removal considered a nursing intervention?", "category": "omission", "label": "verification"}, {"doc_id": 5301061, "edit_id": 0, "question": "What are some of the possible outcomes of a lack of spiritual health in elderly individuals with high blood pressure?", "category": "omission", "label": "consequence"}, {"doc_id": 5301061, "edit_id": 1, "question": "How common is high blood pressure among older individuals?", "category": "omission", "label": "extent"}, {"doc_id": 5301061, "edit_id": 2, "question": "Why is it important to improve the spiritual wellbeing of elderly individuals with high blood pressure? ", "category": "omission", "label": "cause"}, {"doc_id": 5301061, "edit_id": 3, "question": "What is the age group of the participants in the study?", "category": "omission", "label": "concept"}, {"doc_id": 5301061, "edit_id": 4, "question": "Do all the participants in the study have a certain health condition?", "category": "omission", "label": "verification"}, {"doc_id": 5301061, "edit_id": 5, "question": "What was the role of the second group in the study?", "category": "omission", "label": "concept"}, {"doc_id": 5301061, "edit_id": 6, "question": "How many groups completed the SWB (Spiritual Wellbeing) questionnaire in the study?", "category": "omission", "label": "extent"}, {"doc_id": 5301061, "edit_id": 7, "question": "What statistical method was used to analyze the data in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5301061, "edit_id": 8, "question": "What other statistical analyses were used in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5301061, "edit_id": 9, "question": "Were there any other statistical techniques used in the analysis of the study's data?", "category": "omission", "label": "verification"}, {"doc_id": 5301061, "edit_id": 10, "question": "Was there any difference in the existential aspect of spiritual wellbeing between the two groups before the program began?", "category": "omission", "label": "verification"}, {"doc_id": 5301061, "edit_id": 11, "question": "Were the differences in the scores of spiritual wellbeing, the religious component, and the existential aspect between the two groups significant after the program?", "category": "omission", "label": "verification"}, {"doc_id": 5313491, "edit_id": 0, "question": "How were patients assigned to the different groups?", "category": "omission", "label": "procedural"}, {"doc_id": 5313491, "edit_id": 1, "question": "Were patients assigned to the groups based on their choice or condition?", "category": "omission", "label": "disjunction"}, {"doc_id": 5313491, "edit_id": 2, "question": "What type of solution was used for fluid maintenance in the GDFR group?", "category": "omission", "label": "concept"}, {"doc_id": 5313491, "edit_id": 3, "question": "Are colloid boluses allowed in the GDFR group?", "category": "omission", "label": "verification"}, {"doc_id": 5313491, "edit_id": 4, "question": "Under what conditions are colloid boluses allowed in the GDFR group?", "category": "omission", "label": "procedural"}, {"doc_id": 5313491, "edit_id": 5, "question": "Did the patients in the GDFR group receive colloid during surgery?", "category": "omission", "label": "verification"}, {"doc_id": 5313491, "edit_id": 6, "question": "What was the p-value of the measurement concerning the fluid received during surgery?", "category": "omission", "label": "extent"}, {"doc_id": 5313491, "edit_id": 7, "question": "Was this measurement statistically significant?", "category": "omission", "label": "verification"}, {"doc_id": 5313491, "edit_id": 8, "question": "How long was the ICU stay for the patients in the GDFR group?", "category": "omission", "label": "extent"}, {"doc_id": 5313491, "edit_id": 9, "question": "What was the range of the ICU length of stay for the patients in the GDFR group?", "category": "omission", "label": "extent"}, {"doc_id": 5313491, "edit_id": 10, "question": "How long was the ICU stay for the patients in the control group?", "category": "omission", "label": "extent"}, {"doc_id": 5313491, "edit_id": 11, "question": "What was the p-value for the difference in ICU stay between the two groups?", "category": "omission", "label": "extent"}, {"doc_id": 5313491, "edit_id": 12, "question": "What was the total number of complications in the GDFR group?", "category": "omission", "label": "extent"}, {"doc_id": 5313491, "edit_id": 13, "question": "What proportion of patients in the GDFR group developed complications?", "category": "omission", "label": "extent"}, {"doc_id": 5313491, "edit_id": 14, "question": "What was the p-value for the observation of complications in the GDFR group?", "category": "omission", "label": "extent"}, {"doc_id": 5350209, "edit_id": 0, "question": "Do these strong health warnings on alcoholic drinks affect people's intentions to drink less alcohol?", "category": "omission", "label": "verification"}, {"doc_id": 5350209, "edit_id": 1, "question": "Why are these health warning messages considered strong? ", "category": "omission", "label": "concept"}, {"doc_id": 5350209, "edit_id": 2, "question": "Does the speed at which one consumes alcohol affect the level of intoxication?", "category": "omission", "label": "verification"}, {"doc_id": 5350209, "edit_id": 3, "question": "Are these findings a first of their kind in relation to the impact of health warnings on alcohol consumption speed?", "category": "omission", "label": "verification"}, {"doc_id": 5379203, "edit_id": 0, "question": "What type of study was this research?", "category": "omission", "label": "concept"}, {"doc_id": 5379203, "edit_id": 1, "question": "Did the researchers use a parallel model for this OSAS study?", "category": "omission", "label": "verification"}, {"doc_id": 5379203, "edit_id": 2, "question": "Were the patients in the study newly referred for treatment?", "category": "omission", "label": "verification"}, {"doc_id": 5379203, "edit_id": 3, "question": "How did they detect the presence of OSAS in Group A patients?", "category": "omission", "label": "procedural"}, {"doc_id": 5379203, "edit_id": 4, "question": "How was OSAS detected in group B?", "category": "omission", "label": "procedural"}, {"doc_id": 5379203, "edit_id": 5, "question": "What was done before the CPAP treatment was administered to the patients?", "category": "omission", "label": "procedural"}, {"doc_id": 5379203, "edit_id": 6, "question": "Where did the Group A patients undergo their overnight autoCPAP titration procedure? ", "category": "omission", "label": "procedural"}, {"doc_id": 5379203, "edit_id": 7, "question": "Can you describe the type of analysis that was done on the patients using CPAP?", "category": "omission", "label": "procedural"}, {"doc_id": 5379203, "edit_id": 8, "question": "How many patients were included in the analysis for each group?", "category": "omission", "label": "extent"}, {"doc_id": 5379203, "edit_id": 9, "question": "Were there any patients with AHI \u2265 15/hr who were given CPAP treatment?", "category": "omission", "label": "verification"}, {"doc_id": 5416724, "edit_id": 0, "question": "How was neck immobilisation achieved in the patients of this study?", "category": "omission", "label": "procedural"}, {"doc_id": 5416724, "edit_id": 1, "question": "How would you describe the Airtraq laryngoscope in terms of its introduction or development?", "category": "omission", "label": "concept"}, {"doc_id": 5416724, "edit_id": 2, "question": "Did the patients involved in this study agree to be a part of it?", "category": "omission", "label": "verification"}, {"doc_id": 5416724, "edit_id": 3, "question": "What was the health status of the patients involved in this study?", "category": "omission", "label": "concept"}, {"doc_id": 5416724, "edit_id": 4, "question": "What was the age range of the patients involved in this study?", "category": "omission", "label": "extent"}, {"doc_id": 5416724, "edit_id": 5, "question": "How were the patients divided into groups for the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5416724, "edit_id": 6, "question": "Did the study document any additional manoeuvres used during the intubation process?", "category": "omission", "label": "verification"}, {"doc_id": 5416724, "edit_id": 7, "question": "What type of statistical analysis was used in the study?", "category": "omission", "label": "concept"}, {"doc_id": 5416724, "edit_id": 8, "question": "Did the study use any method to correct for multiple comparisons in the statistical analysis?", "category": "omission", "label": "verification"}, {"doc_id": 5416724, "edit_id": 9, "question": "What type of statistical testing was the Bonferroni correction used on in the study?", "category": "omission", "label": "concept"}, {"doc_id": 5416724, "edit_id": 10, "question": "How similar were the patients in terms of their demographic profile?", "category": "omission", "label": "extent"}, {"doc_id": 5416724, "edit_id": 11, "question": "What was the effect of the Airtraq laryngoscope on the Intubation Difficulty Scale (IDS) scores?", "category": "omission", "label": "consequence"}, {"doc_id": 5416724, "edit_id": 12, "question": "What was the average change in the Intubation Difficulty Scale (IDS) scores when using the Macintosh laryngoscope?", "category": "omission", "label": "consequence"}, {"doc_id": 5416724, "edit_id": 13, "question": "How did the Intubation Difficulty Scale (IDS) score reduction using the Airtraq laryngoscope compare to the reduction using the McCoy laryngoscope?", "category": "omission", "label": "comparison"}, {"doc_id": 5416724, "edit_id": 14, "question": "How did the Intubation Difficulty Scale (IDS) score reduction using the Airtraq laryngoscope compare to the reduction using the Macintosh laryngoscope?", "category": "omission", "label": "comparison"}, {"doc_id": 5416724, "edit_id": 15, "question": "How did the use of the Airtraq laryngoscope affect the view of the throat area, as measured by the Cormack-Lehane scale?", "category": "omission", "label": "consequence"}, {"doc_id": 5416724, "edit_id": 16, "question": "What percentage of patients had a grade 1 view of the throat area, according to the Cormack-Lehane scale, when using the Airtraq laryngoscope?", "category": "omission", "label": "extent"}, {"doc_id": 5416724, "edit_id": 17, "question": "Were there any patients who had a grade 3 or 4 view of the throat area, according to the Cormack-Lehane scale, when using the Airtraq laryngoscope?", "category": "omission", "label": "verification"}, {"doc_id": 5416724, "edit_id": 18, "question": "How did the performance of the Airtraq laryngoscope compare to the McCoy and Macintosh laryngoscopes in the study?", "category": "omission", "label": "comparison"}, {"doc_id": 5433398, "edit_id": 0, "question": "What type of clinical trial was conducted to evaluate the effectiveness of different care strategies for MS patients?", "category": "omission", "label": "concept"}, {"doc_id": 5433398, "edit_id": 1, "question": "How were the MS patients assigned to the different care strategies in the trial? ", "category": "omission", "label": "procedural"}, {"doc_id": 5433398, "edit_id": 2, "question": " How many centers participated in the clinical trial?", "category": "omission", "label": "extent"}, {"doc_id": 5433398, "edit_id": 3, "question": "Can you describe one of the care strategies studied in the trial?", "category": "omission", "label": "example"}, {"doc_id": 5433398, "edit_id": 4, "question": " What does the integrated multidisciplinary (IMD) approach involve?", "category": "omission", "label": "concept"}, {"doc_id": 5433398, "edit_id": 5, "question": "How was the patient's quality of life measured in the trial?", "category": "omission", "label": "procedural"}, {"doc_id": 5433398, "edit_id": 6, "question": "How did the median MSIS 29 scores change in the control group over the course of the trial?", "category": "omission", "label": "extent"}, {"doc_id": 5433398, "edit_id": 7, "question": "How significant was the difference in quality of life scores between the two treatment strategies?", "category": "omission", "label": "comparison"}, {"doc_id": 5433398, "edit_id": 8, "question": "Did the difference in quality of life scores between the two groups remain significant after adjusting for other variables?", "category": "omission", "label": "verification"}, {"doc_id": 5433398, "edit_id": 9, "question": "Can you describe the study design of the clinical trial?", "category": "omission", "label": "concept"}, {"doc_id": 5440036, "edit_id": 0, "question": "For which eye surgery is postoperative nausea and vomiting (PONV) commonly observed? ", "category": "omission", "label": "example"}, {"doc_id": 5440036, "edit_id": 1, "question": "Apart from eye enucleation, is there another surgery where postoperative nausea and vomiting (PONV) is commonly observed?", "category": "omission", "label": "disjunction"}, {"doc_id": 5440036, "edit_id": 2, "question": "What kind of trial was conducted in the study?", "category": "omission", "label": "concept"}, {"doc_id": 5440036, "edit_id": 3, "question": "Apart from reducing the incident of postoperative nausea and vomiting (PONV), what is another potential benefit of using a lower dose of palonosetron in combination with droperidol?", "category": "omission", "label": "consequence"}, {"doc_id": 5440036, "edit_id": 4, "question": "What health classifications were the patients in, according to the American Society of Anesthesiologists?", "category": "omission", "label": "concept"}, {"doc_id": 5440036, "edit_id": 5, "question": "Apart from eye enucleation, what other type of eye surgery were the patients in the study scheduled for?", "category": "omission", "label": "example"}, {"doc_id": 5440036, "edit_id": 6, "question": "What dosage of palonosetron was administered to the patients in the P2.5 group?", "category": "omission", "label": "extent"}, {"doc_id": 5440036, "edit_id": 7, "question": "How much palonosetron did the patients in the P7.5 group receive?", "category": "omission", "label": "extent"}, {"doc_id": 5440036, "edit_id": 8, "question": "Apart from palonosetron, did the group P+D receive any other drug and what was its dosage?", "category": "omission", "label": "disjunction"}, {"doc_id": 5440036, "edit_id": 9, "question": "How were the treatments to prevent vomiting (antiemetic regimens) given to the patients?", "category": "omission", "label": "procedural"}, {"doc_id": 5440036, "edit_id": 10, "question": "When were the treatments to prevent vomiting (antiemetic regimens) given to the patients?", "category": "omission", "label": "procedural"}, {"doc_id": 5440036, "edit_id": 11, "question": "Did the patients in Group P2.5 have a measured level of nausea?", "category": "omission", "label": "verification"}, {"doc_id": 5440036, "edit_id": 12, "question": "At which time intervals was the intensity of nausea evaluated in Group P2.5?", "category": "omission", "label": "procedural"}, {"doc_id": 5440036, "edit_id": 13, "question": "Were the differences in the levels of nausea experienced by the different groups significant?", "category": "omission", "label": "verification"}, {"doc_id": 5440036, "edit_id": 14, "question": "Were the differences in vomiting levels among the different groups significant?", "category": "omission", "label": "verification"}, {"doc_id": 5440036, "edit_id": 15, "question": "Was there a significant difference in the rate at which patients completely responded to treatment (CR rate) among the different treatment groups?", "category": "omission", "label": "verification"}, {"doc_id": 5440036, "edit_id": 16, "question": "What percentage of patients in Group P2.5 did not experience any nausea or vomiting at all throughout the study? ", "category": "omission", "label": "extent"}, {"doc_id": 5440036, "edit_id": 17, "question": "How many patients in Group P7.5 were completely free of nausea and vomiting throughout the study? ", "category": "omission", "label": "extent"}, {"doc_id": 5440036, "edit_id": 18, "question": "Was there a significant difference among the treatment groups in the proportion of patients who did not experience any nausea or vomiting?", "category": "omission", "label": "verification"}, {"doc_id": 5440036, "edit_id": 19, "question": "What effect did combining a low dose of palonosetron with droperidol have on preventing postoperative nausea and vomiting (PONV)?", "category": "omission", "label": "consequence"}, {"doc_id": 5440036, "edit_id": 20, "question": "Is palonosetron ever used in higher doses and, if so, for what purpose?", "category": "omission", "label": "procedural"}, {"doc_id": 5440738, "edit_id": 0, "question": "What other benefits could automated messaging provide besides keeping patients engaged with their treatment?", "category": "omission", "label": "consequence"}, {"doc_id": 5440738, "edit_id": 1, "question": "Besides sending messages, what other features does the text messaging service have?", "category": "omission", "label": "example"}, {"doc_id": 5440738, "edit_id": 2, "question": "What kinds of messages were included in the text messaging service?", "category": "omission", "label": "example"}, {"doc_id": 5440738, "edit_id": 3, "question": "Where was the mood data from the text messaging service sent and stored?", "category": "omission", "label": "procedural"}, {"doc_id": 5440738, "edit_id": 4, "question": "Besides mood data, were there other types of data collected and stored on HealthySMS?", "category": "omission", "label": "verification"}, {"doc_id": 5440738, "edit_id": 5, "question": "Who was responsible for reviewing the data that was collected and stored on HealthySMS?", "category": "omission", "label": "concept"}, {"doc_id": 5440738, "edit_id": 6, "question": "How was the data collected through the text messaging service and stored on HealthySMS used in therapy sessions?", "category": "omission", "label": "procedural"}, {"doc_id": 5440738, "edit_id": 7, "question": "How many therapy sessions were included in the treatment program?", "category": "omission", "label": "extent"}, {"doc_id": 5440738, "edit_id": 8, "question": "How frequently were the therapy sessions held in the treatment program?", "category": "omission", "label": "extent"}, {"doc_id": 5442667, "edit_id": 0, "question": "What are the consequences of managing complex medication therapies in older adults?", "category": "omission", "label": "consequence"}, {"doc_id": 5442667, "edit_id": 1, "question": "Why is inappropriate prescribing common in older adults with multiple comorbidities?", "category": "omission", "label": "cause"}, {"doc_id": 5442667, "edit_id": 2, "question": "Are all drugs with anticholinergic properties recognized as such?", "category": "omission", "label": "verification"}, {"doc_id": 5442667, "edit_id": 3, "question": "What risks are associated with using too much anticholinergic medication?", "category": "omission", "label": "consequence"}, {"doc_id": 5442667, "edit_id": 4, "question": "How effective have medication therapy management (MTM) interventions been so far?", "category": "omission", "label": "extent"}, {"doc_id": 5442667, "edit_id": 5, "question": "What was one of the ways the study measured changes in drug use?", "category": "omission", "label": "procedural"}, {"doc_id": 5442667, "edit_id": 6, "question": "How else did the study monitor changes in drug use?", "category": "omission", "label": "procedural"}, {"doc_id": 5442667, "edit_id": 7, "question": "When were the anticholinergic drug scale (ADS) scores compared?", "category": "omission", "label": "procedural"}, {"doc_id": 5442667, "edit_id": 8, "question": "How many women participated in the study?", "category": "omission", "label": "extent"}, {"doc_id": 5442667, "edit_id": 9, "question": "What was the percentage of women among the participants of the study?", "category": "omission", "label": "extent"}, {"doc_id": 5442667, "edit_id": 10, "question": "How many participants in the study were white?", "category": "omission", "label": "extent"}, {"doc_id": 5442667, "edit_id": 11, "question": "What was the percentage of white persons among the study participants?", "category": "omission", "label": "extent"}, {"doc_id": 5442667, "edit_id": 12, "question": "How was the cognitive status of the study participants measured?", "category": "omission", "label": "procedural"}, {"doc_id": 5442667, "edit_id": 13, "question": "What was the clinical dementia rating (CDR) score of the cognitively normal individuals?", "category": "omission", "label": "extent"}, {"doc_id": 5442667, "edit_id": 14, "question": "What was the average age of the study participants?", "category": "omission", "label": "extent"}, {"doc_id": 5442667, "edit_id": 15, "question": "What was the average medication appropriateness index (MAI) score at the start of the study?", "category": "omission", "label": "extent"}, {"doc_id": 5442667, "edit_id": 16, "question": "What was the standard deviation of the medication appropriateness index (MAI) scores at the start of the study?", "category": "omission", "label": "extent"}, {"doc_id": 5442667, "edit_id": 17, "question": "What was the average anticholinergic drug scale (ADS) score at the start of the study?", "category": "omission", "label": "extent"}, {"doc_id": 5442667, "edit_id": 18, "question": "What was the standard deviation of the anticholinergic drug scale (ADS) scores at the start of the study?", "category": "omission", "label": "extent"}, {"doc_id": 5442667, "edit_id": 19, "question": "Was there a significant difference between the two groups after they were divided?", "category": "omission", "label": "verification"}, {"doc_id": 5442667, "edit_id": 20, "question": "What was a notable characteristic of the intervention group?", "category": "omission", "label": "concept"}, {"doc_id": 5442667, "edit_id": 21, "question": "What was included in all the analyses conducted in the study?", "category": "omission", "label": "concept"}, {"doc_id": 5442667, "edit_id": 22, "question": "What was the impact of the intervention on the two groups?", "category": "omission", "label": "consequence"}, {"doc_id": 5442667, "edit_id": 23, "question": "How much did the medication appropriateness index (MAI) score change for the group that received medication therapy management?", "category": "omission", "label": "extent"}, {"doc_id": 5442667, "edit_id": 24, "question": "What aspect did the group with extra support show significant improvement?", "category": "omission", "label": "concept"}, {"doc_id": 5442667, "edit_id": 25, "question": "How much did the medication appropriateness index (MAI) score change for the group that received usual care?", "category": "omission", "label": "extent"}, {"doc_id": 5442667, "edit_id": 26, "question": "What was the significance level of the difference in medication appropriateness index (MAI) scores between the two groups?", "category": "omission", "label": "concept"}, {"doc_id": 5442667, "edit_id": 27, "question": "Other than the medication appropriateness index, where else did the intervention group show improvement?", "category": "omission", "label": "concept"}, {"doc_id": 5442667, "edit_id": 28, "question": "How much did anticholinergic drug scale (ADS) scores change for the group that received medication therapy management?", "category": "omission", "label": "extent"}, {"doc_id": 5442667, "edit_id": 29, "question": "How much did anticholinergic drug scale (ADS) scores change for the group that received usual care?", "category": "omission", "label": "extent"}, {"doc_id": 5442667, "edit_id": 30, "question": "How promising were the results of using medication therapy management intervention?", "category": "omission", "label": "judgmental"}, {"doc_id": 5442667, "edit_id": 31, "question": "What is the ultimate goal when managing medications for older adults?", "category": "omission", "label": "concept"}, {"doc_id": 5442667, "edit_id": 32, "question": "Do you know the registration number of the clinical trial?", "category": "omission", "label": "verification"}, {"doc_id": 5442667, "edit_id": 33, "question": "When was the study registered?", "category": "omission", "label": "extent"}, {"doc_id": 5442667, "edit_id": 34, "question": "Is there a digital identifier for the online version of this study's article?", "category": "omission", "label": "verification"}, {"doc_id": 5442667, "edit_id": 35, "question": "Who can access the supplementary material of the study?", "category": "omission", "label": "concept"}, {"doc_id": 5448649, "edit_id": 0, "question": "What type of study was conducted to test the combination of cyclophosphamide and personalized peptide vaccination?", "category": "omission", "label": "concept"}, {"doc_id": 5448649, "edit_id": 1, "question": "How much cyclophosphamide was administered to the patients and for how long?", "category": "omission", "label": "extent"}, {"doc_id": 5448649, "edit_id": 2, "question": "How many peptides were selected for the personalized peptide vaccination?", "category": "omission", "label": "extent"}, {"doc_id": 5448649, "edit_id": 3, "question": "How was the effectiveness of the vaccines evaluated?", "category": "omission", "label": "procedural"}, {"doc_id": 5448649, "edit_id": 4, "question": "How long was the median time patients on the combined treatment of cyclophosphamide and personalized vaccine were free from cancer progression?", "category": "omission", "label": "extent"}, {"doc_id": 5448649, "edit_id": 5, "question": "What was the hazard ratio associated with the progression-free survival in the patients that were given the combination treatment?", "category": "omission", "label": "concept"}, {"doc_id": 5448649, "edit_id": 6, "question": "Were there any changes in plasma IL-6 levels after vaccination?", "category": "omission", "label": "verification"}, {"doc_id": 5448649, "edit_id": 7, "question": "What effect might an increase in IL-6 levels have on immune responses?", "category": "omission", "label": "cause"}, {"doc_id": 5448649, "edit_id": 8, "question": "What kind of treatment are the patients receiving?", "category": "omission", "label": "concept"}, {"doc_id": 5491994, "edit_id": 0, "question": "Why is it important for patients to understand their diagnosis and treatment plan?", "category": "omission", "label": "cause"}, {"doc_id": 5491994, "edit_id": 1, "question": "What type of 3D printing method was used to create the educational model?", "category": "omission", "label": "concept"}, {"doc_id": 5491994, "edit_id": 2, "question": "What exactly does the 3D model represent?", "category": "omission", "label": "concept"}, {"doc_id": 5491994, "edit_id": 3, "question": "What kind of data is used to create the 3D model?", "category": "omission", "label": "concept"}, {"doc_id": 5491994, "edit_id": 4, "question": "What was the ultimate goal of creating this 3D model?", "category": "omission", "label": "concept"}, {"doc_id": 5491994, "edit_id": 5, "question": "Was the 3D model created in one go or were there several attempts?", "category": "omission", "label": "verification"}, {"doc_id": 5491994, "edit_id": 6, "question": "How was the effectiveness of the 3D model evaluated?", "category": "omission", "label": "procedural"}, {"doc_id": 5491994, "edit_id": 7, "question": "Did the 3D model help patients better understand their physician's explanation of treatment options?", "category": "omission", "label": "consequence"}, {"doc_id": 5491994, "edit_id": 8, "question": "Did patients have better understanding of their own anatomy after seeing the 3D model?", "category": "omission", "label": "consequence"}, {"doc_id": 5491994, "edit_id": 9, "question": "Did patients have a better understanding of their disease after seeing the 3D model?", "category": "omission", "label": "verification"}, {"doc_id": 5491994, "edit_id": 10, "question": "Did patients find the 3D model an effective way to visualize their condition and treatment options?", "category": "omission", "label": "verification"}, {"doc_id": 5498715, "edit_id": 0, "question": "What type of diseases can regular exercise help prevent?", "category": "omission", "label": "example"}, {"doc_id": 5498715, "edit_id": 1, "question": "What type of research study was conducted?", "category": "omission", "label": "concept"}, {"doc_id": 5498715, "edit_id": 2, "question": "What type of assessments did the questionnaire include?", "category": "omission", "label": "concept"}, {"doc_id": 5498715, "edit_id": 3, "question": "What purpose does the global physical activity questionnaire (GPAQ) serve in the questionnaire? ", "category": "omission", "label": "concept"}, {"doc_id": 5498715, "edit_id": 4, "question": "How was the validity of the questionnaires ensured?", "category": "omission", "label": "procedural"}, {"doc_id": 5498715, "edit_id": 5, "question": "How was the reliability of the questionnaires ensured?", "category": "omission", "label": "procedural"}, {"doc_id": 5498715, "edit_id": 6, "question": "What kind of education session did the control group receive?", "category": "omission", "label": "concept"}, {"doc_id": 5498715, "edit_id": 7, "question": "What was the result of the intervention on total physical activity (PA) a few months following its implementation?", "category": "omission", "label": "consequence"}, {"doc_id": 5498715, "edit_id": 8, "question": "Was the increase in total physical activity (PA) statistically significant?", "category": "omission", "label": "verification"}, {"doc_id": 5498715, "edit_id": 9, "question": "Was the increase in flexibility observed in the participants statistically significant?", "category": "omission", "label": "verification"}, {"doc_id": 5498715, "edit_id": 10, "question": "What effect did the intervention have on the women's intrinsic motivation?", "category": "omission", "label": "consequence"}, {"doc_id": 5498715, "edit_id": 11, "question": "Was the motivational interviewing intervention effective?", "category": "omission", "label": "verification"}, {"doc_id": 5498715, "edit_id": 12, "question": "Where can the official registration of the study be found?", "category": "omission", "label": "concept"}, {"doc_id": 5506592, "edit_id": 0, "question": "What kind of community engagement methods were used in the Camino Verde trial?", "category": "omission", "label": "concept"}, {"doc_id": 5506592, "edit_id": 1, "question": "How were the communities selected for the Camino Verde trial?", "category": "omission", "label": "procedural"}, {"doc_id": 5506592, "edit_id": 2, "question": "Where are the coastal regions involved in the Mexico part of the Camino Verde trial located?", "category": "omission", "label": "concept"}, {"doc_id": 5506592, "edit_id": 3, "question": "In which country is Guerrero State, the location of the coastal regions involved in the Camino Verde trial?", "category": "omission", "label": "concept"}, {"doc_id": 5506592, "edit_id": 4, "question": "Apart from 2010, was there another year when a household questionnaire survey was conducted in the communities involved in the Camino Verde trial?", "category": "omission", "label": "verification"}, {"doc_id": 5506697, "edit_id": 0, "question": "How many patients were there in the group to receive the drug combination, OFC?", "category": "omission", "label": "extent"}, {"doc_id": 5506697, "edit_id": 1, "question": "What method was used to assess the patients' quality of life in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5506697, "edit_id": 2, "question": "Did the parents also take part in assessing the patients' quality of life?", "category": "omission", "label": "verification"}, {"doc_id": 5506697, "edit_id": 3, "question": "How was the initial quality of life (before treatment) of the patients measured in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5506697, "edit_id": 4, "question": "How was it determined that the patients had impaired Quality of Life?", "category": "omission", "label": "procedural"}, {"doc_id": 5506697, "edit_id": 5, "question": "How was the improvement in self-esteem measured in the patients during the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5506697, "edit_id": 6, "question": "How was the improvement in the patients' depression symptoms measured in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5506697, "edit_id": 7, "question": "Did the study only look at overall symptom improvement or did it look at specific symptoms too?", "category": "omission", "label": "disjunction"}, {"doc_id": 5506697, "edit_id": 8, "question": "How many specific symptoms, among the 17 CDRS-R items, showed significant improvement in the OFC group?", "category": "omission", "label": "extent"}, {"doc_id": 5506697, "edit_id": 9, "question": "What was the condition of the patients in regards to their bipolar disorder at the start of the study?", "category": "omission", "label": "concept"}, {"doc_id": 5506697, "edit_id": 10, "question": "Who noticed more areas of improvement, the patients or the parents?", "category": "omission", "label": "comparison"}, {"doc_id": 5513842, "edit_id": 0, "question": "What type of PVB injection was used in this study?", "category": "omission", "label": "concept"}, {"doc_id": 5513842, "edit_id": 1, "question": "How were patients assigned to either the PVB group or the control group?", "category": "omission", "label": "procedural"}, {"doc_id": 5513842, "edit_id": 2, "question": "How was the severity of the patient's pain assessed in this study?", "category": "omission", "label": "procedural"}, {"doc_id": 5513842, "edit_id": 3, "question": "What was the average pain score of patients at rest in the PVB group?", "category": "omission", "label": "extent"}, {"doc_id": 5513842, "edit_id": 4, "question": "How severe was the pain for the control group while at rest?", "category": "omission", "label": "extent"}, {"doc_id": 5513842, "edit_id": 5, "question": "What was the pain score recorded for the PVB group when they moved?", "category": "omission", "label": "extent"}, {"doc_id": 5513842, "edit_id": 6, "question": "What pain levels were observed for the control group when they moved after surgery?", "category": "omission", "label": "extent"}, {"doc_id": 5513842, "edit_id": 7, "question": "What types of opioid medications were given to patients in this study?", "category": "omission", "label": "example"}, {"doc_id": 5513842, "edit_id": 8, "question": "How much tramadol did the PVB group consume on average 24 hours after surgery?", "category": "omission", "label": "extent"}, {"doc_id": 5513842, "edit_id": 9, "question": "Was the single-shot thoracic PVB the only method utilized for pain relief in this study? ", "category": "omission", "label": "verification"}, {"doc_id": 5514258, "edit_id": 0, "question": "What database did the researchers use for this study?", "category": "omission", "label": "procedural"}, {"doc_id": 5514258, "edit_id": 1, "question": "What was one of the main aims of this study, in relation to salivary gland cancer patients?", "category": "omission", "label": "concept"}, {"doc_id": 5514258, "edit_id": 2, "question": "What specific treatment was the study investigating for its impact on the survival of these patients?", "category": "omission", "label": "concept"}, {"doc_id": 5514258, "edit_id": 3, "question": "How many patients with major salivary gland cancer were examined in this study?", "category": "omission", "label": "extent"}, {"doc_id": 5514258, "edit_id": 4, "question": "Where were the patient records sourced from for this study?", "category": "omission", "label": "procedural"}, {"doc_id": 5514258, "edit_id": 5, "question": "What type of primary treatment did all the patients receive in this study?", "category": "omission", "label": "concept"}, {"doc_id": 5514258, "edit_id": 6, "question": "What is one condition that would categorize a patient as high risk in this study?", "category": "omission", "label": "concept"}, {"doc_id": 5514258, "edit_id": 7, "question": "What is another factor that could classify a patient as high risk in this study?", "category": "omission", "label": "concept"}, {"doc_id": 5514258, "edit_id": 8, "question": "What is one of the factors that would put a patient in the intermediate risk category in this study?", "category": "omission", "label": "concept"}, {"doc_id": 5514258, "edit_id": 9, "question": "What is another criterion for classifying a patient as intermediate risk in this study?", "category": "omission", "label": "concept"}, {"doc_id": 5514258, "edit_id": 10, "question": "For how long were the patients tracked on average in this study?", "category": "omission", "label": "extent"}, {"doc_id": 5514258, "edit_id": 11, "question": "What was the hazard ratio recorded for the high-risk group in this study?", "category": "omission", "label": "extent"}, {"doc_id": 5514258, "edit_id": 12, "question": "Which group of patients does the study suggest would benefit from adjuvant radiation therapy?", "category": "omission", "label": "concept"}, {"doc_id": 5514258, "edit_id": 13, "question": "Why couldn't the researchers analyze the local impact of additional radiation treatment in this study?", "category": "omission", "label": "cause"}, {"doc_id": 5518918, "edit_id": 0, "question": "Are there any challenges faced in getting patients to participate in cardiac rehabilitation?", "category": "omission", "label": "verification"}, {"doc_id": 5518918, "edit_id": 1, "question": "What kind of support was offered to patients doing home-based cardiac rehabilitation?", "category": "omission", "label": "concept"}, {"doc_id": 5518918, "edit_id": 2, "question": "How long did the rehabilitation study last?", "category": "omission", "label": "extent"}, {"doc_id": 5518918, "edit_id": 3, "question": "Did the patients\u2019 physical fitness show any improvement after the completion of the cardiac rehabilitation program?", "category": "omission", "label": "verification"}, {"doc_id": 5518918, "edit_id": 4, "question": "Was the improvement in physical fitness at the end of the rehab program significant?", "category": "omission", "label": "verification"}, {"doc_id": 5518918, "edit_id": 5, "question": "Did patients' physical fitness still show improvement a year after the rehab program?", "category": "omission", "label": "verification"}, {"doc_id": 5518918, "edit_id": 6, "question": "What was the willingness-to-pay for a higher probability of cost-effectiveness in the rehabilitation program?", "category": "omission", "label": "extent"}, {"doc_id": 5518918, "edit_id": 7, "question": "How was the cost-effectiveness of the rehabilitation program measured?", "category": "omission", "label": "procedural"}, {"doc_id": 5518918, "edit_id": 8, "question": "What was the status of the patients when they enrolled in the study?", "category": "omission", "label": "concept"}, {"doc_id": 5529957, "edit_id": 0, "question": "What specific type of non-operable chronic lung disease were the patients suffering from in this study?", "category": "omission", "label": "concept"}, {"doc_id": 5529957, "edit_id": 1, "question": "Did the study include patients who had previously undergone any type of lung surgery?", "category": "omission", "label": "verification"}, {"doc_id": 5529957, "edit_id": 2, "question": "What was the name of the larger medical study this comparison was a part of?", "category": "omission", "label": "concept"}, {"doc_id": 5529957, "edit_id": 3, "question": "What was the maximum dosage of riociguat given to the patients in this study?", "category": "omission", "label": "extent"}, {"doc_id": 5529957, "edit_id": 4, "question": "How regularly was Riociguat given to the patients during this trial?", "category": "omission", "label": "procedural"}, {"doc_id": 5529957, "edit_id": 5, "question": "How many of the patients who were treated with Riociguat had non-operable CTEPH?", "category": "omission", "label": "extent"}, {"doc_id": 5529957, "edit_id": 6, "question": "What was the average change in lung resistance to blood flow for the inoperable CTEPH patients who were treated with Riociguat? ", "category": "omission", "label": "extent"}, {"doc_id": 5529957, "edit_id": 7, "question": "What was the statistical range within which we are 95% sure that the average decrease in lung resistance to blood flow among inoperable patients falls?", "category": "omission", "label": "extent"}, {"doc_id": 5529957, "edit_id": 8, "question": "Was the drug Riociguat used to treat patients whose disease was recurring or persistent after surgery too?", "category": "omission", "label": "verification"}, {"doc_id": 5529957, "edit_id": 9, "question": "How many of the patients treated with Riociguat had a form of CTEPH that was persistent or recurring after surgery?", "category": "omission", "label": "extent"}, {"doc_id": 5529957, "edit_id": 10, "question": "How much did the average blood pressure in the lungs decrease in patients with inoperable disease after receiving Riociguat?", "category": "omission", "label": "extent"}, {"doc_id": 5529957, "edit_id": 11, "question": "What was the range within which the actual average decrease in lung blood pressure in inoperable patients is likely to fall, according to statistical analysis?", "category": "omission", "label": "extent"}, {"doc_id": 5529957, "edit_id": 12, "question": "Were some of the patients in this study suffering from CTEPH that could not be treated with surgery?", "category": "omission", "label": "verification"}, {"doc_id": 5545112, "edit_id": 0, "question": "What condition related to Vitamin D levels did the participants in the study have?", "category": "omission", "label": "concept"}, {"doc_id": 5545112, "edit_id": 1, "question": "What kind of research design was used to perform this study?", "category": "omission", "label": "concept"}, {"doc_id": 5545112, "edit_id": 2, "question": "Where was this study conducted?", "category": "omission", "label": "concept"}, {"doc_id": 5545112, "edit_id": 3, "question": "Where is Community Regional Medical Center located?", "category": "omission", "label": "concept"}, {"doc_id": 5545112, "edit_id": 4, "question": "What was the measure used to check patients' vitamin D levels for eligibility in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5545112, "edit_id": 5, "question": "What were the eligibility criteria based on serum 25(OH)D levels for the study?", "category": "omission", "label": "concept"}, {"doc_id": 5545112, "edit_id": 6, "question": "How was the quality of life of the patients assessed in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5545112, "edit_id": 7, "question": "How was the disease activity of ulcerative colitis assessed in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5545112, "edit_id": 8, "question": "What type of tests were used to compare the two treatment groups in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5545112, "edit_id": 9, "question": "What measures were compared between the two treatment groups in the study?", "category": "omission", "label": "comparison"}, {"doc_id": 5545112, "edit_id": 10, "question": "What statistical test was used in this study?", "category": "omission", "label": "procedural"}, {"doc_id": 5545112, "edit_id": 11, "question": "What variables were measured or assessed in the study?", "category": "omission", "label": "concept"}, {"doc_id": 5545112, "edit_id": 12, "question": "What software was used for the statistical computation in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5545112, "edit_id": 13, "question": "What was the effect of vitamin D3 supplementation on vitamin D levels over time in the study?", "category": "omission", "label": "consequence"}, {"doc_id": 5545112, "edit_id": 14, "question": "What caused the increase in Vitamin D levels in the study participants?", "category": "omission", "label": "cause"}, {"doc_id": 5545112, "edit_id": 15, "question": "How much of an increase in vitamin D levels was seen in the group taking 4,000 IU of vitamin D3 daily?", "category": "omission", "label": "extent"}, {"doc_id": 5545112, "edit_id": 16, "question": "How much of an increase in vitamin D levels was seen in the group taking 2,000 IU of vitamin D3 daily?", "category": "omission", "label": "extent"}, {"doc_id": 5545112, "edit_id": 17, "question": "Was the increase in vitamin D levels in the 4,000 IU group statistically significant?", "category": "omission", "label": "verification"}, {"doc_id": 5545112, "edit_id": 18, "question": "Was the increase in vitamin D levels in the 2,000 IU group statistically significant?", "category": "omission", "label": "verification"}, {"doc_id": 5545112, "edit_id": 19, "question": "What level of vitamin D is considered normal or sufficient?", "category": "omission", "label": "concept"}, {"doc_id": 5545112, "edit_id": 20, "question": "How many patients with ulcerative colitis were included in the group receiving 4,000 IU of vitamin D3 daily?", "category": "omission", "label": "extent"}, {"doc_id": 5545112, "edit_id": 21, "question": "How many patients with ulcerative colitis were included in the group receiving 2,000 IU of vitamin D3 daily?", "category": "omission", "label": "extent"}, {"doc_id": 5545112, "edit_id": 22, "question": "By how much did the quality of life scores, as measured by the SIBDQ, increase for the group getting 4,000 IU of vitamin D3 daily?", "category": "omission", "label": "extent"}, {"doc_id": 5545112, "edit_id": 23, "question": "By how much did the quality of life scores (SIBDQ) increase for the group getting 2,000 IU of vitamin D3 daily?", "category": "omission", "label": "extent"}, {"doc_id": 5545112, "edit_id": 24, "question": "Was the improvement in quality of life scores in the 4,000 IU/day group statistically significant?", "category": "omission", "label": "verification"}, {"doc_id": 5545112, "edit_id": 25, "question": "Was the improvement in quality of life scores in the 2,000 IU/day group statistically significant?", "category": "omission", "label": "verification"}, {"doc_id": 5545112, "edit_id": 26, "question": "By how much did the Partial Mayo UC Score, a measure of disease activity, decrease on average in the group getting 2,000 IU of vitamin D3 daily?", "category": "omission", "label": "extent"}, {"doc_id": 5545112, "edit_id": 27, "question": "What was the standard deviation of the decrease in Partial Mayo UC Score among the group getting 2,000 IU of vitamin D3 daily?", "category": "omission", "label": "extent"}, {"doc_id": 5545112, "edit_id": 28, "question": "Was the decrease in the Partial Mayo UC Score in the 2,000 IU vitamin D3 group statistically significant?", "category": "omission", "label": "verification"}, {"doc_id": 5545112, "edit_id": 29, "question": "By how much did the Partial Mayo UC Score, a measure of disease activity, decrease on average in the group getting 4,000 IU of vitamin D3 daily?", "category": "omission", "label": "extent"}, {"doc_id": 5545112, "edit_id": 30, "question": "What was the standard deviation of the decrease in Partial Mayo UC Score among the group getting 4,000 IU of vitamin D3 daily?", "category": "omission", "label": "extent"}, {"doc_id": 5545112, "edit_id": 31, "question": "Was the decrease in the Partial Mayo UC Score in the 4,000 IU vitamin D3 group statistically significant?", "category": "omission", "label": "verification"}, {"doc_id": 5545112, "edit_id": 32, "question": "Did the inflammatory marker (CRP levels) show any change after 90 days of daily vitamin D3 supplementation?", "category": "omission", "label": "verification"}, {"doc_id": 5545112, "edit_id": 33, "question": "In which groups was the decrease in CRP levels observed after 90 days of daily vitamin D3 supplementation?", "category": "omission", "label": "disjunction"}, {"doc_id": 5545112, "edit_id": 34, "question": "By how much did the CRP levels decrease in the 2,000 IU group?", "category": "omission", "label": "extent"}, {"doc_id": 5545112, "edit_id": 35, "question": "By how much did the CRP levels decrease in the 4,000 IU group?", "category": "omission", "label": "extent"}, {"doc_id": 5545112, "edit_id": 36, "question": "Was the decrease in CRP levels in the 2,000 IU group statistically significant?", "category": "omission", "label": "verification"}, {"doc_id": 5545112, "edit_id": 37, "question": "Was the decrease in CRP levels in the 4,000 IU group statistically significant?", "category": "omission", "label": "verification"}, {"doc_id": 5545112, "edit_id": 38, "question": "Which dose of vitamin D3 was more effective in increasing vitamin D levels?", "category": "omission", "label": "comparison"}, {"doc_id": 5545112, "edit_id": 39, "question": "How is the effectiveness of vitamin D3 supplementation measured in this study?", "category": "omission", "label": "procedural"}, {"doc_id": 5545112, "edit_id": 40, "question": "Do the patients in this study have any particular condition related to Vitamin D?", "category": "omission", "label": "concept"}, {"doc_id": 5555437, "edit_id": 0, "question": "What is the standard treatment for limited-stage small-cell lung cancer?", "category": "omission", "label": "concept"}, {"doc_id": 5555437, "edit_id": 1, "question": "Is there a consensus regarding the best schedule for giving radiotherapy to patients with limited-stage small-cell lung cancer?", "category": "omission", "label": "verification"}, {"doc_id": 5555437, "edit_id": 2, "question": "Is there a clearly defined best dose for radiotherapy in treating limited-stage small-cell lung cancer?", "category": "omission", "label": "verification"}, {"doc_id": 5555437, "edit_id": 3, "question": "What type of cancer was the focus of this study?", "category": "omission", "label": "concept"}, {"doc_id": 5555437, "edit_id": 4, "question": "What type of trial was the CONVERT trial?", "category": "omission", "label": "concept"}, {"doc_id": 5555437, "edit_id": 5, "question": "In what phase was the CONVERT trial?", "category": "omission", "label": "concept"}, {"doc_id": 5555437, "edit_id": 6, "question": "What was the aim of the CONVERT trial?", "category": "omission", "label": "concept"}, {"doc_id": 5555437, "edit_id": 7, "question": "What was the age range of the patients enrolled in the study?", "category": "omission", "label": "extent"}, {"doc_id": 5555437, "edit_id": 8, "question": "How old were the patients who were enrolled into the CONVERT trial?", "category": "omission", "label": "extent"}, {"doc_id": 5555437, "edit_id": 9, "question": "How was the diagnosis of the limited-stage small-cell lung cancer made in patients for this study?", "category": "omission", "label": "procedural"}, {"doc_id": 5555437, "edit_id": 10, "question": "What was the health status of the patients, according to the Eastern Cooperative Oncology Group scale?", "category": "omission", "label": "concept"}, {"doc_id": 5555437, "edit_id": 11, "question": "What was the condition of the patients' lungs in the study?", "category": "omission", "label": "concept"}, {"doc_id": 5555437, "edit_id": 12, "question": "Where were the patients for the CONVERT trial recruited from?", "category": "omission", "label": "concept"}, {"doc_id": 5555437, "edit_id": 13, "question": "How were patients assigned to different treatment groups in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5555437, "edit_id": 14, "question": "What was the main outcome that the researchers were interested in for this study?", "category": "omission", "label": "concept"}, {"doc_id": 5555437, "edit_id": 15, "question": "What was the survival rate difference between both treatment groups after two years?", "category": "omission", "label": "comparison"}, {"doc_id": 5555437, "edit_id": 16, "question": "What was the absolute difference in the survival rates at 2 years between the two treatment groups?", "category": "omission", "label": "comparison"}, {"doc_id": 5555437, "edit_id": 17, "question": "How many patients experienced severe decrease in white blood cells (grade 4 neutropenia) in the group that received twice-daily radiotherapy?", "category": "omission", "label": "extent"}, {"doc_id": 5555437, "edit_id": 18, "question": "Where can details about the trial be found?", "category": "omission", "label": "concept"}, {"doc_id": 5555437, "edit_id": 19, "question": "What is the registry number of the trial on ClinicalTrials.gov?", "category": "omission", "label": "concept"}, {"doc_id": 5555437, "edit_id": 20, "question": "What is the current status of the trial?", "category": "omission", "label": "verification"}, {"doc_id": 5555437, "edit_id": 21, "question": "Does the European Organisation for Research and Treatment of Cancer have a dedicated fund for cancer research?", "category": "omission", "label": "verification"}, {"doc_id": 5555437, "edit_id": 22, "question": "Who in France is involved in cancer research?", "category": "omission", "label": "example"}, {"doc_id": 5555437, "edit_id": 23, "question": "Does the European Organisation for Research and Treatment of Cancer have a group dedicated to lung cancer?", "category": "omission", "label": "verification"}, {"doc_id": 5571493, "edit_id": 0, "question": "What was the specific volume and concentration of the saline solution used in the tests?", "category": "omission", "label": "extent"}, {"doc_id": 5571493, "edit_id": 1, "question": "Besides saline, was there any other type of solution used in the experiments? If so, what was the volume and concentration?", "category": "omission", "label": "disjunction"}, {"doc_id": 5571493, "edit_id": 2, "question": "What was the exact dose of quinine administered to the volunteers?", "category": "omission", "label": "extent"}, {"doc_id": 5571493, "edit_id": 3, "question": "Was there a gender predominance among the volunteers involved in the study? ", "category": "omission", "label": "verification"}, {"doc_id": 5571493, "edit_id": 4, "question": "How many experimental examinations or \"explorations\" were performed during the study?", "category": "omission", "label": "extent"}, {"doc_id": 5571493, "edit_id": 5, "question": "Was there a predetermined sequence or order for the fourth exploration during the study?", "category": "omission", "label": "verification"}, {"doc_id": 5571493, "edit_id": 6, "question": "How was the sequence or order of the fourth exploration determined?", "category": "omission", "label": "procedural"}, {"doc_id": 5571493, "edit_id": 7, "question": "What was the average blood sugar level during the 4-hour period when the volunteers were given saline solution but not quinine?", "category": "omission", "label": "extent"}, {"doc_id": 5571493, "edit_id": 8, "question": "Was the change in average blood sugar levels with and without quinine, when using saline solution, significant?", "category": "omission", "label": "verification"}, {"doc_id": 5571493, "edit_id": 9, "question": "What was the average blood sugar level during the 4-hour period when the volunteers were given glucose solution but not quinine?", "category": "omission", "label": "extent"}, {"doc_id": 5571493, "edit_id": 10, "question": "Was the change in average blood sugar levels with and without quinine, when using glucose solution, significant?", "category": "omission", "label": "verification"}, {"doc_id": 5571493, "edit_id": 11, "question": "How significant was the decrease in blood sugar levels, statistically speaking?", "category": "omission", "label": "extent"}, {"doc_id": 5571493, "edit_id": 12, "question": "What was the lowest recorded blood glucose level during these tests?", "category": "omission", "label": "extent"}, {"doc_id": 5571493, "edit_id": 13, "question": "How statistically significant was the nadir value reached in the blood sugar levels?", "category": "omission", "label": "extent"}, {"doc_id": 5588713, "edit_id": 0, "question": "How big are the nanoparticles mentioned in this study?", "category": "omission", "label": "extent"}, {"doc_id": 5588713, "edit_id": 1, "question": "Was the testing done inside the body or outside?", "category": "omission", "label": "disjunction"}, {"doc_id": 5588713, "edit_id": 2, "question": "Who initiated the study?", "category": "omission", "label": "cause"}, {"doc_id": 5588713, "edit_id": 3, "question": "What was the health status of the participants in the study?", "category": "omission", "label": "concept"}, {"doc_id": 5588713, "edit_id": 4, "question": "What were the dosage amounts of the carbon nanoparticles used in the study?", "category": "omission", "label": "extent"}, {"doc_id": 5588713, "edit_id": 5, "question": "In which part of the lungs were the carbon nanoparticles administrated?", "category": "omission", "label": "concept"}, {"doc_id": 5588713, "edit_id": 6, "question": "What change was observed in the blood after the carbon nanoparticle exposure?", "category": "omission", "label": "consequence"}, {"doc_id": 5588713, "edit_id": 7, "question": "Was the increase in blood neutrophils after the carbon nanoparticles exposure notable or statistically significant?", "category": "omission", "label": "verification"}, {"doc_id": 5588713, "edit_id": 8, "question": "Was the increase in blood neutrophils dependent on the amount of carbon nanoparticles given?", "category": "omission", "label": "verification"}, {"doc_id": 5588713, "edit_id": 9, "question": "What was the p-value of the increase in blood neutrophils?", "category": "omission", "label": "extent"}, {"doc_id": 5588713, "edit_id": 10, "question": "What was the highest dose of carbon nanoparticles administered to individuals?", "category": "omission", "label": "extent"}, {"doc_id": 5588713, "edit_id": 11, "question": "What effect did the top-dose of 100 \u03bcg of carbon nanoparticles have?", "category": "omission", "label": "consequence"}, {"doc_id": 5588713, "edit_id": 12, "question": "What was the specific measurement that significantly increased with the top-dose of 100 \u03bcg of carbon nanoparticles?", "category": "omission", "label": "consequence"}, {"doc_id": 5588713, "edit_id": 13, "question": "What was the increase in percentage neutrophils in blood compared to?", "category": "omission", "label": "comparison"}, {"doc_id": 5588713, "edit_id": 14, "question": "What was the statistical significance level of the increase in percentage neutrophils in blood?", "category": "omission", "label": "extent"}, {"doc_id": 5588713, "edit_id": 15, "question": "On what type of cells was the effect observed?", "category": "omission", "label": "concept"}, {"doc_id": 5588713, "edit_id": 16, "question": "Who were the subjects of the study?", "category": "omission", "label": "concept"}, {"doc_id": 5588713, "edit_id": 17, "question": "When was the statement or trial registration made?", "category": "omission", "label": "extent"}, {"doc_id": 5626376, "edit_id": 0, "question": "Under what circumstances was the assessment conducted?", "category": "omission", "label": "procedural"}, {"doc_id": 5626376, "edit_id": 1, "question": "Was the study done based on past data or was it designed to observe outcomes in the future?", "category": "omission", "label": "verification"}, {"doc_id": 5626376, "edit_id": 2, "question": "Were the evaluators aware of which treatment each patient received in the study?", "category": "omission", "label": "verification"}, {"doc_id": 5626376, "edit_id": 3, "question": "Was this study an initial test or a full-scale research effort?", "category": "omission", "label": "verification"}, {"doc_id": 5626376, "edit_id": 4, "question": "Is HA1 known by any other names?", "category": "omission", "label": "concept"}, {"doc_id": 5626376, "edit_id": 5, "question": "What is another name for HA2?", "category": "omission", "label": "concept"}, {"doc_id": 5626376, "edit_id": 6, "question": "Does HA3 have another name?", "category": "omission", "label": "concept"}, {"doc_id": 5626376, "edit_id": 7, "question": "Is there another name for PRP?", "category": "omission", "label": "concept"}, {"doc_id": 5626376, "edit_id": 8, "question": "What method was used to evaluate the clinical outcomes?", "category": "omission", "label": "procedural"}, {"doc_id": 5626376, "edit_id": 9, "question": "What does MCII stand for and when is it used?", "category": "omission", "label": "concept"}, {"doc_id": 5626376, "edit_id": 10, "question": "For which two conditions was the MCII applied to measure improvement?", "category": "omission", "label": "concept"}, {"doc_id": 5626376, "edit_id": 11, "question": "At 18 months, how did the pain and function of the standard care (control) group change in terms of total WOMAC score?", "category": "omission", "label": "comparison"}, {"doc_id": 5626376, "edit_id": 12, "question": "Were there any significant differences between the control group and other treatment groups at 18 months?", "category": "omission", "label": "verification"}, {"doc_id": 5626376, "edit_id": 13, "question": "When is viscosupplementation used in patients with knee issues?", "category": "omission", "label": "procedural"}, {"doc_id": 5626376, "edit_id": 14, "question": "What specific type of knee damage did the patients in this study have?", "category": "omission", "label": "concept"}, {"doc_id": 5626376, "edit_id": 15, "question": "For future studies, what recommendations are given in terms of the number of participants?", "category": "omission", "label": "extent"}, {"doc_id": 5626376, "edit_id": 16, "question": "What other aspects could future studies potentially focus on, besides increasing the number of participants?", "category": "omission", "label": "example"}, {"doc_id": 5626376, "edit_id": 17, "question": "To whom would the results of these future larger studies be important or of interest?", "category": "omission", "label": "concept"}, {"doc_id": 5682159, "edit_id": 0, "question": "How many different types of hyaluronic acid fillers were compared in the study?", "category": "omission", "label": "extent"}, {"doc_id": 5682159, "edit_id": 1, "question": "What is the use of hyaluronic acid fillers in aesthetic procedures?", "category": "omission", "label": "concept"}, {"doc_id": 5682159, "edit_id": 2, "question": "What was the condition of the subjects' cheeks in the study?", "category": "omission", "label": "concept"}, {"doc_id": 5682159, "edit_id": 3, "question": "Which specific product was used on one side of the face for malar enhancement in this study?", "category": "omission", "label": "concept"}, {"doc_id": 5682159, "edit_id": 4, "question": "Which specific product was used on the other side of the face for malar enhancement in this study?", "category": "omission", "label": "concept"}, {"doc_id": 5682159, "edit_id": 5, "question": "What is not allowed regarding anesthetics in the treatment procedure in this study?", "category": "omission", "label": "procedural"}, {"doc_id": 5682159, "edit_id": 6, "question": "Was overcorrection, or adding more filler than necessary, permitted in this study?", "category": "omission", "label": "verification"}, {"doc_id": 5682159, "edit_id": 7, "question": "Were additional touch-ups after the initial treatment allowed in this study?", "category": "omission", "label": "verification"}, {"doc_id": 5682159, "edit_id": 8, "question": "How did the subjects give their assessments in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5682159, "edit_id": 9, "question": "Which tool was used to measure the aesthetic improvement in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5682159, "edit_id": 10, "question": "Besides the Global Aesthetic Improvement Scale, how else was patient satisfaction measured in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5682159, "edit_id": 11, "question": "Was there any other product that was also used in the study apart from CPM-26?", "category": "omission", "label": "verification"}, {"doc_id": 5682159, "edit_id": 12, "question": "What were the satisfaction rates for the side treated with CPM-26 after 3, 12, and 18 months?", "category": "omission", "label": "extent"}, {"doc_id": 5682159, "edit_id": 13, "question": "What were the satisfaction rates for the side treated with VYC-20 after 3, 12, and 18 months?", "category": "omission", "label": "extent"}, {"doc_id": 5682159, "edit_id": 14, "question": "Is this the first time that CPM-26 and VYC-20 have been directly compared?", "category": "omission", "label": "verification"}, {"doc_id": 5702778, "edit_id": 0, "question": "How many samples from the second group, where enamel was scratched or 'etched', were tested for hardness?", "category": "omission", "label": "extent"}, {"doc_id": 5702778, "edit_id": 1, "question": "How did they compare the changes in enamel hardness across the different groups?", "category": "omission", "label": "comparison"}, {"doc_id": 5702778, "edit_id": 2, "question": "What specific statistical method did they use to compare the differences in enamel hardness between the different groups?", "category": "omission", "label": "procedural"}, {"doc_id": 5702778, "edit_id": 3, "question": "Besides the paired t-tests, was there any other statistical method used in comparing the enamel hardness in different groups?", "category": "omission", "label": "verification"}, {"doc_id": 5730627, "edit_id": 0, "question": "What is the first choice of medication for young people with ADHD?", "category": "omission", "label": "concept"}, {"doc_id": 5730627, "edit_id": 1, "question": "Were the study subjects randomly assigned to groups receiving different treatments?", "category": "omission", "label": "procedural"}, {"doc_id": 5730627, "edit_id": 2, "question": "Were the studies double-blind?", "category": "omission", "label": "verification"}, {"doc_id": 5730627, "edit_id": 3, "question": "Was there a direct comparison between the two drugs in the study?", "category": "omission", "label": "verification"}, {"doc_id": 5730627, "edit_id": 4, "question": "What dose of LDX was administered in the 8-week study?", "category": "omission", "label": "extent"}, {"doc_id": 5730627, "edit_id": 5, "question": "How many adolescents received LDX in the 8-week study?", "category": "omission", "label": "extent"}, {"doc_id": 5730627, "edit_id": 6, "question": "How many adolescents received OROS-MPH in the 8-week study and at what dosage?", "category": "omission", "label": "extent"}, {"doc_id": 5730627, "edit_id": 7, "question": "How many adolescents received a placebo in the 8-week study?", "category": "omission", "label": "extent"}, {"doc_id": 5730627, "edit_id": 8, "question": "Was there an additional study apart from the 8-week one involving these adolescents?", "category": "omission", "label": "verification"}, {"doc_id": 5730627, "edit_id": 9, "question": "From what point did the researchers start measuring changes in ADHD symptoms in the adolescents?", "category": "omission", "label": "procedural"}, {"doc_id": 5730627, "edit_id": 10, "question": "Were there different types of studies conducted on the adolescents with ADHD?", "category": "omission", "label": "verification"}, {"doc_id": 5730627, "edit_id": 11, "question": "What was the duration of the forced-dose study?", "category": "omission", "label": "extent"}, {"doc_id": 5730627, "edit_id": 12, "question": "How was the effectiveness of the drugs evaluated?", "category": "omission", "label": "procedural"}, {"doc_id": 5730627, "edit_id": 13, "question": "Besides changes in ADHD symptoms, what other measure was used to evaluate improvement?", "category": "omission", "label": "concept"}, {"doc_id": 5730627, "edit_id": 14, "question": "How much did the ADHD symptoms change in the placebo group of the forced-dose study?", "category": "omission", "label": "extent"}, {"doc_id": 5730627, "edit_id": 15, "question": "How much did the ADHD symptoms change in the LDX group of the forced-dose study?", "category": "omission", "label": "extent"}, {"doc_id": 5730627, "edit_id": 16, "question": "What was the change in ADHD symptoms in the OROS-MPH group in the forced-dose study?", "category": "omission", "label": "concept"}, {"doc_id": 5730627, "edit_id": 17, "question": "How often did treatment-emergent adverse events (side effects that appeared after treatment) occur with LDX in the forced-dose study?", "category": "omission", "label": "extent"}, {"doc_id": 5730627, "edit_id": 18, "question": "How often did side effects occur with OROS-MPH in the forced-dose study?", "category": "omission", "label": "extent"}, {"doc_id": 5730627, "edit_id": 19, "question": "Which medication worked better in the forced-dose study, LDX or OROS-MPH?", "category": "omission", "label": "comparison"}, {"doc_id": 5730627, "edit_id": 20, "question": "What do these findings say about the effectiveness of psychostimulants (the class of drugs to which LDX and OROS-MPH belong) for treating ADHD?", "category": "omission", "label": "consequence"}, {"doc_id": 5771057, "edit_id": 0, "question": "What was the average age of the participants in the first group?", "category": "omission", "label": "extent"}, {"doc_id": 5771057, "edit_id": 1, "question": "What type of test was included in the Woodcock\u2013Johnson III assessment?", "category": "omission", "label": "concept"}, {"doc_id": 5771057, "edit_id": 2, "question": "Were there any subtests related to hearing in the Woodcock\u2013Johnson III assessment?", "category": "omission", "label": "verification"}, {"doc_id": 5771057, "edit_id": 3, "question": "Was there a subtest that evaluated visual skills in the Woodcock\u2013Johnson III assessment?", "category": "omission", "label": "verification"}, {"doc_id": 5771057, "edit_id": 4, "question": "Was there a subtest in the Woodcock\u2013Johnson III assessment that measured how quickly participants can make decisions?", "category": "omission", "label": "verification"}, {"doc_id": 5771057, "edit_id": 5, "question": "How many different conditions were there in which the participants were tested?", "category": "omission", "label": "extent"}, {"doc_id": 5771057, "edit_id": 6, "question": "Can you provide an example of one of the dual-task experimental conditions?", "category": "omission", "label": "example"}, {"doc_id": 5771057, "edit_id": 7, "question": "What was the nature of the second dual-task experimental condition?", "category": "omission", "label": "concept"}, {"doc_id": 5771057, "edit_id": 8, "question": "Can you describe the third dual-task experimental condition?", "category": "omission", "label": "concept"}, {"doc_id": 5771057, "edit_id": 9, "question": "What were the auditory tasks related to in these experimental conditions?", "category": "omission", "label": "concept"}, {"doc_id": 5771057, "edit_id": 10, "question": "What type of visual task was included in every experimental condition?", "category": "omission", "label": "concept"}, {"doc_id": 5771057, "edit_id": 11, "question": "What type of analysis was used to evaluate the results of this study?", "category": "omission", "label": "concept"}, {"doc_id": 5771057, "edit_id": 12, "question": "Apart from repeated measures analysis of variance, was there any other type of analysis used in the study?", "category": "omission", "label": "verification"}, {"doc_id": 5771057, "edit_id": 13, "question": "In what field or context is the Woodcock\u2013Johnson III test usually employed?", "category": "omission", "label": "concept"}, {"doc_id": 5805261, "edit_id": 0, "question": "How many cases of liver cancer (HCCs) were represented in this study?", "category": "omission", "label": "extent"}, {"doc_id": 5805261, "edit_id": 1, "question": "What statistical method was used to compare the cancer-free survival rates after 1 and 2 years for both treatment methods?", "category": "omission", "label": "procedural"}, {"doc_id": 5805261, "edit_id": 2, "question": "Was the difference in treatment time between the two groups found to be statistically significant?", "category": "omission", "label": "verification"}, {"doc_id": 5805261, "edit_id": 3, "question": "Was the amount of energy used in each treatment method different, and if so, was this difference statistically significant?", "category": "omission", "label": "comparison"}, {"doc_id": 5805261, "edit_id": 4, "question": "What was the cancer-free survival rate in the SB-RFA group after 2 years?", "category": "omission", "label": "extent"}, {"doc_id": 5805261, "edit_id": 5, "question": "What was the cancer-free survival rate in the SM-RFA group after 2 years?", "category": "omission", "label": "extent"}, {"doc_id": 5805261, "edit_id": 6, "question": "What type of electrodes does the SB-RFA treatment method use?", "category": "omission", "label": "concept"}, {"doc_id": 5808396, "edit_id": 0, "question": "What do we currently know about strategies to help sexual violence survivors overcome stigma?", "category": "omission", "label": "concept"}, {"doc_id": 5808396, "edit_id": 1, "question": "Are there any specific settings where the lack of strategies to reduce stigma among sexual violence survivors is especially noticeable?", "category": "omission", "label": "concept"}, {"doc_id": 5808396, "edit_id": 2, "question": "What kind of mental health issues were reported by the women included in the study?", "category": "omission", "label": "concept"}, {"doc_id": 5808396, "edit_id": 3, "question": "How did the sexual violence affect the women's daily life?", "category": "omission", "label": "consequence"}, {"doc_id": 5808396, "edit_id": 4, "question": "Where were the study participants from?", "category": "omission", "label": "concept"}, {"doc_id": 5808396, "edit_id": 5, "question": "Did the study look at how feeling stigmatized or discriminated against affected depression and anxiety symptoms?", "category": "omission", "label": "verification"}, {"doc_id": 5808396, "edit_id": 6, "question": "Did the researchers consider whether stigma influenced symptoms of posttraumatic stress?", "category": "omission", "label": "verification"}, {"doc_id": 5808396, "edit_id": 7, "question": "How effective was group psychotherapy in helping survivors with their mental health?", "category": "omission", "label": "extent"}, {"doc_id": 5809707, "edit_id": 0, "question": "What type of procedure were the patients in the study having?", "category": "omission", "label": "concept"}, {"doc_id": 5809707, "edit_id": 1, "question": "Was the procedure that the patients were having a necessary one or was it elective?", "category": "omission", "label": "disjunction"}, {"doc_id": 5809707, "edit_id": 2, "question": "How were the patients divided into their respective groups for the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5809707, "edit_id": 3, "question": "What kind of premedication was administered to the patients in the second group?", "category": "omission", "label": "concept"}, {"doc_id": 5809707, "edit_id": 4, "question": "How were the patients in the third group premedicated for the procedure?", "category": "omission", "label": "procedural"}, {"doc_id": 5809707, "edit_id": 5, "question": "How was the premedication given to the patients?", "category": "omission", "label": "procedural"}, {"doc_id": 5809707, "edit_id": 6, "question": "Which medication was used as a premedication for patients in the second group?", "category": "omission", "label": "concept"}, {"doc_id": 5809707, "edit_id": 7, "question": "What medication was used as a premedication for patients in the third group?", "category": "omission", "label": "concept"}, {"doc_id": 5809707, "edit_id": 8, "question": "What amount of fentanyl was given to patients in the second group?", "category": "omission", "label": "extent"}, {"doc_id": 5809707, "edit_id": 9, "question": "What was the dosage of ketamine given to the patients in group 3?", "category": "omission", "label": "extent"}, {"doc_id": 5809707, "edit_id": 10, "question": "How was the medication before and during the procedure given to the patients in all three groups?", "category": "omission", "label": "procedural"}, {"doc_id": 5809707, "edit_id": 11, "question": "Was there any condition observed related to the heart rate of the patients during the procedure?", "category": "omission", "label": "verification"}, {"doc_id": 5809707, "edit_id": 12, "question": "What tool or method was used to monitor the patients' recovery after the anesthesia was administered?", "category": "omission", "label": "procedural"}, {"doc_id": 5809707, "edit_id": 13, "question": "What particular benchmark in the recovery of the patients after the procedure was recorded?", "category": "omission", "label": "concept"}, {"doc_id": 5809707, "edit_id": 14, "question": "Is it possible for a patient to reach a particular score on the Post Anesthesia Discharge Score (PADS)?", "category": "omission", "label": "verification"}, {"doc_id": 5809707, "edit_id": 15, "question": "Which group among the three took the longest time to reach a high recovery score based on the Post Anesthesia Discharge Score (PADS)?", "category": "omission", "label": "comparison"}, {"doc_id": 5809707, "edit_id": 16, "question": "Was the time to reach a high recovery score based on the Post Anesthesia Discharge Score (PADS) measured for all patient groups?", "category": "omission", "label": "verification"}, {"doc_id": 5809707, "edit_id": 17, "question": "Can fentanyl be used as medication during the ultrasound scan procedure, and if so, what's the dosage?", "category": "omission", "label": "disjunction"}, {"doc_id": 5809707, "edit_id": 18, "question": "Can ketamine also be used as medication for this procedure, and if so, how much?", "category": "omission", "label": "extent"}, {"doc_id": 5809707, "edit_id": 19, "question": "Is fentanyl used in combination with another drug during the procedure, and if so, in what way?", "category": "omission", "label": "disjunction"}, {"doc_id": 5827507, "edit_id": 0, "question": "What type of disorder is dentinal hypersensitivity? ", "category": "omission", "label": "concept"}, {"doc_id": 5827507, "edit_id": 1, "question": "What kind of pain do patients with dentinal hypersensitivity experience?", "category": "omission", "label": "concept"}, {"doc_id": 5827507, "edit_id": 2, "question": "What triggers the pain in dentinal hypersensitivity?", "category": "omission", "label": "cause"}, {"doc_id": 5827507, "edit_id": 3, "question": "Are there different ways to treat dentinal hypersensitivity?", "category": "omission", "label": "concept"}, {"doc_id": 5827507, "edit_id": 4, "question": "What treatment did Group 1 receive in the study?", "category": "omission", "label": "concept"}, {"doc_id": 5827507, "edit_id": 5, "question": "What treatment was given to Group 2 in the study?", "category": "omission", "label": "concept"}, {"doc_id": 5827507, "edit_id": 6, "question": "What was the power of the diode laser used in treating Group 2?", "category": "omission", "label": "extent"}, {"doc_id": 5827507, "edit_id": 7, "question": "What was the wavelength of the diode laser used in the study?", "category": "omission", "label": "extent"}, {"doc_id": 5827507, "edit_id": 8, "question": "How was the diode laser used in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5827507, "edit_id": 9, "question": "What was the power wattage of the diode laser used in the study?", "category": "omission", "label": "extent"}, {"doc_id": 5827507, "edit_id": 10, "question": "What treatment was given to Group 3 in the study?", "category": "omission", "label": "disjunction"}, {"doc_id": 5827507, "edit_id": 11, "question": "How did they measure the pain levels of the patients?", "category": "omission", "label": "procedural"}, {"doc_id": 5827507, "edit_id": 12, "question": "What was done with the visual analog scale scores from the patients?", "category": "omission", "label": "procedural"}, {"doc_id": 5827507, "edit_id": 13, "question": "To what were the visual analog scale scores compared?", "category": "omission", "label": "comparison"}, {"doc_id": 5827507, "edit_id": 14, "question": "What other tests were the visual analog scale scores compared to?", "category": "omission", "label": "comparison"}, {"doc_id": 5827507, "edit_id": 15, "question": "Were the visual analog scale scores compared to any other types of tests?", "category": "omission", "label": "verification"}, {"doc_id": 5827507, "edit_id": 16, "question": "How was the treatment carried out in Group 3?", "category": "omission", "label": "procedural"}, {"doc_id": 5827507, "edit_id": 17, "question": "What form of treatment did Group 2 use?", "category": "omission", "label": "disjunction"}, {"doc_id": 5827507, "edit_id": 18, "question": "What form of treatment did Group 1 use?", "category": "omission", "label": "disjunction"}, {"doc_id": 5827507, "edit_id": 19, "question": "Between the diode laser and the potassium nitrate treatment, which one showed better results?", "category": "omission", "label": "comparison"}, {"doc_id": 5827507, "edit_id": 20, "question": "What statistical method was used in the analysis?", "category": "omission", "label": "procedural"}, {"doc_id": 5827507, "edit_id": 21, "question": "Besides the one-way ANOVA, what other statistical test was used in the analysis?", "category": "omission", "label": "procedural"}, {"doc_id": 5827507, "edit_id": 22, "question": "What did the analysis show about the visual analog scale scores?", "category": "omission", "label": "consequence"}, {"doc_id": 5827507, "edit_id": 23, "question": "What was the level of significance set for the analysis?", "category": "omission", "label": "extent"}, {"doc_id": 5827507, "edit_id": 24, "question": "What treatment method is recommended based on the results of this study?", "category": "omission", "label": "judgmental"}, {"doc_id": 5827507, "edit_id": 25, "question": "For which patients is the combined application of 5% potassium nitrate and diode laser recommended?", "category": "omission", "label": "disjunction"}, {"doc_id": 5827507, "edit_id": 26, "question": "How certain are the researchers about their recommendation for treatment?", "category": "omission", "label": "extent"}, {"doc_id": 5852865, "edit_id": 0, "question": "What components make up the substance located in the center of the human eye?", "category": "omission", "label": "concept"}, {"doc_id": 5852865, "edit_id": 1, "question": "What is the term for the accumulation of lutein, zeaxanthin, and mesozeaxanthin in the retina?", "category": "omission", "label": "concept"}, {"doc_id": 5852865, "edit_id": 2, "question": "Are there any supplements that contain the components needed for the macular pigment?", "category": "omission", "label": "verification"}, {"doc_id": 5852865, "edit_id": 3, "question": "What type of supplement was the first group taking?", "category": "omission", "label": "disjunction"}, {"doc_id": 5852865, "edit_id": 4, "question": "What type of supplement was the second group taking?", "category": "omission", "label": "disjunction"}, {"doc_id": 5852865, "edit_id": 5, "question": "Which group had a larger increase in the quantity of the macular substance in their eyes?", "category": "omission", "label": "comparison"}, {"doc_id": 5852865, "edit_id": 6, "question": "What was the increase in the macular substance for the group that took the supplement with all three components?", "category": "omission", "label": "extent"}, {"doc_id": 5852865, "edit_id": 7, "question": "Which group had a smaller increase in the quantity of the macular substance in their eyes?", "category": "omission", "label": "comparison"}, {"doc_id": 5852865, "edit_id": 8, "question": "What was the increase in the macular substance for the group that took the supplement with just lutein?", "category": "omission", "label": "extent"}, {"doc_id": 5852865, "edit_id": 9, "question": "Was the difference in the increase of macular substance between the two groups statistically significant?", "category": "omission", "label": "verification"}, {"doc_id": 5852865, "edit_id": 10, "question": "What was the p-value of the statistical test that showed the difference between the two groups?", "category": "omission", "label": "extent"}, {"doc_id": 5852865, "edit_id": 11, "question": "Was the p-value more or less than the usual threshold for statistical significance which is 0.05?", "category": "omission", "label": "verification"}, {"doc_id": 5852865, "edit_id": 12, "question": "In which participants was the trend of smaller increases in macular substance particularly noticeable?", "category": "omission", "label": "comparison"}, {"doc_id": 5852865, "edit_id": 13, "question": "What is the baseline value referring to?", "category": "omission", "label": "concept"}, {"doc_id": 5852865, "edit_id": 14, "question": "Was the trend of smaller increases in macular substance in participants with higher baseline levels a significant finding?", "category": "omission", "label": "verification"}, {"doc_id": 5852865, "edit_id": 15, "question": "What was the p-value for the statistical significance of the trend in participants with higher baseline levels?", "category": "omission", "label": "extent"}, {"doc_id": 5853038, "edit_id": 0, "question": "Is this study unique in any way to the United Arab Emirates?", "category": "omission", "label": "verification"}, {"doc_id": 5853038, "edit_id": 1, "question": "Is it common to use these plant extracts in toothpaste in the United Arab Emirates?", "category": "omission", "label": "verification"}, {"doc_id": 5853038, "edit_id": 2, "question": "When was this study conducted?", "category": "omission", "label": "extent"}, {"doc_id": 5853038, "edit_id": 3, "question": "What did the participants do after they used their regular toothpaste for two weeks?", "category": "omission", "label": "procedural"}, {"doc_id": 5853038, "edit_id": 4, "question": "What software was used for the analysis of the data collected from the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5853038, "edit_id": 5, "question": "What kind of statistical test was used in the data analysis of the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5853038, "edit_id": 6, "question": "How effective was the Meswak-based toothpaste at reducing plaque scores according to the study's findings?", "category": "omission", "label": "consequence"}, {"doc_id": 5861369, "edit_id": 0, "question": "What additional medical tests did the women undergo as part of the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5861369, "edit_id": 1, "question": "Were any specific health or well-being surveys used in the study?", "category": "omission", "label": "verification"}, {"doc_id": 5861369, "edit_id": 2, "question": "Were any specific questionnaires used to evaluate the women's mental health during the study?", "category": "omission", "label": "verification"}, {"doc_id": 5861369, "edit_id": 3, "question": "What other tools were used to assess patients' quality of life in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5863413, "edit_id": 0, "question": "What is the nature of the skin disease lichen planus?", "category": "omission", "label": "concept"}, {"doc_id": 5863413, "edit_id": 1, "question": "What kind of a disease is Lichen planus?", "category": "omission", "label": "concept"}, {"doc_id": 5863413, "edit_id": 2, "question": "What is the primary treatment method for the oral form of lichen planus?", "category": "omission", "label": "procedural"}, {"doc_id": 5863413, "edit_id": 3, "question": "Is there a natural treatment alternative for oral lichen planus?", "category": "omission", "label": "disjunction"}, {"doc_id": 5863413, "edit_id": 4, "question": "What was the condition of the people who partook in the study on lichen planus?", "category": "omission", "label": "extent"}, {"doc_id": 5863413, "edit_id": 5, "question": "How was the steroid treatment administered to the patients in the control group of the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5863413, "edit_id": 6, "question": "When was the initial evaluation of the patient\u2019s condition done in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5863413, "edit_id": 7, "question": "When was the first follow-up or progress check conducted in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5863413, "edit_id": 8, "question": "When was the second progress check-up held in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5863413, "edit_id": 9, "question": "How were the symptoms of oral lichen planus evaluated in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5863413, "edit_id": 10, "question": "What statistical significance did the variation in symptom improvement between the two patient groups show in the study?", "category": "omission", "label": "consequence"}, {"doc_id": 5863413, "edit_id": 11, "question": "What specific steroid formulation was used in the management of oral lichen planus in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5866486, "edit_id": 0, "question": "What type of head trauma did the patients in the study have? ", "category": "omission", "label": "example"}, {"doc_id": 5866486, "edit_id": 1, "question": "Was there any other type of head trauma in the patients apart from acute head trauma? ", "category": "omission", "label": "disjunction"}, {"doc_id": 5866486, "edit_id": 2, "question": "Did all the patients in the study have both acute and sub-acute head trauma?", "category": "omission", "label": "verification"}, {"doc_id": 5866486, "edit_id": 3, "question": "Did all the participants in the study have a history of head trauma?", "category": "omission", "label": "verification"}, {"doc_id": 5866486, "edit_id": 4, "question": "What symptoms were common in all the patients in the study?", "category": "omission", "label": "example"}, {"doc_id": 5866486, "edit_id": 5, "question": "How were the patients divided into the two groups for the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5866486, "edit_id": 6, "question": "Can you name the type of medication that was used as part of the therapy in the study?", "category": "omission", "label": "example"}, {"doc_id": 5866486, "edit_id": 7, "question": "What happened to the initial vestibular rehabilitation program that was designed for the study?", "category": "omission", "label": "consequence"}, {"doc_id": 5866486, "edit_id": 8, "question": "Who was responsible for revising and verifying the rehabilitation program?", "category": "omission", "label": "verification"}, {"doc_id": 5866486, "edit_id": 9, "question": "Who makes up the joint committee that revised and validated the program?", "category": "omission", "label": "concept"}, {"doc_id": 5866486, "edit_id": 10, "question": "Was there a significant difference in progress between the two patient groups?", "category": "omission", "label": "comparison"}, {"doc_id": 5891985, "edit_id": 0, "question": "What other potential impacts is liraglutide suggested to have besides improving how the body uses sugar and fats? ", "category": "omission", "label": "consequence"}, {"doc_id": 5891985, "edit_id": 1, "question": "How is adhesion molecule activation related to diabetes?", "category": "omission", "label": "cause"}, {"doc_id": 5891985, "edit_id": 2, "question": "Besides the body's use of sugar and fat, what specific substance's effects were examined in the study?", "category": "omission", "label": "concept"}, {"doc_id": 5891985, "edit_id": 3, "question": "Was the production of insulin by beta cells in the pancreas considered in the study?", "category": "omission", "label": "verification"}, {"doc_id": 5891985, "edit_id": 4, "question": "What else was measured apart from sugar and fat levels?", "category": "omission", "label": "concept"}, {"doc_id": 5891985, "edit_id": 5, "question": "What condition did all patients in the study have?", "category": "omission", "label": "concept"}, {"doc_id": 5891985, "edit_id": 6, "question": "What was the average age of the patients in the study?", "category": "omission", "label": "extent"}, {"doc_id": 5891985, "edit_id": 7, "question": "How much did the ages of the patients vary in the study?", "category": "omission", "label": "extent"}, {"doc_id": 5891985, "edit_id": 8, "question": "What form and frequency of treatment did one group of patients receive?", "category": "omission", "label": "procedural"}, {"doc_id": 5891985, "edit_id": 9, "question": "What test was conducted before the study began?", "category": "omission", "label": "procedural"}, {"doc_id": 5891985, "edit_id": 10, "question": "How much glucose was used for the oral glucose tolerance test?", "category": "omission", "label": "extent"}, {"doc_id": 5891985, "edit_id": 11, "question": "What happened to the NEFA levels after 8 weeks?", "category": "omission", "label": "consequence"}, {"doc_id": 5891985, "edit_id": 12, "question": "What happened to the sVCAM-1 levels after 8 weeks?", "category": "omission", "label": "consequence"}, {"doc_id": 5891985, "edit_id": 13, "question": "What happened to the levels of sVCAM-1 after 8 weeks of liraglutide treatment?", "category": "omission", "label": "consequence"}, {"doc_id": 5891985, "edit_id": 14, "question": "To what extent did the sVCAM-1 levels decrease after 8 weeks of liraglutide treatment?", "category": "omission", "label": "extent"}, {"doc_id": 5891985, "edit_id": 15, "question": "How did the levels of NEFA change after 120 minutes in liraglutide-treated patients compared to those treated with metformin?", "category": "omission", "label": "comparison"}, {"doc_id": 5891985, "edit_id": 16, "question": "How did the difference in NEFA levels before and after liraglutide treatment compare to those before and after metformin treatment?", "category": "omission", "label": "comparison"}, {"doc_id": 5891985, "edit_id": 17, "question": "Can you tell me the specific changes in AUCins observed before and after liraglutide treatment?", "category": "omission", "label": "consequence"}, {"doc_id": 5891985, "edit_id": 18, "question": "What was the comparative effect of liraglutide and metformin treatments on insulin presence in the bloodstream, measured as AUCins?", "category": "omission", "label": "comparison"}, {"doc_id": 5891985, "edit_id": 19, "question": "What were some of the specific measurements taken after the treatments?", "category": "omission", "label": "procedural"}, {"doc_id": 5891985, "edit_id": 20, "question": "What happened to fasting NEFA levels after liraglutide treatment?", "category": "omission", "label": "consequence"}, {"doc_id": 5891985, "edit_id": 21, "question": "How did fasting NEFA levels change after metformin treatment?", "category": "omission", "label": "consequence"}, {"doc_id": 5891985, "edit_id": 22, "question": "What specific measurement was made after 8 weeks of liraglutide treatment?", "category": "omission", "label": "procedural"}, {"doc_id": 5891985, "edit_id": 23, "question": "What was measured after 8 weeks of liraglutide treatment concerning sVCAM-1?", "category": "omission", "label": "procedural"}, {"doc_id": 5891985, "edit_id": 24, "question": "Is there a relationship between the reduction of 120 min NEFA and the decrease of sVCAM-1?", "category": "omission", "label": "verification"}, {"doc_id": 5891985, "edit_id": 25, "question": "How strong is the positive correlation between the reduction of 120 min NEFA and the decrease of sVCAM-1?", "category": "omission", "label": "extent"}, {"doc_id": 5891985, "edit_id": 26, "question": "What treatment was more effective in reducing non-esterified free fatty acids (NEFA) at 120 minutes? ", "category": "omission", "label": "comparison"}, {"doc_id": 5891985, "edit_id": 27, "question": "What treatment was more effective in suppressing sVCAM-1 levels? ", "category": "omission", "label": "comparison"}, {"doc_id": 5891985, "edit_id": 28, "question": "How did metformin's effectiveness in reducing non-esterified free fatty acids (NEFA) at 120 minutes compare to liraglutide's?", "category": "omission", "label": "comparison"}, {"doc_id": 5891985, "edit_id": 29, "question": "How did metformin's effectiveness in suppressing sVCAM-1 levels compare to liraglutide's?", "category": "omission", "label": "comparison"}, {"doc_id": 5891985, "edit_id": 30, "question": "Besides regulating sugar and fats, is liraglutide associated with any other benefits for diabetic patients?", "category": "omission", "label": "verification"}, {"doc_id": 5891985, "edit_id": 31, "question": "Does liraglutide have any potential benefits related to inflammation?", "category": "omission", "label": "verification"}, {"doc_id": 5891985, "edit_id": 32, "question": "What format was the supplementary material provided in?", "category": "omission", "label": "concept"}, {"doc_id": 5891985, "edit_id": 33, "question": "Was there any additional material provided along with the study's main findings?", "category": "omission", "label": "verification"}, {"doc_id": 5891985, "edit_id": 34, "question": "Is there an online version of the study available?", "category": "omission", "label": "verification"}, {"doc_id": 5891985, "edit_id": 35, "question": "Does the online version of the study include any additional material?", "category": "omission", "label": "verification"}, {"doc_id": 5891985, "edit_id": 36, "question": "Who can access the supplementary material provided with the study?", "category": "omission", "label": "concept"}, {"doc_id": 5923799, "edit_id": 0, "question": "How were the children divided into the Taekwondo and control groups?", "category": "omission", "label": "procedural"}, {"doc_id": 5923799, "edit_id": 1, "question": "What was the duration of each Taekwondo training session?", "category": "omission", "label": "concept"}, {"doc_id": 5923799, "edit_id": 2, "question": "What type of fitness test was conducted to measure the children's balance?", "category": "omission", "label": "concept"}, {"doc_id": 5923799, "edit_id": 3, "question": "How did the Taekwondo group and the control group compare in terms of balance as indicated by the Stork test results?", "category": "omission", "label": "comparison"}, {"doc_id": 5923799, "edit_id": 4, "question": "What was the level of statistical significance for these tests and evaluations?", "category": "omission", "label": "concept"}, {"doc_id": 5923799, "edit_id": 5, "question": "How did the children's sociability scores compare before and after the Taekwondo classes?", "category": "omission", "label": "comparison"}, {"doc_id": 5923799, "edit_id": 6, "question": "Was the increase in sociability score after the intervention statistically significant?", "category": "omission", "label": "verification"}, {"doc_id": 5923799, "edit_id": 7, "question": "Was the improvement in balance as indicated by the Stork test statistically significant?", "category": "omission", "label": "verification"}, {"doc_id": 5966460, "edit_id": 0, "question": "Who specifically is the Griffithsin gel being tested for?", "category": "omission", "label": "concept"}, {"doc_id": 5966460, "edit_id": 1, "question": "How important is the study of the Griffithsin gel?", "category": "omission", "label": "extent"}, {"doc_id": 5966460, "edit_id": 2, "question": "Beyond the effects on proteins, what else did the researchers study in their evaluation of the Griffithsin gel?", "category": "omission", "label": "concept"}, {"doc_id": 5966460, "edit_id": 3, "question": "How many monkeys were used in the study and what species were they?", "category": "omission", "label": "extent"}, {"doc_id": 5966460, "edit_id": 4, "question": "What was the concentration of Griffithsin in the gels used in the study?", "category": "omission", "label": "extent"}, {"doc_id": 5966460, "edit_id": 5, "question": "What technology did the scientists use to evaluate the impact of the gel on proteins?", "category": "omission", "label": "procedural"}, {"doc_id": 5966460, "edit_id": 6, "question": "How did the researchers study the changes in the microbiome?", "category": "omission", "label": "procedural"}, {"doc_id": 5966460, "edit_id": 7, "question": "What function do the proteins affected by the dummy gels have?", "category": "omission", "label": "concept"}, {"doc_id": 5966460, "edit_id": 8, "question": "What beneficial microbes increased after the application of the dummy gels?", "category": "omission", "label": "concept"}, {"doc_id": 5966460, "edit_id": 9, "question": "What were the effects of the Griffithsin gel and the dummy gels compared to?", "category": "omission", "label": "comparison"}, {"doc_id": 5966460, "edit_id": 10, "question": "What does the study say about the safety of the Griffithsin gel?", "category": "omission", "label": "consequence"}, {"doc_id": 5966460, "edit_id": 11, "question": "What is the intended use of the 0.1% Griffithsin gel?", "category": "omission", "label": "concept"}, {"doc_id": 5976307, "edit_id": 0, "question": "What type of clinical trial was conducted?", "category": "omission", "label": "concept"}, {"doc_id": 5976307, "edit_id": 1, "question": "What was the primary focus or outcome of this clinical trial?", "category": "omission", "label": "consequence"}, {"doc_id": 5976307, "edit_id": 2, "question": "What other factors, apart from heart and lung side effects, did the trial observe?", "category": "omission", "label": "concept"}, {"doc_id": 5976307, "edit_id": 3, "question": "Were there any additional outcomes evaluated related to the use of sedatives?", "category": "omission", "label": "verification"}, {"doc_id": 5976307, "edit_id": 4, "question": "Was the difference in heart and lung side effects between the two patient groups significant?", "category": "omission", "label": "verification"}, {"doc_id": 5976307, "edit_id": 5, "question": "How many patients experienced changes in vital signs in the group that received propofol?", "category": "omission", "label": "extent"}, {"doc_id": 5976307, "edit_id": 6, "question": "Was the difference in the number of complications during the procedure between the etomidate and propofol groups significant?", "category": "omission", "label": "verification"}, {"doc_id": 5976307, "edit_id": 7, "question": "What percentage of patients in the etomidate group experienced muscle twitching (myoclonus)?", "category": "omission", "label": "extent"}, {"doc_id": 5976307, "edit_id": 8, "question": "What percentage of patients in the propofol group experienced muscle twitching (myoclonus)?", "category": "omission", "label": "extent"}, {"doc_id": 5976307, "edit_id": 9, "question": "What type of analysis was carried out on the trial data?", "category": "omission", "label": "procedural"}, {"doc_id": 5976307, "edit_id": 10, "question": "Was the P-value from the multivariate analysis statistically significant?", "category": "omission", "label": "verification"}, {"doc_id": 5976307, "edit_id": 11, "question": "Who do the researchers recommend should receive etomidate with midazolam?", "category": "omission", "label": "concept"}, {"doc_id": 5976307, "edit_id": 12, "question": "Who do the researchers suggest might be suitable for receiving propofol with midazolam?", "category": "omission", "label": "concept"}, {"doc_id": 5976501, "edit_id": 0, "question": "What is generally considered the most effective means of preventing diabetes in prediabetic adults?", "category": "omission", "label": "concept"}, {"doc_id": 5976501, "edit_id": 1, "question": "Has there been a change in the prevalence of diabetes?", "category": "omission", "label": "verification"}, {"doc_id": 5976501, "edit_id": 2, "question": "Is the prevalence of diabetes increasing even though lifestyle changes can help prevent it?", "category": "omission", "label": "verification"}, {"doc_id": 5976501, "edit_id": 3, "question": "Can you give more details about the design of the study conducted on 5-ALA?", "category": "omission", "label": "procedural"}, {"doc_id": 5976501, "edit_id": 4, "question": "What type of group comparison was used in the study with 5-ALA?", "category": "omission", "label": "concept"}, {"doc_id": 5976501, "edit_id": 5, "question": "How did the researchers measure depressive symptoms in their study?", "category": "omission", "label": "procedural"}, {"doc_id": 5976501, "edit_id": 6, "question": "What tool was used to measure levels of stress in the study participants?", "category": "omission", "label": "procedural"}, {"doc_id": 5976501, "edit_id": 7, "question": "What specific mood elements were the researchers investigating in the study?", "category": "omission", "label": "concept"}, {"doc_id": 5976501, "edit_id": 8, "question": "What software did the researchers use to analyze their data?", "category": "omission", "label": "procedural"}, {"doc_id": 5976501, "edit_id": 9, "question": "What type of statistical analysis method was used in the study to examine the data?", "category": "omission", "label": "procedural"}, {"doc_id": 5976501, "edit_id": 10, "question": "What was analyzed in the study to determine the supplement's effect?", "category": "omission", "label": "concept"}, {"doc_id": 5976501, "edit_id": 11, "question": "Besides conducting the study, what other aspect did the researchers work on regarding the topic?", "category": "omission", "label": "concept"}, {"doc_id": 5976501, "edit_id": 12, "question": "What resource did the researchers use for their literature review?", "category": "omission", "label": "procedural"}, {"doc_id": 5976501, "edit_id": 13, "question": "Was the improvement in coping ability due to 5-ALA intake statistically significant, and what was the p-value?", "category": "omission", "label": "verification"}, {"doc_id": 5976501, "edit_id": 14, "question": "What kind of relationship was found between the intake of 5-ALA and the outcomes?", "category": "omission", "label": "concept"}, {"doc_id": 5976501, "edit_id": 15, "question": "What was the p-value for the perceived change in effort in relation to the intake of 5-ALA?", "category": "omission", "label": "verification"}, {"doc_id": 5976501, "edit_id": 16, "question": "How significant was the effect of 5-ALA intake on feelings of loneliness, as measured by the p-value?", "category": "omission", "label": "verification"}, {"doc_id": 5976501, "edit_id": 17, "question": "What was the p-value for the impact of 5-ALA on coping ability?", "category": "omission", "label": "verification"}, {"doc_id": 5985618, "edit_id": 0, "question": "What is a common symptom of chronic cheesy throat issue, or chronic caseous tonsillitis?", "category": "omission", "label": "concept"}, {"doc_id": 5985618, "edit_id": 1, "question": "What is the cause of the bad breath in these patients?", "category": "omission", "label": "cause"}, {"doc_id": 5985618, "edit_id": 2, "question": "How was the study designed for these patients?", "category": "omission", "label": "procedural"}, {"doc_id": 5985618, "edit_id": 3, "question": "How were the patients divided for the treatments?", "category": "omission", "label": "procedural"}, {"doc_id": 5985618, "edit_id": 4, "question": "What was the procedure received by Group A?", "category": "omission", "label": "procedural"}, {"doc_id": 5985618, "edit_id": 5, "question": "What was the procedure received by Group B?", "category": "omission", "label": "procedural"}, {"doc_id": 5985618, "edit_id": 6, "question": "What were the symptoms looked at in this study?", "category": "omission", "label": "concept"}, {"doc_id": 5985618, "edit_id": 7, "question": "How were the levels of pain in patients measured?", "category": "omission", "label": "procedural"}, {"doc_id": 5985618, "edit_id": 8, "question": "Which group had higher pain scores according to the study?", "category": "omission", "label": "comparison"}, {"doc_id": 5985618, "edit_id": 9, "question": "How is a statistically significant result defined in this study?", "category": "omission", "label": "concept"}, {"doc_id": 5985618, "edit_id": 10, "question": "What was the calculated P value in the comparison of the duration of both procedures?", "category": "omission", "label": "extent"}, {"doc_id": 5985618, "edit_id": 11, "question": "What are the procedures being compared used to treat?", "category": "omission", "label": "concept"}, {"doc_id": 5986443, "edit_id": 0, "question": "What is another condition associated with aging besides loss of muscle mass?", "category": "omission", "label": "example"}, {"doc_id": 5986443, "edit_id": 1, "question": "When did the women in the study consume the whey protein?", "category": "omission", "label": "extent"}, {"doc_id": 5986443, "edit_id": 2, "question": "What aspect of health did the study focus on, apart from muscle strength and walk time?", "category": "omission", "label": "concept"}, {"doc_id": 5986443, "edit_id": 3, "question": "Who were the participants of the study?", "category": "omission", "label": "concept"}, {"doc_id": 5986443, "edit_id": 4, "question": "How many women were in the group that took whey protein before resistance training and a placebo after?", "category": "omission", "label": "extent"}, {"doc_id": 5986443, "edit_id": 5, "question": "How many women were in the group that took a placebo before resistance training and whey protein after?", "category": "omission", "label": "extent"}, {"doc_id": 5986443, "edit_id": 6, "question": "What did the third group ingest before and after resistance training?", "category": "omission", "label": "concept"}, {"doc_id": 5986443, "edit_id": 7, "question": "How many women were in the third group that took a placebo before and after resistance training?", "category": "omission", "label": "extent"}, {"doc_id": 5986443, "edit_id": 8, "question": "What was the amount of whey protein or placebo ingested by each group of women in the study?", "category": "omission", "label": "extent"}, {"doc_id": 5986443, "edit_id": 9, "question": "How many sets were included in each session of the resistance training program?", "category": "omission", "label": "extent"}, {"doc_id": 5986443, "edit_id": 10, "question": "How many repetitions were there in each set of the resistance training program?", "category": "omission", "label": "extent"}, {"doc_id": 5986443, "edit_id": 11, "question": "What else was assessed besides muscle mass, strength, and walk time after the study?", "category": "omission", "label": "concept"}, {"doc_id": 5986443, "edit_id": 12, "question": "What were the differences in skeletal muscle mass increases between the three groups?", "category": "omission", "label": "comparison"}, {"doc_id": 5986443, "edit_id": 13, "question": "What was the percentage increase in skeletal muscle mass for the group that took whey protein before resistance training and a placebo after?", "category": "omission", "label": "extent"}, {"doc_id": 5986443, "edit_id": 14, "question": "What was the percentage increase in skeletal muscle mass for the group that took a placebo before resistance training and whey protein after?", "category": "omission", "label": "extent"}, {"doc_id": 5986443, "edit_id": 15, "question": "What was the percentage increase in skeletal muscle mass for the group that took a placebo before and after resistance training?", "category": "omission", "label": "extent"}, {"doc_id": 5986443, "edit_id": 16, "question": "What were the differences in strength increases between the three groups?", "category": "omission", "label": "comparison"}, {"doc_id": 5986443, "edit_id": 17, "question": "What was the percentage increase in strength for the group that took whey protein before resistance training and a placebo after?", "category": "omission", "label": "extent"}, {"doc_id": 5986443, "edit_id": 18, "question": "What was the percentage increase in strength for the group that took a placebo before resistance training and whey protein after?", "category": "omission", "label": "extent"}, {"doc_id": 5986443, "edit_id": 19, "question": "What was the percentage increase in strength for the group that took a placebo before and after resistance training?", "category": "omission", "label": "extent"}, {"doc_id": 5986443, "edit_id": 20, "question": "Was the whey protein supplementation effective in promoting changes in skeletal muscle mass?", "category": "omission", "label": "verification"}, {"doc_id": 65514, "edit_id": 0, "question": "Why is the government encouraging the use of the local drug Eucor\u00a9?", "category": "omission", "label": "cause"}, {"doc_id": 65514, "edit_id": 1, "question": "Is there any particular reason why Simvastatin was chosen for this study?", "category": "omission", "label": "cause"}, {"doc_id": 65514, "edit_id": 2, "question": "What kind of version is Eucor\u00a9 of Simvastatin?", "category": "omission", "label": "concept"}, {"doc_id": 65514, "edit_id": 3, "question": "How were the results of the two Simvastatin products compared in this study?", "category": "omission", "label": "comparison"}, {"doc_id": 65514, "edit_id": 4, "question": "Aside from effectiveness, were there any differences in safety noted between Eucor\u00a9 and Zocor\u00a9?", "category": "omission", "label": "comparison"}]